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Time-lapse system(s) (TLS) have, potentially, two benefits over standard 
incubation systems; an undisturbed culture environment and an enormous 
volume of images of the embryos within them. The current research aimed to 
determine if a TLS could provide a comparably stable culture environment 
compared to a standard incubator measured as pH, osmolality and treatment 
success rates. Second, the hypothesis that patient, treatment and 
environment specific embryo selection algorithms (ESAs) are required to 
improve the efficacy of a TLS as an embryo assessment tool was tested.  
 
A TLS was shown to provide a comparably stable environment when 
compared to a standard incubator in terms of pH and osmolality. In addition, 
using a strict matched-pair design, embryos cultured in a TLS resulted in a 
significantly higher implantation, clinical pregnancy and live birth rates. It was 
also concluded that, of six published ESAs, none performed with clinically 
relevant predictive capabilities when applied to the same cohort of known 
implantation embryos. Owing to this, the identification of five abnormal 
division events as significantly reducing an embryos implantation potential 
was performed providing an easily adopted, clinically relevant means to 
deselect embryos cultured in a TLS. A regression analysis found a number of 
treatment and patient parameters having a significant effect on crucial 
morphokinetic parameters, although no systemic effect was observed. Finally, 
an interim analysis of a sibling oocyte study of three, commercially available 
culture media revealed significant differences in the time of embryo 
compaction as well as embryo quality and utilisation.  
 
Together, these results highlight that a TLS provides a stable culture 
environment and leads to increased implantation, clinical pregnancy and live 
birth rates. It is also likely that the patient, treatment type and environment 
can significantly alter an embryos morphokinetic profile and specific ESAs are 
required to unlock the true potential of time-lapse technology.   
 






To all the laboratory staff at the Hewitt Fertility Centres for their 
understanding, support and accepting my extended absence with grace.  
 
To Dr Axel Kaehne for statistical support.  
 
To my family, for also accepting my endless absence.  
 
To my supervisors, Professor Jeremy Brown and Dr Garry McDowell, for their 
support and kind words. To Professor Roy Homburg for the same.  
 
To Dr Steve Troup, whom I am very grateful to have had the opportunity to 
work alongside, who is a valuable teacher and a steadying influence.  
 
Especially to John, from whom I have been exceptionally absent. For his 






















Barrie A, Homburg R, McDowell G, Brown J, Kingsland C, Troup S. Embryos 
cultured in a time-lapse system result in superior treatment outcomes: a strict 




Barrie A, Homburg R, McDowell G, Brown J, Kingsland C, Troup S. 
Examining the efficacy of six published time-lapse imaging embryo selection 
algorithms to predict implantation to demonstrate the need for the 
development of specific, in-house morphokinetic selection algorithms. Fertil 
Steril 2017 Jan 6:pii: S0015-0282 (16) 63014-5.doi: 




Barrie A, Homburg R, McDowell G, Brown J, Kingsland C, Troup S. A 
preliminary investigation into the prevalence and implantation potential of five 
abnormal embryonic phenotypes assessed using time-lapse imaging. Reprod 













List of figures 
 
Figure n Title 
Figure 1  Standard vs. EmbryoScope® osmolality results graphs 
Figure 2  Standard vs. EmbryoScope® measured pH results  
Figure 3  Standard vs. EmbryoScope® incubator traces  
Figure 4  Standard vs. EmbryoScope® CO2 results 
Figure 5 
Implantation rates of each category of six published embryo 
selection algorithms 
Figure 6 
Schematic representation of the five abnormal embryo 
phenotypes 
Figure 7 Fate of embryos from each abnormal embryo phenotype 
Figure 8 
Ammonium levels (µmol/l) in three commercially available culture 
media sampled from EmbryoSlides® 
Figure 9 
Ammonium levels (µmol/l) in three commercially available culture 




























List of tables 
 
Table n Title 
Table 1 Osmolality ranges of various commercial media 
Table 2  pH ranges of various commercial media 
Table 3 Standard incubation osmolality results 
Table 4  EmbryoScope® incubation osmolality results 
Table 5  Standard vs. EmbryoScope® osmolality results 
Table 6 Standard vs. EmbryoScope® incubation measured pH results 
Table 7 Standard vs. EmbryoScope® CO2 readings 
Table 8 
Baseline demographic data for standard vs. EmbryoScope® 
incubation 
Table 9 Data end points for standard vs. EmbryoScope® incubation 
Table 10 
Summary of embryo selection criterion and main results of 
validation of six published embryo selection algorithms 
Table 11 
Summary of publications used for examination of efficacy of 
embryo selection algorithms 
Table 12 Definitions of embryo quality 
Table 13 Baseline data for each abnormal embryo phenotype 
Table 14 
Baseline information for embryos not exhibiting an abnormal 
division pattern 
Table 15 
Descriptive data regarding embryos that underwent an abnormal 
division pattern 
Table 16 
Baseline information for embryos undergoing an abnormal division 
pattern  
Table 17 
Multiple regression analysis results for the effect of maternal age, 
maternal BMI, suppression protocol, infertility diagnosis and 
treatment type on absolute morphokinetic parameters 
Table 18 
Multiple regression analysis results for the effect of maternal age, 
maternal BMI, suppression protocol, infertility diagnosis and 
treatment type on interval morphokinetic parameters 
Table 19 
Baseline patient information for the analysed embryo cohort in the 
multiple regression analysis 





Table 21 Proportion of embryos reaching the blastocyst stage and their quality 
Table 22 
Number of embryos undergoing an irregular division event in the 
three culture media 
Table 23 
The effect of culture media type on nineteen morphokinetic 
parameters 
Table 24 
Ammonium levels (µmol/l) in three commercially available culture 
media sampled from EmbryoSlides® 
Table 25 
Ammonium levels (µmol/l) in three commercially available culture 
































List of abbreviations 
AC  Absent cleavage 
ACE  Association of Clinical Embryologists 
aCGH  Array comparative genomic hybridisation 
AQB  Average quality blastocyst  
AQE  Average quality embryo 
ART  Assisted reproductive technologies 
AS  Angelman syndrome 
AUC  Area under the curve 
BFS  British Fertility Society 
BPR  Biochemical pregnancy rate 
BMI  Body mass index 
BWS  Beckwith-Weidemann Syndrome 
CC  Chaotic cleavage 
CL  Cell lysis 
CO2  Carbon dioxide 
CPR  Clinical pregnancy rate 
DC  Direct cleavage 
DET  Double embryo transfer 
D-IVF  Donor in vitro fertilisation 
D-ICSI Donor intracytoplasmic sperm injection 
DMR  Differentially methylated regions 
DNA  Deoxyribonuclease 
DOHaD Developmental origin of health and disease 
EDTA  Ethylenediaminetetraacetic acid 
Eeva™ Early embryo viability assessment 
ESA  Embryo selection algorithm 
ESHRE European society of human reproduction and embryology 
F-DC  False direct cleavage 
FET  Frozen embryo transfer 
fhb  Fetal heartbeat 
FISH  Florescent in situ hybridisation 
FNS  Fertility nurse specialist 
GQB  Good quality blastocyst 
GQE  Good quality embryo 
h  Hours 
hCG  Human chorionic gonadotrophin 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid  
HFC  Hewitt Fertility Centre 
HFEA  Human Fertilisation and Embryology Authority  
hpi  Hours post insemination  
HTF  Human tubal fluid 
ICSI  Intracytoplasmic sperm injection 
IDEAS Infertility database for embryology and andrology 
IR  Implantation rate 
IRAS  Integrated research application system 
IVF  In vitro fertilisation 
Kg  Kilograms 




KSOM Potassium supplemented simplex optimised medium 
LBR  Live birth rate 
LR  Likelihood ratio 
MI  Metaphase I oocyte 
MII  Metaphase II oocyte 
MR  Miscarriage rate 
MNB  Multinucleated blastomeres 
N2  Nitrogen 
NaCl  Sodium chloride 
NIRS  Near infrared spectroscopy 
NPV  Negative predictive value 
O2  Oxygen 
OCC  Oocyte cumulus complex 
PGD  Preimplantation genetic diagnosis 
PGS  Preimplantation genetic screening 
pHe  External pH 
pHi  Internal pH 
PN  Pronuclei 
PPV  Positive predictive value 
PQB  Poor quality blastocyst 
PQE  Poor quality embryo  
RC  Reverse cleavage 
rcf  Relative centrifugal force 
RCT  Randomised controlled trial  
REC  Research ethics committee 
S.D   Standard deviation 
SET  Single embryo transfer 
SPSS  Statistical package for the social sciences 
T-DC  True direct cleavage 
TLS  Time-lapse system 
U-DC  Unconfirmed direct cleavage 
VS  Viability score 













CHAPTER 1: General introduction 
 
In vitro (from Latin meaning; in glass) fertilisation (IVF) is a laboratory 
procedure developed in the last half of the 20th century by noted scientists 
Robert Edwards and Patrick Steptoe. In 1978 the first birth from assisted 
reproductive technologies (ART) was seen. Since then, births from ART have 
reached 5.4 million worldwide with over 200,000 births in the UK (European 
society of human reproduction and embryology (ESHRE), 2016). In principle, 
the idea of assisted conception is to perform fertilisation outside of the human 
body followed by the transfer of embryo(s) into the recipient’s uterus to 
overcome fertility issues and increase the chance of pregnancy. In a normal 
female reproductive cycle, a single oocyte will be ovulated from the ovary and, 
following intercourse, will fertilise in the fallopian tube where it will then 
develop over six to eight days leading to implantation and a pregnancy. By 
contrast, IVF involves the drug-induced, super-ovulation of the female causing 
multiple oocytes to be produced. These oocytes are then collected from the 
female and fertilised in vitro following the collection of semen from the male 
through masturbation. The development of any subsequent embryos is then 
monitored whilst the environment in which they are contained is controlled at 
37°C, 6% carbon dioxide (CO2) and 5% oxygen (O2) (at most clinics in the 
UK). Embryo (s) are then transferred into the uterus after, usually, five days of 
culture in the laboratory where the embryo would be classed as a blastocyst.  
 
Over the past thirty years there have been numerous developments within 
assisted conception allowing the treatment of many couples unable to 
conceive naturally due to an ever-increasing list of infertility diagnoses. 
Currently, the national average success rate of assisted conception 
treatments is 33.7% live birth rate (LBR) in good prognosis patients (maternal 
age under 35) and 13.8% LBR in poorer prognosis patients (maternal age 40-
42) (www.hfea.gov.uk, 2017). Assisted conception units, such as the Hewitt 
Fertility Centre (HFC), are constantly striving for higher success rates whether 
this is through the employment of new drugs, protocols or novel embryo 




indicator for success; generally, if the embryo is high quality then the chance 
of pregnancy is higher than if the embryo were low quality (Cutting et al, 
2008). However, the patient also affects the chance of success; if the patient 
is less than 35 years of age then their chance of pregnancy is higher than if 
the patient is over 40 years of age as is evident from those LBR quoted earlier 
(www.hfea.gov.uk, 2017).  Consequently, efforts for improved success are 
geared towards producing and choosing better embryos, as well as 
investigating and treating patient parameters such as recurrent miscarriage 
and unexplained infertility.  
 
The desirable outcome of assisted conception treatment is the generation of a 
healthy singleton and, increasingly, the avoidance of multiple pregnancy and 
its associated complications. Since the birth of assisted conception the 
maternal and neonatal health implications have been monitored closely and it 
has been recognised that the number of multiple births following assisted 
conception is sixteen times higher than the incidence following natural 
conception (www.hfea.gov.uk, 2017). Clearly, this increase in multiple births is 
due to the transfer of more than one embryo owing to the lack of reliable 
embryo selection methods thirty years ago, a situation that persists even 
today, albeit to a lesser degree. By far the simplest way to achieve a healthy 
singleton is to perform a single embryo transfer (SET), an approach now 
widely adopted in the UK. Evidently, this approach necessitates selection of 
embryo(s) with highest implantation potential, and has led to the development 
of many novel embryo selection methods. These include both non-invasive 
(extended embryo culture to the blastocyst stage, metabolomic embryo 
profiling and morphokinetics) and invasive (preimplantation genetic diagnosis 
(PGD) and screening (PGS)) methods.  
 
Current embryo selection methods rely on observing the embryos at specific, 
restricted time points throughout their development facilitated by removing the 
dishes containing the embryos and viewing them under a microscope; the 
result being a total of five to six static images over the same number of days. 
This selection method, simply termed ‘embryo grading’, is one adopted by all 




the importance of the quality of a transferred embryo and the limited ability to 
reliably assess embryos via static observations, this method of embryo 
grading may not be sophisticated enough. With the advent of time-lapse 
systems (TLS), embryos can now be monitored continuously throughout their 
development in a relatively undisturbed in vitro environment. The 
EmbryoScope® incubator (Figure 1, appendices section 9.1) is a 
commercially available time-lapse imaging incubator, which automatically 
records an image of the embryo every ten to twenty minutes in five to seven 
focal planes giving hundreds of images of an embryo’s development over the 
course of its in vitro culture. Embryos contained within this sophisticated 
incubator can be assessed in much greater detail and embryologists are now 
able to view many more embryological phenomena. Furthermore, it is 
possible to pinpoint the specific timings in which an embryo progresses 
through each cell stage, such information being previously unavailable. 
Therefore, instead of having vague ranges for specific embryo divisions, as is 
the current case, a more accurate range can be defined. The use of these 
specific embryo development timings is a method termed morphokinetics. 
Although a significant amount of information regarding an embryo’s 
development is available to the embryologists, the value of much of the 
information is, as yet, largely unknown. The use of these incubators present 
changes to long-standing laboratory practice as well as a new incubation 
method aside from the time-lapse imaging capacity. The research study 
presented sought to evaluate both the intricacies of the EmbryoScope® 
incubation system and the intricacies of the embryos contained within it.  With 
this intention, this research study aimed to test that the EmbryoScope® is a 
well-matched incubation method for human preimplantation embryos and that 
the morphokinetic information that a time-lapse enabled incubator provides 
can become a useful adjunct to existing embryo selection methods.  
1.1 Current and alternative embryo selection methods 
In order to effectively delineate the research study, it is prudent to first discuss 
other available methods of embryo selection, both invasive and non-invasive. 
Currently, there is no consensus for the best approach to embryo selection 




embryo grading schemes exist (Alpha Scientists in Reproductive Medicine 
and ESHRE Special Interest group of Embryology, 2011) and success rates 
appear to have reached a plateau for many (www.hfea.co.uk, 2017). In 
addition, it is reasonable to suggest that the in vitro environment is artificial 
and if there were methods that could be developed or employed to select 
embryos sooner in their preimplantation development timeline then this would 
be an added benefit. As such, there is now a growing need for more robust 
and valid embryo selection methods and as a result, they are continuously 
researched and developed.  
1.1.1 Non-invasive: basic embryo grading 
	
Current morphological methods for embryo selection have been utilised for 
many years and are thought to be useful for effective embryo selection 
involving a number of different parameters; pronuclear morphology (z-scoring) 
(Tesarik and Greco, 1999; Scott, 2003); polar body alignment and 
appearance (Payne et al, 1997; De Placido et al, 2002); appearance of 
cytoplasm and zona pellucida (Palmstierna et al, 1998); early cleavage 
(Lundin et al, 2001; Isiklar et al, 2002); multinucleation (Pickering et al, 1995; 
Jackson et al, 1998; Yakin et al, 2005); cell (blastomere) morphology (Shapiro 
et al, 2000; Hardarson et al, 2001; Johansson et al, 2003); and fragmentation  
(van Royen et al, 2003; Munne, 2006). Specifically, for cleavage stage 
embryos (up to day three of preimplantation development), the number of 
blastomeres the embryo has, the evenness of the blastomeres and the 
amount of fragmentation in the embryo are most commonly considered. For 
blastocyst stage embryos, the level of expansion, the inner cell mass and the 
trophectoderm are commonly considered. In a recently published, evidence-
based, scheme (Cutting et al, 2008, Figure 2, appendices section 9.1) 
embryos are assigned a grade that broadly corresponds to their ability implant 
represented as a series of numbers and letters. The embryologist then uses 
this information to select the best embryo(s) for transfer. Basic embryo 
grading was the inaugural method of embryo selection and remains the gold 
standard however, a clear drawback of this basic embryo selection method is 
the translation of one embryologist’s static visualisation of an embryo into a 




addition, removing embryos from the incubator, in order to visualise their 
morphology, causes the environmental parameters (temperature and gas 
concentrations), to which the embryo is exposed, to become sub-optimal and, 
potentially, cause stress to the embryo. Therefore, embryos are removed from 
the incubator no more than twice per day meaning embryo selection, using 
conventional incubation and basic embryo grading, must rely on five or six 
observations made by numerous embryologists that are then translated onto 
paper for interpretation by others. These shortcomings obviously impinge on 
effective embryo selection; the first premise for undertaking this research 
study.  
1.1.2 Non-invasive: extended embryo culture 
	
Extended embryo culture, introduced in the late 1990’s (Gardner et al, 1998a, 
b; Schoolcraft et al, 1999), is a method of embryo selection that involves 
keeping embryos in vitro for an additional two to three days (a total of five or 
six days) allowing the most competent embryos to progress. Historically, 
embryos would be kept in vitro until they reached four to eight cells (day two 
or three of embryo development, respectively) and those of the highest quality 
would subsequently be transferred. Those embryos less functionally 
competent are much less likely to develop to the blastocyst stage, thereby 
facilitating the selection of embryos with the highest implantation potential. In 
essence, extended culture employs a ‘survival of the fittest’ self-selection 
approach. Basic embryo grading as a selection method is still relied upon 
when multiple blastocysts are formed and, as described, numerous grading 
schemes for blastocysts have been established (Figure 3, appendices section 
9.1), (Dokras et al, 1993; Shoukir et al, 1998; Balaban et al, 2000; Yoon et al, 
2001; Kovacic et al, 2004; Cutting et al, 2008) and many centres also develop 
their own.  
 
Extended embryo culture is a highly successful method of embryo selection 
that has led to an increase in pregnancy rates in many centres (Shapiro et al, 
2002; Frattarelli et al, 2003; Criniti et al, 2005; Khalaf et al, 2008; Zander-Fox 




of the most important for many years, however, there is evidence to suggest 
that extended culture can cause unnecessary stress to the embryo which can 
potentially lead to an increase in specific disorders in resulting children 
(Doherty et al, 2000; Khoshla et al, 2001; DeBaun et al, 2003; Gicquel et al, 
2003; Maher et al, 2003; Halliday et al, 2004; Allen and Reardon, 2005; 
Fauque et al, 2007; Lim et al, 2009; Manipalvitari et al, 2009). These 
disorders have been termed imprinting disorders and result from genetic 
aberrations in an embryo’s natural genomic imprinting process.  
 
Genomic imprinting is an epigenetic phenomenon whereby methylation of 
deoxyribonucleic acid (DNA) causes mono-allelic expression of genes 
throughout the human genome. A small proportion of the human genome is 
thought to be subject to imprinting with at least 80 known genes subject to 
imprinting (Turnpenny and Ellard, 2007). During gametogenesis, the imprinted 
regions from the previous generation are erased and new imprints are 
established using the mechanism of methylation (Gomes et al, 2009). These 
imprints are then maintained through preimplantation development and 
sustained through a de novo methylation that occurs in early preimplantation 
development. Different clinical features result depending on how the genes 
are inherited and how they are methylated (Turnpenny and Ellard, 2007). 
There are a number of disorders associated with imprinting defects such as 
Prader-Willi Syndrome and Angelman Syndrome (AS) resulting from aberrant 
methylation patterns on chromosome 15. The mechanisms by which ART 
induce methylation aberrations is largely unclear, however it is well known 
that there are two critical points in epigenetic reprogramming occurring during 
gametogenesis and preimplantation development (Morgan et al, 2005). It has 
been theorised that manipulation and exposure to in vitro environments at 
these crucial times could cause instability of the maintenance of the 
methylation patterns (Fauque et al, 2007). In particular it has been concluded 
that the maternally expressed H19 gene, as well as specific loci, appear to be 
more sensitive to environmental manipulations (Doherty et al, 2000; Li et al, 
2005a; Fauque et al, 2007; Gomes et al, 2009).  It has also been suggested 




accurate methylation leading to the aberrations seen in some imprinting 
disorders (Fauque et al, 2007). From an Australian population, it was 
concluded that if a child has Beckwith-Weidemann syndrome (BWS), the 
chance that the child was conceived through ART is 18 times higher than for a 
child without BWS (Halliday et al, 2004). In addition to this, imprinting 
disorders, specifically AS, have been linked to intra-cytoplasmic sperm 
injection (ICSI), an additional laboratory manipulation used for couples where 
the male patient has a particularly low sperm concentration, morphology or 
motility (Cox et al, 2002; Orstavik et al, 2003). Many studies have reported up 
to a nine-fold increase in the incidence of imprinting disorders in children 
conceived by ART (DeBaun et al, 2003; Gicquel et al, 2003; Halliday et al, 
2004; Allen and Reardon, 2005; Ludwig, 2005; Maher et al, 2003; Orstavik et 
al, 2003; Sutcliffe et al, 2006; Fauque et al, 2007). 
 
Along with the retrospective analysis studies outlined above, differentially 
methylated regions (DMRs) have been examined. Mouse embryos have been 
shown to have aberrant expression of the DMR H19 when cultured in vitro (Li 
et al, 2005a). Numerous studies have revealed that patients with BWS 
conceived by ART consistently show isolated loss of methylation at the 
maternal KvDMR loci (DeBaun et al, 2003; Gicquel et al, 2003; Maher et al, 
2003).  In conjunction with this, a recent study revealed that abnormal 
methylation of the KvDMR region is also found in clinically normal individuals 
conceived by ART (Gomes et al, 2009). This could be attributed to a level of 
mosaicism, a natural phenomenon where the chromosome complement in 
each blastomere is slightly different, but supports the theory that ART can 
cause methylation aberrations. Similarly, 25 patients with BWS conceived 
through ART showed, predominantly, hypomethylation of the KvDMR loci but 
also had an increased chance of other loci being methylated when compared 
to those patients who were naturally conceived (Lim et al, 2009) also 
confirmed by others (Manipalvitari et al, 2009).  Further studies, using mouse 
embryos, have concluded a higher level of methylation in in vitro embryos 





However, there have been numerous surveys in many countries (Denmark, 
Europe, USA, Australia) all finding a relatively small increase in imprinting 
disorders associated with ART suggesting that while the risk is increased, it is 
not significant enough to be attributed solely to the process of ART. A very 
extensive investigation determined the level of methylation of ten DMRs 
including H19 and KvDMR in 113 clinically normal patients conceived through 
ART compared to 73 naturally conceived patients. This study found no 
difference in the level of methylation in any of the DMRs investigated (Tierling 
et al, 2010). Although this study did not investigate those patients with 
clinically proven imprinting disorders and used relatively low numbers, this is 
contrasting evidence to that outlined above. This investigation did however 
find a link between a DMR methylation pattern, birth weight and length. 
Nevertheless, it should be noted here, that a power calculation was conducted 
for this study revealing that over 4000 ART cases and 4000 control cases 
would be needed to gain conclusive answers. A further study found no 
difference in methylation patterns in three DMRs (IGF2, Cdkn1c and Slc221L) 
between in vivo and in vitro mouse embryos, although, as previously 
mentioned, an aberrant methylation pattern was noted in this study in KvDMR 
for those embryos cultured in vitro (Li et al, 2005a). A large survey conducted 
in 2005 in Denmark analysing the health of all children born between 1995 
and 2001 by both ART and natural conception assessed a total of 442,349 
naturally conceived and 6052 ART conceived patients (Lidegaard et al, 2005). 
After a follow-up for an average of four years, no significant increase in the 
incidence of imprinting disorders was found.  
 
It is clear that there is conflicting evidence for the argument that extended 
culture, or that of the in vitro environment as a whole, causes methylation 
aberrations however there may be explanations for these discrepancies. 
Super ovulation, a mandatory part of an IVF/ICSI treatment cycle, has been 
associated with aberrant methylation of H19, therefore, if different methods for 
super ovulation are used, this may cause differences in the methylation 
patterns (Fauque et al, 2007; Guens et al, 2007). Furthermore, it has been 




methylation status of DMRs could lead to bias amplification when a single 
analysis is relied upon. With this in mind, Tierling et al (2010) repeated any 
abnormal scores found in their experiment that may indicate changes to 
methylation, and these were predominantly amplification errors rather than 
true results. Most interestingly, a phenomenon where embryos possess a 
level of flexibility and are capable of compensating for in vitro impedes leading 
to methylation deformities could explain the variation seen in experiments, 
however, this is merely a theory (Fauque et al, 2007). Interestingly, it has also 
been suggested that the differences seen between studies could be attributed 
to ethnic variations (Tierling et al, 2010).  
 
Although contradictory evidence is presented, the basic principle, that the in 
vitro environment is artificial and the early stages of embryo development are 
crucial, is clear. It is therefore logical to assume that any method that could 
reduce these potential in vitro insults would be beneficial. Extended embryo 
culture is an embryo selection method employed by most assisted conception 
units, including the HFC, and an increase in success rates is evident. Further 
research is required regarding methylation patterns in relation to extended 
embryo culture and the effect on the preimplantation embryo to draw firmer 
conclusions. However, the use of time-lapse technology provides an 
environment more reflective of in vivo thus reducing in vitro stress as well as 
the capacity to, potentially, negate the need for extended culture whilst 
maintaining, if not improving, the current success rates; the second premise 
for undertaking the research study presented here.  
1.1.3 Non-invasive: metabolomic embryo profiling 
	
As early as 1987, it was known that embryos utilised different concentrations 
of substrates and that this could be related to their viability (Gardner and 
Leese, 1987). Further to this, it was then discovered that embryos utilised 
different substrates at different stages of preimplantation development 
(Gardner and Leese, 1988). If these molecular profiles could be defined then 
a non-invasive method to predict embryo viability could be developed. With 




of an embryo was investigated. Metabolomics is defined as the systematic 
analysis of the inventory of metabolites, as small molecular biomarkers, that 
represent the functional phenotype at a cellular level used to explain the 
change in metabolic regulation as a function of abnormal development (Botros 
et al, 2008).   
 
It is attractive to be able to quantify an embryos’ substrate usage as well as 
their waste production thus, the whole metabolome is of interest to many 
research groups. There have been a number of experiments utilising Raman 
spectroscopy to correlate embryos’ metabolomic profiles with implantation 
potential by assessing the spent culture media. A series of experiments 
totalling 490 spent culture media samples found a significant correlation 
between implantation potential and an embryo’s ‘viability score’ (VS) (Seli et 
al, 2006; Nagy and Posillico, 2007; Scott et al, 2007; Seli et al, 2007; Scott et 
al, 2008). Another popular technology for the determination of the whole 
metabolome of an embryo is near infrared spectroscopy (NIRS). There have 
been a number of studies on prominent embryo developmental stages; day 
two, three and five (Kato et al, 2007; Vergouw et al, 2007a; Seli et al, 2008b). 
These studies all found a significant correlation between the implantation 
potential of embryos and their respective VS produced from the NIRS. 
Interestingly, these experiments also concluded that there was no correlation 
between VS and an embryo’s morphology grade with striking results such as 
98% of embryos being classed as top quality morphologically but only 29% of 
these implanting (Vergouw et al, 2007a). The results of this particular 
experiment support the first premise of this research study; basic embryo 
grading methods may not effectively reflect an embryo’s ability to create a 
pregnancy. A further experiment analysing the whole metabolome of 228 day 
three or day five spent culture media samples, using nuclear magnetic 
resonance spectroscopy, found a significant positive correlation between the 
implantation potential of embryos producing a high VS (Nagy and Posillico, 
2007).  
 




markers have been identified that could give a similarly useful indication of the 
embryos viability. Between 2007 and 2008 there were three experiments by 
the same group analysing a total of 129 samples of spent culture media from 
day three embryos. This analysis concluded that there was a marked 
difference in biomarkers such as lactate, alanine and glycine between spent 
culture media of embryos that resulted in pregnancy when compared to those 
that did not. Specifically, an increase in glutamate and a decrease in alanine, 
pyruvate and glucose were significantly correlated with viable pregnancies 
and finally, the ratio between glutamate and alanine/lactate was higher for 
implanted embryos (Seli et al, 2007a; Seli et al, 2008a; Seli et al, 2008c) 
supported by others (Brison et al, 2004; Scott et al, 2008).  
 
Oxidative metabolism as a potential marker for a non-invasive selection 
method has also been studied. Two studies, analysing a total of 425 spent 
culture media samples of day two, three and five embryos using NIRS, found 
a significant correlation between five oxidative metabolism biomarkers and 
implantation potential (Hardarson et al, 2007; Vergouw et al, 2007b). In 
addition to these results it was concluded that morphology scores did not 
correlate with either the oxidative metabolic activity or pregnancy outcome 
with 86% of transferred embryos being classed as good quality 
morphologically but only 27% resulting in pregnancy (Vergouw et al, 2007b); 
further supporting evidence of the shortcoming of basic embryo grading 
selection methods.   
 
As the principle aim of assisted conception is to achieve pregnancies for as 
many patients as possible, any available technology that claims to help with 
this is well received. Promisingly, there appears to be very little contradictory 
evidence suggesting that metabolomic profiling as a method of embryo 
selection will not be clinically relevant and, as a result of experiments 
performed to define embryo metabolomics, various technologies have been 
developed that claim to be able to determine an embryo’s viability from the 
non-invasive analysis of metabolites in a clinical setting. One of these, 




instrument was found and it was withdrawn from use. There have been no 
significant developments for its use clinically and so the goal of utilising 
embryo metabolomics in a clinical setting appears to be distant; the third 
premise to support the undertaking of the presented research study. 
1.1.4 Invasive: embryo biopsy  
	
Preimplantation genetic diagnosis (PGD) and PGS are laboratory procedures 
used to identify the chromosomal complement of cellular material taken from 
either oocytes or embryos.  The basis for the use of these techniques is that, 
in over half of all embryos produced in vitro, the chromosome complement is 
abnormal (termed aneuploid) and the likelihood of these embryos creating a 
pregnancy is reduced (Donoso et al, 2007). This has been partly attributed to 
the reduction in fertility that occurs with increasing maternal age (Hassold and 
Chiu, 1985).  At birth, females have a finite number of oocytes and the initial 
stages of meiosis of these oocytes take place during fetal development. 
However, the developing oocytes enter a period of arrest until after puberty 
during which time the chromosomes are suspended in alignment on the 
spindle. The completion of meiosis only occurs upon fertilisation and it has 
been suggested that this extended suspension could damage the spindle and 
decrease its segregation ability (Fragouli et al, 2006) thus causing aneuploidy. 
It therefore stands to reason that the higher the maternal age, the longer the 
spindle must uphold this strenuous confirmation thus increasing the incidence 
of aneuploidy. 
 
Using laboratory techniques such as florescent in situ hybridisation (FISH) 
(Zamora et al, 2011), polymerase chain reaction (Sermon and De Rycke, 
2007) and more recently, array or microarray comparative genomic 
hybridisation (aCGH) (Geraedts and Sermon, 2016) PGD and PGS have 
been used to assess an embryos genetic competence. Although similar 
embryo selection tools, PGD and PGS have a single major difference; PGD 
offers a diagnostic result for many specific chromosomal loci for, usually, 
fertile patients whereas PGS gives a result for the number of whole 




performed on rabbit embryos in 1968 (Edwards and Gardner, 1968) and first 
used in human embryos in 1989 (Grady, 1995). Much debate surrounds the 
methodology of cell collection and the optimal developmental stage for biopsy, 
with some highlighting the benefits of polar body biopsy (Fragouli et al, 2010; 
Chang et al, 2011) and others trophectoderm biopsy (Dokras et al, 1990; 
McArthur et al, 2005) although it is now largely accepted that trophectoderm 
biopsy (performed at the blastocyst stage) is the most favoured (Geraedts and 
Sermon, 2016). In addition to this, figures from the PGD consortium revealed 
a 19.9% LBR (1152 babies born from 5780 cycles) when PGD was applied 
(De Rycke et al, 2015). A LBR significantly lower than the national average for 
good prognosis patients (33.7%) in a fertile population with the transfer of an 
embryo that has been quantified as chromosomally normal throws the efficacy 
of such an invasive procedure into question. Preimplantation genetic 
diagnosis does, however, have a clear place for the detection of inherited 
disorders.  
 
Preimplantation genetic screening is a more recent addition to the embryo 
selection arsenal. In PGS, usually a single blastomere (in some cases two) or 
multiple trophectoderm cells are aspirated from the developing embryo and 
the chromosome number analysed. This process assesses that the number of 
chromosomes in the cells is correct, as described previously, a major 
contributing factor to pregnancy failure in infertile patients. Large cohort 
studies sought to assess the effectiveness of PGS as an embryo selection 
technique where few found that PGS could increase the chance of pregnancy 
and effectively identify those embryos with the highest implantation potential 
(Verlinsky and Kuliev, 2004, Milan et al, 2010). Most reported that PGS does 
not help in embryo selection and can drastically decrease implantation rates 
(Staessen et al, 2004; Mastenbroek et al, 2007; Sermon et al, 2007). More 
recently, reviews have concluded that PGS is yet to be proven to be clinically 
effective (Gleicher et al, 2014; Mastenbroek and Repping, 2014). It would 
therefore seem that PGS is not as a successful selection technique as the 
ART community would have hoped. For basic embryo selection the 




Aside from the differing reports of success, these invasive methods have one 
significant drawback termed mosaicism. Mosaicism describes a natural 
phenomenon when one or more of the cells within an embryo have differing 
chromosome numbers. As a result, when a single cell or biopsy is used to 
define the chromosomal complement of a whole embryo, it may not be a true 
reflection of the whole due to the possibility that the embryo is exhibiting 
mosaicism. Some sought to overcome this problem by taking two biopsies 
from an embryo. However, when, for example, an eight-cell embryo has a 
quarter of its cells removed, it informs a level of damage that may prevent the 
embryo from continuing with development. This theory could, partially, explain 
the reduction in success rates seen when using PGS (as described above) 
(Cohen et al, 2007).  
 
Regardless of the glaringly obvious drawbacks of these methods (high 
invasive nature, mosaicism, lack of increase in pregnancy rates) many more 
exist; allele dropout, false positive results, false negative results, expense; the 
reason why these invasive methods are not employed by all fertility units.  To 
this end, the research study was supported by this further premise that 
invasive methods of embryo selection are not reliable, require further scrutiny 
of the biopsy type and stage and are largely inaccessible due to expense, 
specialised materials required for diagnostic tests and the essentially high skill 
level.  
1.2 Time-lapse imaging as a novel method of embryo selection 
It is now possible to defend the use of time-lapse imaging as a novel, reliable 
method of embryo selection in a clinical setting. As previously described, in 
order to select embryos, they are currently removed from the incubator and 
visualised under a microscope for a matter of seconds, providing the observer 
with a snapshot of the embryo’s development. This method has two 
limitations; a restricted overview of an embryo’s development and the 
exposure of the embryo to suboptimal conditions such as reduced 
temperature and gas concentrations. However, with the introduction of time-
lapse imaging, where an image of each embryo is taken every five to ten 




embryos in a completely undisturbed environment. As the availability of these 
TLS increased, attention was first focused on assessing their clinical safety. 
Once this had been established and the available technologies 
(Primovision™, EmbryoScope®, Early Embryo Viability Assessment 
(Eeva™)) validated for clinical use (Freour et al, 2012; Nakahara et al, 2010; 
Basile et al, 2011; Cruz et al, 2011; Kirkegaard et al, 2012) research then 
focussed on determining how the TLS could be used to increase pregnancy 
rates through in-depth embryo analysis and an undisturbed culture system.  
1.2.1 Morphokinetics and embryo viability 
	
Many morphokinetic parameters have been identified that correlate with the 
embryo's ability to create a pregnancy both in humans and animals; the 
appearance and disappearance of pronuclei (PN) and nuclei at each cell 
stage (Payne et al, 1997; Lemmen et al, 2008; Scott, 2010; Azzarello et al, 
2012) the length of time between early cytokineses (Gonzales et al, 1995; 
Ramsing and Cellesen, 2006; Ramsing et al, 2007; Lechniak et al, 2008; 
Herrero et al, 2011; Cruz et al, 2012; Hlinka et al, 2012; Meseguer et al, 
2011), and start times of blastulation (Campbell et al, 2013a).  
 
Additional embryological phenomena have been observed using TLS 
including the reabsorption of fragments. Hardarson et al (2002) provided the 
first evidence that cellular fragments are able to ‘disappear’ during in vitro 
culture. This is an important observation especially when it has been 
suggested that a separate grading system be introduced to reflect 
fragmentation position and distribution as it was found that larger fragments 
may impinge on implantation to a greater degree than those that are localised 
or small and scattered (Alikani et al, 1999). As fragmentation has been 
included in current embryo grading methods for many years and has been 
strongly correlated with pregnancy rate (Alikani et al, 1999; Fujimoto et al, 
2011) the use of TLS could illuminate fragment behaviour to aid in future 
embryo selection.  
 
A further embryological feature that could be illuminated using TLS is the 




analysis of DC including 5225 embryos found that 13.68% of these elicited 
DC. From those embryos transferred (1659) 6.6% elicited DC and of these 
1.21% implanted. This research demonstrated that embryos that undergo DC 
have extremely reduced implantation potential and it is thought that this is due 
to a “short cell cycle” where the cells have not taken enough time to undergo 
the correct DNA replication which should take between 10-12 hours (h) (Rubio 
et al, 2012). In conjunction with unusual embryo division patterns, that of 
reverse cleavage (RC) has been described (Hickman et al, 2012) where a cell 
undergoes a division and then reabsorbs the resulting cell. The phenomenon 
of RC has been shown to have no effect on the embryos continued 
development however time-lapse imaging may be used to better inform users 
of the reasons why this might occur and what it could truly mean for an 
embryo’s viability. 
 
With these parameters in mind, many used implantation rate (IR), clinical 
pregnancy rate (CPR) and LBR as indicators of embryo viability (Lemmen et 
al, 2008; Meseguer et al, 2011; Kirkegaard et al, 2012), however some used 
an embryos ability to create a blastocyst to indicate viability (Wong et al, 
2010; Dal Canto et al, 2012; Hlinka et al, 2012; Cruz et al, 2012). Owing to the 
evidence previously presented regarding imprinting disorders, if an embryo’s 
viability could be determined earlier in development then the benefits of 
extended culture could remain without the potentially harmful side effects. In 
relation to this, Cruz et al (2012) examined 834 embryos and suggested that 
early embryo development was strongly correlated with blastocyst formation 
rate (BFR). An earlier study suggested that it is possible to predict blastocyst 
formation with a 93% specificity based on the first few cell divisions of 
preimplantation embryo development (Wong et al, 2010). Of the 242 embryos 
analysed, 100 were cultured to the blastocyst stage and 14 were analysed to 
test the parameters set out. It was predicted that, out of the 14 embryos, nine 
would reach the blastocyst stage and five would arrest all of which, except 
one, were correct. These data used low numbers and the incorrect prediction 
of an embryo to arrest is a fundamental failure. Nevertheless, these data 
suggest, with a 93% specificity (the proportion of arrested embryos that were 




divisions in an embryo, also supported by others (Dal Canto et al, 2012; 
Hlinka et al, 2012). Although, independent morphokinetic parameters such as 
time to two-cells have, thus far, been well studied (Gonzales et al, 1995; 
Ramsing and Cellesen, 2006; Ramsing et al, 2007; Lechniak et al, 2008; 
Herrero et al, 2011; Meseguer et al, 2011; Cruz et al, 2012; Hlinka et al, 
2012), there have been few investigations linking an embryo’s morphokinetics 
to parameters such as patient age, culture media and treatment type.  
1.2.2 Development and use of embryo selection algorithms  
	
Single morphokinetic parameters have been used to develop embryo 
selection algorithms (ESAs). Embryo selection algorithms outline a set of 
questions for the user where, depending on the answers to the questions 
asked, a result is given that will aid in the selection of the best embryo(s) for 
utilisation. There are various types of ESAs; hierarchical, additive and 
multiplicative. Most algorithms published thus far are hierarchical containing a 
maximum of three parameters. These algorithms are classed as hierarchical 
because the first question asked is deemed to be more predictive of 
implantation (or other appropriate end-point) than the last. Additive and 
multiplicative models can involve more than three parameters and assign 
each question with a weight. The weights are then either added (in an additive 
model) or multiplied (in a multiplicative model) to give a continuous rather than 
a discrete score, as in a hierarchical.  
 
Multiple ESAs have been published each with different parameters, optimum 
timings and end points (Wong et al, 2010; Meseguer et al, 2011; Azzarello et 
al, 2012; Cruz et al, 2012; Chavez et al, 2012; Campbell et al, 2013a; 
Chamayou et al, 2013; Dal Canto et al, 2012). However, as the development 
of ESAs was pursued, it was recognised that centres were annotating in 
different ways and a consensus was required. After deliberation regarding 
possible annotations, a consensus was published (Table 1, appendices 
section 9.1).  
 
An ESA, published in 2011 (Meseguer et al, 2011, Figure 4, appendices 




upon the introduction of the time-lapse enabled incubator, the 
EmbryoScope®. This ESA, like all those published, uses morphokinetic 
parameters to identify embryos with the highest chance of creating a 
pregnancy and has been demonstrated to achieve 86% specificity. This 
hierarchical algorithm places importance on the time at which the embryo 
reaches the five-cell stage (t5), the time between the third and fourth cell 
divisions (s2) and the time between the second and third cell divisions (cc2), 
respectively. The algorithm then assigns a grade (A+ to E) to each embryo 
where A+ indicates the most likely to implant and E the least likely to implant. 
A retrospective cohort study using over 7000 cycles was then undertaken 
where a significant increase in CPR was found, attributed mainly to the use of 
morphokinetic parameters and the developed ESA (Meseguer et al, 2012). 
Due to the strength that this publication posed, the ESA was employed at the 
HFC as an adjunct to established embryo-grading protocols. After a period of 
approximately nine months, the ESA was validated using HFC data. Between 
22nd October 2011 and 14th July 2012, 173 embryos cultured in the 
EmbryoScope® at the HFC with known implantation were identified. Known 
implantation data (KID) relates to those patients having a SET resulting in 
either a fetal heartbeat (fhb) at ultrasound scan (six to seven weeks post 
embryo transfer) or a negative urinary human chorionic gonadotrophin (hCG) 
test, and those patients having a double embryo transfer (DET) resulting in 
either a negative urinary hCG test or two fhb identified at ultrasound scan (six 
to seven weeks post embryo transfer). This ensures that the transferred 
embryos fate is known, allowing analysis of embryo quality and its relation to 
treatment outcome. The ESA score (A+ - D-) that each of the 173 embryos 
had attained was then correlated with IR (Figure 5, appendices section 9.1). 
Those embryos assigned an A+, supposedly those most capable of 
implanting, had a comparable implantation rate (40%) to those assigned a D- 
(37%). Consequently, the development of an HFC-specific ESA began. This 
involved the assessment of the same 173 embryos, and the optimum time 
frames for each of the morphokinetic parameters of interest. Seven 
parameters were assessed for the development of the HFC ESA; t2, t3, t4, t5, 
t2-t3 (cc2), t3-t4 (s2) and t4-t5 (cc3). The timings of each parameter for each 




was classed the optimum time frame for this parameter to occur. Once the 
optimum timings had been identified for each parameter, the predictive 
capability of each was then assessed using a logistic regression analysis. 
This analysis revealed two parameters that were significantly predictive of 
implantation (Table 2, appendices section 9.1). The hierarchical HFC ESA 
(Figure 6, appendices section 9.1) was then developed with the parameter of 
highest predictive power as the first tier (time between three and four-cells 
(s2)) followed by the next most predictive parameter (time between four and 
five-cells (cc3)) ending with the time to five-cells (t5). Although the influence of 
t5 was statistically insignificant in this analysis, it was added to the ESA by 
virtue of its importance in the published ESA. The resulting difference in IR 
between A+ and D- embryos was then much greater (68% vs. 9%, p=0.001, 
chi-square test) (Figure 7, appendices section 9.1).  Before the application of 
the HFC ESA clinically, it first required validation. After a further period of 
approximately 12 months, 511 KID embryos were identified, eliminating the 
original 173 used for model development. Both the published ESA and the 
HFC ESA were applied to this cohort of embryos and the implantation rates 
assessed (Figure 8, appendices section 9.1). These analyses revealed a 
difference in each of the ESAs ability to detect both high and low implantation 
capacity embryos with the HFC ESA able to detect these embryos more 
effectively than the published ESA. However, limitations to the HFC ESA were 
identified; a high number of embryos were being classed in the B categories 
with very few being classed in the C categories. This result highlights the 
imperative for the evolution of the HFC ESA. 
1.3 Research aims 
The ultimate aims of this research were to support that i) the EmbryoScope® 
can provide a comparable incubation environment when compared to 
standard incubators employed at the HFC and ii) the information that a TLS 
provides can contribute to effective embryo selection in an IVF laboratory in 
the form of patient, treatment and environment specific ESAs. Although this 
area of research is currently prominent in the assisted conception field, the 
current research sought to undertake that which had not yet been addressed 




assessed. This involved an evaluation of basic environmental parameters 
between the two incubation systems; osmolality and pH. Further to this a 
strict, matched-pair analysis comparing the treatment outcomes of embryos 
cultured in a time-lapse enabled incubator when compared to a standard 
incubator employed at the HFC was performed. Secondly, the annotation 
aspect of time-lapse enabled incubators was scrutinised. This involved the 
validation of six current published ESAs on a maximised number of KID 
embryos to determine their efficacy thus highlighting the need for the 
development of more specific ESAs. Further interrogation of the data that the 
EmbryoScope® gives access to informed the analysis of five abnormal 
embryo development events and how these can be used as deselection 
criteria; another step towards more specific methods of embryo selection or 
deselection.  Finally, patient, treatment and environmental factors were 
assessed to further aid in the development of specific ESAs. The first part of 
this section involved a sibling oocyte design where patient’s oocytes/embryos 
were randomised to three commercially available culture media. The aim of 
this was to determine if there was a need for the development of culture-
specific ESAs. Second, a regression analysis was performed to determine the 
effects of patient (maternal age, infertility diagnosis, maternal body mass 
index (BMI)) and treatment (suppression protocol, treatment type) parameters 
on embryo morphokinetics in line with one of the overall aims of this research; 













CHAPTER 2: General materials and methods 
 
Unless stated otherwise the below materials and methods were adhered to 
throughout. In cases where either/or is stipulated below, the relevant methods 
will be stated within each chapter.  
2.1 Research governance 
All investigations were approved by the NHS Haydock research ethics 
committee (REC) (ref: 14/NW/1043) and the institutional REC (appendices 
section 9.2). All procedures and protocols (appendices section 9.3) complied 
with UK regulation (Human Fertilisation and Embryology Act, 1990, 2008). 
2.2 Ovarian stimulation  
Pituitary down regulation was achieved using either a gonadotrophin releasing 
hormone agonist (buserelin, Suprecur®, Sanofi Aventis, UK) or antagonist 
(cetrorelix acetate, Cetrotide®, Merck Serono, Germany). Ovarian stimulation 
was performed using urine derived or recombinant follicle stimulating 
hormone (Progynova (Bayer, Germany), Fostimon, Merional (IBSA, 
Switzerland), Menopur® (Ferring Fertility, Switzerland), Gonal f® (Merck 
Serono). Doses were adjusted based on patient demographic and response. 
Patients were given 5000IU of subcutaneous hCG (Gonasi® HP, IBSA 
Pharmaceuticals, Italy) 36h prior to oocyte collection. Luteal support was 
provided using 400mg of progesterone pessaries twice daily (Cyclogest®, 
Actavis, UK) until the pregnancy test was performed.  
2.3 Oocyte retrieval and embryology 
Ultrasound guided oocyte collection was performed transvaginally under 
sedation (Diprivan, Fresenius Kabi, USA). Collected oocyte-cumulus 
complexes were cultured in 4-well dishes (Nunc™, Thermo Scientific, USA) 
containing 0.65ml G-IVF™ (Vitrolife) overlayed with 0.35ml OVOIL™ 
(Vitrolife) in a standard incubator. Sperm preparation was performed using a 
standard gradient separation (for ejaculated sperm only) at 0.3 relative 
centrifugal force (rcf) for ten minutes (ISolate®, Irvine Scientific, USA) 
followed by two washes at 0.6rcf for ten minutes using G-IVF™. Those 




Vitrolife) and mechanical digestion. ICSI was performed on all metaphase II 
(MII) oocytes approximately four hours following oocyte collection after which 
time all injected oocytes were placed in individual culture drops of either G-
1™ or G-TL™ (Vitrolife). Embryos were cultured in either an EmbryoSlide® in 
the EmbryoScope® (Vitrolife) or a 4-well dish in a standard incubator (Sanyo 
Multigas Incubator MCO-18M). Those oocytes destined for standard 
insemination had this performed approximately four hours after collection and 
replaced into a standard incubator until fertilisation check the following day. 
Oocytes were then checked for fertilisation approximately 16-18 hours post-
insemination (hpi) and all fertilised oocytes along with all unfertilised MII 
oocytes were placed in individual culture drops of G-1™ or G-TL™ and 
cultured in either the an EmbryoSlide® in the EmbryoScope® or a 4-well dish 
in a standard incubator. Where culture to day five was undertaken, and 
sequential culture media was used, a media change was performed on day 
three. For those embryos cultured in the EmbryoScope®, 20µl from each well 
was aspirated and replaced with 20µl of G-2™ (Vitrolife). For those embryos 
cultured in standard incubation, all embryos were moved to a new 4-well 
culture dish comprising individual 20µl drops of G-2™. Embryo selection for 
those cultured in the EmbryoScope® was performed using the national 
grading scheme (Association of Clinical Embryologists (ACE)/ British Fertility 
Society (BFS) guidelines, Cutting et al, 2008) with an internally derived 
embryo selection, time-lapse algorithm as an adjunct if a decision could not 
be made between embryos of similar morphology. Where applicable, embryo 
selection for those cultured in the standard incubator was performed using the 
national grading scheme only. The internally derived embryo selection 
algorithm used three morphokinetic parameters; the time between three-cell 
and four-cell (s2), the time between four-cell and five-cell (cc3), the time to 
five-cell (t5) (Figure 6, appendices section 9.1). The national grading scheme 
combines three parameters for day three embryos; cell number (n), 
blastomere evenness (1-4) and fragmentation (1-4). For day five embryos, the 
national grading scheme includes the level of expansion (1-6), quality of the 
inner cell mass (A-E) and quality of the trophectoderm (A-C). Embryo transfer 
was performed using the highest-grade embryo(s) either three or five days 




patient had on day three as well as how many were to be transferred. 
Selected embryos were cultured in EmbryoGlue® (Vitrolife) prior to embryo 
transfer. Embryos were cultured at 37°C, 6% CO2, 5% O2, 89% nitrogen (N2) 
throughout.  
2.4 Analysis of time-lapse information  
The image interval on the EmbryoScope® was set to ten minutes with seven 
focal planes. Images were collected for the duration of culture immediately 
following ICSI or fertilisation check (for IVF derived embryos) to utilisation. 
Annotation was performed manually as part of the clinical workload in the 
embryology laboratory using the published annotation consensus (Ciray et al, 
2014). Accuracy of annotation was corroborated by the participation of the 
annotating embryologists in an internal quality assurance scheme for 
morphokinetic analysis. Unless stated otherwise, t0 was defined as the time of 
insemination/injection for pronuclear fading and pronuclear fading for all other 
morphokinetic parameters.  
 
2.5 Statistical analysis 
Various statistical analyses were performed based on the datasets available 
and are outlined in each chapter. A University statistician was consulted on 














CHAPTER 3: The EmbryoScope® as an incubator; 
fundamental measurements of pH and osmolality 
3.1 Introduction 
Osmolality and pH are pivotal in the culture of human preimplantation 
embryos and must be appropriately maintained for effective development and 
subsequent pregnancy in assisted reproductive technologies (ART). The 
investigation of these environmental factors will be addressed here as 
‘stressors’ to the preimplantation embryo and represent two of many. Stress 
can be defined broadly as anything that affects homeostasis. Various forms 
have been extensively researched including culture media composition, 
oxygen tension, method of fertilisation and even culture dish rigidity all having 
been shown to impact embryo development, specifically morphology and 
gene expression (Rinaudo and Schultz, 2004; Rinaudo et al, 2006; Giritharan 
et al, 2007; 2010; 2012; Kolahi et al, 2012). There is little literature detailing 
the effects of pH and osmolality, most likely due to their ‘unseen’ nature 
however, the author speculates that research in this area might spike when 
children born from assisted conception reach an age where pathologies could 
manifest.  
 
Osmolality and pH of culture media will be put into context by considering 
each separately, describing their physiological background, importance in 
preimplantation embryo development and finally, existing literature that helps 
delineate the effects of deviations in them. Experiments were performed to 
assess the ability of a time-lapse enabled incubator, the EmbryoScope®, to 
maintain the pH and the osmolality of culture media compared to standard 
incubation. The aims of these experiments were to confirm the stable culture 
conditions of the EmbryoScope® and demonstrate that it may enable a 
reduction in the exposure of the embryos contained within it to in vitro 
stressors. There have been a number of publications on the superiority of the 
EmbryoScope® in terms of increasing success rates in an ART laboratory 
(Meseguer et al, 2012; Rubio et al, 2014) along with promising results at the 




the author is aware, this is the first series of experiments to investigate the 
culture conditions, per se, of the EmbryoScope® compared to a standard 
incubator. 
3.2 Osmolality 
3.2.1 Definition  
	
Osmolality is defined as the amount solute per kilogram (kg) of solvent and is 
recorded as mOsm/kg. This, although similar, is different to the less accurate 
measure of osmolarity, which is defined using the solvent volume, and is 
recorded as mOsm/l (Swain et al, 2012). Osmolality is directly related to the 
process of osmosis and, simply, is a measure of the level of water in a given 
environment. Osmolality is regulated in cells primarily by the movement of 
water across a semi-permeable membrane from an area of low solute 
concentration (hypoosmotic) to an area of high solute concentration 
(hyperosmotic) and thus, solutes exert osmotic pressure and can alter cell 
volume. These solutes are often referred to as osmolytes; compounds 
affecting osmolality (Goodman, 2007).  
3.2.2 Osmolality in the context of the embryo 
	
The culture of preimplantation embryos began in 1912 with rabbit embryos 
(Brachet, 1912). During the development of preimplantation embryo culture, 
many struggled to overcome developmental blocks exhibited by different 
species at various cell stages. However, culture media was then developed 
that could sustain human embryos from oocyte to blastocyst. It was not until 
1956 that preimplantation embryos were cultured successfully to the 
blastocyst stage (Whitten, 1956). This break-through has been attributed to 
particular differences in the culture media used today; the addition of 
glutamine and ethylenediaminetetraacetic acid (EDTA) and the reduction in 
osmolality from 290mOsm/kg to 250mOsm/kg. The reduction in osmolality 
was deemed the most likely contributing factor to the successful development 
of preimplantation embryos, the basis for which has two theories. Firstly, it 
was thought that the reduction in osmolality mimicked the in vivo environment 




experiments finding that the in vivo environment had the same salt 
concentrations as serum elsewhere in the system and also indicated that, if 
anything, it may be slightly higher in the reproductive tract in comparison to 
other areas (Williams et al, 1972; Collins and Baltz, 1999). This was 
confirmed with experiments revealing the in vivo reproductive environment to 
be as high as 360mOsm/kg (Borland et al, 1977; Van Winkle et al, 1990). The 
second theory was linked to the knowledge that preimplantation embryos 
required organic osmolytes to develop effectively. In earlier culture media 
compositions, these organic osmolytes were not present and so 
preimplantation embryos may have been unable to develop effectively (Baltz 
and Tartia, 2010). However, it has been suggested that embryos might not 
require these organic osmolytes at lower osmolality’s thus the absence of 
these osmolytes did not negatively affect embryo development.  
 
As a reduction is osmolality led to successful embryo development in vitro yet 
the in vivo osmolality level has been shown to be higher, an embryo must 
possess mechanisms for alleviating the effect of these higher osmolality’s in 
the reproductive tract that cannot be activated in vitro; a potential caveat of 
commercially available media (Dawson and Baltz, 1997). A range of 
osmolality’s have been employed by commercially available culture media 
with most between 260mOsm/kg and 280mOsm/kg (Table 1). Even a brief 
exposure to osmolality’s outwith the desirable ranges can cause impaired 
development (Van Winkle et al, 1990; Biggers et al, 1993, Dawson and Baltz, 
1997) with osmolality’s over 300mOsm/kg causing severe developmental 
retardation (Van Winkle et al, 1990; Hay-Schmidt, 1993; Miyoshi et al, 1994).  
 
It is well known that cell volume homeostasis is a key factor in successful 
embryo development (Baltz and Tartia, 2010) and preimplantation embryos 
contain various mechanisms to ensure cell volume is regulated effectively 
including the activation of appropriate transporters (for example Na+/K+ 
ATPase’s and glycine transporters), increased expression of various genes 
such as CCM2 which codes for a protein involved in the regulation of cell 
junctions and p38 MAPK, a class of protein kinases that are responsive to 






Table 1. Osmolality ranges of various commercial media (adapted 
from Quinn, 2014) 








Fert media 265±8 
Cleavage media 265±8 







Global 260-270 (265) 
Global Fert 280-292 (285) 
Blastocyst  260-270 (265) 
HTF 280-292 (285) 
HTFxtra 280-292 (285) 
MEDICULT 






Sydney IVF fert 285-295 
Sydney IVF cleavage 285-295 




 cells have been shown to regulate the level of osmolytes in their cytoplasm 
through the export (where cell swelling occurs) and import (where cell 
shrinkage occurs) of solutes. Usually, in situations where solutes must be 
imported into the cells, inorganic ions are selected, however these can cause 
protein destabilisation and metabolic disruptions (Dawson and Baltz, 1997). 
Cells can also utilise organic compounds for cell volume regulation and these 
have been suggested to reduce the negative impact of their inorganic 
counterparts (Dawson and Baltz, 1997). Known organic osmolytes include 
small zwitterionic amino acids, methylammonium compounds and sugars 
including, glycine and betaine (Dawson and Baltz, 1997).  Cells are able to 
withstand higher osmolality’s than they would be exposed to physiologically 
as long as the medium in which they are cultured contains organic osmolytes 
such as those described above (Van Winkle et al, 1990; Dawson and Baltz, 
1997; Baltz, 2001).  
 
Hammer et al (2000) demonstrated that embryos possess processes to 
counteract increases in osmolality. When the osmolality was increased from 
250 to 310mOsm/kg the amount of glycine increased indicating that it was 
being accumulated to provide osmotic support. This has also been linked to 
the viability of preimplantation embryos using metabolomic experiments 
where a high glycine turnover was associated with higher viability (Brison et 
al, 2004) demonstrating that embryos that have activated glycine transporters 
are more able to overcome cell blocks and progress beyond certain cell 
stages. In line with this, Baltz and Tartia (2010) have also concluded that if an 
embryo’s ability to use glycine for cell volume control is disrupted then 
fertilised oocytes fail to develop to blastocysts. Incidentally, this has 
interesting connotations for the assessment of single blastomeres arresting 
and consequently lysing within a cleavage stage embryo as is regularly seen 
when using a TLS thus posing another consideration for further research in 
this area; do single cells that arrest and lyse lack glycine transporters? 
3.2.3 How osmolality affects the embryo 
	
Once the successful culture of blastocysts was achieved, focus on osmolality 




osmolality’s but much of the research has been conducted on porcine, murine 
and bovine embryos therefore extrapolations to the human, as always, must 
be made with caution.  
 
In 1994, the effects of osmolality were assessed using rat embryos (Miyoshi 
et al, 1994). This experiment was simple in design and effective in achieving 
it’s aims. The experiments involved six groups of 44 embryos each. Sodium 
chloride (NaCl) was used to achieve osmolality’s of 212, 244, 256, 264, 276 
and 304mOsm/kg. The percentage of two-cell, four-cell, morula and 
blastocyst embryos were observed for each group. It appeared that embryos 
were able to progress to the two-cell stage at any of the tested osmolality’s 
however only 11% embryos reached the four-cell stage when cultured in 
304mOsm/kg compared to 98% at 256mOsm/kg. No embryos cultured in 
304mOsm/kg reached the morula or blastocyst stage compared to 80% and 
61% at 256mOsm/kg, respectively. These results were statistically significant 
and the optimum osmolality was defined as 244-264mOsm/kg. The authors of 
this experiment noted that their method for varying the osmolality may have 
caused the change in embryo development and they were therefore unable to 
attribute the changes to osmolality definitively. Three years later, Dawson and 
Baltz (1997) conducted an experiment to test the effects of osmolality on the 
development of murine embryos and used two methods to vary the osmolality; 
NaCl and an organic osmolyte. One conclusion from this experiment was that 
embryonic development was identically inhibited by raised osmolality using 
NaCl or an organic osmolyte therefore, although authors of the previous study 
were justified in their identification of a potential flaw in their experiment, this 
was disproved by their successors. In this experiment, murine embryos were 
cultured in modified culture media (potassium-supplemented simplex 
optimised medium (KSOM)) at 230, 250, 290, 310 and 340mOsm/l each with 
or without 1mM glutamine (acting as the organic osmolyte). Of note is that the 
measure of osmotic pressure in this case was osmolarity as opposed to 
osmolality thus an increased degree of inaccuracy is to be expected due to 
the sensitivity of solvent volume to temperature. From this experiment, raising 
the osmolarity of the medium with additional NaCl had a significant negative 




optimum osmolarity was identified as 290mOsm/l in the absence of glutamine. 
At osmolarity's above 310mOsm/l almost no blastocysts developed in the 
absence of glutamine. In addition, at osmolarity's above 310mOsm/l, the most 
marked difference in embryo development was seen in the absence and 
presence of glutamine with over 70% of embryos reaching the blastocyst 
stage when glutamine was present but only 10% of embryos reaching the 
blastocyst stage in the absence of glutamine, compounding the need for 
organic osmolytes in any commercial culture media with a high osmolality.  
 
A further experiment assessed the impact of osmolality on embryo 
development by altering the osmolality of human tubal fluid (HTF) using NaCl 
to give varying osmolality’s (270, 290, 310, 330mOsm/kg) (Swain et al, 2012). 
This experiment found that, compared to 310mOsm/kg, 330mOsm/kg yielded 
significantly lower rates of development to eight-cells at 48hpi and total 
blastocyst formation at 96hpi. Nevertheless, no significant differences in 
embryo development were observed between embryos cultured in 310 and 
330mOsm/kg at any other time point or between 270 and 290mOsm/kg at any 
time point. These experiments indicate that increased osmolality can have an 
effect on embryo development, which has been confirmed by others 
demonstrating a negative impact of increased osmolality (>310mOsm/kg) on 
embryo development (Brinster, 1965; Hay-Schmidt, 1993; Liu and Foote, 
1996; Richards et al, 2010).  
 
Experiments conducted in 2006 used porcine embryos to determine the 
effects of nine different culture systems on embryo development (Ozawa et al, 
2006). The oocytes were exposed to a short insemination time following in 
vitro maturation with 40 embryos assigned to each group. All embryos were 
cultured to day six of development with two media changes on days two and 
four. The osmolality was adjusted to 285mOsm/kg using pure water for all 
culture systems and the media used in experimental groups was pre-
equilibrated in 5% CO2. Six repeated measurements were taken of each 
group. The nine groups included a combination of various culture systems 
that are routinely adopted clinically; open or closed incubation, with or without 




with or without oil (1 – (control) no HEPES, no oil, open; 2 – no HEPES, no 
oil, open; 3 – no HEPES, oil, open; 4 – HEPES, no oil, open; 5 – HEPES, oil, 
open; 6 – no HEPES, no oil, closed; 7 – no HEPES, oil, closed; 8 – HEPES, 
no oil, closed; 9 – HEPES, oil, closed). An open system describes a system 
where no lid is used on the carrier (i.e. culture dish). A closed system 
describes a system where the lid is used on the carrier. HEPES buffer is one 
that aids in the maintenance of the pH of the culture media contained in the 
carrier. Oil is often used to cover the culture media contained in the carrier 
and aims to reduce gaseous exchange and thus fluctuations in pH. These 
culture systems have both benefits and drawbacks and are adopted in 
different variations between units. The total number of cells in the resulting 
blastocysts was lower in all closed groups compared to open groups and 
gradually increased within the closed groups (group 6 to 9). In addition, the 
total number of blastocysts on day six was lower in groups 6 and 7. These 
results indicate that a closed embryo culture system may not be as conducive 
to embryo cleavage as an open system. The authors concluded that there 
seemed to be no association between embryo development and osmolality 
because the osmolality remained unchanged in the groups where changes in 
embryo development were seen, contrary to evidence discussed previously.  
3.2.4 How osmolality can be affected   
	
Having discussed how osmolality effects embryos it is prudent to discuss what 
can cause these changes in osmolality. Clearly, the conditions or techniques 
used during media preparation could impact osmolality. Culture media that 
was not used for the culture of any gametes or embryos (unused) was tested 
in a series of observations in 2012 that elucidated interesting features of the 
ART laboratory that could affect the osmolality of culture media. The volume 
of media (10, 20, 40µl), drop type (wash or micro-drop), temperature of 
preparation surface and time to prepare were all assessed. It was shown that 
the osmolality was significantly higher when the surface temperature was 
37°C as opposed to 23°C, micro-drops were prepared as opposed to wash 
drops and when the size of micro-drop was smaller. This was the first report 
demonstrating that the way in which culture media is prepared can have a 




Experiments have also been conducted assessing the optimum culture 
conditions in standard incubation. In one set of experiments different dish 
types, oil overlays, micro-drop sizes, with or without lids and in a humidified 
and non-humidified incubator were assessed.  When using 4-well culture 
dishes, the micro-drop and oil overlay volume was varied and cultured with 
both lids on and lids off. No change in osmolality was seen when an oil 
overlay of 0.7ml was used regardless of the micro-drop size (20µl or 30µl) with 
both the lids on and off. When the oil overlay was decreased from 0.7ml to 
0.5ml, however, a gradual increase in osmolality was seen over 72h up to 
420mOsm/kg with the lids off and 320mOsm/kg with the lids on. This indicates 
that adequate oil overlay is crucial for culture systems and the addition of a lid 
where the oil overlay is not sufficient does not prevent an increase in 
osmolality. When using 60mm round dishes where the lid was present, the 
osmolality remained relatively stable. For those experiments involving 60mm 
round dishes where the lid was removed the osmolality significantly increased 
to 458mOsm/kg when 50µl of media and 7ml of oil were used. The osmolality 
also steadily increased when 200µl of media and 8ml oil was used illustrating 
insufficient oil overlay for the volume of media used. The presence of humidity 
was also considered in this series of experiments and although an increase in 
osmolality was evident, it was seen in both humidified and non-humidified 
environments so the change in osmolality was not a result of humidity, or lack 
of. The conclusion of this was that the presence of a humidified environment 
did not have an effect on the osmolality of the culture media (Barrie et al, 
2012).  
 
The manufacturers of the TLS in question also performed a series of 
experiments to support the clinical application of the incubator. These 
experiments were performed in order to assess the level of medium 
evaporation over the course of five days using a standard EmbryoSlide® set-
up (25µl in each of the 12 wells covered with 1.2ml oil overlay). A total of 
4.15% of medium was lost over the course of five days and amounted to a 
0.014g reduction in weight of the EmbryoSlide® (FertiliTechNote, 2013). 
However, the results do not translate this to a quantifiable change in 




the context of osmolality, it is difficult to ascertain it’s significance. Crudely, if 
this 4.15% loss were extrapolated to osmolality then, with a starting osmolality 
of 280mOsm/kg, this change would increase the osmolality to approximately 
292mOsm/kg (FertiliTechNote, 2013); considered by some to be an 
acceptable level (Table 1). In addition, the EmbryoScope® incubator, unlike 
most standard incubators, is not humidified. However, as discussed, humidity 
may not be critical for maintenance of osmolality. The experiments outlined 
here aim to determine the effectiveness of the EmbryoScope® incubator at 
maintaining an osmolality conducive to human preimplantation embryo 
development and highlight it’s ability to reduce the amount of stress that an 

























3.3.1 Definition  
	
pH is a measure of acidity or alkalinity of a solution and is an abbreviation 
meaning ‘power of hydrogen’. It is represented on a logarithmic scale where a 
difference in one pH unit is equivalent to a tenfold difference in hydrogen ion 
concentration meaning that a strongly acidic solution can have one-hundred 
million, million times more hydrogen ions than a strongly basic solution 
(Swain, 2010).  
 
During human embryo culture pH is maintained through the interaction of CO2 
supplied by the incubator and bicarbonate in the media (Swain, 2010). Carbon 
dioxide is relatively small and uncharged; it can diffuse readily through the cell 
membrane where it combines with water to form carbonic acid, which rapidly 
dissociates into a bicarbonate ion and a hydrogen ion (McLiman, 1972). pH is 
often described using the Henderson-Hasselbalch equation that denotes pH 
as a measure of acidity (Henderson, 1908).  
pH = pKa + log10 ([A-]/[HA]) 
Where; 
pKa = -log10(Ka) = -log10 (([H3O+][A-])/[HA])  
[A-] = molar concentration of the acid’s conjugate base 
[HA] = molar concentration of the undissociated weak acid 
 
Broadly, as long as the CO2 concentration is kept at the required level, the pH 
should fall within physiological ranges for preimplantation embryo 
development (Mortimer and Mortimer, 2004). 
3.3.2 pH in the context of the embryo 
	
As with osmolality, commercial companies have provided suggested optimal 
pH levels for their culture medium (Table 2) that are all attained through a 
variation in CO2 concentration provided by the incubator. There are very few 
publications on this requirement of embryo culture because the maintenance 
of pH at a physiological range simply requires the stabilisation of CO2. As with 




Table 2. pH ranges of various commercial media (adapted from 
Swain, 2010) 








Fert media 7.3±0.1 
Cleavage media 7.2±0.1 
Blastocyst media 7.3±0.1 
IVM 7.2±0.1 
VITROLIFE 
G5 Series 7.27±0.07 
LIFE GLOBAL 
Global 7.2-7.4 











Sydney IVF fert 7.3-7.5 
Sydney IVF cleavage 7.3-7.5 




pH for culture of human embryos and the standard for blood chemistry was 
adopted; 7.4. However, the concentration of bicarbonate was found to be 
higher in the reproductive tract than the blood serum in the rabbit 
(Vishwakarma, 1962), rhesus monkey (Maas et al, 1977) and hamster (Lyman 
and Hastings, 1951). In addition to this, some have shown that different 
stages of embryos require different pH’s with fertilisation events seeming to 
require a more alkaline pH (Dale et al, 1998, Hentemann et al, 2011), 
cleavage stage embryos a slightly lower pH and blastocysts a slightly higher 
pH again; this has been come to known as the high-low-high paradigm 
(Swain, 2010). Also, the pH of the fallopian tubes has been shown to be 
alkaline in several species, ranging from 7.7 – 8.2 (Maas et al, 1987; Ben-
Yousef et al, 1996; Zhao and Baltz, 1996; Phillips et al, 2000). However, when 
the pH of the uterine environment was assessed, it was found to be markedly 
reduced and more towards an acidic level (6.96) suggestive of a stage-
specific pH which has been corroborated by a study where enhanced embryo 
development was evident when embryos were exposed to higher pH in the 
early cleavage stages then a lower pH after compaction (Hentemann et al, 
2011). In relation to this, the environment in vivo has been shown to adapt 
when specific events occur. For example, the pH of uterine fluid has been 
shown to increase by 0.2-0.95 units after intercourse for approximately 30 
minutes; a reaction thought to be to protect ejaculated spermatozoa from the 
acidic vaginal secretions and to aid in capacitation (Fox et al, 1973).  pH 
variations are also seen alongside the menstrual cycle signifying a role in pH 
regulation in optimising conception events (Pommerenke and Breckenridge, 
1952; Macdonald and Lumley, 1970; Maas et al, 1976; 1977).  
 
It has been suggested that embryos must possess internal processes in order 
to regulate their pH as has been shown with cell volume regulation and 
osmolality. The resting pH of embryos has been shown to be around 7.0-7.4 
however this represents a considerable range in hydrogen ion concentration. 
Phillips et al (2000) reported a resting pH of 7.0-7.1 whereas Dale et al (1998) 
reported the resting pH to be 7.4. The authors of the former speculate that this 
is due to the culture media used and the compositions of components such as 




pH is regulated by at least two mechanisms in the preimplantation embryo; 
the HCO3-/Cl- exchanger that relieves alkalosis and the Na+/H+ antiporter that 
relieves acidosis. The ability of an embryo to regulate its pH within a narrow 
range requires the presence of HCO3- and CO2. In absence of HCO3-/CO2 
human embryos have been shown to be less able to regulate their 
intracellular pH (pHi). Recovery from alkalosis by the HCO3-/Cl- exchanger 
requires intracellular HCO3-. This has implications for handling human 
embryos in buffered medium with low HCO3- concentrations in atmospheric 
CO2. It has been predicted that exposure to this environment would impair the 
ability of embryos to maintain their pHi since the low CO2 would result in very 
low intracellular HCO3- which would inhibit the HCO3-/Cl- exchange. In 
addition, low external HCO3- would slow any HCO3- dependent mechanism for 
alleviating acidosis thus media containing sufficient HCO3- with appropriate 
CO2 tension is preferable (25mmol/l HCO3- / 5% CO2) (Phillips et al, 2000).  
3.3.3 How pH affects the embryo 
	
Little is known about human embryo pH regulation however there have been 
numerous experiments on other mammalian embryos such as the mouse and 
hamster (Zhao et al, 1995; Lane et al, 1998; 1999a; 1999b; Phillips and Baltz, 
1999). One of the first experiments to investigate the recovery of human 
embryos from fluctuations in pH found that embryos were able to recover from 
alkalosis effectively but the researchers were unable to show recovery from 
acidosis (Dale et al, 1998). The pH of both the external environment (pHe) 
and the pHi have been linked to sustained embryo development (see 
comprehensive review by Swain, 2010). Raising the pH in the environment 
harbouring murine embryos to 7.4 or lowering to 6.8 for as little as three hours 
disrupts localisation of mitochondrial and actin filaments (Squirrell et al, 2001) 
and even minor rises in pH can have dramatic effects on embryo metabolism 
through the destabilisation of enzymes (Swain, 2010). The effects of pH have 
also been extended to fetal outcomes where a disruption in pH has been 
shown to reduce the fetal birth weight of mice (Zander-Fox et al, 2008). 
 
In one set of experiments, there was a marked difference in murine embryo 




pH to 7.0, 7,15 and 7.3. At a pH of 7.0 the embryo formation rate at each 
developmental stage remained constant at 30%. At a pH of 7.15 the embryo 
formation rate for each developmental stage remained constant but was 
higher than that of 7.0 (50% vs. 30%). When the pH was increased to 7.3 the 
embryo formation rate at the early cleavage stage was 70% but decreased to 
25% at the blastocyst stage. The authors concluded that a pH of 7.3 up to day 
two then 7.15 thereafter was optimum (Hentemann et al, 2011). The aims of 
an earlier investigation were to examine the effects of increasing the 
bicarbonate concentration of culture media and the CO2 concentration of the 
incubation atmosphere on eight-cell hamster embryos. When embryos were 
cultured from the eight-cell stage in 5% CO2, a significantly higher proportion 
of embryos developed to the blastocyst stage when compared to ambient CO2 
concentration (approximately 0.04%). When the bicarbonate concentration 
alone was altered, no difference in embryo development was observed but, 
when it was altered in conjunction with the CO2 concentration, embryo 
development was affected where the authors concluded that a combination of 
25nM of bicarbonate at a concentration of 10% CO2 resulted in a significantly 
higher proportion of blastocysts formed. The authors also concluded that the 
difference in embryo development was a result of the changed CO2 
concentration rather than the effect that this has on the pH of the culture 
media. Interestingly, this series of experiments also identified that the 
hatching of embryos from the zona pellucida was pH dependent (Carney and 
Bavister, 1987). 
 
A study conducted in 2000 (Phillips et al) found a mean intracellular pH of 
7.12 from 199 embryos and concluded that embryo morphology was not 
affected by pHi however embryos rated 2 or 3 had a significantly more acidic 
pHi when compared to embryos rated 5 (where 5 denotes a higher quality 
embryo). The authors comment that the numbers in this study were small; 
grade 1 (n=11), grade 2 (n=53), grade 3 (n=122), grade 4 (n=21), grade 5 
(n=6), therefore it would be difficult to conclude that pHi had a significant 
effect on embryo morphology. Several have also reported that changes in 




and Leese, 1988; Edwards et al, 1998a; 1998b; Lane and Gardner, 2000; 
2003). 
However, some have found that the effects of pH on the preimplantation 
embryo are not immediately obvious when considering embryo morphology. 
Mouse embryos fertilised and cultured in either optimal or suboptimal 
conditions in vitro have been shown to exhibit similar morphologies and 
implantation rates when compared to in vivo counterparts however the 
miscarriage rate (MR) was significantly higher in the in vitro cultured embryos 
and highest after suboptimal culture (Holm et al, 1996; Khosla et al, 2001; 
Fernandez-Gonzalez et al, 2004; Block et al, 2010; 2011; Bermejo-Alvarez et 
al, 2012; for a comprehensive review see Feuer and Rinaudo, 2013).  
3.3.4 How pH can be affected  
	
The culture environment is the most prominent source of pH variation. 
However, as previously mentioned, the presence or absence of specific 
compounds required for pH regulation in the embryo, such as HCO3- could 
also lead to unnecessary pH variations.  
 
pH is notoriously difficult to measure in situ, partly due to the availability of 
effective probes for its measurement under normal culture conditions but also 
because of the rapid shift in pH when the surrounding environment is 
changed. A series of simple experiments represented the rapid shift in pH 
experienced when the external environment changes using two different 
culture systems; 50µl media drops covered with oil or 5ml of medium 
(Mortimer and Mortimer, 2004). In the former, the pH began to rise as soon as 
the dish was removed from the incubator and the pH increased to around 7.65 
within two minutes. Once replaced back into the incubator, the media required 
35 minutes to re-equilibrate. When considering the latter culture system (5ml 
medium only) the pH increased to approximately 7.8 within two minutes from 
dish removal and required 15 minutes to re-equilibrate. A further experiment 
assessed the pH of nine different culture systems, as described previously 
with regards to osmolality (Ozawa et al, 2006). In these experiments, the pH 
was shown to be significantly higher in a closed culture system not 




in a closed system supplemented with HEPES and covered with oil did not 
significantly differ from the control. This experiment highlights the need to 
consider the culture systems used to ensure a stable environment for embryo 
culture. 
3.3.5 Research Aims 
	
The evidence presented above indicates that embryos are highly reactive to 
their external environment. Despite embryos having been shown to be able to 
withstand a range of pH and osmolality’s there is an argument against 
exposing embryos to these variations as they act as stressors to embryonic 
development. These stressors can affect the ability of an embryo to continue 
with development normally and could result in sub-optimal embryo 
development. This relates to the quiet embryo hypothesis (Leese, 2002) 
where embryos that have a low turnover of substrates are more viable than 
those that have a high turnover. This hypothesis is based on the rationale that 
the use of substrates can be attributed to repair processes such as DNA 
repair pathways. Varying pH and osmolality could cause errors in DNA 
replication, thus the embryo would need to undertake more metabolic 
processes to repair any damage caused.  In addition to the immediate in vitro 
effects, one hypothesis exists that has been corroborated beyond doubt that 
the environment under which critical developmental events occur, for 
example, preimplantation development, can have an effect on the health of 
the individual much later in life (Barker and Osmond, 1986). This hypothesis is 
known as the Barker hypothesis or the developmental origin or health and 
disease (DOHaD) and should be acknowledged when considering optimum 
culture conditions for preimplantation embryos.  
 
Optimum osmolality appears to be defined in the literature as between 260-
290mOsm/kg and pH appears to be approximately 7.4, however, 
commercially available media still have variable levels (Table 1 and 2). It 
appears that development of culture media has largely been experimental 
with little scientific reasoning for changes to components of media resulting in 
differences in embryo development. The exact components of commercially 




experiments on seven types they were found, not surprisingly, to vary 
considerably (Morbeck et al, 2014).  
 
Although the aims of the experiments presented here are not to determine the 
optimum pH and osmolality for embryo culture, the confirmation that embryo 
culture in a TLS, the EmbryoScope®, is maintained at stable and 
physiological levels, are. To this end, the aim of this series of experiments 
was to demonstrate that the EmbryoScope® provides a stable culture system, 
maintaining a constant osmolality and pH and thus a potential reduction in the 
level of stress embryos contained within it are exposed to. 
3.4 Materials and methods 
This laboratory experiment involved repeated measurements of the osmolality 
(mOsm/kg) and pH of media not used for gamete or embryo culture (unused) 
incubated in either a standard incubator (Sanyo Multigas Incubator MCO-
18M, 37°C, 5% O2, 6% CO2) or a TLS (EmbryoScope®, Vitrolife, 37°C, 5% 
O2, 6% CO2). Target population, participant recruitment and 
inclusion/exclusion criteria were not applicable due to the use of unused 
culture media and lack of patient involvement.  
3.4.1 Osmolality assessment  
	
Culture dishes were set-up to allow repeated measurements of 60µl of media 
every 24h for a total of 144h in each system (n (standard) = 14, n 
(EmbryoScope®) = 14). Culture dishes (4-well) containing three 20µl micro-
drops of G-TL™ with 0.7ml oil overlay (OVOIL™) in each of the first three 
wells and 0.65ml G-TL™ with 0.35ml oil overlay in the fourth well. The fourth 
well was not used for sampling as this served as a reservoir of media for the 
micro-drops used during dish preparation. This dish configuration was 
adopted to represent standard culture conditions as it was used routinely 
before the introduction of TLS at the HFC. EmbryoSlides® were prepared 
including 12 micro wells of 25µl G-TL™ with 1.4ml oil overlay. Both dish types 
were placed in their respective incubators and the time recorded as time zero. 




immediately before use using sterile water (0.00mOsm/kg) and a calibration 
solution of 300mOsm/kg.  
 
A 60µl sample of uncultured G-TL™ was taken immediately using an air 
displacement pipette (Gilson p100) and the osmolality determined to act as a 
reference. The culture media was sampled every 24h thereafter up to 144h. 
Each sample was taken by placing pipette directly into the culture drops and 
removing the required volume of media (15µl) from each micro-drop in the 4-
well dishes and 20µl from each micro well in the EmbryoSlide®. The pipette 
tip was cleaned with a lint-free tissue to remove oil residue, which could 
interfere with the osmolality measurement, and the sample expelled into a 
pre-labeled Eppendorf® tube. This process was repeated until the 
Eppendorf® tube contained 60µl; a sufficient volume for analysis. Osmolality 
was measured using a micro-digital osmometer, which uses the principle that 
the measurement of a freezing point of a solution is directly related to its 
osmotic concentration. 
3.4.2 pH assessment 
	
A pH meter (Research Instruments Ltd, Cornwall) was cleaned and calibrated 
using deoinised water and potassium chloride. The probe holder was filled 
with 0.6ml pre-equilibrated G-TL™ using a syringe to ensure the probe was 
completely submerged. The media was then covered with 0.2ml oil to both 
mimic the culture conditions used in the laboratory and also to prevent 
evaporation of the culture media during the measurement period. The probe 
was then inserted into the probe holder and placed inside a standard 
incubator. The probe was allowed to reach temperature and a reading was 
taken every 30 minutes for five hours. The above process was then repeated 
for the EmbryoScope® incubator.  
 
As pH is notoriously difficult to measure, the variation in pH in both the 
standard and EmbryoScope® incubators was also determined using the CO2 
concentration as an indicator. Incubator traces were taken from both the 
standard and EmbryoScope® incubators for a normal working day using the 




EmbryoScope® itself, respectively. Readings of CO2 were taken from these 
traces at hour intervals over ten hours.  
3.4.3 Statistical analyses 
	
All analyses were conducted with the statistical analysis package, Prism® 5 
(GraphPad Software©, USA). To inform the type of statistical test to be used, 
normality was determined using Shapiro-Wilk and Kolmogorov-Smirnov 
normality tests. Where normality was confirmed, a paired t-test was used to 
determine significance between measurements. Where normality was not 
confirmed the Mann-Whitney U test was used to determine significance 
between measurements.  Differences were considered significant at p<0.05.  
3.5 Results 
	
3.5.1 Osmolality  
	
Measurements taken reflect no significant change in osmolality for either 
culture system with mean ± standard deviation for standard and 
EmbryoScope® incubation systems as 292.9 ± 11.98 and 294.1 ± 11.81, 
respectively (Tables 3, 4, Figure 1A, 1B).  Analysis intervals were consistent 
for each measurement. Over the course of the experimental period the 
osmolality remained relatively unchanged in both the standard incubator and 
the EmbryoScope® at approximately 295mOsm/kg. The standard deviations 
for the standard incubator and the EmbryoScope® indicate that the variation 
was similar between the two culture systems, although high. Statistical 
analyses for the osmolality measurements indicate that there was no 
statistically significant difference within culture systems demonstrating 
accuracy of the replicate measurements.  Furthermore, there was no 
statistically significant difference between the culture systems indicating that 
the EmbryoScope® maintains a consistent culture environment. When 
comparing the average osmolality between standard and EmbryoScope® 








Table 3. Standard incubation osmolality results 
Expected sample time 





0h 275.0 281.0 
24h (23h 5m) 297.0 282.0 
48h (47h 38m) 308.0 286.0 
72h (71h 38m) 329.0 291.0 
96h (95h 36m) 284.0 284.0 
120h (119h 38m) 325.0 288.0 
144h (143h 38m) 288.0 283.0 
The repeated measurements of osmolality over 144h in a standard 
incubation system (n=14) p=0.0528 (two-tailed paired t-test) 
 
 
Table 4. EmbryoScope® incubation osmolality results 
Expected sample time 





0h 275.0 281.0 
24h (23h 2m) 286.0 284.0 
48h (47h 38m) 326.0 304.0 
72h (71h 35m) 288.0 312.0 
96h (95h 33m) 291.0 289.0 
120h (119h 35m) 296.0 293.0 
144h (143h 35m) 296.0 297.0 
The repeated measurements of osmolality over 144h in an 






















0h 278.0 278.0 
24h 289.5 285.0 
48h 297.0 315.0 
72h 310.0 300.0 
96h 284.0 290.0 
120h 306.5 294.5 
144h 285.5 296.5 
Mean 292.9 294.1 
S.D  11.98 11.81 
A comparison of the means of the repeated measurements (taken from Table 3 and 
Table 4) from the standard and EmbryoScope® incubation systems. p= 0.8517 (two-



































Figure 1. Standard vs. EmbryoScope® osmolality results graphs. A; 
repeated osmolality measurements (‘1’ and ‘2’) for the standard incubator 
(p>0.05). B; repeated measurements (‘1’ and ‘2’) for the EmbryoScope® 
incubator (p>0.05). C; comparison of standard and EmbryoScope® incubation 
systems (p>0.05).   
(A) Standard Incubation 



















































(C) Standard vs. EmbryoScope® Incubation 






The pH measurements taken using a pH meter revealed mean ± standard 
deviation for standard and EmbryoScope® incubation systems of 7.64 (±0.18) 
and 7.75 (±0.12), respectively, shown to be statistically significant 
(p=0.00027) (Table 6, Figure 2). However, the culture media was not 
maintained in the probe holder effectively and was seen to evaporate 
considerably after five hours. Carbon dioxide incubator traces taken of each 
incubation system on a normal working day in the laboratory are shown in 
Figure 3. The percent CO2 was taken every hour for ten hours from both the 
standard incubator trace (Figure 3A) and the EmbryoScope® incubator trace 
(Figure 3B). These analyses revealed significantly different results of a mean 
± standard deviation for standard and EmbryoScope® incubation systems of 































1 7.5 7.6 7.8 7.5 
2 7.4 7.6 7.7 7.6 
3 7.6 7.5 7.7 7.9 
4 7.7 7.5 7.7 7.9 
5 8.0 7.5 7.8 7.9 
6 8.2 7.5 7.7 7.9 
7 7.7 7.6 7.7 7.9 
8 7.6 7.6 7.6 7.7 
9 7.6 7.7 7.7 7.6 
10 7.6 7.7 7.7 7.9 
The repeated measurements of pH using a pH meter in standard and EmbryoScope® 
incubation systems (n=20), p=0.00027 (Mann-Whitney U test).  
 
 
Figure 2. Standard vs. EmbryoScope® measured pH results. Repeated pH 
measurements taken over five hours every 30 minutes in standard and EmbryoScope® 
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Figure 3. Standard vs. EmbryoScope® incubator traces for normal working day.  
Figure 3A. Carbon dioxide trace for a standard incubator on a normal working day. Red 
diamonds indicate the measurement taken at each hour with a dashed line along to the x-
axis indicating the CO2 level (X1, X2, X3 – X10) 
Figure 3B. A CO2 trace for an EmbryoScope® incubator on a normal working day. Red 
diamonds indicate the measurement taken at each hour. As the measurements are constant 





Table 7. Standard vs. EmbryoScope® CO2 readings  
 Standard % CO2 EmbryoScope® % CO2 
1 5.70 6.10 
2 5.30 6.10 
3 5.62 6.10 
4 5.55 6.10 
5 5.35 6.00 
6 5.63 6.10 
7 5.68 6.10 
8 5.81 6.10 
9 5.71 6.10 
10 5.72 6.10 
Comparison of CO2 readings from standard and EmbryoScope® incubation 
systems on a normal working day (n=10) p < 0.0001 (Mann-Whitney U test). 
 
 
Figure 4. Standard vs. EmbryoScope® CO2 results. Carbon dioxide 
measurements taken every hour over ten hours in standard and 
EmbryoScope® incubation systems using incubator independent monitoring 
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The results presented indicate that the EmbryoScope® as an incubator is as 
stable as a standard incubator when considering osmolality and substantially 
more stable when considering pH.  Specifically, when the osmolality is 
addressed, the mean osmolality achieved in each incubation system did not 
differ significantly. In addition, the standard deviations were comparable 
indicating a similar variation in the measurements between the two systems. 
This provides reassurance to users that the culture environment of this 
technology (the EmbryoScope®) is as stable as standard counterparts. It is 
not surprising that both systems maintain a relatively stable osmolality as this 
would be reflected and, inevitably, reported, in embryo development leading 
to changes in the methods of culture.  Importantly, the aims of these 
experiments were to confirm the stability of the EmbryoScope® environment, 
in relation to osmolality, which has been achieved.  
 
When considering the results obtained for the series of experiments to 
measure pH, converse to osmolality, a variation was seen. For those results 
obtained using the pH meter the variation in the results was similar (as 
reflected in the standard deviations) but the EmbryoScope® values were 
statistically significantly higher. The results obtained amount to an increase in 
pH of approximately 0.11. There may be a number of reasons for this 
increased result, discussed later, however in terms of stability, the results 
were comparable. Conversely, when using the CO2 measurements as a proxy 
to determine a variation in pH the difference between the two systems was 
obvious. The standard deviation in the standard incubator versus the 
EmbryoScope® were 0.16 and 0.03, respectively, highlighting the variability in 
the readings taken from the standard incubator trace. The EmbryoScope® 
CO2 readings were also significantly higher than those in the standard 
incubator, but not outwith the accepted limit. Due to the difficulties associated 
with measuring pH using a pH meter (discussed later), the CO2 readings are 
likely to represent the variation in culture conditions more appropriately and 
thus indicate that the EmbryoScope® offers a considerably more stable 




provides further reassurance to users that the EmbryoScope® is appropriate 
for human embryo culture.  
 
A significant variation in the functional components of culture media (i.e. pH 
and osmolality) can have detrimental effects on embryo development but is 
more likely to cause unseen effects. These suboptimal conditions can inflict 
stress on the embryo meaning it has to access coping or repair mechanisms 
to counteract suboptimal culture conditions. This notion is well documented 
and relates to the Barker hypothesis or the developmental origins of health 
and disease (DOHaD) (Barker and Osmond, 1986). This hypothesis was put 
forward when nutritional stress in utero was manifested as low birth weights 
and heightened risk of adult cardiovascular disease. The first, and arguably 
most, evident examples of this hypothesis were the use of thalidomide to 
relieve morning sickness in 1950-1960 resulting in widespread birth defects 
(McBride, 1961; Brent and Holmes, 1988) and the Dutch Hunger Winter study 
where rations were decreased to 400-800 calories per day for five months 
resulting in glucose intolerance, obesity and cardiac dysfunction in adult life of 
children born during this famine (de Rooij et al, 2006a; 2006b; 2006c; 2006d; 
2010). The cause of these manifestations is likely, at a molecular level, to 
relate to changes in how genes are transcribed and expressed. The 
phenomenon of genomic imprinting, more specifically, it’s defection, is one 
such example of how suboptimal conditions can affect an embryos health.  
 
Although there is conflicting evidence for the argument that exposure of 
embryos to in vitro culture conditions can cause unseen effects such as 
methylation aberrations (discussed previously), the basic principle, that the in 
vitro environment is artificial and the early stages of embryo development are 
crucial, is clear. An embryos response to stress highlights its ability to evolve 
to it’s surrounding environment but could affect growth and metabolism and 
force the embryo to divert resources away from coordination of ‘normal’ 
processes towards those that have been introduced by suboptimal culture; the 
basis for the quiet embryo hypothesis (Leese, 2002). It is therefore logical to 
assume that any method, technology or equipment that could reduce these in 




methylation patterns in relation to in vitro embryo culture and the effect on the 
preimplantation embryo to draw firmer conclusions. However, it appears that 
the use of a TLS may, certainly when considering pH, reduce the amount of 
‘stress’ an embryo is exposed to during its in vitro culture. 
3.7 Conclusion 
Osmolality and pH are pivotal in the culture of human preimplantation 
embryos and must be appropriately maintained for effective development and 
subsequent pregnancy in ART. An embryo can be affected by fluctuations in 
these factors, manifested in their quality, but the exposure of embryos to 
these stressors is also apparent later in life. With the advent of new 
technologies, there is the possibility that the maintenance of these 
environmental factors at stable levels can be easily achieved. The aim of this 
series of experiments was to demonstrate that the EmbryoScope® offers a 
stable environment in terms of pH and osmolality which is evident from the 
results presented here. This represents a significant step towards the 















CHAPTER 4: The EmbryoScope® as an incubator; 
comparison of success rates to a standard incubator  
4.1 Prelude 
The previous chapter details that of environmental differences between two 
incubation systems; a standard incubator and a TLS (EmbryoScope®). The 
purpose for performing this research study was to determine if a TLS 
(EmbryoScope®) could provide comparable culture conditions when 
compared to a standard incubator employed at the HFC. The following 
chapter supports this aim by outlining a strict-matched pair analysis to 
compare treatment success rates between standard incubation and the 
EmbryoScope®.  
 
4.2 Embryos cultured in a time-lapse system result in superior 
treatment outcomes; a strict matched pair analysis (Paper 1) 
4.2.1 Abstract 
	
A retrospective, strict matched-pair analysis on 728 treatment cycles between 
January 2011 and September 2014 was performed. 364 treatment cycles, 
where all embryos were cultured and examined in the EmbryoScope®, were 
matched to treatment cycles where all embryos were cultured in a standard 
incubator with conventional morphological examination. Matching was 
performed for patient age, number of oocytes collected, treatment type and 
date of oocyte collection (± six months). The clinical (CPR), implantation (IR), 
live birth (LBR) and miscarriage rates (MR) were calculated and considered 
significant at p<0.05 (Chi-square test). Clinical pregnancy rate, IR and LBR 
were found to be statistically significantly higher in the time-lapse system 
(TLS) group compared to the standard incubation group (CPR; 44.8% vs. 
36.5%, p=0.023. IR; 39.3% vs. 32.2%, p=0.029. LBR; 43.1% vs. 33.8%, 
p=0.009). Although there was a 5.5% decrease in the MR for the TLS group 
when compared to the standard incubation group, this result was not 
statistically significant (18.9% vs. 24.4%, p=0.192). There is a paucity of well-




result in superior treatment outcomes, and this strict-matched pair analysis 
with a large cohort of treatment cycles indicates the advantage of using TLS.  
4.2.2 Introduction 
	
The first application of TLS in embryology was recorded in 1968 where chick 
embryos exposed to teratogenic doses of hypoxia were analysed (Grabowski 
and Schroeder, 1968). Following this, studies relating to preimplantation 
embryonic development were published (Colly-d’Hooghe et al, 1977; Milligan 
et al, 1978; Lueck and Aladjem, 1980; Massip and Mulnard, 1980; Milligan et 
al, 1980; Schatten and Schatten, 1980; Alexandre and Mulnard, 1988). One of 
the earliest clinical applications of TLS was reported in 1997 regarding polar 
body extrusion and pronuclear formation in human oocytes (Payne et al, 
1997). Subsequently, the internalisation of fragments observed in human 
embryos was published (Hardarson et al, 2002) followed by a report of mouse 
embryo collapse analysed using time-lapse photography (Niimura, 2003). 
Focus turned to the use of TLS in a clinical setting in 2008 with a number of 
publications exclusively studying preimplantation embryonic development 
using TLS and how the information these systems provided could be used to 
determine embryo viability (Arav et al, 2008; Lemmen et al, 2008; Mio and 
Maeda, 2008). The first commercially available TLS began installations in 
Europe in 2011. TLS for clinical application have now been readily adopted 
worldwide with instruments installed in numerous countries. Although the 
body of evidence remains weak, it suggests that TLS can increase the 
chances of a pregnancy for many undergoing assisted reproduction.  
 
The use of TLS in clinical laboratories allows for a detailed analysis of 
embryos contained within it giving over 700 images per embryo. This is 
compared to the conventional snap-shot observations acquired when using an 
incubator without time-lapse capabilities that require translation into a written 
series of numbers and letters open to interpretation by other members of the 
scientific team. The wealth of information that a TLS provides inevitably 
creates the need to modify how embryos are selected for use and as such 
there are many reports linking time-lapse parameters (termed morphokinetics) 




A recent Cochrane review retrieved 33 articles relating to the use of TLS and 
their relative effect in treatment success with only ten studies being potentially 
eligible for inclusion (Armstrong et al, 2015). After further evaluation, three 
studies were included as true randomised controlled trials (RCT). These trials 
totalled 994 couples with the majority contributed by one study (Rubio et al, 
2012). Following analysis it was concluded that for all types of TLS, with or 
without cell-tracking, embryo selection algorithms, versus standard embryo 
incubation there was no conclusive evidence of a difference in clinical, live 
birth, miscarriage and stillbirth rates per couple randomised. The aim of the 
following investigation was to examine whether TLS can be considered 
superior to standard incubation systems when considering CPR, IR, LBR and 
MR by performing a strict matched-pair analysis with a large cohort of 
patients.  
4.2.3 Material and methods 
	
A retrospective, observational, strict matched pair investigation was designed. 
Data for this research were obtained from 728 treatment cycles between 
January 2011 and September 2014. This data comprised 364 patients having 
embryos cultured in a standard incubator (Sanyo Multigas MCO-18M, 37°C, 
6% CO2) (group 1) and 364 having their embryos cultured in a TLS, the 
EmbryoScope® (Vitrolife, Gothenburg, 37°C, 6% CO2, 5% O2) (group 2). 
Although in group 1 214 were cultured in 20% O2 and 150 in 5% O2, a 
statistical examination of the LBR showed no significant differences between 
these groups (20% O2 vs. 5% O2; 34.1% vs. 34.0%, p=0.92) which were 
subsequently pooled. All treatments included in this analysis were from known 
implantation embryos i.e. a single or a double embryo transfer where transfer 
of two embryos resulted in either a negative pregnancy test or two fetal 
heartbeats.  
4.2.3.1 Patient criteria 
	
All patients with embryos cultured in the EmbryoScope® with known outcome 
were matched to patients having embryos cultured in a standard incubator for 
patient age (exact), number of oocytes collected (exact), treatment type and 




were allocated to either standard or TLS culture randomly, based on 
availability. In February 2014 the laboratory became 100% time-lapse enabled 
meaning all patients had all embryos cultured in a TLS.  
4.2.3.2 Oocyte retrieval and embryology 
	
Injected oocytes and embryos were cultured in G-1™ followed by G-2™. For 
those destined for standard incubation, injected oocytes/embryos were 
cultured in 4-well dishes. For those destined for EmbryoScope® culture, 
injected oocytes/embryos were cultured in EmbryoSlides®. 
4.2.3.3 Outcome measures and statistical analyses 
	
Clinical pregnancy rate, IR, LBR and MR were calculated. Clinical pregnancy 
rate was calculated as the number of patients having a fhb at 6-7 weeks 
gestation confirmed by ultrasound scan (regardless of number of fhb) out of 
the number of embryo transfers performed. Implantation rate was calculated 
as the total number of fhb (i.e. inclusive of higher order pregnancies) out of 
the number of embryos transferred. LBR was calculated as the number of all 
live births out of the number of embryo transfers. Finally, MR was calculated 
as the number of positive hCG tests (urinary sample taken 14 days following a 
day three transfer or 11 days following a day five transfer) that did not result in 
a fhb at ultrasound scan at 6-7 weeks gestation. Results were analysed using 
the Chi-square test (Prism® 5 (GraphPad Software©, USA)).  
4.2.4 Results 
	
A total of 728 treatment cycles were analysed and the CPR, IR, LBR and MR 
calculated (see Table 8 for baseline demographic information). Clinical 
pregnancy rate, IR and LBR were statistically significantly different between 
the two groups (Table 9). The CPR for group 1 (control, standard incubation) 
when compared to group 2 (TLS) was 36.5% vs. 44.8%, respectively, p = 
0.023. The IR for group 1 when compared to group 2 was 32.2% vs. 39.3%, 
respectively, p = 0.029. The LBR for group 1 when compared to group 2 was 




5.5% increase in the MR for group 1 when compared to group 2, this result 



































Table 8. Baseline demographic data for standard vs. EmbryoScope® 
incubation. 





SET (n) 300 283 
0.11  DET (n) 64 81 
Cleavage stage transfers (n) 116 101 
0.20 Blastocyst stage transfers (n) 248 263 
Previous attempts (mean ± 
S.D) 1.35 (±0.92) 1.45 (±0.95) - 
Average patient age (mean ± 
S.D) 34.04 ± 4.00 
Average oocytes collected 
(mean ± S.D) 10.13 ± 4.72 
Embryos transferred (n) 428 445 0.64 
Data includes the number of SET and DET, proportion of cleavage and 
blastocyst transfers, number of previous attempts, number of embryos 
transferred, average patient age and average oocytes collected in group 1 
and group 2. Data were analysed using the Chi-square test. SET; single 




Table 9. Data end point results for standard vs. EmbryoScope® 
incubation. 
 Group 1 (Standard) 
Group 2 
(EmbryoScope®) p-value 
CPR (%) 133/364 (36.5) 163/364 (44.8) <0.03* 
IR (%) 138/428 (32.2) 175/445 (39.3) <0.03* 
LBR (%) 123/364 (33.8) 157/364 (43.1) <0.01* 
MR (%) 43/176 (24.4) 38/201 (18.9) >0.1 
Clinical pregnancy rate (CPR), implantation rate (IR), live birth rate (LBR) and 
miscarriage rate (MR) for both standard and EmbryoScope® incubation. All 
results were considered to be statistically significantly different between the 











The results of this strict matched pair analysis reveal that embryos cultured 
and examined in the EmbryoScope® incubator result in superior treatment 
outcomes in this laboratory. These results are in concordance with others 
(Rubio et al, 2014; Yang et al, 2014; Adamson et al, 2016; Basile et al, 2015) 
but have been contradicted elsewhere (Nakahara et al, 2010; Cruz et al, 
2011; Kirkegaard et al, 2012; Kahraman et al, 2013; Kovacs et al, 2013; 
Armstrong et al, 2015; Park et al, 2015). A recent Cochrane review 
(Armstrong et al, 2015) suggested that there was insufficient evidence to 
conclude that TLS with or without cell tracking technology would be beneficial 
to patients undergoing ART. Included in this were three eligible RCTs the first 
of which contributed most of the data for the review. This study was a multi-
centre RCT of patients undergoing ICSI, using donated or autologous 
oocytes. In total, 843 couples were randomised; 438 to TLS and 405 to 
standard incubation. The CPR and MR were calculated as end-points. 
Although this analysis revealed a significant increase in treatment outcomes, 
considerable reasons for bias were identified. Firstly, patients could request 
the intervention (TLS) therefore allocation was, in fact, non-random.  
Secondly, the study was classed as ‘double-blinded’ due to the gynaecologist 
and statistician being unaware of the arm to which the patients had been 
randomised. However, the patients and embryologists were given this 
information. Although unlikely to create a significant bias, this detail could 
invalidate the results. Finally, the heterogeneity of the sample was 
considerable including the use of donated, and thus both fresh and frozen 
oocytes (Rubio et al, 2014). The remaining two RCTs included in the review 
were conducted on a small number of couples, one being interim results only, 
leaving a combined total of 61 to 65 in each arm (Kahraman et al, 2013; 
Kovacs et al, 2013). The reviewers reported a high risk of attrition bias in one 
of these studies due to the principal investigator undertaking the 
randomisation and also because there was no blinding. Overall, the reviewers 
stated that there was no conclusive evidence of a difference between 
standard incubation and TLS when considering CPR, MR, LBR and stillbirth 




shown no significant differences in treatment outcomes between embryos 
cultured in standard incubation versus TLS (Nakahara et al, 2010; Cruz et al, 
2011; Kirkegaard et al, 2012; Park et al, 2015).  
 
Differences in results found thus far in the matter of TLS could be attributed to 
a number of factors. Firstly, a benefit of TLS that one laboratory might enjoy 
may not be so with another due to the conditions of the laboratory in the first 
instance. In brief, a well-designed, stable culture environment (TLS) 
introduced into what was a relatively unstable culture condition may elicit an 
immediate uplift in treatment outcomes. Whereas, to place this technology 
into an already optimal culture environment, may not reveal such results. 
There are many factors that vary between laboratories that could impact this; 
the type of culture media (single or sequential), culture dish type, volume of 
media used for culturing embryos, volume of oil overlay, the type of incubator 
and the embryo grading and embryo transfer policies. It is therefore 
reasonable to conclude that some laboratories may benefit from TLS more 
than others.  
 
Secondly, during the culture of embryos in the EmbryoScope® in this analysis 
an in-house derived embryo selection algorithm was used. This indicates that 
the analysis presented here does not distinguish between the two, commonly 
stated, major benefits of TLS; the undisturbed nature of the systems or the 
use of embryo selection algorithms. Whilst the authors acknowledge that this 
could create ambiguity, it can also be defended. This detail means that this 
analysis addresses TLS as a whole in the manner in which it should be 
utilised; using the information provided by the images. It also gives further 
explanation for the heterogeneity of success of TLS. Some laboratories 
utilising TLS have access to large amounts of data meaning in-house 
derivation and validation of predictive models can be performed; a method 
much preferred to utilising an externally derived embryo selection algorithm. 
In these laboratories, where internally derived models are used, although not 
proven, a greater benefit to using TLS would be expected. Naturally, in those 
laboratories that do not have access to a data-set allowing in-house derivation 




decision which has been cautioned (Kirkegaard et al, 2013a; Yalçınkaya et al, 
2014). The earliest publications regarding TLS aimed to assess the safety of 
the systems (Nakahara et al, 2010; Cruz et al, 2011; Freour et al, 2012; 
Kirkegaard et al, 2012). Many of these studies randomised oocytes or 
embryos between two culture systems (standard and TLS) and found no 
differences in treatment outcomes of embryo quality parameters. The use of 
an embryo selection algorithm in these studies is not mentioned, thus these 
analyses assessed the effectiveness of the incubator itself, not the information 
it provided. Once satisfaction with the safety of the system had been reached 
attention was then turned to how the information from the TLS could be 
utilised. Further reports were then published that revealed an uplift in outcome 
parameters (Rubio et al, 2014; VerMilyea et al, 2014; Yang et al, 2014; Basile 
et al, 2015; Milewski et al, 2015; Siristatidis et al, 2015) with one obvious 
difference; these analyses included the use of an embryo selection algorithm 
and could provide evidence of the benefits of using TLS alongside an embryo 
selection algorithm. The study previously described (Rubio et al, 2014) 
supports the above notion whereby those embryos cultured in a standard 
incubator were assessed for selection based on morphology alone and those 
in TLS were selected using an internally derived, multivariable model. A 
significantly higher ongoing pregnancy rate was found in TLS compared to 
standard incubation (51.4% vs. 41.7% per cycle and 54.5% vs. 45.3% per 
embryo transfer, respectively) as well as a significantly decreased early 
pregnancy loss in TLS (16.6% vs. 25.8%). In addition, the implantation rate 
was significantly increased in the TLS group (44.9% vs. 37.1%) (Rubio et al, 
2014). A further investigation sought to select the most competent blastocysts 
for transfer by combining TLS and aCGH for patients undergoing PGS 
designed as a prospective study with sibling oocytes.  1163 metaphase II 
oocytes from 138 PGS patients were included and oocytes were randomised 
to two groups after ICSI; group A were cultured in TLS and group B in 
standard incubation. Array CGH using trophectodoerm biopsy on both groups 
was carried out and one or two euploid blastocysts either within the 
morphokinetic ranges (group A) or morphological grades (group B) were 
transferred. The CPR and IR were found to be significantly higher in group A 




respectively) demonstrating that when embryo selection algorithms are used 
as an adjunct to select embryos for transfer, superior treatment outcomes can 
be achieved (Yang et al, 2014). These investigations address TLS as an 
incubator whilst also using the data it provides, synonymous with the current 
analyses, indicating that embryo selection algorithms derived using TLS are 
able to select embryos more effectively than standard morphology 
assessments. It is not surprising that an increase in treatment outcomes is 
seen in these cases owing to the wealth of information that is available to the 
user of TLS to do basic, but powerful, embryo selection. 
 
Literature regarding TLS now predominantly concerns development of embryo 
selection algorithms or reviews concluding that further evidence for its (TLS) 
superiority is required. The authors believe that predictive models can be very 
useful, in the first instance for de-selection (rather than selection) of embryos 
undergoing abnormal cleavage events such as DC and RC shown to have a 
significantly reduced chance of creating a pregnancy (Rubio et al, 2012; Liu et 
al, 2014) but also, if developed effectively, to select the best embryo from a 
cohort for a specific patient demographic. Patient characteristics including 
infertility diagnosis (Sundvall et al, 2015) and maternal age (Hampl and 
Stepan, 2013; Chawla et al, 2015) as well as treatment characteristics 
including treatment type and culture conditions (Lemmen et al, 2008; Wale 
and Gardner, 2010; Ciray et al, 2012; Cruz et al, 2013; Kirkegaard et al, 
2013b) have been shown to affect an embryo’s morphokinetic profile and the 
resulting subtle differences may be used to identify which embryo has the 
highest implantation potential. Herein lies a further reason for possible 




This matched pair analysis indicates that treatment cycles where embryos are 
cultured and examined in TLS result in superior outcomes including CPR, IR, 
LBR and MR. Although the notion is novel, the authors believe that the real 
benefit of TLS lies in the development of patient specific embryo selection 




in treatment outcomes when an embryo selection algorithm is not used and 
future research should be geared towards developing effective embryo 




The above research was prepared for publication in Human Fertility. The 
research was accepted and published on 24th November 2016 (appendices 




























Preceding chapters of this thesis have been concerned with the confirmation 
that a TLS (EmbryoScope®) could provide comparable culture conditions and 
treatment success rates to a standard incubator employed at the test site. 
Since this aim of the research study has been supported, subsequent 
chapters will be concerned with harnessing the information that the 
EmbryoScope® incubator provides. This will commence with an examination 
of existing methods for the use of TLS for effective embryo selection in the 
form of the validation of six, existing embryo selection algorithms (ESAs).  
5.2 Examining the efficacy of six published time-lapse imaging embryo 
selection algorithms to predict implantation to demonstrate the need for 
the development of specific, in house morphokinetic selection 
algorithms (Paper 2) 
5.2.1 Abstract 
	
The objective of this research study was to determine the efficacy of six 
embryo selection algorithms (ESAs) when applied to a large, exclusive set of 
known implantation embryos. A total of 884 IVF or ICSI treatment cycles (977 
embryos) performed between September 2014 and September 2015 were 
included in this single-site retrospective, observational analysis. Embryos 
were cultured using G-TL™ (Vitrolife) at 5% O2, 89% N2, 6% CO2, 37°C in 
EmbryoScope® instruments. The efficacy of each ESA to predict implantation 
was defined using specificity, sensitivity, positive predictive value (PPV), 
negative predictive value (NPV), area under the receiver operating 
characteristic curve (AUC) and likelihood ratio (LR). The differences in 
implantation rates (IR) in the categories outlined by each ESA were 
statistically analysed (Fisher’s exact and Kruskall Wallis test). When applied 
to an exclusive cohort of known implantation embryos, the PPVs of each ESA 




were 62.12%, 68.26%, 71.35%, 76.19%, 61.10% and 64.14%. The sensitivity 
was 16.70%, 75.33%, 72.94%, 98.67%, 51.19% and 62.33% and the 
specificity was 85.83%, 33.33%, 42.33%, 2.67%, 48.17% and 42.33%, The 
AUC were 0.584, 0.558, 0.573, 0.612, 0.543 and 0.629. Two of the ESAs 
resulted in significant differences in the embryo classifications in terms of IR 
(p<0.05). These results highlight the need for the development of in house, 
patient, treatment and environment specific ESAs. These data suggest that 
currently available ESAs may not be clinically applicable and lose their 
diagnostic value when externally applied.  
5.2.2 Introduction 
	
Traditional methods for embryo selection have been utilised for over twenty 
years. There are numerous morphological parameters that are thought to be 
useful for correct embryo selection; pronuclear morphology (z scoring) 
(Tesarik and Greco, 1999; Scott, 2003), polar body alignment and 
appearance (Payne et al, 1997; De Placido et al, 2002), appearance of 
cytoplasm and zona pellucida (Plamstierna et al, 1998), early cleavage 
(Lundin et al, 2001; Isiklar et al, 2002), multinucleation (Pickering et al, 1995; 
Jackson et al, 1998; Yakin et al, 2005), and blastomere morphology (Shapiro 
et al, 2000; Hardarson et al, 2001; Johansson et al, 2003). Basic embryo 
grading, including the number of blastomeres, evenness in the size of the 
blastomeres and the level of fragmentation remains the gold standard for 
embryo selection. However, using this method in a traditional sense (with a 
standard bench top incubator) has two limitations; a restricted overview of an 
embryo’s development and the exposure of the embryo to suboptimal 
temperatures and gas concentrations. With the introduction of TLS, where an 
image of each embryo is taken every 10 to 20 minutes, more intricate embryo 
parameters can be viewed whilst leaving the embryos in an undisturbed 
environment. As the availability of TLS increased, attention was first focused 
on assessing their clinical safety. Once this had been established and the 
available technologies validated for clinical use (Freour et al, 2012; Nakahara 
et al, 2010; Basile et al, 2011; Cruz et al, 2011; Kirkegaard et al, 2012), 
research then turned to determining how the TLS could be utilised to increase 






Through both the research that followed and that performed previously, many 
morphokinetic parameters were identified that correlated with the embryo's 
ability to create a pregnancy both in humans and animals; the appearance 
and disappearance of pronuclei (PN) and nuclei at each cell stage (Payne et 
al, 1997; Lemmen et al, 2008; Scott, 2010; Azzarello et al, 2012), the length of 
time between early cytokinesis (Gonzales et al, 1995; Ramsing and Cellesen, 
2006; Ramsing et al, 2007; Lechniak et al, 2008; Herrero et al, 2011; 
Meseguer et al, 2011; Cruz et al, 2012; Hlinka et al, 2012) and initiation of 
blastulation (Campbell et al, 2013a). Further embryological phenomena have 
been observed using time-lapse imaging including the reabsorption of 
fragments (Hardarson et al, 2002), direct cleavage (DC) of embryos from one 
to three cells (Rubio et al, 2012) and reverse cleavage (RC) (Liu et al, 2014). 
These phenomena have been shown to affect an embryos implantation 
potential to varying degrees however, their discovery could lead to more 
effective embryo selection within a laboratory utilising TLS.   
 
Single embryo parameters, such as those named above, have been linked to 
embryo viability (see reference Kirkegaard et al, 2012 for review) and now 
these parameters have been used to develop ESAs. These ESAs seek to 
combine a number of morphokinetic parameters that have been linked to an 
embryo’s viability expressed either as formation of a blastocyst, implantation 
or a live birth. This study aims to examine the efficacy of six published ESAs 
(Azzarello et al, 2012; Basile et al, 2015; Cruz et al, 2012; Campbell et al, 
2013a; Chamayou et al, 2013; Dal Canto et al, 2012) for predicting an 
embryo’s viability, expressed as IR, in a clinically applicable setting aiming to 
demonstrate the need to develop specific, in-house ESAs. Examined ESAs 
were selected based on their clinical applicability to the test site, assessed 
superficially prior to analysis.  
5.2.3 Materials and methods 
	
This investigation was a single site, retrospective observational design. Data 




September 2015. Clinical pregnancy was confirmed by the presence of a fhb 
at ultrasound scan at six weeks gestation. All treatments included in this 
analysis were from known implantation embryos i.e. a single (SET) or a 
double embryo transfer (DET) where the transfer of two embryos resulted in 
either a negative test or two fetal heartbeats (fhbs).  
5.2.3.1 Patient criteria 
	
No specific patient criteria were applied to the following investigation. This 
investigation sought to maximise the number of embryos available for 
inclusion as well as to include a heterogeneous cohort of embryos that would 
be representative of those found in an IVF laboratory.  
5.2.3.2 Oocyte retrieval and embryology 
	
All injected oocytes, fertilised oocytes and unfertilised metaphase II oocytes 
were placed in individual culture drops of G-TL™ and cultured in the 
EmbryoScope®.  
5.2.3.3 Analysis of time-lapse information 
	
A single embryologist assessed images for the required morphokinetic 
parameters. The parameters annotated included time to pronuclear fading 
(tPNf), time to two-cell (t2), three-cell (t3), four-cell (t4), five-cell (t5), eight-cell 
(t8), time to start of blastoculation (tSB), time to blastocyst (tB, defined when 
the blastocoele has filled over half of the embryo and there is a <10% 
increase in the embryo diameter (i.e. the beginning of expansion) quantified 
using the line tools on the EmbryoScope® instrument). From these 
annotations, two further annotations were calculated (s2; time between three 
and four-cell; and cc2; time to complete the second cell cycle). Each of the 
ESAs were then retrospectively applied to the same cohort of known 
implantation embryos.  
5.2.3.4 Outcome measures and statistical analyses 
	
Positive predictive value, NPV, specificity and sensitivity, likelihood ratio (LR) 




methods of measurement were chosen for analysis due to their relationship to 
validity and predictive power. Positive predictive value (PPV) was defined as 
the percentage of embryos creating a fhb as well as a favourable ESA 
outcome. Negative predictive value was defined as the percentage of 
embryos not creating a fhb as well as an unfavourable ESA outcome. 
Sensitivity was defined as the ability of the ESA to correctly classify an 
embryo as viable. Specificity was defined as the ability of the ESA to correctly 
classify an embryo as non-viable.  
 
Each of the test measures were determined using the following calculations: 
PPV = true positives / (true positives + false positives) 
NPV = true negative / (true negatives + false negatives) 
Sensitivity = true positives / (true positives + false negatives) 
Specificity = true negatives / (true negatives + false positives) 
 
The likelihood ratio (LR) was determined using the following calculation: 
LR = sensitivity / (1 – specificity) 
 
The AUC was calculated for each ESA. The IR in each category of the ESA 
was compared using Fisher’s exact test (for ESAs with two outcome 
categories i.e. true, false) and Kruskall Wallis test (for ESAs with more than 
two outcome categories i.e. A, B, C and D). Results were considered 
statistically significant at p<0.05. Statistical analysis was performed using the 
statistical package Prism® 5 (GraphPad Software©, USA) 
5.2.4 Results 
	
A total of 977 known implantation embryos from 884 treatment cycles were 
subject to retrospective analysis to determine the efficacy of six published 
ESAs (Table 10). Of these, 529 of these embryos were created using 
conventional IVF while 448 were created using ICSI. The mean patient age 
was 33.44 ± 4.53 with an average treatment attempt number of 1.37. The 
primary aetiologies for infertility were male factor (32.2%), maternal age 
(4.1%), ovulatory disorders (9.9%), tubal disorders (6.6%), uterine disorders 




and unexplained (41.9%). All embryo transfers were performed on day five 
(blastocyst) with 93 DETs and 791 single embryo transfers performed. 
Agonist protocols comprised 50.36% of treatment cycles with the remainder, 
an antagonist protocol. An overall IR of 39.7% was achieved with 388 of the 
977 embryos implanting and 589 not implanting.   
 
The PPV for each of the ESAs did not reach above 45% in any case. The 
NPV was between 60-70% for all ESAs analysed (Table 10). The sensitivity 
and specificity were considerably more variable (Table 10), as would be 
expected, identifying that two ESAs had a high sensitivity (Campbell et al, 
2013a; Chamayou et al, 2013) and another, a high specificity (Azzarello et al, 
2012). Finally, the AUC analysis revealed values from 0.512 to 0.629 (Table 
10). 
 
The IR for each category of four of the analysed ESAs did not vary 
significantly (p>0.05) (Figure 5). However, the IR for the three categories of 
the aneuploidy risk classification ESA (Campbell et al, 2013a) varied 
significantly (p<0.0001) as did category A with category D in the ESA 
developed by Basile et al, (2015). The aneuploidy risk classification ESA also 
had the strongest LR (1.26) and PPV (44.28%). Incidentally, the number of 
embryos classified as high risk using this ESA was just three, of which one 
implanted giving this category an IR of 33.33%; a potentially misleading result. 
The absolute difference between the IR of low and medium risk embryos was 





















































































































































































































































































































































































































































































































































































































































































































All six of the examined ESAs (Azzarello et al, 2012; Cruz et al, 2012; Basile et 
al, 2015; Campbell et al, 2013a; Chamayou et al, 2013; Dal Canto et al, 2012) 
achieved an AUC less than 0.65 (0.584, 0.558, 0.573, 0.612, 0.543, 0.629, 
respectively), indicating reduced predictive capability. None of the ESAs 
achieved a PPV above 45% (42.57, 41.52, 44.28, 38.91, 38.29, 40.45%, 
respectively) also indicative of poor diagnostic value. The NPV reached over 
60% in all of the ESAs (62.12, 68.26, 71.34, 76.19, 61.10, 64.14%, 
respectively). The specificity of each ESA was variable indicating that some 
ESAs are able to identify embryos with a reduced chance of implantation 
better than others (85.83, 33.33, 42.33, 2.67, 48.17, 42.33%, respectively) 
also reflected in the NPV. This variability was, inevitably, seen in the 
sensitivity of the assessed ESAs (16.71, 75.33, 72.94, 98.67, 51.59, 62.33%, 
respectively). In all of the ESAs assessed, the LR was close to 1 (1.18, 1.13, 
1.26, 1.01, 0.99, 1.08, respectively). The LRs of all ESAs revealed that there 
was little predictive power of implantation where a favourable ESA result is 
obtained (Table 10). Likelihood ratios range from 0 to infinity and a LR close 
or equal to 1 indicates a lack of diagnostic value; the furthest from 1 that any 
of the ESAs in this investigation reached was 0.26 indicating that an embryo 
has a 0.26 increased chance of creating a pregnancy if a favourable ESA 
outcome is achieved. 
 
Worthy of note are the ESAs that were found to have statistical significance 
between the categories of embryo classification (Campbell et al, 2013a; 
Basile et al, 2015). However, the number of embryos classified as high risk of 
aneuploidy in the aneuploidy risk classification ESA was just three of 977. 
Further validation, performed by the developers of this ESA (Campbell et al, 
2013b) using 88 embryos, classified four as high risk of aneuploidy. Clearly, 
using this ESA, the chance of an embryo being classified as high risk is low 
which raises issues about the specificity of the ESA especially when evidence 
suggests that over 50% embryos are aneuploidy (Fragouli and Wells, 2011). 
With an AUC of 0.575 and a 0.26-increased chance that an embryo would 




represent a robust, clinically applicable embryo selection method. 
Nonetheless, this ESA is the most effective out of the six assessed when a 
combination of specificity, sensitivity, PPV, NPV, AUC, LR and differences in 
implantations between each embryo classification category is considered. The 
other ESA to gain statistical significance between the categories when 
considering IR was that of Basile et al (2015). Statistical significance was 
found between the IRs of category A and D indicating that this ESA may 
perform well in terms of identification of poor quality embryos. This is also 
reflected in a high sensitivity and NPV. However, the LR remains low at 1.13 
and the other measures of the effectiveness of the ESA (specificity, PPV and 
AUC) indicate this ESA may not be as effective at determining higher 
implantation potential embryos.  
 
The analyses performed indicate that ESAs available in the literature may not 
provide substantial, additional aid for embryo selection in a clinically relevant 
setting. The current investigation highlights that externally derived ESAs are 
developed, inevitably, under conditions different to that of the adoptive centre 
(Table 11) encouraging the development of in-house, specific ESAs. It has 
been shown that the method by which embryos are created (IVF or ICSI) can 
affect their temporal behaviour (Cruz et al, 2013; Bodri et al, 2015; Liu et al, 
2015).  In addition to varying treatment types, a number of the analysed ESAs 
excluded certain patient groups to avoid confounding factors. This includes 
those with endometriosis, polycystic ovary syndrome (PCOS), severe male 
factor infertility and maternal age over 39 years. This exclusion constitutes a 
proportion of patients that make up a significant fraction of patients treated in 
an IVF laboratory and onto which these ESAs could be critically useful.  
 
There is evidence to suggest that the reason for infertility could affect an 
embryo’s morphokinetic profile in particular those with PCOS (Wissing et al, 
2014) thus their exclusion in the ESA development is understandable but 
reduces its clinical applicability unless a specific ESA is developed for this 
specific patient group. Furthermore, one group’s ESA was developed using 













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































In addition, the majority of the ESAs were developed on embryos created 
under an agonist protocol. However, one group’s ESA development cohort 
contained a proportion of embryos created under an antagonist protocol 
(Campbell et al, 2013a). The use of agonist and antagonist protocols has yet 
to be shown to affect an embryo’s morphokinetic profile however, they have 
been linked to embryo quality (Murber et al, 2009; Vengetesh et al, 2015) 
which could indicate that there is a potential for them to also have a temporal 
effect.  
 
Finally, and perhaps most significantly, varying culture conditions were used 
in the development of these ESAs. It has been shown that an embryos 
morphokinetic profile is significantly altered in different culture media 
specifically between sequential and single-step media (Ciray et al, 2012; 
Barrie et al, 2015). This means that those developed using sequential media 
may not be effective in selecting embryos cultured in single-step media, and 
vice versa. In addition, varying CO2 and O2 gas concentrations were used in 
the development of a number of these published ESAs. Oxygen tension has 
been specifically linked to an embryo’s morphokinetic profile in both humans 
(Kirkegaard et al, 2013c) and mice (Wale and Gardner, 2010) where those 
embryos cultured at 20% O2 have reduced developmental rates and the 
completion of the third cell cycle is significantly delayed. Of the six ESAs 
analysed, one comprised multiple centres (Basile et al, 2015). The culture 
conditions varied slightly between centres therefore it could be argued that 
this ESA has a broader clinical use whilst maintaining similar predictive power 
measurements (i.e. sensitivity, specificity, PPV, NPV, LR, AUC) to the other 
ESAs investigated. It should be highlighted however, that the algorithm 
developed in this original article used oocyte donors, a natural bias for 
outcomes focusing on embryological features and implantation potential. 
These fundamental differences in the development of each ESA need to be 
seriously considered before their external adoption. It is highly unlikely that an 
external centre will have the same patient, treatment and environmental 
parameters as that of the developing centre.  
 




nature of annotating morphokinetic parameters, the differences in image 
capture analysis, such as the number of focal planes, and the varying 
definition of time-zero. The subjective nature of annotations creates 
unreliability in the external application of ESAs. There has been some 
development with this due to the publication of annotation guidelines in 2014 
(Ciray et al, 2014) however, this will not eliminate the subjectivity completely. 
Interestingly, there are now two commercially available ‘one size fits all’ ESAs 
that, based on the results presented here, should not perform as well as 
expected. Variations in image acquisition are unlikely to create significant 
disparity however, coupled with the variability between ‘annotators’, an 
increasing level of inaccuracy could be created. Although undefined in some 
of the publications, the definition of t0 varies between groups with some using 
t0 as the time of insemination or injection, the inaugural and arguably the 
most common method, and others the mid-point of ICSI. It has now been 
largely accepted that the use of insemination/ injection is arbitrary and the 
exact moment that the sperm enters the oocyte is indeterminate for IVF cases 
and, where possible, time of PN fading should be used as t0 (Liu et al, 2015).  
 
It could be argued that a limitation of the current analyses is the potential for 
bias due to the use of an in house ESA with similar morphokinetic parameters 
to one of the externally derived ESAs (Cruz et al, 2012) to aid in embryo 
selection of the analysed embryos. Owing to this, a comparison of the 
proportion of embryos in each of the categories (A-D) in the original 
manuscript for the external ESA in question (Cruz et al, 2012) with the current 
analyses was performed. From this analysis, the proportion of embryos in 
each category did not differ between the original manuscript of the external 
ESA and the current analyses (A; 39.7% (106/267) vs. 37.3% (364/977), B; 
13.5% (36/267) vs. 14.3% (140/977); C; 36.0% (96/267) vs. 36.1% (353/977); 
D; 10.8% (29/267) vs. 12.3% (120/977), respectively) This provides 
reassurance that any bias created from the use of similar morphokinetic 
parameters in the selection of the embryos used in this analysis is minimal.  
 
Finally, it is important to consider that the use of a TLS as a method for 




Racowsky, 2014). As can be seen from the results presented here, the poor 
performance of the investigated ESAs allows the field to question the overall 
clinical applicability of the use of TLS. There is considerable heterogeneity in 
the origin and culture of the embryos used for the development of these ESAs 
and it should be considered that these parameters affect the ability of a one-
size-fits all approach to function effectively. Perhaps the development of 
patient, treatment and environment specific, optimum morphokinetic time 
ranges will present a means of utilising TLS achieving a higher predictive 
power. There are ideal conditions under which to test the efficacy of externally 
derived ESAs, select embryos based only on morphology then perform the 
analyses presented here or, preferably, prospective application. At the study 
site, morphokinetics have been used since the introduction of TLS into the lab 
to aid in embryo selection therefore a dataset large enough to perform the 
former of these two methodologies would not be possible. The authors do, 
however, recognise the strength of a prospective methodology for the aims 
presented here. This will be the focus of future research in this area to better 
delineate the benefits of using TLS in the clinical embryology laboratory.  
5.2.6 Conclusion 
	
The development of ESAs, thus far, has not involved the control of 
confounding factors such as media type, patient age and treatment type, 
except inadvertently by virtue of availability. They are often developed under 
the environmental parameters available in the laboratory performing the 
development and thus are clinically relevant in these cases alone. For 
external application, the ESAs lose their predictive capabilities. The primary 
objective of ESAs is to allow the selection of the best embryo from a cohort in 
a clinical setting. Those presented here, clarify that embryo morphokinetics 
could be used for embryo selection however, they do not offer clinically 
relevant means to aid in embryo selection in other laboratories unless the 
development criteria are also adopted. The collective contribution of 
confounding factors means that derived ESAs can only be applied to that on 
which they were developed and when applied to a heterogeneous cohort of 
embryos, as would be found in an IVF laboratory, the capability of the ESA to 




the development of ESAs that are specific to subgroups of patients, 
environments and treatments. At the very least, embryology laboratories 
should proceed with caution when implementing ESAs derived from published 
sources and consider thorough in house validation of such ESAs before 
clinical use, if at all.  
5.2.7 Dissemination  
 
The above research was prepared for publication in Fertility and Sterility. The 
research was accepted and published on 6th January 2017 (appendices 






















CHAPTER 6: The analysis of abnormal embryos as a 
method for embryo deselection 
6.1 Prelude 
	
Chapter 5, presenting a paper demonstrating that existing, published ESAs 
lose clinical applicability when externally utilised, informs the research that 
follows. It becomes clear that more effective methods of embryo selection, or, 
as the case may be, deselection, are required in the first instance while the 
development of patient, treatment and environment specific ESAs is 
investigated. The use of deselection criteria may be readily available, less 
heavily influenced by patient, environment and treatment parameters and 
easily adopted by others utilising TLS. Thus, the following chapter outlines the 
prevalence and implantation potential of five abnormal embryonic phenotypes 
and their conceivable merit for use as embryo deselection criteria.  
6.2 A preliminary investigation into the prevalence and implantation 
potential of five abnormal embryonic phenotypes assessed using time-
lapse imaging (Paper 3) 
6.2.1 Abstract 
	
This retrospective, single site observational study aimed to delineate five 
abnormal embryonic developmental phenotypes assessing their prevalence, 
implantation potential and suitability for inclusion in embryo selection models 
in an IVF laboratory. A total of 15, 819 embryos from 4559 treatment cycles 
cultured in EmbryoScope® incubators between January 2014 and January 
2016 were included. Time-lapse images were assessed retrospectively for 
five abnormal embryo phenotypes; direct cleavage, reverse cleavage, absent 
cleavage, chaotic cleavage and cell lysis. The prevalence of each abnormal 
phenotype was assessed. The embryo fate, embryo quality and implantation 
rate were determined and compared to a control embryo cohort. The 
collective prevalence for the five abnormal phenotypes was 11.39% where 
chaotic cleavage and direct cleavage together constituted 9.63%. The 




absent, chaotic cleavage and cell lysis, respectively. The overall implantation 
rate for all abnormal embryos was significantly lower compared to the control 
population (6.9% vs. 38.66%, p<0.0001, Fisher's exact). The proportion of 
good quality embryos in each category never reached over 24%. Embryos 
exhibiting an abnormal phenotype may have reduced developmental 
capability manifested in both embryo quality and implantation potential when 
compared to a control embryo cohort. 
6.2.2 Introduction 
	
Abnormal cleavage patterns exhibited by some embryos include, but are not 
limited to; abnormal syngamy, direct cleavage, reverse cleavage, absent 
cleavage, chaotic cleavage and cell lysis.  
 
The first of five abnormal cleavage patterns investigated here is direct 
cleavage (DC). This is the cleavage of one blastomere into three, instead of 
the expected two, daughter cells (Figure 6). The ability of these embryos to 
create a pregnancy has been shown to be significantly reduced (Rubio et al, 
2012) where 13.7% of all examined embryos and 6.6% of transferred 
embryos underwent DC, with 1.2% resulting in a clinical pregnancy. These 
embryos have been shown to have a markedly decreased blastocyst 
formation rate when compared to their normal counterparts (Athayde Wirka et 
al, 2014).  
 
The second abnormal phenotype to be considered is reverse cleavage (RC); 
the phenomenon of blastomere fusion (Figure 6). Of 789 embryos assessed 
for RC, defined as blastomere fusion or failed cleavage, 27.4% of embryos 
were found to exhibit this abnormal cleavage pattern and were shown to have 
a reduced implantation potential (Liu et al, 2014). An examination of 1698 
embryos detected a prevalence of RC of 6.8% however embryos appeared to 
have similar fragmentation, cell evenness and morphokinetic profiles 
compared to their non-reverse cleaved counterparts (Hickman et al, 2012). 
This research concluded that RC does not seem to impair embryo 
development to the blastocyst stage supported by the findings of others 
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Schematic representation of the five abnormal embryo phenotypes. Schematic includes 











Absent cleavage (AC) is defined as the process by which a blastomere 
undergoes a pseudo division (seen as a ‘roll’) that does not produce two 
discernable blastomeres but a single, or multiple, extra nuclei within the single 
blastomere (Figure 6). Absent cleavage has previously been categorised 
under RC, termed type II RC (Liu et al, 2014). Of those embryos that 
underwent RC (27.4%), 82% were classed as type II; absent cleavage rather 
than blastomere fusion. Further evidence of this specific developmental 
pattern has not yet been published. This is perhaps due to the likelihood that 
these embryos will not be used for treatment thus circumventing a clinical 
need to further define this phenomenon. 
 
Chaotic cleavage (CC) results when an embryo undergoes apparent cleavage 
but does not create distinctive blastomeres (Figure 6). A single investigation 
studying this cleavage pattern in 639 embryos found an overall prevalence of 
15%, a blastocyst formation rate of 14% and an IR of 0% (Athayde Wirka et 
al, 2014). Interestingly, this investigation also found that 35.2% of those 
exhibiting CC had good cleavage stage quality. This was however, markedly 
lower than the other abnormal phenotypes observed (DC and abnormal 
syngamy). Again, as with AC, this phenomenon may be under investigated 
due to the reduced likelihood that embryos exhibiting this phenotype will be 
used in treatment.  
 
Finally, an abnormal embryo developmental phenomenon that has yet to be 
discussed in the literature, in terms of time-lapse imaging of embryos from 
fresh treatment cycles, is cell lysis (CL) (Figure 6); a process often visualised 
in frozen thawed embryos (Rienzi et al, 2005; Tang et al, 2006; Yeung et al, 
2009; Bottin et al, 2015). In an analysis of 891 frozen embryo transfer (FET) 
cycles, no pregnancies resulted if CL occurred in over 50% of the embryo. 
However, if CL accounted for 25 to 50% of the embryo the pregnancy rate 
was 3.2%; significantly lower than if less than 25% CL had occurred (16.6%) 





Although these investigations are not entirely synonymous with the current 
analysis, they provide evidence that embryos with lysed cells have a reduced 
implantation potential.  
 
As discussed above, there is disparity in the literature with regards to the 
prevalence and implication of the presence of certain abnormal phenotypes. 
Further investigation into these phenomena is required to determine if their 
presence is severe enough to exclude these embryos from selection for use in 
treatment. Five abnormal cleavage patterns exhibited by embryos (DC, RC, 
AC, CC and CL) are explored in 15,819 embryos detailing their prevalence, 
implantation potential, and the suitability for inclusion of these potential 
deselection criteria in embryo selection models.  
6.2.3 Materials and methods 
	
This investigation was a single site, retrospective observational design. Data 
were obtained from 4559 treatment cycles including 15,819 embryos cultured 
in the EmbryoScope® incubators between January 2014 and January 2016. 
6.2.3.1 Patient criteria 
	
There were no specific patient criteria applied to this investigation.  
6.2.3.2 Oocyte retrieval and embryology 
	
All injected oocytes, fertilised oocytes and unfertilised metaphase II oocytes 
were placed in individual culture drops of G1™ (for all cycles pre September 
2014) or G-TL™ (all cycles post September 2014) and cultured in the 
EmbryoScope®.  
6.2.3.3 Analysis of time-lapse information 
	
For DC, embryos were classified into one of three categories; true DC (T-DC, 
defined as all three resultant cells cleaving on the subsequent cell cycle, each 
having a nucleus and each included in the morula), false DC (F-DC, one or 
more of the above criteria not fulfilled) and unconfirmed DC (U-DC, unable to 
classify as true or false). Unconfirmed DC embryos were defined as such due 




the morula stage was reached. A justification for the choice of this 
classification, not reported elsewhere, lies in unit specific data where two 
obviously distinct DC event patterns were visualised using a TLS. This, as 
well as previous reports of DC patterns (Kola et al, 1987; Kalatova et al, 
2015), led to the development of the three-tiered classification of DC events. 
With regards to the final criterion for T-DC classification (inclusion of all cells 
in the morula), this stage of development was used as an indicator that all 
cells, abnormal or not, would contribute to the eventual blastocyst and would 
not be excluded. Further to this, DC could be proposed as a correction 
mechanism whereby the DC event is a means to remove surplus genetic 
material thus excluding the cells from the eventual blastocyst, described here 
as F-DC and a more favourable type of DC event. Direct cleavage from both 
one to three cells and from two to five cells were included in the analysis.  
Reverse cleavage is defined simply as blastomere fusion. Absent cleavage is 
defined as the process by which a blastomere undergoes a pseudo division 
(seen as a ‘roll’) that does not produce two discernable blastomeres but a 
single, or multiple, extra nuclei within the single blastomere. Chaotic cleavage 
is observed when an embryo undergoes apparent cleavage but does not 
create distinctive blastomeres. Cell lysis is defined as the loss of a blastomere 
through cell lysis (Figure 6). Although not exclusively a phenomena visualised 
through time-lapse technology and one that can be visualised using standard 
embryo morphology assessments, CL is predominantly seen in embryos 
following cryopreservation whereas here CL is described in fresh embryos. 
Thus, this was included in the current investigation to determine the effect of 
CL on the viability of a fresh embryo.  
6.2.3.4 Outcome measures and statistical analyses 
	
The overall prevalence of the five abnormal embryo phenotypes was defined 
per embryo and per treatment cycle. The average patient age, oocytes 
collected and previous attempts were calculated for each of the five 
categories. The fate (transfer, freeze, discard) of each abnormal embryo was 
determined as well as their quality on the day of utilisation defined as good, 




determined where the origin of the fetal heartbeat could be confirmed i.e. 
using known implantation data from an abnormal embryo or not. The number 
of single and double abnormal embryo transfers and the stage at which the 
abnormal embryo(s) was transferred was also determined (Table 13). 
Statistical analyses included the student t-test for the comparison of the 
abnormal phenotype baseline information (patient age, oocytes collected and 
previous attempts) to the control embryo baseline data. The Fisher’s exact 
test was used to compare the IR of the abnormal embryos with normal 
counterparts. Results were considered significant at p<0.05. Statistical 











































Cleavage stage embryos with even blastomeres 
(<20% difference in diameter) and <20% 
fragmentation 
Blastocyst embryos with prominent and compact 





Cleavage stage embryos with 20-50% difference in 
cell diameter and/or 20-50% fragmentation 
Blastocyst stage embryos with easily discernable 





Cleavage stage embryo with >50% difference in 
blastomere diameter and/or >50% fragmentation 
Blastocyst stage embryos with few cells forming the 
inner cell mass and very few cells making up the 
trophectoderm 
Definitions of embryo quality used to classify embryos as good, average and 








































T-DC 1 1 1 0 0 1 
F-DC 6 6 6 0 0 6 
U-DC 16 15 14 1 5 10 
DC 23 22 21 1 5 17 (1xDET) 
RC 9 8 7 1 2 (1xDET) 6 
AC 4 3 2 1 1 2 (1xDET) 
CC 48 37 26 11 20 
(5xDET) 
17 (6xDET) 
CL 2 2 2 0 0 2 
Overall 86 72 58 14 28 44 
Embryo transfer baseline information for each abnormal embryo phenotype 
including the total number of transfers, the number of single embryo transfers 
(SET), double embryo transfers (DET), cleavage stage transfers and 
blastocyst stage transfers. T-DC; true direct cleavage. F-DC; false direct 
cleavage. U-DC; unconfirmed direct cleavage. DC; direct cleavage. RC; 






Data were obtained from 15,819 embryos from 4559 treatment cycles cultured 
in the EmbryoScope® between January 2014 and January 2016. Of the 
15,819 embryos, 14,008 were derived from 3273 treatment cycles where no 
abnormal divisions of interest (DC, CC, RC, AC and CL) were observed and 
thus constituted the control group. These embryos resulted in 3456 embryos 
transferred and 1336 fhbs (IR = 38.66%) (Table 14). The remaining embryos 
(1811) were found to pertain to a treatment cycle (n=1286) exhibiting an 
embryo with one of the abnormal division patterns of interest.  
 
Abnormal phenotypes with the highest prevalence per embryo observed were 
DC and CC at 4.38% (T-DC, F-DC, U-DC, collectively) and 5.25%, 
respectively. The remaining phenotypes had considerably lower prevalence 
ranging from 0.41 to 0.84% (Table 15). The overall prevalence of abnormal 
division patterns per embryo observed was 11.39% (Table 15). The IR of 
abnormal embryos ranged from 0 to 33.3% (Table 15). Of the five abnormal 
division patterns the IR of U-DC, CC and RC were significantly lower than 
normal counterparts; 12.5% (2/16), 2.1% (1/48) and 0% (0/9), respectively 
(Table 15). Furthermore, the overall IR of all abnormal embryos was 
significantly lower than normal counterparts (6.9% (6/86) vs. 38.66%) (Table 
14 and 15) and of the six implanted embryos, five resulted in a live birth, with 
no birth defects, and one remains ongoing. In all cases the percent of good 
quality embryo (GQE/B) resulting from those exhibiting abnormal division 
patterns never reached above 24% and the majority of embryos were 
classified as poor quality (Table 15). This is also reflected in the utilisation of 
these embryos where the highest proportion of each group was discarded 
(Figure 7). The proportion of embryos undergoing either DC from one-to-three 
or two-to-five cells in each of the DC categories was as follows, respectively; 








Table 14. Baseline information for embryos not exhibiting an abnormal 
division pattern.  
Total embryos (n) 14008 
      Embryo transfers(n) 3273 
Embryos transferred (n) 3456 
Sum fhb (n) 1336 
Count fhb (n) 1269 
IR (%) 38.66 
CPR (%) 38.77 
Baseline information for embryos not exhibiting an abnormal division pattern 
Including total number of embryos, number of embryos transferred, number of 
embryo transfers, total (sum) fetal heartbeats (fhb), count of fhb (regardless of 
number), implantation rate (IR), clinical pregnancy rate (CPR). Implantation 
rate was calculated as sum fhb/embryos transferred. Clinical pregnancy rate 























Proportion of embryos transferred, frozen or discarded that underwent an 
abnormal division pattern where direct cleavage (DC) includes true direct 
cleavage (T-DC), false direct cleavage (F-DC) and unconfirmed direct 
cleavage (U-DC) combined. RC; reverse cleavage, AC; absent cleavage, CC; 



















Patient age was significantly lower for those undergoing DC, RC and CC to 
those not exhibiting an abnormal division pattern. The number of oocytes 
collected was found to be significantly higher in treatment cycles containing 
abnormal embryos than those not containing embryos exhibiting an abnormal 
division pattern. Finally, the number of previous attempts was not found to be 
significantly different between any of the abnormal division categories and the 
control embryo cohort (Table 16). Baseline information from treatment cycles 
containing an abnormal embryo did not contribute to baseline information for 

















The prevalence of DC in the literature has been stated as 13.7% (Rubio et al, 
2012) and 18% (Hickman et al, 2012). In the current analysis the overall 
prevalence of DC was 4.38% (U-DC, F-DC and T-DC combined) occurring in 
1.22 embryos per treatment cycle. The implantation potential of embryos 
undergoing DC has been stated as just 1.2% (Rubio et al, 2012) however, in 
the current analysis the IR was found to be 17.4% (4/23) (T-DC, F-DC and U-
DC combined); not significantly lower than that of the control embryo cohort 
although this could be attributed to the reduced numbers. A classification 
system of DC was not adopted by other publications therefore if F-DC were 
not considered, the IR would be significantly lower than those not exhibiting a 
DC. Of the three categories, those that were classed as F-DC had the highest 
IR, as one might expect from the definition. There is a paucity of literature 
regarding the exact mechanisms underlying the phenomenon of DC however 
a recent comprehensive review discusses both molecular and cellular 
mechanisms that could be related (Kalatova et al, 2015). In particular, 
centrosome defects are suggested as possible causes for DC facilitated 
through the lack of certain regulatory proteins such as p53. The presence of 
surplus centrosomes leading to DC, as suggested by Kalatova et al (2015), is 
reflected in an early investigation of tripolar oocytes. Genetic assessment of 
tripolar DC oocytes revealed three division patterns; DC to three cells (62%); 
cleavage to a morphologically normal two-cell ‘embryo’ (24%) and cleavage to 
a two cell ‘embryo’ plus an extrusion (14%) (Kola et al, 1987). All triploid 
oocytes that had undergone DC to three cells were chromosomally abnormal 
with each containing a varied number of chromosomes (here considered a T-
DC). Those that cleaved to morphologically normal two cell ‘embryos’ were 
found to be true triploid with each blastomere containing a 69XXX/XXY 
chromosome complement. However, of those oocytes that cleaved to a two 
cell ‘embryo’ plus an extrusion, 75% were found to have two diploid 
blastomeres and a haploid extrusion. In the analysis presented here, the IR of 
F-DC, those embryos analogous to the two cell embryo plus an extrusion, was 
33.3% (2/6). Caution should be taken as the numbers are considerably 




however, this represents a result just over 5% lower than that of a 
phenotypically normal embryo. Although speculative, the findings by Kola et al 
(1987) not only corroborate the aforementioned theory by Kalatova et al 
(2015) of amplified centrosome material, but could also indicate that embryos 
have the potential to correct genetic abnormalities. There are many studies 
detailing self correction between the cleavage stage and the blastocyst stage 
of embryo development (Voullaire et al, 2000; Li et al, 2005b; Munne et al, 
2005; Barbash-Hazan et al, 2008; Northrop et al, 2010). It has been noted 
that trisomy embryos correct more often than other aneuploidies (Barbash-
Hazan et al, 2008) possibly occurring through the loss of a chromosome in 
trisomy cells (Munne et al, 2005). In addition, in previous reports, CC could be 
misinterpreted as a DC thus causing the prevalence of DC to appear falsely 
increased. The increased IR of DC seen in the present investigation 
compared to previous reports may also be due to observers having 
experience with the different categorisations of DC, making them proficient at 
recognising patterns of F-DC, such as blastomere behaviour, allowing 
preferential selection of a potential F-DC in U-DC cases. The reduced patient 
age and increased number of oocytes collected may reflect a simple 
association between maternal age and number of oocytes collected. 
However, it may also indicate that stimulation can lead to reduced oocyte 
quality (Aboulghar et al, 1997) and high oocyte numbers (>15) can reduce the 
chance of a live birth (Ji et al, 2013), which could manifest as an abnormality 
such as DC.  
 
Reverse cleavage occurred in 65 embryos (1.07 embryos per treatment cycle) 
of which 36 were either transferred or frozen where 26 were classed as good 
or average quality. It is likely that embryos classed as poor quality were 
utilised due to unavailability of others. The IR of embryos undergoing RC in 
the current investigation was 0% (0/9). The prevalence of RC has been 
reported as 6.8, 7 and as high as 27.4% in previous reports (Hickman et al, 
2012; Desai et al, 2014; Liu et al, 2014). However, the rate of formation of 
usable embryos is in conjunction with others at approximately 40% (Desai et 
al, 2014). There have been reports that RC is affected by other variables such 




a possible explanation for the disagreement presented here could be due to 
the difference in baseline patient and treatment variables, a consideration for 
further investigation. The phenomenon of RC has been recognised previously 
with regards to frozen thawed embryos (Trounson, 1984; Balakier et al, 2000). 
Balakier et al (2000) sought to determine the chromosomal changes in 
blastomeres that undergo fusion following thawing. This analysis included 
1141 embryos frozen on day two and 873 frozen on day three. Reverse 
cleavage was found in 51 embryos of which 70% were classed as good 
quality. The overall frequency of RC was 4.6% in day two embryos and 1.5% 
in day three embryos. A slightly higher incidence of blastomere fusion was 
found in embryos created using IVF when compared to ICSI. When a control 
group was observed (embryos not subject to freezing and thawing) the 
prevalence of RC was 0.3%, a result not far from that recorded in the present 
study (0.41%). The IR of embryos that underwent blastomere fusion following 
thawing in the above investigation was very poor with 15 embryo transfers 
containing one abnormal and one normal embryo resulting in a single live 
birth only. Again, a result similar to that seen in the present investigation 
where no pregnancies resulted from nine embryos transferred that had 
undergone RC. The chromosomal status of blastomeres resulting from fusion 
was also examined where embryos affected by RC were transformed into 
either polyploidy or mosaic embryos. The authors suggested that the 
occurrence of blastomere fusion could be associated with existing membrane 
abnormalities that could promote fusion affected by factors such as pH, 
temperature and osmolality differences. Interestingly, in some fields of 
research the production of tetraploid embryos is advantageous and it has 
been concluded that tetraploidy does not prohibit preimplantation 
development (Eglitis, 1980); corroboration for the development of 
approximately 40% good or average quality embryos in the present 
investigation. This investigation could conclude similarly to others where the 
presence of RC did not seem to affect an embryos ability to create a good 
quality embryo but does impair an embryos ability to implant.  
 
Absent cleavage has been characterised as a type of RC in a previous report 




phenotype. The prevalence per embryo of this abnormality compared to RC is 
more than double (0.84 vs. 0.41%) and of the four embryos that were 
transferred with this phenotype, one implanted. However, in a previous report, 
of 22 embryos, none implanted that underwent type I or type II RC (defined 
here as AC) (Liu et al, 2014). In another investigation using disaggregated 
human embryos, blastomeres were scored for the number of nuclei present 
after 16 to 20h culture and a small proportion of mononucleated blastomeres 
exhibited two nuclei after culture. It was hypothesised that approximately 30% 
of these occurred through AC (Pickering et al, 1995). Here, AC was shown to 
occur in 1.08 embryos per treatment cycle and of the 133 embryos exhibiting 
AC, 122 were classed as poor quality and 116 were discarded. Unlike DC, RC 
and CC however, the patient age was not shown to be significantly different 
when compared to the control embryo cohort.  
 
Chaotic cleavage has an overall prevalence per embryo of 5.25%; by far the 
highest of the five abnormal phenotypes. Occurring in 1.82 embryos per 
treatment cycle suggestive of a patient, treatment or environmental effect 
rather than a spontaneous event. One comprehensive analysis identified the 
prevalence of CC to be 15%, with a blastocyst formation rate of 14% and an 
IR of 0% (Athayde Wirka et al, 2014). In the current analysis, the IR of these 
embryos was 2.1% (1/48); significantly lower than the IR of the control embryo 
cohort. Of the utilised embryos, just 18.2% were classed as good quality, 
27.3% as average and 54.5% as poor. Interestingly, it has previously been 
found that 35.2% of those exhibiting CC were classed as good quality, a result 
not synonymous with the current analysis. A possible explanation for this 
disagreement is the TLS used. In the current analysis, EmbryoScope® was 
the TLS of choice however, in the analysis by Athayde Wirka et al (2014) the 
Eeva™ system was used. The Eeva™ system uses dark field illumination to 
enable the software within it to track blastomeres. The EmbryoScope® does 
not use dark field illumination which could make distinction of blastomeres 
from fragments more straightforward. An investigation conducted on patients 
carrying a Robertsonian translocation (the fusion of two acrocentric 
chromosomes), revealed that a high proportion of embryos resulting from 




aneuploid segregation of the Robertsonian translocation being the only 
reason for the infertility, there may be a post zygotic manifestation leading to 
uncontrolled chromosome segregation (Conn et al, 1998). The presence of 
chaotically dividing embryos has been noted elsewhere (Harper and Delhanty, 
1996; Delhanty et al, 1997; Laverge et al, 1997) and has also been identified 
as a patient related phenomenon (Delhanty et al, 1997) a statement 
synonymous with CC occurring in up to 1.82 embryos per treatment cycle.   
 
Cell lysis is largely discussed in the literature when considering frozen thawed 
embryos and, as discussed previously, there is an associatively low IR (Tang 
et al, 2006). 59.2% of the embryos were classed as poor quality with 55.6% of 
the total discarded. Just 13.6% were considered good quality and 27.2% 
average quality, a result similar to other abnormal phenotypes. As very few 
embryos were shown to exhibit this phenotype, and fewer still were 
transferred, it is difficult to draw conclusions about the implications of this 
abnormal phenotype. It would be reasonable to use previous evidence 
regarding frozen thawed embryos to attribute their potential for success. 
However, CL in frozen embryos is likely as a result of cryo-damage during the 
freeze thaw process whereas, in fresh embryos, the CL could be as a result of 
exposure to another stressor such as suboptimal pH, temperature or 
osmolality. Cells that lyse may have a heightened sensitivity to changes in the 
environment, or lack a cytoplasmic constituent that regulates cell volume, for 
example, leading to its lysis.  
6.2.5.1 Abnormal phenotypes as deselection criteria 
	
Where possible, U-DC and T-DC embryos should not be selected for transfer 
if other embryos are available, even when embryo quality is considered. It is 
important to note at this point that embryos transferred at the cleavage stage 
undergoing DC (of which there were five in the current analysis) will inevitably 
be classed as U-DC. These embryos may have resulted in F-DC thus caution 
is advised due to a potential bias in the current results of U-DC cleavage 
stage embryos. For this reason, extended culture of DC embryos may be 




further in embryo selection and management of patient expectation. Chaotic 
cleavage, the most common abnormal phenotype in the current analysis, has 
been linked to severe chromosomal abnormalities in the literature which could 
be patient specific therefore it’s possible that the phenomenon could occur 
more than once in a patient cohort indicating an underlying genetic condition. 
Where CC embryos are transferred the expected IR is 2.1% regardless of 
embryo quality. For this reason, identification of CC as a deselection tool 
should be considered for laboratories utilising TLS. Just fewer than 92% of 
embryos that exhibit AC create poor quality embryos thus they would likely be 
automatically discounted from clinical use. Reverse cleavage and CL each 
have an IR of 0%, albeit from low numbers of transferred embryos. However, 
the relative prevalence is low, the majority of embryos exhibiting these 
phenomena are poor quality and they are not able to implant therefore these 
embryos should not be selected for transfer where possible. These 
recommendations have been implemented at the study site to aid in embryo 
selection. In addition to the above, the need for accurate and consistent 
annotation of embryos is imperative for any centre utilising TLS. This issue 
was raised a number of years ago resulting in the publication of suggested 
terminology in order to create consensus among users (Ciray et al, 2014). 
Consensus is paramount and caution is advised when implementing or 
analysing time-lapse parameters discussed by others.  
 
This preliminary investigation sought to determine the prevalence, 
implantation potential and suitability for inclusion in ESAs of five abnormal 
cleavage events. To determine IR, only known implantation embryos were 
used leading to a significant reduction in the number of embryos available for 
analysis. Nevertheless, this number would be difficult to achieve at another 
single site based on the study site using TLS for all patients and performing 
over 2000 treatment cycles per year. In addition, the ability to track the 
implantation of these embryos is made more difficult with the increased 
likelihood of transferring two embryos in these cases, potentially due to 
reduced embryo quality in the available embryo cohort. Based on the results 
presented here, future analyses should focus on embryos undergoing more 




cleavage event occurs, the effect of treatment parameters such as ICSI and 
day of transfer as well as the assessment of a relationship between the 
abnormal phenotypes and multinucleated blastomeres (MNB). In addition, the 
authors plan to perform an extension of this analysis to include embryo quality 
and outcome information regarding DC one-to-three versus two-to-five cells in 
the DC classifications presented here. Finally, scrutiny should be paid to CL 
where the specific timings of the CL event should be assessed and linked to 
the relative impact on embryo viability.  
 
In conclusion, embryos exhibiting an abnormal phenotype appear to have 
reduced developmental capability expressed as both embryo quality and 
implantation potential. Time-lapse systems are bringing to light many unusual 
and, most likely, fundamentally complicated embryological phenomena 
requiring in depth analysis that could ultimately improve the outcome of 
treatment cycles.  
6.2.6 Dissemination  
 
The above research was prepared for publication in Reproductive 
BioMedicine Online. The research was accepted for publication on 17th 



















CHAPTER 7: The effect of environmental factors on 
embryo development  
7.1 Prelude 
	
Preceding chapters, with regards to annotation, have been concerned with 
interrogation of the information that a TLS can provide in the form of validation 
of externally derived ESAs as well as the identification of five abnormal 
cleavage events that have been shown to reduce an embryos chance of 
implantation. The following chapter aims to assess the effect of patient, 
treatment and environmental factors on morphokinetic parameters. This 
chapter includes an interim analysis of a sibling oocyte study which aims to 
determine differences, if any, in embryo development, both morphokinetic and 
morphologic, between three commercially available culture media. Further to 
this, a regression analysis was performed to identify any patient and treatment 
parameters significantly affecting nineteen morphokinetic features of embryo 
development. This chapter aims to support the hypothesis that specific ESAs 
are required for the true potential of TLS to be realised.  
7.2 Embryo quality and morphokinetics are affected by culture 
media type: an interim analysis of a sibling oocyte study.  
	
7.2.1 Abstract  
	
Literature suggests that treatment, environment and patient parameters can 
affect an embryo’s early morphokinetic profile indicating that the use of 
standardised morphokinetic ESAs may not be clinically effective. An ongoing 
sibling oocyte study was commenced in August 2016 where embryos from 
patients having ICSI or IVF treatment, were randomised, following injection or 
fertilisation check, to three commercially available culture media, namely G-
TL™, SAGE-1-Step™ and Continuous Single Culture® (CSC). Nineteen 
absolute and interval morphokinetic parameters were assessed for 
differences using the related-samples Friedman’s two-way analysis of 




normality using D-Agostino and Pearson normality test.  Blastocyst formation 
rate (BFR), utilisation rate (UR) and incidence of abnormal cleavage events 
were analysed using Fisher’s exact test. All results were considered 
significant at p<0.05. Patients (n=32) contributed 432 oocytes resulting in 293 
embryos. The BFR was not different between any culture media at 64.15%, 
77.89% and 73.91%, for G-TL™, Sage-1-Step™ and CSC, respectively 
(p=0.08). The UR (embryos transferred and cryopreserved) were, however, 
significantly different; 39.62%, 65.26% and 57.61%, respectively (p=0.0009). 
A total of 80 embryos underwent an abnormal division event (cell lysis, direct 
cleavage, chaotic cleavage, absent cleavage and reverse cleavage) although 
there was no significant difference in the incidence of abnormal division 
between the three media at 43.75%, 22.50% and 33.75%, respectively 
(p=0.07). Absolute (t2, t3, t4, t5, t6, t7, t8, t9, tM, tSB, tB) and interval 
morphokinetic parameters (s2, s3, cc2, cc3, cc4, t9-tM, tM-tSB, tSB-tB) were 
assessed. Of 293 embryos, 36.18% were cultured in G-TL™, 32.42% in 
SAGE-1-Step™ and 31.40% in CSC. Of the nineteen morphokinetic 
parameters assessed, tM (p=0.03) and t9-tM (p=0.005) were significantly 
reduced in embryos cultured in CSC. This investigation allows for the control 
of confounding factors of patient or treatment origin therefore, it is surmised, 
any observed effect is a true reflection of the culture media. This implies that 
the development and validation of ESAs must be specific, robust and 
prospective before being introduced for clinical use.  
7.2.2 Introduction 
	
Since the introduction of TLS into the IVF laboratory, many have sought to 
utilise its capability to visualise an embryo’s morphokinetic timeline as a proxy 
for embryo viability. This aim led to the development of ESAs. Such ESAs 
have, thus far, been developed on the premise that preimplantation embryos 
are classed as independent observations therefore the interference of 
confounding factors has not been accounted for (Kirkegaard et al, 2016) 
creating a one-size-fits-all approach. The external validation of certain 
developed ESAs has highlighted that they lose clinical effectiveness and are 
not easily transferred as shown in Chapter 5 and by others (Freour et al, 




of external application of developed ESAs, evidence also emerged suggesting 
that embryo morphokinetics could be affected by a number of patient and 
treatment parameters such as BMI (Bellver et al, 2013), lifestyle choices such 
as smoking (Freour et al, 2013), the use of IVF or ICSI for fertilisation (Cruz et 
al, 2013) and the drugs used for controlled ovarian stimulation (Munoz et al, 
2012; 2013). Following this, regression analyses were performed to determine 
the effect of patient, treatment and environmental parameters on an embryos 
morphokinetic timeline as outlined later in Chapter 7 as well as by others 
(Kirkegaard et al, 2016). That carried out by Kirkegaard et al (2016) observed 
that embryos had delayed development when maternal age, FSH dose and 
attempt number were increased. In addition to the effect of patient and 
treatment parameters, the environment has also been assessed; specifically 
the culture media.   
 
Human embryo culture has been, and remains, extensively investigated. 
However, human embryo metabolism is far from being fully understood. This 
is primarily because of its complex nature but also because of the lack of 
human material to perform investigations as well as the absence of an 
appropriate in vivo animal model (Menezo et al, 2013). The effect of culture 
media on embryo development has focused on the two culture systems 
available to the laboratory; single-step and sequential (Biggers and 
Racowsky, 2002; Sepulveda et al, 2009; Biggers et al, 2005; Perin et al, 2008; 
Hentemann and Bertheussen, 2009). The principles of each system relate to 
two hypotheses regarding embryo metabolism; ‘let the embryo choose’ and 
‘back to nature’ (Summers and Biggers, 2003). The former is one that is 
currently favoured and is the principle underpinning the use of a single-step 
culture medium. This system provides the embryo with all the nutrients 
required for development to the blastocyst stage and relies upon the embryo 
utilising that which it requires. The latter denotes the use of a sequential 
culture system where a change in culture medium is required on day three of 
embryo development and each formulation of culture media (pre and post day 
three of development) provides only those substrates that the embryo 
requires at each particular stage. Analyses seeking to determine whether 




in comparing fundamentally different culture systems; single-step versus 
sequential (Ciray et al, 2012; Basile et al, 2013). This may reflect the 
increased availability of commercial versions of single-step culture media in 
recent years as well as the rapid interest in TLS and the notion of an 
undisturbed environment. Although single-step culture media are now 
common place in IVF laboratories, there remains of paucity of data relating to 
the morphokinetic effects of such culture media, particularly beyond the five-
cell stage.  
 
The current investigation aimed to observe the effect of three different types 
of commercially available single-step culture media (G-TL™ (Vitrolife), SAGE 
1-Step™ (Origio), Continuous Single Culture® (CSC) (Irvine Scientific)) on 
nineteen morphokinetic parameters and embryo quality using a sibling oocyte 
study design. The detrimental effects of ammonium on embryo development 
on in vitro embryo development have been previously described (Lane et al, 
2001; Zander et al, 2006; Lane and Gardner, 2003; Gardner and Lane, 1993; 
Lane and Gardner, 1994; Lane and Gardner, 1996). As such, it was 
considered prudent to also investigate ammonium accumulation in the three 
culture media over the course of a standard incubation period in both the 
EmbryoScope® incubator in EmbryoSlides® and in a standard incubator in 
tubes. It was deemed appropriate that an interim analysis be performed to 
assess the results thus far in terms of fulfilling the original power calculation 
(appendices section 9.4.2). 
7.2.3 Materials and methods 
	
Patient recruitment commenced in August 2016. Patients were approached at 
their initial consultation or initial clinical appointment where they were given 
the patient information sheet and consent form (appendices section 9.4.3) by 
a research nurse. Patients were given at least 14 days to consider the 
information and sign the consent form. The patients were then re-approached 
at their baseline scan to confirm participation. For those that had consented to 






7.2.3.1 Patient criteria 
	
Inclusion criteria for participation in the trial included; both partners less than 
38 years old; first treatment cycle; fresh, autologous gametes used in 
treatment; conventional IVF or ICSI used to create embryos; six oocytes 
injected for ICSI or three embryos created following IVF. A total of 32 patients 
fulfilled the inclusion criteria, consented to participate and had 
oocytes/embryos randomised. 
7.2.3.2 Oocyte retrieval and embryology 
	
Following ICSI or fertilisation check (for IVF cases only), injected oocytes 
(ICSI) or embryos (IVF) were randomly assigned, equally, to one of the three 
culture media; G-TL™, SAGE 1-Step™ and CSC. For this analysis, G-TL™ 
was classed as the control media by virtue of its established use at the test 
site. As such, where one surplus injected oocyte or embryo was available, it 
was assigned to G-TL™. Where two surplus injected oocytes or embryos 
were available, one was assigned to G-TL™ and one to SAGE 1-Step™. 
Those oocytes/embryos destined for culture in G-TL™ received a thorough 
wash in one well of a 4-well dish containing 0.65ml of equilibrated G-TL™ 
before being cultured in drops 1-4 of an EmbryoSlide®. Those 
oocytes/embryos destined for culture in SAGE 1-Step™ received a thorough 
wash in one well of a 4-well dish containing 0.65ml of equilibrated SAGE 1-
Step™ before being cultured in drops 5-8 of an EmbryoSlide®. Those 
oocytes/embryos destined for culture in CSC received a thorough wash in one 
well of a 4-well dish containing 0.65ml of equilibrated CSC before being 
cultured in drops 9-12 of an EmbryoSlide®. Where more than 12 
oocytes/embryos were to be randomised, a second EmbryoSlide® was used 
in the same manner as the first. Culture conditions for the three culture media 
were consistent and no media-specific optimisation was performed prior to the 
study.  
7.2.3.3 Ammonium assessment 
	
Ammonium assessment was carried out in two vessels; EmbryoSlide® dishes 




of 100µl of media every 24h for a total of 168h (day -1 to day 6) from the three 
media types (n (G-TL™) = 24, n (SAGE 1-Step™) = 24, n (CSC) = 24). 
EmbryoSlides® were prepared including 12 micro wells of 25µl of either G-
TL™, SAGE 1-Step™ or CSC with 1.4ml oil overlay. Dishes were placed in 
EmbryoScope® instruments and the time entered recorded as time zero. 
Three 100µl samples of each culture media was taken immediately (day -1) 
and every 24h thereafter, with immediate snap freezing (placed in a -50°C 
freezer), up to 168h. Each sample was taken by placing the pipette directly 
into the culture drops and removing the required volume of media whilst 
ensuring no oil was aspirated. The pipette tip was cleaned with a lint-free 
tissue to remove oil residue and the sample expelled into a pre-labeled 
Eppendorf® tube. This process was repeated until the Eppendorf® tube 
contained 100µl. The sample was then snap frozen until analysis. 5ml tubes 
containing 1ml of each culture media were prepared. Three 100µl samples of 
each culture media was taken immediately (day -1) and every 24h thereafter, 
with immediate snap freezing, up to 168h (n (G-TL™) = 24, n (SAGE 1-
Step™) = 24, n (CSC) = 24). Analysis of ammonium accumulation was 
performed using a glutamate dehydrogenase methodology (MULTIGENT 
Ammonia Ultra).  
7.2.3.4 Outcome measures and statistical analyses 
	
Nineteen absolute and interval morphokinetic parameters were assessed 
between three culture media using the related-samples Friedman’s two-way 
analysis of variance by ranks or a one-way ANOVA based on a test for 
normality (D’Agostino and Pearson normality test); t2-t9, tM, tSB, tB, s2, s3, 
cc2, cc3, cc4, t9-tM, tM-tSB, tSB-tB. Blastocyst formation rate (BFR), 
utilisation rate (UR), proportion of top quality blastocysts and incidence of 
abnormal cleavage events were analysed using Fisher’s exact test. A two-
tailed sample size calculation with 95% power value and 0.05 alpha value was 
performed (appendices section 9.4.2) however as this is an interim analysis 
these requirements were not fulfilled. Differences in ammonium build-up were 
determined between the three culture media in the two vessel types also 




one-way ANOVA based on a test for normality (D’Agostino and Pearson 
normality test). All results were considered significant at p<0.05. 
7.2.4 Results 
	
7.2.4.1 Media trial results 
	
A total of 293 embryos resulted from the participation of 32 patients in the 
media trial (data summary in Table 20). Of the 32 participants, 20 underwent 
IVF and 12 underwent ICSI. For clinical reasons, in seven cycles, all embryos 
were electively frozen, and the remaining 25 resulted in a blastocyst transfer 
(Table 20). The fates of embryos varied significantly between G-TL™, SAGE 
1-Step™ and CSC with a lower proportion of embryos cultured in G-TL™ 
resulting in utilisation (p=0.0009, Table 20). Of the 293 embryos, 210 created 
blastocysts (Table 21). The proportion of good, average and poor quality 
blastocysts (GQB, AQB, PQB) varied significantly between culture media with 
fewer top quality embryos being created from embryos cultured in G-TL™ 
(p=0.04, Table 21). A total of 80 of the 293 embryos underwent an abnormal 
division event; CL, DC, CC, AC or RC (Table 22). The proportion of abnormal 
embryos in each culture media did not differ significantly (p=0.07) (Table 22).  
 
Full annotation from tPNf through to tB was undertaken in 210 blastocysts, 
however, 72 of these embryos did not have a full match with all culture media. 
This is a result of an uneven number of embryos cultured in the media either 
following ICSI (unable to predict fertilisation therefore some media contained 
no fertilised oocytes) or from the fertilisation of a number of oocytes not 
divisible by three following IVF fertilisation check. A further 51 of the 210 
embryos reaching the blastocyst stage underwent an abnormal division event, 
therefore, one or more annotations were not performed. The remaining 
embryos (87) had full annotation from tPNf to tB and there was appropriate 
matching to perform the statistical analysis. Statistical differences were found 
between the three culture media when considering tM (p=0.03) and the time 
between t9 and tM (p=0.005). All other morphokinetic parameters did not vary 





Table 20. Data summary of participants of the three culture media trial. 
Patients (n) 32 
IVF cycles (n) 20 
ICSI cycles (n) 12 
Blastocyst transfer (n) 25 
Freeze all cycles (n) 7 
 
 G-TL™ SAGE 1-Step™ CSC Total 
Oocytes (n) 130 114 104 348 
Embryos (n) 106 95 92 293 
Embryos transferred (n) 6 13 7 26 
Embryos frozen (n) 36 49 46 131 
Embryos discarded (n) 64 33 39 136 
Utilisation rate (%) 39.62* 65.26 57.61 53.58 
Number of participants, IVF and ICSI cycles, blastocyst transfers and freeze all 
cycles, number of oocytes, embryos and the utilisation of embryos in each of the 
culture media. The utilisation rate is significantly reduced when embryos are 
cultured in G-TL™ (p=0.0009, Fisher’s exact test). No media-specific optimisation 
was performed prior to the study.  
 
Table 21. Proportion of embryos reaching the blastocyst stage and their quality. 
  G-TL™ SAGE 1-Step™ CSC 
  n % n % n % 
Cleavage stage embryos 12 11.32 6 6.32 14 15.22 
M/CM stage embryos  13 12.26 7 7.37 6 6.52 
Necrotic embryos 13 12.26 8 8.42 4 4.35 
Blastocyst stage embryos  68 64.15 74 77.89 68 73.91 
GQB 33 48.53* 50 67.57 44 64.71 
AQB 10 14.71 12 16.22 11 16.18 
PQB 25 36.76 12 16.22 13 19.12 
Number of embryos reaching the cleavage stage, morula (M) or cavitating morula 
(M), those that became necrotic and those reaching the blastocyst stage. There is 
a significantly lower proportion of good quality blastocysts (GQB) obtained when 
embryos are cultured in G-TL™ (p=0.04, Fishers exact test). No media-specific 
optimisation was performed prior to the study. AQB; average quality blastocyst. 







Table 22. Number of embryos undergoing an abnormal division event in each of 
the three culture media. 
 G-TL™ SAGE 1-Step™ CSC Total  
Abnormal division events (n) 35 18 27 80 
CL (n) 2 0 0 2 
DC (n) 9 4 11 24 
CC (n) 20 11 10 41 
AC (n) 3 3 3 9 
RC (n) 1 0 3 4 
No significant difference in the proportion of embryos undergoing an abnormal 
division event was found (p=0.07, Fishers exact test).  CL; cell lysis. DC; direct 





















Table 23. The effect of culture media type on nineteen morphokinetic 











Statistical test P value 
tPNf 
(hpi) 23.00±2.97 23.44±2.42 23.67±2.55 Non-parametric 0.08 
t2 (h) 2.57±0.42 2.63±0.54 2.56±0.45 Non-parametric 0.79 
t3 (h) 13.39±1.43 13.62±1.20 13.44±1.19 Non-parametric 0.42 
t4 (h) 14.45±3.12 14.35±1.76 14.08±1.36 Non-parametric 0.08 
t5 (h) 26.50±2.68 26.85±2.39 26.83±2.46 Parametric 0.33 
t6 (h) 27.89±3.60 28.39±4.67 27.74±2.60 Non-parametric 0.97 
t7 (h) 30.14±6.66 30.09±5.55 30.54±5.28 Non-parametric 0.52 
t8 (h) 33.53±8.58 32.53±6.28 32.95±6.72 Non-parametric 0.87 
t9 (h) 47.14±5.32 46.77±4.86 47.11±6.12 Non-parametric 0.79 
tM (h) 56.24±6.35 57.39±8.82 53.41±7.15 Parametric 0.03* 
tSB (h) 70.08±6.39 71.13±7.82 69.25±5.37 Parametric 0.34 
tB (h) 81.86±9.53 82.30±9.82 79.88±7.52 Non-parametric 0.73 
s2 (h) 1.06±2.65 0.74±1.27 0.64±0.63 Non-parametric 0.94 
s3 (h) 7.03±7.47 5.67±5.52 6.12±6.40 Non-parametric 0.97 
cc2 (h) 10.82±1.20 10.99±1.24 10.88±0.96 Non-parametric 0.49 
cc3 (h) 12.05±2.48 12.50±2.08 12.75±1.66 Non-parametric 0.52 
cc4 (h) 13.60±6.24 14.24±5.36 14.16±6.35 Parametric 0.9 
t9tM (h) 9.11±4.26 10.62±7.63 6.31±3.78 Parametric 0.005* 
tMtSB (h) 13.84±4.26 13.73±4.97 15.84±6.06 Non-parametric 0.26 
tSBtB (h) 11.78±5.00 11.18±4.55 10.63±5.63 Non-parametric 0.79 
Absolute morphokinetic parameters assessed include tPNf (time to pronuclear 
fading), time to two-cell (t2) through to time to nine-cell (t9), time to start of 
morula (tM), blastulation (tSB) and blastocyst (tB). Interval morphokinetic 
parameters include s2 (t3-t4), s3 (t5-t8), cc2 (t2-t3), cc3 (t4-t5), cc4 (t8-t9), t9-
tM, tM-tSB and tSB-tB. Statistically significant differences were found between 
embryos in the three culture media when considering tM and t9-tM (p=0.03, 
0.005, respectively, one-way ANOVA). S.D.; standard deviation. hpi; hours 











7.2.4.2 Ammonium results 
	
Ammonium levels increased over the course of 168h starting at a minimum 
level of 15.92µmol/l (CSC in EmbryoSlides®) up to a maximum of 56.64µmol/l 
(CSC in EmbryoSlides®) (Table 24, Figure 8). Of the total 144 measurements 
taken, seven were returned as ‘null’; CSC in a 5ml tube at 120h, G-TL™ in an 
EmbryoSlide® at 144h, CSC in an EmbryoSlide® at 0h, 48h, 72h, 96h and 
168h. ‘Null’ indicated that the assay was unable to be performed for a number 
of possible reasons including insufficient sample volume, which is the most 
likely, or reagent or equipment malfunction. Considerable intra-sample 
variability was observed between the triplicate measurements as shown in the 
standard deviations (0.0 to 17.52). The levels of ammonium in CSC increased 
significantly more than SAGE 1-Step™ when cultured in tubes (p=0.0009, 
Friedman test) (Table 25, Figure 9). However, the ‘rate’ of accumulation of 
ammonium did not appear to differ in any other culture media in either tubes 
























Table 24. Ammonium levels (µmol/l) in three commercially available 
culture media from EmbryoSlides® 
 
G-TL™ (µmol/l) 
(mean ± S.D) 
SAGE 1-Step™ 
(µmol/l) 
(mean ± S.D) 
CSC (µmol/l) 
(mean ± S.D) 
0h 28.54 ± 9.87 20.95 ± 2.56 15.92 ± 0.49* 
24h 37.51 ± 1.77 25.07 ± 0.64 23.38 ± 1.44 
48h 46.38 ± 2.08 24.42 ± 1.42 27.08 ± 1.27* 
72h 40.15 ± 4.47 31.38 ± 7.16 33.48 ± 0.00* 
96h 42.26 ± 1.2 26.26 ± 1.38 39.34 ± 2.43* 
120h 35.41 ± 1.53 31.47 ± 5.96 42.58 ± 2.03 
144h 34.86 ± 0.59* 30.98 ± 3.16 51.63 ± 1.47 
168h 39.95 ± 1.99 42.36 ± 7.67 56.64 ± 3.7* 
Ammonium levels in G-TL™, SAGE 1-Step™ and CSC sampled from 
EmbryoSlides® cultured in the EmbryoScope® over 168h. No significant 
differences were detected between groups (p=0.0789, Friedman test). S.D; 
standard deviation.  

















Table 25. Ammonium levels (µmol/l) in three commercially available 
culture media from 5ml tubes 
 
G-TL™ (µmol/l)  
(mean ± S.D) 
SAGE 1-Step™ a 
(µmol/l)  
(mean ± S.D) 
CSCa (µmol/l)  
(mean ± S.D) 
0h 25.23 ± 4.47 18.71 ± 1.0 29.18 ± 8.19 
24h 27.62 ± 2.15 19.52 ± 2.62 27.27 ± 2.52 
48h 28.73 ± 3.08 21.01 ± 4.45 32.99 ± 0.56 
72h 30.94 ± 3.08 20.64 ± 2.25 36.07 ± 2.68 
96h 32.41 ± 1.76 24.49 ± 3.1 40.18 ± 2.91 
120h 29.55 ± 0.96 27.25 ± 2.25 56.14 ± 12.84* 
144h 34.61 ± 1.61 28.53 ± 2.35 59.35 ± 17.52 
168h 32.71 ± 0.68 42.95 ± 0.39 51.76 ± 0.83 
Ammonium levels in G-TL™, SAGE 1-Step™ and CSC sampled from 5ml 
tubes cultured in a standard bench-top incubator over 168h. S.D; standard 
deviation.  
* - one of three results returned as ‘null.’ 


















Figure 8. Mean (and standard error bars) ammonium levels (µmol/l) in three 
commercially available culture media. G-TL™, SAGE 1-Step™ and CSC 
sampled from EmbryoSlides® cultured in the EmbryoScope® over 168h. No 
significant differences were detected between groups (p=0.0789, Friedman test). 
 
 
Figure 9. Mean (and standard error bars) ammonium levels (µmol/l) in three 
commercially available culture media. G-TL™, SAGE 1-Step™ and CSC 
sampled from 5ml tubes cultured in a standard incubator over 168h. CSC 
ammonium levels were statistically significantly higher than SAGE 1-Step™ 
(p=0.0009, Friedman test). No other significant differences between groups 
(p>0.05, Friedman test). 












































The morphokinetic differences of human embryos cultured in three 
commercially available single-step culture media were assessed using a 
sibling oocyte study design. The ammonium concentration in each was 
determined over the course of 168h to establish any differences in this 
unavoidable feature of human embryo culture media. Differences in 
ammonium concentrations may have confounded any true morphokinetic 
differences arising from the culture media per se. Embryos cultured in CSC 
underwent compaction significantly earlier in their development than those 
cultured in G-TL™ or SAGE 1-Step™. In addition, although not statistically 
significant, those stages that follow compaction (tSB, tB) also occurred sooner 
in the morphokinetic timeline for those embryos cultured in CSC. When 
considering embryo development broadly, the proportion of GQB was 
significantly reduced in embryos cultured in G-TL™ and consequently, 
embryos in this culture media were not utilised as often as those in SAGE 1-
Step™ or CSC. There was a noticeable increase in the concentration of 
ammonium over the course of the 168h in all three culture media and there 
was a statistically higher concentration of ammonium in CSC over the course 
of incubation when sampled from a 5ml tube in a standard incubator 
compared to SAGE 1-Step™.  
 
These data suggest that embryos are affected, both morphologically and 
morphokinetically, by the environment in which they are cultured. There have 
been numerous accounts of the effect of culture media on static observations 
of embryos (Quinn, 2004; Balaban and Urman, 2005; Lane and Gardner, 
2007; Sepulveda et al, 2009). Unfortunately, these are not particularly 
relevant to this discussion as most lack the information regarding the specific 
time points or cell numbers meaning the variation could simply be as a result 
of the time of observation. Where morphokinetics are concerned, there is a 
lack of evidence for the comparison of different single-step culture media for 
parameters beyond the cleavage stage of development. Nevertheless, they 
provide evidence for the embryonic effect of the culture environment. The first 




morphokinetics (Ciray et al, 2012) aimed to compare that of early embryo 
development in sequential and single-step culture media from the same 
manufacturer. This study involved a total of 446 oocytes from 51 couples that 
were randomly assigned to either the single-step or sequential culture media 
after injection. The authors concluded that embryos cultured in single-step 
culture media exhibited shorter cleavage times when compared to sequential 
media for all cell divisions up to the five-cell stage. The authors observed a 
significantly higher proportion of utilised embryos in the sequential culture 
media than the single-step media. Although the first publication to highlight 
these morphokinetic differences, the article did not demonstrate a sample size 
calculation therefore it is difficult to determine if it was powered appropriately. 
These results are similar to a service evaluation study performed at the HFC 
where a comparison was made between sequential and single-step culture 
media from the same manufacturer. In this retrospective comparison, a total 
of 6392 embryos over six months were analysed. A statistically significant 
difference for all cleavage events up to the five-cell stage was observed. In 
contrast to the aforementioned study, these data suggested that a higher 
proportion of embryos were utilised that were cultured in the single-step 
medium when compared to the sequential medium (Barrie et al, 2015). A 
further investigation (Basile et al, 2013) assessed the morphokinetic 
parameters of 723 embryos from 75 couples in a single-step culture media 
and a sequential culture media from different manufacturers. This experiment 
found no statistically significant differences in any cleavage event up to the 
five-cell stage, contradictory to those previously published. The authors 
highlighted some pitfalls of their experimentation; primarily, the sole use of 
donor oocytes. Although this methodological choice eliminates some 
confounding factors regarding oocyte quality from the infertile female, it also 
restricts the value of the results, as they are less transferrable to the 
population in question. A more recent prospective analysis compared the 
early embryo cleavage kinetics between two sequential culture systems using 
620 sibling oocytes (Zhang et al, 2016). This study reported no significant 
differences in any morphokinetic timing, morphology, UR or IR. However, this 
research used lax inclusion criteria (patients less than 45 with a BMI less than 




against (Liu et al, 2015), along with no mention of the statistical test used thus 
making it difficult to determine if the statistical analysis was appropriate.  
 
There have been two analyses, using mouse embryos, investigating the 
effects of culture media on morphokinetics beyond the five-cell stage showing 
that certain morphokinetic parameters are affected by constituents in the 
culture media; in the absence of protein t2, cc2, t5-t8 were delayed however, 
in the presence of protein t8-tSB were delayed (Morbeck et al, 2014). More 
recently, a similar analysis has been performed using single-step culture 
media only (Morbeck et al, 2017). This analysis revealed that mouse embryos 
had similar morphokinetic timelines between four commercially available 
single-step culture media however, they were differentially affected by oxygen 
concentration. These analyses, assessing morphokinetic differences between 
culture media, provide evidence that the environment in which embryos are 
cultured can affect morphokinetic parameters.  
 
For the analysis presented here, it is important to consider the constituent 
differences in each of these culture media in order to determine possible 
reasons for the variations seen however, this information is not readily 
available to the end-user which is a long-standing grievance of scientists 
undertaking embryo culture in an IVF laboratory. Morbeck and colleagues 
sought to determine the constituent differences of commercially available 
culture media to elucidate the disparity in their composition; a feat not 
achieved before. Firstly, the composition of seven culture media was 
assessed for glucose, organic acids, amino acids, electrolytes and other 
compounds found in human embryo culture media (Morbeck et al, 2014). 
Stark differences were discovered, notably glucose, one of the main energy 
substrates for embryo development, where concentrations ranged from 0.1 to 
3.2mM. The lactate to pyruvate ratio, also key substrates for embryo 
development, varied considerably ranging from 5-126 and 1.2-105 for 
cleavage, and blastocyst stages, respectively. Other profound differences 
included the discovery of three metals in one media (aluminium, iron and 
manganese) and a 30-times higher concentration of amino acids in one 




popularity of single-step culture media, the same group then analysed four 
commercially available culture media, three of which are those analysed in the 
present research, namely, G-TL™, SAGE 1-Step™, and CSC. This 
examination revealed marked differences in these culture media. G-TL™ had 
five-times higher concentration of glucose than SAGE 1-step™ and two-times 
higher than CSC. Also, G-TL™ also had a two-fold increase in pyruvate 
compared to both CSC and SAGE 1-Step™ (Morbeck et al, 2017).  
 
Using this information it is possible to theorise reasons for the variations in 
both embryo quality and embryo morphokinetics in the current research study. 
Firstly, consideration should be given to the significant differences in glucose 
concentrations as documented by Morbeck et al (2017). It has been 
suggested that glucose has inhibitory effects on embryo development at 
certain stages (Schini and Banister, 1988; Chatot et al, 1989). A significant 
increase in the number of blastocyst cells has also been observed when 
glucose is removed from the culture media at the preimplantation stages 
(Conaghan et al, 1993). It was hypothesised that this could have been a result 
of enhanced cleavage rate at the earlier stages of embryo development. This 
evidence could provide a theory for the reduced number of good quality 
blastocysts in G-TL™ compared to other culture media as G-TL™ had a 
substantially higher concentration of glucose present when analysed in a 
previous report (Morbeck et al, 2017).  
 
In terms of the differences in morphokinetics seen in embryos cultured in CSC 
(i.e. reaching tM faster) these constituent differences may have an influence 
although it is difficult to ascertain the complex interactions that are inevitably 
at work in these circumstances. It is known that pyruvate is the primary 
energy source for pre-compaction embryos and glucose for post-compaction 
embryos (Gardner, 1998). In addition there is a complex relationship between 
metabolites, specifically glucose and amino acids, where negative effects of 
the presence of glucose in the pre-compaction stages in single-step media 
can be counterbalanced by the presence of amino acids (Menezo et al, 2013; 
Guyader-Joly et al, 1997). In the analysis conducted by Morbeck et al (2017), 




culture media assessed here as well as half as much glucose and pyruvate 
compared to G-TL™ and SAGE 1-Step™.  
 
Another obvious difference in the constituents of these three culture media is 
the calcium to magnesium ratio. Calcium is essential for compaction to occur 
in vitro and, of all of the culture media, CSC had the highest calcium to 
magnesium ratio (2.4) when compared to G-TL™ and SAGE 1-Step™ (0.6, 
1.2, respectively) (Morbeck et al, 2017). Interestingly, the use of compaction 
as a marker for embryo viability has been addressed where those embryos 
that compacted earlier have an increased chance of implantation (Alpha 
Scientists in Reproductive Medicine and ESHRE Special Interest Group of 
Embryology, 2011; Le Cruguel et al, 2013). In addition, delayed compaction 
has been observed as a result of a developmental perturbation such as 
embryo biopsy (Bar-El et al, 2016). Clearly, these culture media have vast 
differences in terms of the metabolites that they contain and it may be the 
case that these differences have an effect on embryo morphokinetics.  
 
Where ammonium concentration is concerned, the data presented 
demonstrate an increase over the course of 168h in all three culture media in 
both vessels (EmbryoSlide® and 5ml tube). However, when sampled from 
5ml tubes, there was a significantly increased level of ammonium in CSC 
compared to SAGE 1-Step™. Amino acids spontaneously breakdown in 
culture to produce ammonium and the embryo also metabolises amino acids 
to produce more ammonium (Gardner and Lane, 1993; Lane et al, 2001). 
Amino acids act as pHi regulators, osmolytes and energy substrates and have 
the capacity to either stimulate or inhibit embryo development (Bavister and 
Arlotto, 1990; Bavister and McKiernan, 1992). Increased ammonium 
concentrations in culture media have been significantly linked to embryo and 
fetal development, predominantly in mice (Lane et al, 2001; Zander et al, 
2006; Lane and Gardner, 2003; Gardner and Lane, 1993; Lane and Gardner, 
1994; Gardner and Lane, 1996). To determine these effects on human 
embryos is difficult, as this would require supplementation of the culture 
media with a compound known to be toxic to other species’ embryonic 




suggested to effect embryo development through three possible pathways; 
decreasing the concentration of alpha-ketoglutarate by its conversion to 
glutamate impairing the flux through the Krebs cycle leading to serious 
depletion of ATP in the cell. Second, ammonium can activate the enzyme 
phosphofructokinase, which creates an increase in glycolytic activity in turn 
shown to be detrimental to embryo development. Finally, ammonium as a 
weak base can also increase the internal pH of cells in vitro (Gardner and 
Lane, 1993; Lane and Gardner, 2003).  
 
The results of the ammonium analysis here mirror those found elsewhere 
where those media based on a KSOM formulation (CSC) have a build-up of 
ammonium over the course of 120h up to 55µmol/l (Lane and Gardner, 1993). 
Although the level of ammonium in each of the culture media in the present 
analysis did not reach the critical level of 75µmol/l described in the literature 
(Gardner et al, 2013), this analysis only involved unused culture medium. 
Pertinent to the results in the current analysis are discoveries relating to 
amino acids and pH of the culture media analysed. The analysis conducted by 
Morbeck et al (2017) found that G-TL™, SAGE 1-Step™ and CSC had similar 
pH (7.32, 7.35 and 7.25, respectively) but substantial differences in the total 
amino acid concentrations; 2250µmol/l, 2075µmol/l, 1863µmol/l, respectively, 
with nine essential and five non-essential amino acids higher in G-TL™ and 
SAGE 1-Step™. In addition, this group revealed that G-TL™ lacked 
glutamate, was low in aspartate and additionally contained taurine. G-TL™ 
and SAGE 1-Step™ also had low levels of glutamine. The expected results 
based on this information are not what were observed in the current analysis; 
the media having the highest concentration of amino acids (G-TL™) did not 
have the highest overall ammonium concentrations. It could be however, 
together with the knowledge that there is approximately a three-fold increase 
in ammonium concentration when embryos are present (Gardner and Lane, 
1993) that if there are more amino acids available to the embryo, they may 
metabolise them and generate higher levels of ammonium thus leading to an 
overall reduction in embryo quality, and as such utilisation, as seen in those 
embryos cultured in G-TL™.  In addition, various non-essential amino acids 




therefore if these are present in higher concentrations in G-TL™ this offers 
further explanation for the reduction in embryo quality and utilisation seen. It is 
however, important to note, that no media-specific optimisation was 
performed prior to this study and, owing to the study design (i.e. all three 
culture media in one dish), it would not have been possible to introduce 
differing CO2 concentrations for each culture media. This may be a 
consideration for the reduction in performance of G-TL™ in the present study 
where the pH of the culture media may have been operating at a sub-optimal 
level causing a reduction in the embryo quality and subsequent utilisation 
rate.  
7.2.6 Conclusion  
 
There is a lack of literature comparing morphokinetics, firstly, between 
different single-step culture media and secondly, those parameters beyond 
the five-cell stage.  The current analysis presents evidence that the culture 
environment may affect embryo morphokinetics however this is not as 
obvious as might be expected based on the substantial differences in 
constituents found in the three culture media. Differences in embryo 
development in the three single-step culture media examined were observed 
where the number of good quality blastocysts and the utilisation rate was 
significantly reduced in one type. This assessment represents an interim 
analysis that has not yet fulfilled the sample size required for appropriate 
statistical power. It would be prudent to include additional outcome analyses 
such as pregnancy outcomes however considerably more data would be 
required to determine differences in IR, CPR, and LBR, if any. The results of 
this analysis should be considered when utilising externally derived ESAs and 
the development of patient, treatment and environment specific ESAs should 
be encouraged to account for morphokinetic differences observed in 











7.3 Morphokinetic parameters of embryo development are affected 
by its origin 
7.3.1 Abstract 
	
Since the introduction of time-lapse imaging, more effective methods for 
embryo selection are being sought. As a result, basic investigations linking an 
embryo’s viability to it’s morphokinetic profile have been produced with many 
developing embryo selection algorithms (ESAs). However, there is a lack of 
consideration for the effect of confounding factors such as patient and 
treatment parameters on morphokinetic parameters. This research study 
aimed to determine the effect of patient and treatment parameters on 
nineteen embryo morphokinetic parameters. A total of 2376 embryos from 
639 treatment cycles were analysed in this single-site, retrospective cohort 
analysis using a multiple regression to determine the effect of maternal patient 
age, maternal BMI, suppression protocol, infertility diagnosis and treatment 
type on nineteen morphokinetic parameters using pronuclear fading as time-
zero (t0); time to each cellular division (tn) including t2, t3, t4, t5, t6, t7, t8, t9, 
time to start of compaction (tM), start of blastulation (tSB), full blastocyst (tB) 
and the intervals between each stage including s2, s3, cc2, cc3, cc4, t9-tM, 
tM-tSB and tSB-tB. Data were collated between September 2014 and January 
2016. Patients were included once and embryos were cultured for six days in 
a time-lapse enabled incubator (EmbryoScope®). Results were considered 
significant at p<0.05 and beta coefficients were analysed to quantify any 
significant effects of patient and treatment factors on morphokinetic 
parameters. Complex relationships between various morphokinetic 
parameters and specific patient and treatment factors exist rather than any 
systemic effect. Maternal age was shown to significantly affect t2, t4, tB and 
tM-tSB. An increase in one year of age results in a decrease in t2 by 0.006 
hours (h), t4 by 0.029h, an increase in tB by 0.78h and an increase in tM-tSB 
by 0.92h. Maternal BMI was shown to affect t2 alone where a one-unit 
increase BMI resulted in a decrease in t2 by 0.009h. Those embryos created 
using ICSI (excluding those utilising donor sperm) had significantly different 
t2, tSB, tB, cc2 and tM-tSB measurements compared to those created using 




and tB 1.510h later. Embryos derived from ICSI also have significantly longer 
cc2 (by 0.185h) and tM-tSB (by 0.637h). Suppression protocol had no 
significant effect on any morphokinetic parameter. Morphokinetic analyses 
are, by their nature, subjective. The investigated confounders were not 
exhaustive, as paternal factors, such as age, and the dose of gonadotrophins 
for example, were not considered. In addition, the cohort of embryos available 
to examine the more rare infertility diagnoses and treatment types were 
limited thus conclusions must be made tentatively. The findings outline the 
need for the consideration of confounding factors when assessing an 
embryo’s ability to achieve implantation. Although morphokinetic parameters 
have been related to embryo viability, it is likely that this will vary dependent 
on the embryo’s origin. These data highlight the need for the development of 
patient and treatment specific ESAs that have been prospectively validated in 
appropriate randomised, controlled trials.  
7.3.2 Introduction 
	
Time-lapse systems (TLS) are no longer a novel technique for the culturing of 
human embryos. It is employed by many internationally and has gained a high 
degree of attention based on little scientific evidence (Armstrong et al, 2015). 
In theory, TLS offer two potential benefits; a highly controlled, undisturbed 
culture environment and an increased level of detail when analysing the 
embryos contained within the system. However, a recent Cochrane review 
concluded that ‘there is insufficient evidence of differences in CPR, LBR, MR 
still birth rate to choose between TLS [time-lapse systems] and standard 
incubation’ (Armstrong et al, 2015). It is notoriously difficult for clinics to 
perform the much-needed randomised controlled trials for a multitude of 
reasons; funding availability, lack of patient interest and difficulty in the 
approval process. As a result, many turn to retrospective, observational 
investigations to determine the relevance and significance of the environment 
and the information that TLS can provide, of which the pitfalls of such 
experimental designs have been highlighted (Kirkegaard et al, 2016).  
 
What does remain novel about TLS is not their use per se, in the simplest 




can capture images of embryos every five to ten minutes over a period of six 
days, generating over 700 images per embryo. The wealth of information 
available to the user regarding one embryo is, undeniably, astronomical but 
exactly how to use this information is a problem posed and the reason this 
feature of TLS remains novel.  
 
Morphokinetic data (the timings at which an embryo reaches a developmental 
milestone) provided by TLS have been identified that correlate with the 
embryo's ability to create a pregnancy both in humans and animals; the 
appearance and disappearance of PN and nuclei at each cell stage (Payne et 
al, 1997; Lemmen et al, 2008; Scott, 2010; Azzarello et al, 2012) the length of 
time between early cytokineses (Gonzales et al, 1995; Ramsing and Cellesen, 
2006; Ramsing et al, 2007; Lechniak et al, 2008; Herrero et al, 2011; 
Meseguer et al, 2011; Cruz et al, 2012; Hlinka et al, 2012) direct one to three 
cell divisions (Rubio et al, 2012), and start times of blastulation (Campbell et 
al, 2013a).  
 
With this information in tow, many pursued the development of models that 
generate an embryo score known as ESAs. As is well known, ESAs 
incorporate a set of instructions for the user where, depending on the answers 
to the questions asked, a score is given that will aid in the selection, or 
deselection, of embryos in any given cohort. Many ESAs have now been 
developed and published each using differing outcome parameters, exclusion 
and inclusion criteria and morphokinetic parameters to define the selection of 
an embryo (Wong et al, 2010; Meseguer et al, 2011; Azzarello et al, 2012; 
Cruz et al, 2012; Campbell et al, 2013a; Chamayou et al, 2013; Dal Canto et 
al, 2012; Basile et al, 2015). Crucially, a number of these ESAs have been 
validated externally with varying degrees of success (Kirkegaard et al, 2014; 
Yalcinkaya et al, 2014; Freour et al, 2015; Barrie et al, 2017).  
 
Unfortunately, the lack of control for confounding variables in time-lapse 
investigations, especially those involving the derivation of ESAs, reduces their 
transferability and means they are likely to only be applicable to the patients 




potential confounders on embryo morphokinetics has been addressed 
recently where seven timing events were analysed to determine the effects of 
various potential confounders including maternal age, treatment type, BMI, 
cumulative gonadotrophin dose and the number of previous attempts 
(Kirkegaard et al, 2016). From this investigation, the authors concluded that a 
high degree of embryo timing variability can be explained by the patient 
demographic rather than an embryos’ viability when considered as part of a 
large cohort of embryos.  
 
The investigation presented here sought to determine the effects of a number 
of patient and treatment parameters on nineteen morphokinetic parameters 
using a multiple regression analysis methodology. The purpose of this 
investigation was to echo that previously found, to inform future directions of 
research, specifically the consideration of embryo origin during the derivation 
of ESAs, and to highlight that the power of TLS in embryo selection is yet to 
be exposed.   
7.3.3 Materials and methods 
	
Data were obtained from 639 treatment cycles including 2376 embryos 
cultured in the EmbryoScope® incubators between September 2014 to 
January 2016. 
7.3.3.1 Oocyte retrieval and embryology  
	
All injected oocytes (following ICSI) and fertilised oocytes (following IVF 
fertilisation check) were placed in individual culture drops of G-TL™ (Vitrolife) 
and cultured in the EmbryoScope® (Vitrolife).  
 
7.3.3.2 Analysis of time-lapse information 
	
The absolute morphokinetic parameters assessed included time to two-cell 
(t2), three-cell (t3), four-cell (t4), five-cell (t5), six-cell (t6), seven-cell (t7), 
eight-cell (t8), nine-cell (t9), time to start of compaction (tM), start of 
blastulation (tSB) and full blastocyst (tB). The interval morphokinetic 




(cc3), t8 and t9 (cc4), t3 and t4 (s2), t5 to t8 (s3), t9 and tM, tM and tSB, tSB 
and tB.  
7.3.3.3 Outcome measures and statistical analysis 
	
A multiple regression was performed on 2376 embryos to determine the effect 
on t2, t3, t4, t5, t6, t7, t8, t9, tM, tSB, tB, cc2, cc3, cc4, s2, s3, t9-tM, tM-tSB 
and tSB-tB of maternal age, maternal BMI, suppression protocol and primary 
infertility diagnosis. All morphokinetic parameters were classed as continuous, 
dependent variables. Maternal age and BMI were classed as continuous, 
independent variables. Treatment type, primary diagnosis and suppression 
protocol were categorical independent variables. However, because treatment 
type and infertility diagnosis were polytomous they required the use of a 
reference category for statistical analysis. The reference category for 
treatment type was IVF and the reference category for infertility diagnosis was 
male origin. As was the case for all morphokinetic parameters, linearity was 
assessed by partial regression plots and a plot of studentised residuals 
against the predicted values. There was independence of residuals, as 
assessed by a Durbin-Watson statistic (1.00-2.00). There was 
homoscedasticity, as assessed by visual inspection of a plot of studentised 
residuals versus unstandardised predicted values. There was no evidence of 
multicollinearity, as assessed by tolerance values greater than 0.1. No 
studentised deleted residuals were excluded from the analysis as they did not 
have leverage values greater than 0.2 and values for Cook’s distance above 
1. The assumption of normality was met, as assessed by Q-Q Plot 
(appendices section 9.5). Results were considered significant at p<0.05. 
Statistical analysis was performed using the statistical package for the social 
sciences (SPSS) (IBM corporation, 2015) (statistical analysis excerpt in 
appendices section 9.5).  
7.3.4 Results 
	
In total, 2376 embryos from 639 patients were included in this analysis. None 
of the patient or treatment parameters affected the morphokinetics of embryo 
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Instead, complex relationships appeared to exist between specific morphokinetic 
parameters and patient and treatment parameters. Of all assessed parameters, 
suppression protocol (buserelin or cetrotide) had no significant effect on any 
morphokinetic parameter. Maternal age was shown to significantly affect t2, t4, tB and 
tM-tSB. Female patient BMI was shown to affect t2 alone. The assessment on infertility 
diagnosis revealed an affect on t2, t3, t7, t9, tB and tSB-tB when donor sperm was 
used (e.g. in a same sex relationship or in severe male factor cases). In addition, and 
as a reflection of this, when assessing the morphokinetic parameters based on 
treatment type, t2, t3, t5, t6, t9 and cc2 were affected when ICSI using donor sperm 
was performed and t9, tB and tSB-tB were affected when IVF using donor sperm was 
performed. In addition, those embryos created using ICSI (excluding those utilising 
donor sperm) had significantly different t2, tSB, tB, cc2 and tM-tSB measurements 
compared to those created using IVF.  
 
Beta coefficients, indicating the amount of change elicited by the dependent variable 
(morphokinetic parameter) when a one-unit change in the independent variable (patient 
or treatment characteristics) is made give additional information about the extent to 
which morphokinetic parameters are affected by patient and treatment characteristics. 
With regards to maternal age, an increase of one year results in a decrease in t2 by 
0.006h, t4 by 0.029h, an increase in tB by 0.78h and an increase in tM-tSB by 0.92h. 
This result indicates that embryos from younger patients undergo t2 slower than those 
from older patients however are overall faster than older counterparts. Furthermore, 
where ICSI treatment has been performed (excluding donor sperm) embryos undergo 
t2 0.098h earlier, tSB 1.157h later and tB 1.510h later than those undergoing IVF. 
Embryos derived from ICSI also have significantly longer cc2 (by 0.185h) and tM-tSB 
(by 0.637h). This result indicates that embryos derived from ICSI undergo the first 
cleavage of preimplantation embryo development earlier than those undergoing IVF 
however by the blastocyst stage of development ICSI embryos are overall slower than 
those derived from IVF.  
 






Table 19. Baseline patient information for the analysed embryo cohort in the 
multiple regression analysis.  
Number of embryos 2376 
Number of patients 639 
Number of cycles 639 
Maternal age (mean +/- SD) 32.9 +/- 4.4 
Maternal BMI (mean +/- SD) 24.3 +/- 3.7 
Suppression protocol (n / %)  
Buserelin 275 / 41% 
Cetrotide 364 / 59% 
Cause of infertility (n / %)  
Male factor 225 / 35.2% 
Ovarian 114 / 17.8% 
Uterine 88 / 13.8% 
Donor 4 / 0.6% 
Unexplained 193 / 30.2% 
Endocrine 8 / 1.3% 
Secondary 7 / 1.1% 
Treatment Type (n / %)  
IVF 343 / 53.7% 
ICSI 266 / 41.6% 
IMSI 17 / 2.7% 
TESE-ICSI 7 / 1.1% 
D-IVF 4 / 0.6% 
D-ICSI 2 / 0.3% 
Number of eggs collected (mean +/- S.D) 14.7 +/- 7.3 
Number of embryo transfers 503 
Number of embryos transferred 550 
Number of positive pregnancy tests (n / BPR) 213 / 42.3% 
Number of fhbs (n / IR) 219 / 39.8% 
S.D; standard deviation. BMI; body mass index. IVF; in vitro fertilisation. ICSI; intra-
cytoplasmic sperm injection. IMSI; intra-cytoplasmic morphologically selected sperm 
injection. TESE; testicular sperm extraction. D-IVF; donor-IVF. D-ICSI; donor-ICSI. 
BPR; biochemical pregnancy rate (number of positive hCG tests/number of embryo 
transfers). fhbs; fetal heartbeats. IR; implantation rate (number of fetal hearts/ 











The effect of patient and treatment parameters on nineteen morphokinetic parameters 
was tested using a large group of embryos revealing a number of complex 
relationships between specific patient and treatment parameters and certain 
morphokinetic parameters. The analysis presented adds to the results seen by others 
(Kirkegaard et al, 2016) and together with these highlight the presence of confounders 
when considering morphokinetics.  
 
Firstly, maternal age significantly affected four morphokinetic parameters; t2, t4, tB and 
tM-tSB demonstrating that embryos from younger patients undergo t2 slower than 
those from older patients however are, overall, faster. Although the evidence is lacking 
in the literature regarding the specific relationship between morphokinetic parameters 
and maternal age, aneuploidy could be used as a proxy. It is well accepted that the rate 
of aneuploidy increases with maternal age (Franasiak et al, 2014) and a particular 
investigation observed significant differences in blastulation morphokinetic parameters 
and risk of aneuploidy as determined through trophectoderm biopsy (Campbell et al, 
2013a). From this investigation, a risk classification model was developed and, 
although when externally applied lost efficacy (Kirkegaard et al, 2014; Yalcinkaya et al, 
2014; Freour et al, 2015; Barrie et al, 2017), supports the notion that patient age affects 
morphokinetic parameters. Differences of up to a 0.1h increase were observed in 
embryos from older patients; information that could be useful when selecting embryos 
using ESAs that may not have taken patient age into consideration.  
 
The relationship between maternal BMI and embryo quality is yet to be determined 
however, there are interesting investigations emerging assessing the composition of 
follicular fluid from patients with varying BMIs. The effect of BMI seen in this analysis 
could be due to the requirement for a higher dose of gonadotrophins (Zander-Fox et al, 
2012), which has been demonstrated to affect an embryo’s morphokinetic profile 
(Kirkegaard et al, 2016). The influence of maternal BMI was evident only on t2; a gold 
standard for embryo viability dating back 20 years (Shoukir et al, 1997). Although this 
effect is not sustained throughout embryo development the association could be a 
reflection of embryo viability. For every one-unit increase in BMI t2 occurs 0.009h 





research should be directed to determining the effect of extreme BMIs specifically. It 
has been demonstrated that patients with increased BMI have reduced pregnancy 
rates compared to normal BMI patients (Zander-Fox et al, 2012) thus a clinically 
relevant effect on a morphokinetic parameter so heavily related to viability such as t2 is 
not outwith the realms of possibility.  
 
To consider differences in categories in infertility diagnosis the number of treatment 
cycles in these categories must first be highlighted. For those undergoing treatment 
using donor sperm the number of treatment cycles accounted for 0.6% of the total 
number of treatment cycles. Where infertility was secondary to another disorder, seven 
treatment cycles were included. Nonetheless, significant results were obtained that 
should be included in the discussion as they may indicate a need for further 
investigation. At the test site, donor sperm is cryopreserved before use. The freezing of 
spermatozoa has been shown to affect the integrity of the cells in a variety of ways 
(reviewed by Di Santo et al, 2012). More pertinent to this discussion is the effect 
cryopreservation of sperm has on the genes required for fertilisation and embryo 
development (Valcarce et al, 2013). It stands to reason that this effect could be 
exhibited in embryo morphokinetics as well as embryo quality presenting a possible 
reason differences are seen in various morphokinetic parameters. As well as the use of 
donor sperm as an infertility diagnosis, infertility as a result of another disorder 
(secondary) was the only other infertility diagnosis that affected any of the nineteen 
morphokinetic parameters, specifically t2, tM, tB and t9-tM. This group included those 
with, or having previously suffered from cervical or breast cancer, patients with 
diabetes, a genetic condition, and Hodgkin’s disease or Rokatinsky syndrome. This 
group included just 20 embryos from seven patients therefore conclusions are 
speculative and the information is not necessarily immediately clinically relevant. 
However, these data support the overall aim of the investigation; that embryo 
development could be affected by subtle demographical differences and in order to 
support this finding, larger numbers of embryos need to be assessed before this is 
considered when developing ESAs.  
 
The effect of method of insemination on an embryos morphokinetic profile has been 
demonstrated previously (Bodri et al, 2015; Lemmen et al, 2008) however, many used 





The use of these time points as t0 is obviously confounding as they are ambiguous and 
could vary by hours from oocyte to oocyte. In support of this, differences observed in 
embryo morphokinetics have been shown to disappear when an observable time point 
is used for t0 (Cruz et al, 2013). In the current analysis, time of pronuclear fading was 
used as t0 therefore any observed differences in treatment type are more reliable than 
those using time of insemination or injection. In particular those embryos created using 
ICSI had significantly different t2, tSB, tB, cc2 and tM-tSB measurements when 
compared to embryos created through IVF. This result is particularly useful as the 
majority of embryos are created using standard IVF or standard ICSI in an IVF 
laboratory. These significant differences of up to 1.5h indicate that, at the very least, 
ESAs should be developed to accommodate differing treatment types even when a 
definable t0 is used. In agreement with others (Lammers et al, 2015), there were no 
significant differences in morphokinetic parameters when ICSI using testicular retrieved 
sperm was used. However, a few cautionary notes must be made regarding this result. 
Firstly, due to the polytomous nature of this group in the analysis this is in comparison 
to IVF as a fertilisation method whereas other analyses have compared ejaculated 
sperm with surgically retrieved sperm for use in ICSI (Lammers et al, 2015). Secondly, 
this group only accounted for seven patients and 27 embryos. There must be further 
investigations into the more rare treatment types to better examine the need for 
alternative optimum ranges for various morphokinetic parameters to be used in ESAs 
but this result does highlight that a one-size-fits-all approach is unlikely to be 
appropriate.  
 
The current analysis does not include other suspected confounders such as dose of 
gonadotrophins, paternal age or endogenous maternal hormone levels therefore it is by 
no means exhaustive. The analysis serves to demonstrate the effect of certain patient 
and treatment parameters in order to inform future areas of research and highlight that 
variability seen in embryo development is not necessarily an effect of embryo viability, 
as is suggested by those using morphokinetic parameters to predict an embryos ability 
to implant. This is also an indication regarding the use of ESAs and their inability to be 
externally applied with the same efficacy as is observed at the development site. 
Embryo selection algorithms should be developed with variations in patient and 
treatment parameters in mind. It is important that any developed ESAs be prospectively 





embryologists select the most viable embryo in a cohort in terms of morphology, 
morphokinetics and chromosomal complement and yet implantation still does not 
occur. This highlights an obvious confounder that is often overlooked and is likely to 
only be able to be controlled through RCTs; endometrial receptivity. Embryo 
development is seemingly affected in subtle ways by a multitude of factors. The 
formulation of ESAs is not likely to be able to account for the effect of confounders 
entirely and until such a time that appropriate trials have been completed it may be 
beneficial to use macro-morphokinetic markers that are less variable and potentially 
less heavily influenced by confounding factors. In the first instance, these parameters 
can be used to perform effective deselection of those embryos undergoing abnormal 
division events such as DC and RC, both shown to significantly reduce implantation 
potential of embryos (Rubio et al, 2012; Athayde Wirka et al, 2014; Liu et al, 2014; 
Barrie et al, 2017). 
7.3.6 Conclusion  
	
This analysis provides a comprehensive account of the effect of confounding factors on 
an embryos morphokinetic profile. It highlights the subtle nature of embryo 
development and the need to perform appropriate and robust production and validation 
of ESAs if they are to be employed to perform embryo selection in an IVF laboratory. 
Where some of the more rare infertility diagnoses or treatment types are concerned, 
conclusions should be considered tentative but this analysis provides evidence that 
further investigations should be carried out to clarify the complex relationships between 
confounders and morphokinetic parameters. Until the development of ESAs that 
consider the effect of confounders and that have been prospectively applied in RCTs, 
other macro-morphokinetic markers should be considered to perform simple but 
effective deselection using TLS.   
7.3.7 Dissemination 
 
The above research was prepared for publication in Human Reproduction. The 







CHAPTER 8: General discussion, limitations and 
conclusions 
8.1 Chapter 3 general discussion 
	
Chapter 3 was concerned with analysing fundamental parameters in a culture system; 
osmolality and pH. These parameters were measured in a series of experiments 
comparing standard incubation and the EmbryoScope® to determine if the 
EmbryoScope® could provide a culture environment comparable to standard 
incubation. These experiments also sought to represent that the use of this TLS could 
represent a positive step towards the reduction of in vitro stress that a preimplantation 
embryo experiences. From these experiments it was observed that osmolality did not 
vary significantly between standard and EmbryoScope® incubation when culture 
media, over the course of 144h, was examined. However, there were significant 
differences where pH was concerned. As will be delineated, considerable experimental 
issues were experienced in terms of pH measurement however, when a pH meter was 
used as well as the CO2 measurements in the incubators as a proxy for pH, significant 
differences were found between the two systems indicating that the pH is likely to be 
much more variable in standard incubation than in an EmbryoScope®. This result 
provides an answer for the aim of this investigation; to compare the EmbryoScope® to 
the standard incubation technique employed at the HFC in order to determine if the 
EmbryoScope® provides a comparably stable culture environment for the embryos 
contained within it.  
 
There is minimal evidence in the literature regarding any previous experimentation with 
a similar aim but there are a number of studies assessing a TLS in terms of the 
undisturbed environment. An assessment using day two embryo morphology as the 
outcome parameter concluded that embryo quality was not superior in the TLS (Park et 
al, 2015) with others concluding the same (Nakahara et al, 2010; Cruz et al, 2011; 
Kirkegaard et al, 2012). The effect of the microenvironment on human embryo 
development has been documented where the ‘good quality’ embryo rate and 
blastocyst formation rate (BFR) were compared between a standard, front-loading 
incubator and a mini, top-loading incubator after a five second door opening/closing 





loading incubator (39.5% vs. 28.4% and 15.1% vs. 7.8%). In addition, the recovery time 
for the front-load incubator was significantly longer than the top-loading incubator (31.5 
± 2.9 minutes vs. 4.9 ± 0.5 minutes) and the authors attribute this to the large gas-
exchange volume when the door was opened as well as the considerable cold gas 
infusion required to replace that which was lost (Fujiwara et al, 2007). Further to this, in 
an assessment of 285 IVF/ICSI cycles it was found that the total BFR, proportion of 
good blastocysts and number of cryopreserved blastocysts per patient was significantly 
lower in cycles where embryos were assessed everyday for six days as opposed to 
four times over six days. Although there was no difference in implantation rate (IR), the 
authors concluded that a reduction in the observation frequency of embryos outside of 
the incubator could enhance embryo quality and BFR (Zhang et al, 2010).   
 
It would be reasonable to suggest that one of the most likely contributing factors to any 
increase in embryo quality or pregnancy rates in an undisturbed environment is a 
consistent culture temperature. The human body is homeostatic, operating at 37°C and 
it can be assumed that, in vivo, the developing embryo is regulated under the 
homeostasis of the host as with protection against pathogens, for example. In vitro, the 
culture environment is responsible for maintaining a temperature that would be 
experienced in vivo as consistently as possible, thus mimicking in vivo homeostasis. 
Based on this, and that provided from previously successful cell culture, human 
embryos were cultured at 37°C. There is an abundance of evidence regarding the 
detrimental effects a reduction in temperature has on human oocytes (Zenzes et al, 
2001; Sathananthan et al, 1988; Pickering et al, 1990) however, little available 
information regarding human embryos, for obvious reasons. Nonetheless, logically, 
such a drastic effect on oocyte ultrastructure is likely to persist into embryonic 
development therefore, it is crucial to maintain a 37°C environment in vitro. This is 
often achieved through the use of heated equipment in the laboratory such as tube 
warmers and, importantly, heated observation stages. However, when embryos are 
removed from their culture environment the temperature is likely to fall immediately, 
due to the ambient temperature upon removal.  
 
Shortly after the first live birth following in vitro fertilisation, it was suggested that the 
female reproductive tract had a lower basal temperature than the rest of the body and 





1986; Grinstead et al, 1985). Two investigations of particular interest assessed the 
pregnancy rates in humans following embryo culture at reduced temperatures. A 
retrospective analysis using 209 patients allocated embryos to one of two incubators, A 
or B. This allocation was performed based on workload and simply reflected an 
operational need within the laboratory. Temperature measurements were taken over 
the course of culture and A was found to be below 37°C for 47% of the measurements 
compared to 20% for B. The actual mean temperature difference between A and B was 
0.07°C while media pH and CO2 levels were similar. The CPR for incubator A was 61% 
compared to 42% for incubator B (p=0.009). However the proportion of ‘excellent’ 
transfers (no blood or mucus on the catheter) was higher in those cultured in incubator 
A. All other distributions including patient age, male and female risk factors, per cent 
ICSI, embryo quality and number of embryos transferred did not differ between the two 
groups (Higdon et al, 2006). This experiment assessed the chance of pregnancy in 
operationally different temperatures rather than setting the temperatures deliberately 
lower. In a further investigation, the culture temperature was investigated by 
randomising 52 couples’ oocytes (805 in total) into either an incubator set to 37°C or an 
incubator set to 36°C. This investigation resulted in a higher proportion of blastocysts in 
the 37°C group (48.4% vs. 41.2%) however all other outcome parameters were 
comparable; fertilisation rate, aneuploidy rate and IR (Hong et al, 2014). These results 
indicate that the cumulative pregnancy rate is augmented if embryo culture is carried 
out at 37°C which is a contradiction to that originally thought in the 1980’s. It is clear 
that further evidence is required to determine if embryo culture at less than 37°C could 
be beneficial however the experiments thus far highlight that embryo development can 
be affected by the in vitro culture temperature.  
 
A caveat of experiments regarding temperature is firstly the difficulties in measuring 
temperature accurately as most measuring devices have a tolerance of ±1°C and often 
drift out of calibration over time (Higdon et al, 2008). Secondly, by virtue of incubator 
use, it is likely that many may already be culturing embryos lower than 37°C. When a 
TLS is considered, there is substantial difficulty in accurate measurement of the 
temperature of culture media in the culture dishes. This is primarily due to the dishes 
themselves (requirement of a lid and placing the probe through the lid and fixing in an 
appropriate position) and the electronic mechanisms within the incubator creating 





osmolality represent fundamental embryo culture measurements, temperature 
measurement is also imperative. It is likely that the temperature in a TLS is measurably 
more stable than that of a standard incubator and the determination of this through 
feasible scientific experimentation should be considered for future areas of research.  
 
The measurements made in this research also presented technical difficulties. Due to 
the number of EmbryoSlides® required to perform the osmolality analyses, an entire 
EmbryoScope® instrument was dedicated to this experiment. However, due to the 
reduced space within the working IVF laboratory and the demand on standard 
incubators at particular time points in a treatment pathway, the experimental dishes 
contained within the standard incubator were cultured alongside treatment dishes not 
for use within the experiment protocol. This therefore meant that the standard incubator 
door was opened considerably more times when compared to the EmbryoScope®. It 
appears that this did not affect the osmolality readings for the standard incubator, as 
there was no difference in the osmolality over the culture period in either replicate. 
Conversely, it was unknown whether the osmolality of culture media within the 
EmbryoScope® would have varied more if the incubator had been subject to the same 
number of door openings during normal working conditions. To try and resolve this 
issue, a trace was taken from the same EmbryoScope® but from a normal working day 
to quantify the number of door openings and compare it to those during the 
experimental period. From the trace taken, the EmbryoScope® door was opened ten 
times which was comparable to the twelve times it was opened during the experimental 
period. It is reasonable to assume that, as the EmbryoScope® was subject to a similar 
number of door openings during the experimental period as it would have been under 
normal working conditions, the osmolality measurements are reflective of those that 
would be obtained from culture media contained in dishes for clinical use. This same 
consideration must be made when assessing the pH results.  
 
A further difficulty that the authors encountered was the measurement of pH itself. It 
has been concluded by some that there is ‘no point’ in measuring pH routinely 
(Mortimer and Mortimer, 2004) due to its direct dependence on CO2 and the ability to 
measure CO2 easily. pH measurements are often confirmed by two or three methods to 
ensure accurate sampling owing to the difficulty in its measurement. Once a dish is 





changed significantly. This introduces difficulty for accurate sampling and 
measurement. Initially, the measurement of pH using a blood-gas analyser was 
attempted however, the instrument did not respond to the volumes (25µl) and type of 
sample (culture media) that could be provided. Failing this, the authors attempted 
measurement of the pH using Clinitek Status™ device (Bayer HealthCare) routinely 
used to perform urine panels but with the capacity to detect pH. This instrument was 
able to take a measurement and provide a pH value but it was not sensitive enough to 
detect minor changes in pH needed for the proposed experiment.  
 
For these reasons (lack of an appropriate measuring device for sampling of culture 
media and the inaccuracy that sampling culture media brings) in situ measurements of 
pH (i.e. culture media in a culture dish) were not made and an in situ pH meter was 
used instead. This overcame the difficulty of obtaining results, let alone accurate ones, 
but also brought limitations to the extrapolation of results to the culture conditions an 
EmbryoScope® or standard incubator provides. The in situ pH meter constitutes a 
small well that can be filled with culture media that is exposed to the pH probe. The 
media can be covered with oil to prevent evaporation, and thus fluctuations in pH, and 
the probe can be placed anywhere within the incubator allowing the data logger to sit 
outside the incubator. In the standard incubator, the probe was placed on a shelf where 
a culture dish would normally sit and so measurements were reflective of embryos 
cultured in this environment. However, within the EmbryoScope®, due to the size of the 
probe and the movement of the dish tray within the incubator, the probe had to be 
placed below the dish tray just within the door of the incubator. The position reflected 
where dishes would be when the door was to be opened but was not entirely accurate 
in terms of dish placement and movement within the incubator. This is unlikely, 
however, to have caused a significant variation, as the incubator should maintain 
consistent gas levels throughout the chamber. The sensitivity of the CO2 probes inside 
the EmbryoScope® and the standard systems should be taken into account. The 
traces taken were compared to one another yet different probes are likely to be used to 
detect the gas levels in each system. Although this may not pose a substantial issue it 
is still an obvious difference between the systems and therefore using the traces to 
determine the pH should be considered as an adjunct to the measurements using the 






There is also a single limitation of this research that was unavoidable but would be 
relatively easily rectified. One replicate result was performed in the osmolality 
experiments. To perform any more than this would have incurred further consumable 
costs that were not available to the researchers. The lack of replicates is reflected in 
the standard deviations of the results; 11.81 and 11.93. Although they are similar, and 
therefore indicate a similar breadth of variation in the two groups, they are also large 
which represents an increased range of values. If triplicates were to be performed, 
should the results mirror those already attained, a higher number of results are likely to 
cluster around the mean and thus reduce the standard deviation.  
 
This research serves to demonstrate the stability of the EmbryoScope® in terms of pH 
and osmolality and provides a platform for future developments, which should focus on 
other fundamental in vitro culture parameters such as temperature.  
8.2 Chapter 4 general discussion  
	
Having established that the EmbryoScope® incubator provides a comparable, if not 
superior, culture environment in terms of fundamental culture conditions, pH and 
osmolality, focus was then brought to the treatment outcomes. This chapter was 
concerned with comparing the success rates in the form of CPR, IR, LBR and MR 
between standard incubation employed at the HFC and the EmbryoScope® using a 
strict matched-pair analysis design. A total of 728 treatment cycles were assessed and 
the CPR, IR and LBR were found to be significantly higher in those embryos cultured in 
the EmbryoScope®. The MR, although reduced in those embryos cultured in the 
EmbryoScope®, was not significantly different between the two systems.  
 
This research represents a robust, retrospective design and the results indicate a clear 
benefit of culturing embryos in a TLS. Nonetheless, a limitation is it’s retrospective 
nature and the need to perform the gold standard of research methodologies in the 
form of an RCT. A Cochrane review retrieved 33 potential articles that assessed TLS 
for improvements in success rates (Armstrong et al, 2015) however of the 33, only 
three were eligible for scrutiny (Kahraman et al, 2013; Kovacs et al, 2013; Rubio et al, 
2014). The review highlighted that further RCTs were required to draw conclusions 





attained here may indeed be observed if an RCT were to be performed at the study site 
however, a restriction for a centres ability to perform RCTs on this technology is it’s 
widespread, successful use. It would have been ideal to control for other confounding 
factors in this analysis such as primary infertility diagnosis and stimulation regimen. 
However, due to the limited amount of data relating to patients cultured in standard and 
TLS within a sensible time period, due to the switch over at the study site to 100% TLS 
culture, if other suspected confounders had been controlled for the data set would have 
significantly reduced and it may have been necessary to loosen the matching on other 
parameters such as the number of oocytes collected or maternal age. It is with an RCT 
that only the true control of confounders can be achieved. 
 
The future of this area of research would be to perform an RCT using three arms; 
standard incubation, time-lapse incubation without annotation capabilities and time-
lapse incubation with annotation capabilities. This would build on that presented here 
and test the hypothesis that time-lapse annotations contribute to the benefits of utilising 
an incubator that is time-lapse enabled. This is, in part, addressed in the research 
presented. The selection of embryos cultured in a standard incubator is performed 
using a national grading scheme however those in TLS receive the added benefit of an 
ESA. This means that the group cultured in TLS received an enhanced method of 
embryo selection potentially leading to a higher chance of choosing the most viable 
embryo when compared to standard incubation. Some could argue this as a limitation 
to the research design however, it represents an analysis of TLS as it was intended to 
be used clinically; as an incubator as well as an embryo selection method.  
 
The authors believe that the study design used is a valid one that provides further 
reassurance of, at the very least, the lack of harmful effects of the use of TLS for 
human embryo culture demonstrated through enhanced CPR, IR and LBR.  
8.3 Chapter 5 general discussion 
	
The following chapters were concerned with a deeper interrogation of the annotation 
aspect of the EmbryoScope® in confidence that the EmbryoScope® as a basic 
incubator provided comparable if not superior environmental stability. To set the 





the efficacy of available ESAs to determine if the further proposed research was 
justifiable. Although the lack of transferability of pre-constructed ESAs had already 
been demonstrated (Kirkegaard et al, 2014; Yalcinkaya et al, 2014) the concomitant 
assessment of multiple ESAs had not yet been performed. In this chapter, the efficacy 
of six published ESAs to predict implantation was examined using 977 known 
implantation embryos. The efficacy was demonstrated through the sensitivity, 
specificity, PPV, NPV, AUC and LR. The aim of this chapter was to demonstrate that 
these ESAs lost their clinical applicability when applied in an external setting i.e. 
another fertility centre. This was achieved through the results gained where none of the 
tested ESAs reached an AUC higher than 0.6; an indication of a lack of predictive 
capabilities.  
 
The rationale for the validation of the selected six ESAs was to demonstrate the lack of 
transferability of these ESAs to an external setting. Their selection was based on their 
potential popularity in the field as well as being from established research groups. The 
unit-specific generation of ESAs appears to have slowed to be replaced with a focus on 
commercial generation of ESAs presumably due to their [commercial entities] 
accessibility to extremely large multicentre datasets.  The development of such ESAs 
has a clear advantage; they will be developed on a large group of heterogeneous 
embryos indicating that any resulting ESA is likely to be applicable to a heterogeneous 
group of patients. However, the research presented in this chapter provides evidence 
that externally derived ESAs cannot be applied with the same efficacy outside of the 
development and validation site; a limitation that may persist even with larger datasets.   
 
This research is retrospective however, the ideal study design for the aim of this 
research (to demonstrate externally derived ESAs’ dimished transferability) is the 
randomisation of patients to one of six groups where embryo selection would be 
performed using one of six ESAs only. This methodology has not been employed thus 
far, most likely due to the belief that externally derived ESAs are relatively 
transferrable. However, following this initial retrospective analysis, it is likely that this is 
not the case. Wherever a new method for embryo selection is to be introduced 
clinically, a prospective trial should be considered. Certainly, any developed ESAs as a 
result of the research presented here will be prospectively applied in RCTs before their 






A further limitation of the research presented in Chapter 5 is that all embryos that had 
the six ESAs applied to them had been selected using an internal ESA. This internal 
ESA used similar morphokinetic parameters to one analysed (Cruz et al, 2012). It was 
highlighted to the authors that this may cause bias in the results obtained and so a brief 
analysis was performed to determine if the proportion of embryos obtained in each 
category in the original manuscript for the ESA in question differed from that obtained 
in the research presented here. From this, it was observed that the proportions did not 
differ providing reassurance that any bias created from the use of similar morphokinetic 
parameters in the selection of embryos used in this analysis was minimal. However, 
this does reiterate the need for externally derived ESAs to be applied in a prospective, 
randomised manner to eliminate all bias where possible.  
8.4 Chapter 6 general discussion 
	
After gathering sufficient data to support the notion that externally derived ESAs lose 
their clinical applicability when employed at the HFC, the next research aim was to 
develop improved ways of selecting embryos. The development of patient, treatment 
and environment specific ESAs is a complex and imperfect process therefore, to utilise 
the information that the EmbryoScope® provided without creating complicated ESAs, 
macro-morphokinetic parameters were assessed in the form of abnormal embryonic 
phenotypes (including CC, RC, AC, DC and CL). These macro-morphokinetic 
parameters are easily identified, annotated and analysed and appear to be less 
influenced by patient and treatment parameters than absolute or interval morphokinetic 
parameters. This research analysed 15,819 embryos to determine the incidence and IR 
of five of the most commonly visualised abnormal division events; CC, DC, AC, CL and 
RC. A number of these phenomena have been documented previously (Athayde-Wirka 
et al, 2014; Rubio et al, 2012; Liu et al, 2014; Hickman et al, 2012) and reports 
demonstrate a reduction in an embryo’s IR if they were to exhibit these abnormal 
division events. The same was observed in this research where the IR of certain 
abnormal division events was 0%. Owing to the sensitive nature of this field and with 
the knowledge that there is evidence to suggest that the chance of success is reduced 
with embryos undergoing an abnormal division event, it is difficult to design a more 





chapter will inform methods for embryo deselection at the test site where embryos seen 
to undergo one or more of the abnormal division events should be avoided for embryo 
transfer where possible. Importantly, this research also allows appropriate 
management of patient expectations in cases where only embryos that have 
undergone an abnormal division event are available to transfer. Finally, a novel 
classification system of one of the abnormal division events (DC) was developed where 
a scale of severity is suggested that again, can be used clinically to aid in embryo 
selection and manage patient expectations. It may be the case that, with time, more 
embryonic phenomena will be revealed that need to be considered in the same 
manner. It may be prudent, for example, to concentrate future research efforts towards 
the examination of multinucleation at the cell stages and an analysis of those embryos 
that undergo more than one abnormal division event.  
 
The main limitation of the research regarding deselection criteria and the incidence and 
implantation potential of embryos undergoing abnormal division events is the limited 
number of embryos on which conclusions can be drawn. In some of the categories, the 
number of embryos transferred was as low as two. There is an obvious, unavoidable, 
reason for this; they are abnormally developing embryos and if the patient has others 
then they are likely to be chosen over any undergoing an abnormal cleavage event. 
However, the limitation remains. It would be impossible to eliminate this limitation by 
way of a change of study design as there is no available alternative. A prospective 
study design would not be possible in this case for obvious ethical reasons. The study 
site has, most likely, the largest dataset of embryos cultured in TLS in the UK therefore, 
as far as single site analyses are concerned, it would be difficult for others to achieve 
numbers to draw more definitive conclusions than that of the research presented in this 
chapter.  
8.5 Chapter 7 general discussion 
	
Chapter 7 was concerned with determining if patient, treatment and environmental 
factors affect an embryos morphokinetic profile. Where the assessment of the three 
culture media is concerned there are a number of limitations that should be highlighted. 
Firstly, the culture system for each media was not used from the point of oocyte 





the point of time-lapse culture (i.e. following ICSI or IVF fertilisation check). This could 
introduce a bias towards the control culture media (G-TL™) and should be noted when 
assessing the results of the analysis. In addition, if a patient achieved an unequal 
amount of oocytes/embryos (i.e. not a multiple of three) then additional 
oocytes/embryos would be placed in G-TL™ (if a one surplus) and then SAGE 1-
Step™ (if two surplus). The justification for this methodology was that, in order to 
perform robust statistical analysis, each embryo would have to have a match in each 
culture media. In addition, SAGE 1-Step™ was the closest of the two to the control 
media in terms of constituents as CSC is based on KSOM formula optimised for mouse 
embryos and G-TL™ and SAGE 1-Step™ were developed on the basis of 
concentrations of nutrients in the human fallopian tube (Gardner et al, 1996; Morbeck 
et al, 2017). This meant that CSC was naturally at a disadvantage in terms of the 
number of oocytes/embryos cultured within it. However, due to the statistical test used 
(Friedman’s two-way analysis of variance by ranks) and the need to analyse like-for-
like embryos, this bias was removed when considering the effects on morphokinetic 
parameters.  
 
This chapter also provides an account of the susceptible nature of embryo 
morphokinetics and, after determining that the TLS (the EmbryoScope®) is likely to be 
superior in terms of incubation, success rates and existing methods for embryo 
selection are lacking clinical applicability as well as highlighting certain, appropriate 
deselection criteria, this chapter concludes the whole research study suitably. This 
chapter constituted two parts; firstly a sibling oocyte study where a patients 
oocytes/embryos were randomised between three commercially available culture 
media; second, a regression analysis was performed assessing how maternal age, 
maternal BMI, suppression protocol, infertility diagnosis and treatment type influence 
an embryos morphokinetic profile. The results of these investigations revealed that 
embryos are indeed affected, to differing levels, by patient, treatment and 
environmental factors thus supporting the hypothesis that specific ESAs should be 
developed to accommodate these confounders. Once developed, specific ESAs should 
be tested clinically, following retrospective validation, in the form of RCTs; it is in this 






The first obvious limitation of this analysis was the reduced numbers of embryos 
available from patients with the more rare treatment types and infertility diagnoses 
assessed in the regression analysis. This research highlights that some treatment 
types (such as the use of donor sperm) could considerably alter the morphokinetic 
profile of embryos therefore any developed ESAs should take this into consideration. 
However, because the number of treatment cycles that are performed that use donor 
gametes is reduced at the study site, it is difficult to draw robust conclusions. It does 
however, emphasise the need to continue the research into these less common 
treatment types and infertility diagnoses to better understand their effects on an 
embryos morphokinetic profile. It would take a substantial amount of time to collate 
data of a suitable sample size to be able to investigate this with any reliability, certainly 
at the study site, nonetheless, this research should provide a springboard for others to 
investigate a similar relationship; perhaps most suitable to centres that perform a high 
number of treatment cycles utilising donor gametes. There are numerous infertility 
diagnoses that are unlikely to vary in volume between centres, for example. those that 
are secondary to other disorders/diseases such as Rokatinsky syndrome, 
breast/cervical cancer or diabetes. Although significant effects on morphokinetic 
parameters were found when considering this infertility diagnosis, the results must be 
taken, universally, tentatively. When considering these results in the development of 
ESAs it may be possible to apply ESAs to these patient groups as well as the 
deselection criteria described in Chapter 6 to aid in embryo selection and, as always, 
as an adjunct to standard morphology assessments.  
8.6 Overall limitations 
	
Perhaps the most prominent limitation of the presented research is the subjective 
nature of annotations. This project required the manual ‘annotation’ of all embryos used 
for data analysis. Upon commencement, the researchers had to decide whether one 
person should perform these subjective measurements providing a reduced amount of 
data with a high level of validity or should many people perform these annotations to 
provide a high volume of data with a reduced validity? In consideration of this question, 
although the validity of the measurements may be compromised, this would be minimal 
with the correct training as well as continual quality control and assurance.  An internal 





annotations and rectify any unusual responses. In short, this scheme involved intense, 
supervised training given by the researcher to all members of the scientific team at the 
study site. Following the training, each ‘annotator’ was required to annotate one 
embryo per week with the researcher confirming the annotations made. Each 
‘annotator’ was then enrolled onto the monthly quality assurance program involving the 
full annotation of three embryos of the researchers choosing.   
 
There are, of course, inherent biases from this process. Firstly, as the researcher 
provided all training, the aim of this training (all ‘annotators’ being consistent) creates a 
reduction in the transferability of any developed algorithms. It would not be possible for 
the researcher to provide training to whomever utilises the produced ESAs but as the 
annotation consensus definitions (Ciray et al, 2014) were used throughout the 
research, as long as adopting centres also adhered to these consensus definitions, the 
results should be largely transferable. The overriding consideration that the researcher 
faced is the means by which any developed ESAs from this investigation would be 
used; they are intended for use in multiple, international clinics by many users. It 
stands to reason that the use of these ESAs should inform their development.  
 
A further limitation of the presented research is that it considers the assessment of one 
form of TLS only; the EmbryoScope®. Although, arguably, the most popular of the TLS, 
others have merits. Currently, to our knowledge, there are four other variations that are 
commercially available; Eeva™ (Merck Serono, Germany), Primo Vision™ (Vitrolife, 
Sweden), Miri® Time-Lapse Incubator (Esco Medical ApS, Denmark), and Geri® 
(Merck KGaA, Germany). The two former variations are scopes that are fitted within a 
standard incubation system. This would therefore indicate that potentially the initial 
stage of this research would not be applicable, however success rates may still vary. 
The latter two are stand-alone incubators similar to the EmbryoScope® and so may 
offer more stable culture conditions as in Chapter 3 of the presented research. 
However, where annotations are concerned, some of these systems have crucial, 
potentially beneficial, differences. Firstly, the Eeva™ system uses dark-field illumination 
to allow intelligent software to track individual cells and record electronically when a 
division event has occurred. This function is to facilitate the production of a score from 
a programmed ESA that the user does not have access to. Essentially, the Eeva™ 





system to have this facility, which has been shown to have a level of efficacy in 
predicting the formation of a blastocyst rather than IR (Conaghan et al, 2013; Diamond 
et al, 2015). Other TLS do not differ significantly from the EmbryoScope® except that 
both Miri® and Geri® boast individual culture compartments to further stabilise the 
culture conditions for dishes contained within the system other than the one that is 
being removed or entered.  
 
A final general limitation to the research involving time-lapse imaging is the definition of 
time-zero. Originally, time-zero was assigned to the time of injection or insemination of 
the oocytes. However, it was quickly realised that the time of insemination/injection 
represented an arbitrary point in preimplantation development owing to the fact that it is 
impossible to know the exact time that a sperm enters the oocyte in the those embryos 
created using IVF. The sperm could enter the oocyte at any point in approximately 16h 
(time of insemination to time of fertilisation check) thus indicating that embryo 
development (cleavage) would begin sooner in those where the sperm entered earlier. 
Although much more likely to happen sooner than 16hpi, even a difference of two 
hours between oocytes would cause disparity in results and a reduction in the efficacy 
of any applied ESAs. Regarding embryos that were created using ICSI, it is known 
when the sperm enters each oocyte however, none of the commercially available TLS 
have a function to input a different time of injection for each oocyte. Although this would 
be a more specific time point, it still introduces a level of ambiguity, as it is likely that 
the full integration of the sperm would take different amounts of time for each oocyte 
and sperm combination. Absolute timings that were visible during time-lapse 
incubation, the most popular of which is pronuclear fading (Liu et al, 2015) then 
became favourable. When using this parameter, relationships between certain 
morphokinetic parameters and embryo viability as well as differences in these between 
treatment types were no longer apparent (Cruz et al, 2013; Liu et al, 2015). Especially 
when some of the observed differences in the described research here are subtle, the 
use of a consistent time zero, such as pronuclear fading, is imperative. In addition to 
the use of an arbitrary time-zero, another difference in the literature is the time between 
image acquisitions. As shown in Table 11 where the differences in the publications 
regarding the external application of ESAs are listed, many used different image 
acquisition lengths. Again, when the differences detailed in the research here are 





8.7 Conclusions of thesis 
	
The aims of the research presented were firstly to compare the EmbryoScope® (a 
time-lapse enabled incubator) to standard incubation employed at the HFC in terms of 
the culture environment measured in the form of pH, osmolality and treatment success 
rates; CPR, IR, LBR and MR. Secondly, the research aimed to determine if the 
information that a TLS provides can contribute to effective embryo selection in an IVF 
laboratory in the form of patient, treatment and environment specific ESAs. This aim 
was achieved by first, assessing if existing published ESAs could be reliably applied to 
an external cohort of embryos. Second, by determining deselection criteria from a 
maximised dataset and third, by examining the effects of patient, treatment and 
environment specific parameters on an embryos morphokinetic profile.  
 
In the first instance, it can be concluded that the EmbryoScope® provides a stable 
culture environment comparable, and in some instances (pH, CPR, LBR) superior to 
that of a standard incubator employed at the study site. Regarding embryo annotation 
using TLS, it can be concluded that externally derived ESAs lose their clinical 
effectiveness when applied to an independent cohort of known implantation embryos. It 
can also be concluded that effective deselection criteria can be identified that indicate 
an embryos reduced ability to implant. Finally, patient, treatment and environmental 
factors have been identified using robust methodology that affect an embryo’s 
morphokinetic profile thus indicating that future research should focus on the 
development of specific ESAs after which prospective application should be 
considered.  
 
The research study conducted represents novel work in this area in a number of ways. 
The pH and osmolality had, to the researcher’s knowledge, not yet been compared 
between a TLS and a standard incubation system. Furthermore, the external validation 
of more than one ESA on a large embryo cohort had not been performed. In addition, 
the assessment of abnormal division events on a sample size of over 15,000 had not 
yet been achieved. Finally, a sibling oocyte investigation on three commercially 
available culture media assessing the effects on morphokinetics past the five-cell stage 






Overall, the current research holds clinical relevance and it is the opinion of the 
researcher that the true benefits of TLS are yet to be unlocked. It is in the form of 
specific embryo selection methods that the real benefits of a TLS lie. These complex 
methods of embryo selection should account for variations in patient-demographic as 
well as treatment type and environmental factors such as culture media. Once 
developed, these specific ESAs would, ideally, be prospectively applied in a clinical 
setting to evaluate their effectiveness and impact on the outcome of an ART treatment 
cycle. It is with this that the efficacy of embryo selection will be increased which will in 



































Aboulghar MA, Mansour RT, Serour GI, Ramzy AM, Amin YM. (1997) Oocyte quality in 
patients with severe ovarian hyperstimulation syndrome. Fertil Steril 68: 1017-21 
Adamson GD, Abusief ME, Palao L, Witmer J, Palao LM, Gvakharia M. (2015) 
Improved implantation rates of day 3 embryo transfers with the use of an automated 
time-lapse-enabled test to aid in embryo selection. Fertil Steril. 18. pii: S0015-
0282(15)02041-5 
Alexandre H, Mulnard J. (1988) Time-lapse cinematography study of the germinal 
vesicle behaviour in mouse primary oocytes treated with activators of protein kinases A 
and C. Gamete Res. 21(4): 359-65 
Alikani M, Cohen J, Tomkin G, Garrisi GJ, Mack C, Scott RT. (1999) Human embryo 
fragmentation in vitro and its implications for pregnancy and implantation. Fertil Steril. 
71(5): 836-42 
Allen C, Reardon W. (2005) Assisted reproduction technology and defects of genomic 
imprinting. BJOG. 112(12): 1589-94 
Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of 
Embryology. (2011) The Istanbul consensus workshop on embryo assessment: 
proceedings of an expert meeting. Hum Reprod. 26(6):1270–83  
Arav A, Aroyo A, Yavin S, Roth Z. (2008) Prediction of embryonic developmental 
competence by time-lapse observation and 'shortest-half' analysis. Reprod Biomed 
Online. 17(5): 669-75 
Armstrong S, Arroll N, Cree LM, Jordan V, Farquhar C. (2015) Time-lapse systems for 
embryo incubation and assessment in assisted reproduction. Cochrane Database Syst 
Rev. 27; 2: CD011320 
Athayde Wirka K, Chen AA, Conaghan J, Ivani K, Gvakharia M, Behr B et al. (2014) 
Atypical embryo phenotypes identified by time-lapse microscope: high prevalence and 





Azzarello A, Hoest T, Mikkelsen AL. (2012) The impact of pronuclei morphology and 
dynamicity on live birth outcome after time-lapse culture. Hum Reprod. 27: 2649-57 
Balaban B and Urman B. (2005) Comparison of two sequential media for culturing 
cleavage-stage embryos and blastocysts: embryo characteristivs and clinical outcome. 
Reprod Biomed Online. 10(4): 485-91 
Balaban B, Urman B, Sertac A, Alatas C, Aksoy S, Mercan R. (2000) Blastocyst quality 
affects the success of blastocyst-stage embryo transfer. Fertil Steril.  74(2): 282-7 
Balakier H, Cabaca O, Bouman D, Shewchuk AB, Laskin C, Squire JA. (2000) 
Spontaneous blastomere fusion after freezing and thawing of early human embryos 
leads to polyploidy and chromosomal mosaicism. Hum Reprod 15: 2404-10 
Baltz JM, Tartia AP. (2010) Cell volume regulation in oocytes and early embryos: 
connecting physiology to successful culture media. Hum Reprod Update. 16(2): 166-76 
Baltz JM. (2001) Osmoregulation and cell volume regulation in the preimplantation 
embryo. Curr Top Dev Biol. 52:55-106 
Bar-EL L, Kalma Y, Malcov M, Schwartz T, Raviv S, Cohen T, Amir H, Cohen Y, 
Reches A, Amit A, Ben-Yousef D. (2016) Blastomere biopsy for PGD delays embryo 
compaction and blastulation: a time-lapse microscopic analysis. J Assist Reprod Genet. 
33:1449-57 
Barbash-Hazan S, Frumkin T, Malcov M, Yaron Y, Cohen T, Azem F et al. (2008) 
Preimplantation aneuploidy embryos undergo self correction in correlation with their 
developmental potential. Fertil Steril. 92: 890-6 
Barker DJ, Osmond C. (1986) Infant mortality, childhood nutrition, and ischaemic heart 
disease in England and Wales. Lancet. 1:1077-81 






Barrie A, Taylor E, Schnauffer K, Kingsland C, Troup S. (2015) An examination of 
embryo morphokinetics and utilisation in single step and sequential culture media 
systems. Hum Reprod. 30 (Suppl 1): P-282 
Basile N, Morbeck D, Garcia-Velasco J, Bronet F, Meseguer M. (2013) Type of culture 
media does not affect embryo kinetics: a time-lapse analysis of sibling oocytes. Hum 
Reprod. 28(3): 634-41 
Basile N, Morbeck D, Garcis-Velasco J, Bronet F, Meseguer M. (2011) Time-lapse 
technology reveals that embryo kinetics are not affected by culture media. Fertil Steril. 
96 (Suppl): S108 
Basile N, Vime P, Florensa M, Aparicio Ruiz B, Garcia Velasco JA, Remohi J et al. 
(2015) The use of morphokinetics as a predictor of implantation: a mutlicentric study to 
define and validate an algorithm for embryo selection. Hum Reprod. 30: 276-83 
Bavister BD, Arlotto T. (1990) Influence of single amino acids on the development of 
hamster one-cell embryos in vitro. Mol Reprod Dev. 25:45-51 
Bavister BD, McKiernan SH. (1992) Regulation of hamster embryo development in vitro 
by amino acids. Preimplantation Embryo Development. New York: Springer. pp 57-72 
Bellver J, Mifsud A, Grau N, Privitera L, Meseguer M. (2013) Similar morphokinetic 
patterns in embryos derived from obese and normoweight infertile women: a time-lapse 
study. Hum Reprod. 28:794–800 
Ben-Yousef D, Oron Y, Shaigi R. (1996) Intracellular pH of rat eggs is not affected by 
fertilization and the resulting calcium oscillations. Biol Reprod. 55: 461-8 
Bermejo-Alvarez P, Roberts RM, Rosenfeld CS. (2012) Effect of glucose concentration 
during in vitro culture of mouse embryos on development to blastocyst, success of 
embryo transfer, ad litter sex ratio. Mol Reprod Dev. 79: 329-36  
Biggers JD, Lawitts JA, Lechene CP (1993) The protective action of  betaine on the 
deleterious effects of NaCl on preimplantation mouse embryos in vitro. Mol Reprod 





Biggers JD, McGinnis LK, Lawitts JA. (2005) One-step versus two-step culture of 
mouse preimplantation embryos: is there a difference? Hum Reprod. 20:3376–84 
Biggers JD, Racowsky C. (2002) The development of fertilized human ova to the 
blastocyst stage in KSOMAA medium: is a two-step protocol necessary? Reprod 
Biomed Online. 5:133–40 
Block J, Bonilla L, Hansen PJ. (2010) Efficacy of in vitro embryo transfer in lactating 
dairy cows using fresh or vitrified embryos produced in a novel embryo culture medium. 
J Dairy Sci. 93:5234– 5242  
Block J, Hansen PJ, Loureiro B, Bonilla L. (2011) Improving post-transfer survival of 
bovine embryos produced in vitro: actions of insulin-like growth factor-1, colony 
stimulating factor-2 and hyaluronan. Theriogenology. 76:1602–9 
Bodri D, Sugimoto T, Sema JY, Kondo M, Kato R, Kawachiya S et al. (2015) Influence 
of different oocyte insemination techniques on early and late morphokinetic 
parameters: retrospective analysis of 500 time-lapse monitored blastocysts. Fertil 
Steril. 104(5) 1175-81 
Borland RM, Hazra S, Biggers JD, Lechene CP. (1977) The elemental composition of 
the environments of the gametes and preimplantation embryo during the initiation of 
pregnancy. Biol Reprod. 16:147- 57 
Botros L, Sakkas D, Seli E. (2008) Metabolomics and its application for non-invasive 
embryo assessment in IVF. Mol Hum Reprod. 14 (12): 679-690 
Bottin P, Achard V, Courbiere B, Paci M, Gnisci A, Jouve E et al. (2015) Elective single 
embryo transfer policy at 48/72h: which results after fresh transfers and frozen/thawed 
transfers? Gynecologie Obstetrique and Fertilite 43: 297-3 
Brachet A. (1912) Development in vitro de blastodermes et de jeunes embryons de 





Brent RL, Holmes LB. (1988) Clinical and basic science lessons from the thalidomide 
tragedy: what have we learned about the causes of limb defects? Teratology. 38: 241–
51 
Brinster RL. (1965) Studies on the development of mouse embryos in vitro. IV. 
Interaction of energy sources. J Reprod Fertil. 10:227–40  
Brison DR, Houghton FD, Falconer D, Roberts SA, Hawkhead J, Humpherson PG et al. 
(2004) Identification of viable embryos in IVF by non-invasive measurement of amino 
acid turnover. Hum Reprod. 19 (10): 2319-24 
Campbell A, Fishel S, Bowman N, Duffy S, Sedler M, Hickman CF. (2013a) Modelling a 
risk classification of aneuploidy in human embryos using non invasive morphokinetics. 
Reprod Biomed Online. 26: 477-85 
Campbell A, Fishel S, Bowman N, Duffy S, Sedler M, Thornton S. (2013b) 
Retrospective analysis of outcomes after IVF using an aneuploidy risk model derived 
from time-lapse imaging without PGS. Reprod Biomed Online. 27: 140-6 
Carney EW, Bavister BD. (1987) Regulation of hamster embryo development in vitro by 
carbon dioxide. Biol Reprod. 36:1155–63 
Chamayou S, Patrizio P, Storaci G, Tomaselli V, Alecci C, Ragolia C. et al. (2013) The 
use of morphokinetic parameters to select all embryos with full capacity to implant. J 
Assist Reprod Genet. 30: 703-10 
Chang L, Chen SU, Tsai YY, Hung CC, Fang MY, Su YN et al. (2011) An update of 
preimplantation genetic diagnosis in gene diseases, chromosomal translocation, and 
aneuploidy screening. Clin Ex Reprod Med. 38 (3): 126-34 
Chatot CL, Ziomek CA, Bavister BD, Lewis JL, Torres I. (1989) An improved culture 
medium supports development of random-bred 1-cell mouse embryos in vitro. J 





Chavez SL, Loewke KE, Han J, Moussavi F, Colls P, Munne S et al. (2012) Dynamic 
blastomere behavior reflects human embryo ploidy by the four-cell stage. Nat 
Commun. 3: 1251 
Chawla M, Fakih M, Shunnar A, Bayram A, Hellani A, Perumal V et al. (2015) 
Morphokinetic analysis of cleavage stage embryos and its relationship to aneuploidy in 
a retrospective time-lapse imaging study. J Assist Reprod Genet. 32(1): 69-75 
Ciray HN, Aksoy T, Goktas C, Oxturk B, Bahceci M. (2012) Time-lapse evaluation of 
human embryo development in single versus sequential culture media – a sibling 
oocyte study. J Assist Reprod Genet. 9:891-900 
Ciray HN, Campbell A, Agerholm IE, Aguilar J, Chamayou S, Esbert M et al. (2014) 
Proposed guidelines on the nomenclature and annotation of dynamic human embryo 
monitoring by a time-lapse user group. Hum Reprod 29: 2650-60 
Cohen J, Wells D, Munne S. (2007) Removal of 2 cells from cleavage stage embryos is 
likely to reduce the efficacy of chromosomal tests that are used to enhance 
implantation rates. Fertil Steril. 87(3): 496-503 
Collins JL, Baltz JM. (1999) Estimates of mouse oviductal fluid tonicity based on 
osmotic responses of embryos. Biol Reprod. 60:1188–93 
Colly-d'Hooghe M, Valleron AJ, Malaise EP. (1977) Time-lapse cinematography 
studies of cell cycle and mitosis duration. Exp Cell Res. 106(2): 405-7 
Conaghan J, Chen AA, Willman SP, Ivani K, Chenette PE, Boostanfar R et al. (2003) 
Improving embryo selection using a computer-automated time-lapse image analysis 
test plus day 3 morphology: results from a prospective multicenter trial. Fertil Steril. 
100(2): 412-9 
Conaghan J, Handyside AH, Winston RML, Leese HJ. (1993) Effects of pyruvate and 
glucose on the development of human preimplantation embryos in vitro. J Reprod 





Conn CM, Harper JC, Winston RML, Delhanty JDA. (1998) Infertile couples with 
Roberstonian translocations: preimplantation genetic analysis of embryos reveals 
chaotic cleavage divisions. Hum Genet. 102: 117-23 
Cox GF, Burger J, Lip V, Mau UA, Sperling K, Wu BL et al. (2002) Intracytoplasmic 
sperm injection may increase the risk of imprinting defects. Am J Hum Genet. 71:162-
164 
Criniti A, Thyer A, Chow G, Lin P, Klein N, Soules M. (2005) Elective single blastocyst 
transfer reduces twin rates without compromising pregnancy rates. Fertil Steril. 84(6): 
1613-9 
Cruz M, Gadea B, Garrido N, Pedersen KS, Martinez M, Perez-Cano I et al. (2011) 
Embryo quality, blastocyst and ongoing pregnancy rates in oocyte donation patients 
whose embryos were monitored by time-lapse imaging. J Assist Reprod Genet. 28: 
569-73 
Cruz M, Garrido N, Gadea B, Munoz M, Perez-Cano I, Meseguer M. (2013) Oocyte 
insemination techniques are related to alterations of embryo developmental timing in 
an oocyte donation model. Reprod Biomed Online. 27: 367-75 
Cruz M, Garrido N, Herrero J, Perez-Cano I, Munoz M, Meseguer M. (2012) Timing of 
cell divisions in human cleavage stage embryos correlates with blastocyst formation 
and quality. Reprod Biomed Online. 25: 371-81 
Cutting R, Morroll D, Roberts SA, Pickering S, Rutherford A. (2008) Elective single 
embryo transfer: guidelines for practice British Fertility Society and Association of 
Clinical Embryologists; BFS and ACE. Hum Fertil (Camb). 11(3): 131-46 
Dal Canto M, Coticchio G, Mignini Renzini M, De Ponti E, Novara PV et al. (2012) 
Cleavage kinetics analysis of human embryos predicts development to blastocyst and 
implantation. Reprod Biomed Online. 25: 474-80 
Dale B, Menezo Y, Cohen J, DiMatteo L, Wilding M. (1998) Intracellular pH regulation 





Dawson KM, Baltz JM. (1997) Organic osmolytes and embryos: substrates of the Gly 
and beta transport systems protect mouse zygotes against the effects of raised 
osmolarity. Biol Reprod. 56(6):1550-8 
De Placido G, Wilding M, Strina I, Alviggi E, Alviggi C, Mollo A et al. (2002) High 
outcome predictability after IVF using a combined score for zygote and embryo 
morphology and growth rate. Hum Reprod. 17: 2402-9 
de Rooij SR, Painter RC, Philips DI, Osmond C, Michels RP, Godsland IF et al. (2006b) 
Impaired insulin secretion after prenatal exposure to the Dutch famine. Diabetes Care. 
29:1897–1901  
de Rooij SR, Painter RC, Phillips DI, Osmond C, Mchels RP, Bossuyt PM et al. (2006a) 
Hypothalamic-pituitary-adrenal axis activity in adults who were prenatally exposed to 
the Dutch famine. Eur J Endocrinol. 155:153–160 
de Rooij SR, Painter RC, Phillips DI, Osmond C, Tanck MW, Bossuyt PM et al. (2006c) 
Cortisol responses to psychological stress in adults after prenatal exposure to the 
Dutch famine. Psychoneuroendocrinology. 31:1257–65  
de Rooij SR, Painter RC, Roseboom TJ, Phillips DI, Osmond C, Barker DJ et al. 
(2006d) Glucose tolerance at age 58 and the decline of glucose tolerance in 
comparison with age 50 in people prenatally exposed to the Dutch famine. 
Diabetologia. 49:637–43  
de Rooij SR, Wouters H, Yonker JE, Painter RC, Roseboom TJ. (2010) Prenatal 
undernutrition and cognitive function in late adulthood. Proc Natl Acad Sci USA. 
107:16881–6  
De Rycke M, Belva F, Goossens V, Moutou C, SenGupta SB, Traeger-Synodinos J et 
al. (2015) ESHRE PGD Consortium data collection XIII: cycles from January to 






DeBaun MR, Niemitz EL, Feinberg AP. (2003) Association of in vitro fertilisation with 
Beckwith-Weidemann syndrome and epigenetic alterations of LIT1 and H19. Am J 
Hum Genet. 72:156-60 
Delhanty JDA, Harper JC, Ao A, Handyside AH, Winston RML. (1997) Multicolour FISH 
detects frequent chromosomal mosaicism and chaotic division in normal 
preimplantation embryos from fertile patients. Hum Genet. 9: 755–60 
Desai N, Ploskonka S, Goodman LR, Austin C, Goldberg J, Falcone T. (2014) Analysis 
of embryo morphokinetics, multinucleation and cleavage anomalies using continuous 
time-lapse monitoring in blastocyst transfer cycles. Reprod Biol Endocrinol.12: 54 
Di Santo M, Tarozzi N, Nadalini M, Borini A. (2012) Human sperm cryopreservation: 
update on techniques, effect on DNA integrity, and implications for ART. Adv Urol. 
doi:10.1155/2012/854837  
Diamond MP, Suraj V, Behnke EJ, Yang X, Angle MJ, Lambe-Steinmiller JC et al. 
(2015) Using the Eeva Test adjunctively to traditional day 3 morphology is informative 
for consistent embryo assessment within a panel of embryologists with diverse 
experience. J Assist Reprod Genet. 32(1): 61-8 
Doherty AS, Mann MR, Tremblay KD, Bartolomei MS, Schultz RM. (2000) Differential 
effects of culture on imprinted H19 expression in the preimplantation mouse embryo. 
Biol Reprod. 62:1526–35 
Dokras A, Sargent IL, Barlow DH. (1993) Human blastocyst grading: an indicator of 
developmental potential? Hum Reprod. 8(12): 2119-27 
Dokras A, Sargent IL, Ross C, Gardner RL, Barlow DH. (1990) Trophectoderm biopsy 
in human blastocysts. Hum Reprod. 5(7): 821-5 
Donoso P, Staessen C, Fauser BD, Devroey P. (2007) Current value of preimplantation 





Edwards LJ, Williams DA, Gardner DK. (1998a) Intracellular pH of the mouse 
preimplantation embryo: amino acids act as buffers of intracellular pH. Hum Reprod. 
13:3441–8 
Edwards LJ, Williams DA, Gardner DK. (1998b) Intracellular pH of the preimplantation 
mouse embryo: effects of extracellular pH and weak acids. Mol Reprod Dev.50: 434–
42 
Edwards RG, Gardner RL. (1968) Control of the sex ratio at full term in the rabbit by 
trasnferring sexed blastocysts. Nature. 218(5139): 346-9 
Eglitis MA (1980) Formation of tetraploid mouse blastocysts following blastomere 
fusion with polyethylene glycol. J Exp Zool. 213: 309-13 
Fauque P, Jouannet P, Lesaffre C, Ripoche MA, Dandolo L, Vaiman D et al. (2007) 
Assisted reproductive technology affects developmental kinetics, H19 Imprint Control 
Region methylation and H19 gene expression in individual mouse embryos. BMC Dev 
Bio. 7: 116 
Fernandez-Gonzalez R, Moreira P, Bilbao A, Jimenez A, Perez-Crespo M, Ramirez MA 
et al. (2004) Long-term effect of in vitro culture of mouse embryos with serum on 
mRNA expression of imprinting genes, development, and behavior. Proc Natl Acad Sci 
USA. 101:5880–85  




Feuer S, Rinaudo P. (2013) Preimplantation Stress and Development. Birth Defects 
Res C Embryo Today. 96(4) 
Fong B, Watson PH, Watson AJ. (2007) Mouse preimplantation embryo responses to 
culture medium osmolarity include increased expression of CCM2 and p38 MAPK 





Fox CA, Meldrum SJ, Watson BW. (1973) Continuous measurement by radio-telemetry 
of vaginal pH during human coitus. J Reprod Fertil. 33:69–75  
Fragouli E, Katz-Jaffe M, Alfarawati S, Stevens K, Colls P, Goodall NN et al. (2010) 
Comprehensive chromosome screening of polar bod- ies and blastocysts from couples 
experiencing repeated implantation failure. Fertil Steril. 94: 875-87 
Fragouli E, Wells D, Whalley KM, Mills JA, Faed MJ, Delhanty JD. (2006) Increased 
susceptibility to maternal aneuploidy demonstrated by comparative genomic 
hybridization analysis of human MII oocytes and first polar bodies. Cytogenet Genome 
Res. 114(1): 30-8 
Fragouli E, Wells D. (2011) Aneuploidy in the human blastocyst. Cyto Gen Res. 133: 
149–59 
Franasiak JM, Forman EJ, Hong KH, Werner MD, Upham KM, Treff NR et al. (2014) 
The nature of aneuploidy with increased age of the female partner: a review of 15,169 
consecutive trophectoderm biopsies evaluated with comprehensive chromosomal 
screening. Fertil Steril. 101(3): 656-63 
Frattarelli JL. (2003) Blastocyst transfer decreases multiple pregnancy rates in in vitro 
fertilization cycles: a randomized controlled trial. Fertil Steril. 79(1): 228-30 
Freour T, Dessolle L, Lammers J, Lattes S, Barriere P. (2013) Comparison of embryo 
morphokinetics after in vitro fertilization-intracytoplasmic sperm injection in smoking 
and nonsmoking women. Fertil Steril. 99:1944–50 
Freour T, Lammers J, Splingart C, Jean M, Barriere P. (2012) Time-lapse 
(Embryoscope®) as a routine technique in the IVF laboratory: a useful tool for better 
embryo selection? Gynecol Obstet Fertil. 40(9): 476-80 
Freour T, Le Fleuter N, Lammers J, Splingart C, Reignier A, Barriere P. (2015) External 





Fujimoto VY, Browne RW, Bloom MS, Sakkas D, Alikani M. (2011) Pathogenesis, 
developmental consequences, and clinical correlations of human embryo 
fragmentation. Fertil Steril. 95(4): 1197-204 
Fujiwara M, Takahashi K, Izuno M, Duan YR, Kazono M, Kimura F et al. (2007) Effect 
of micro-environment maintenance on embryo culture after in-vitro fertilization: 
comparison of top-load mini incubator and conventional front-load incubator. J Assist 
Reprod Genet. 24(1): 5-9 
Fulka H, Fulka J Jr. (2006) No differences in the DNA methylation pattern in mouse 
zygotes produced in vivo, in vitro, or by intracytoplasmic sperm injection. Fertil Steril. 
86:1534–6 
Gardner DK, Hamilton R, McCallie B, Schoolcraft WB, Katz-Jaffe MG. (2013) Human 
and mouse embryonic development, metabolism and gene expression are altered by 
an ammonium gradient in vitro. Reproduction. 146:49–61 
Gardner DK, Lane M. (1996) Alleviation of the ‘2-cell block’ and development to the 
blastocyst of CF1 mouse embryos: role of amino acids, EDTA and physical 
parameters. Hum Reprod. 11(12): 2703-12 
Gardner DK, Leese HJ (1987) Assessment of embryo viability prior to transfer by the 
noninvasive measurement of glucose uptake. J Exp Zool. 242:103 – 5 
Gardner DK, Leese HJ. (1988) The role of glucose and pyruvate transport in regulating 
nutrient utilization by pre-implantation mouse embryos. Development. 104: 423–9 
Gardner DK, M Lane. (1993) Amino acids and ammonium regulate mouse embryo 
development in culture. Biol Reprod. 48: 377-85 
Gardner DK, Schoolcraft WB, Wagley L, Schienker T, Stevens J, Hesla J. (1998b) A 
propective randomized trial of blastocyst culture and transfer in in-vitro fertilization. 





Gardner DK, Vella P, Lane M, Wagley L, Schienker T, Schoolcraft WB. (1998a) Culture 
and transfer of human blastoctsts increases implantation rates and reduces the need 
for multiple embryo transfers. Fertil Steril. 69(1): 84-8 
Gardner DK. (1998) Changes in requirements and utilization of nutrients during 
mammalian preimplantation embryo development and their significance in embryo 
culture. Theriogenology. 49(1): 83-102 
Geraedts J, Sermon K. (2016) Preimplantation genetic screening 2.0: the theory. Mol 
Hum Reprod. 22 (8): 839-44 
Geuns E, Hilven P, Van Steirteghem A, Liebaers I, De Rycke M. (2007) Methylation 
analysis of KvDMR1 in human oocytes. J Med Genet. 44:144–7 
Gicquel C, Gaston V, Mandelbaum J, Siffroi JP, Flahault A, Le Bouc Y. (2003) In vitro 
fertilization may increase the risk of Beckwith-Wiedemann syndrome related to the 
abnormal imprinting of the KCN1OT gene. Am J Hum Genet. 72:1338-41 
Giritharan G, Delle Piane L, Donjacour A, Esteban FJ, Horcajadas JA, Maltepe E et al. 
(2012) In vitro culture of mouse embryos reduces differential gene expression between 
inner cell mass and trophectoderm. Reprod Sci. 19(3):243–52  
Giritharan G, Li MW, Di Sebastiano F, Esteban FJ, Horcajadas JA, Lloyd KC et al. 
(2010) Effect of ICSI on gene expression and development of mouse preimplantation 
embryos. Hum Reprod. 25:3012–24  
Giritharan G, Talbi S, Donjacour A, Di Sebastiano F, Dobson AT, Rinaudo PF. (2007) 
Effect of in vitro fertilization on gene expression and development of mouse 
preimplantation embryos. Reproduction. 134:63–72  
Gleicher N, Kushnir VA, Barad DH. (2014) Preimplantation egentic screening (PGS) 






Gomes MV, Huber J, Ferraini RA, Amaral Neto AM, Ramos ES. (2009) Abnormal 
methylation at the KvDMR1 imprinting control region in clinically normal children 
conceived by assisted reproductive technologies. Mol Hum Reprod. 15(8): 471-7 
Gonzales DS, Pinheiro JC, Bavister BD. (1995) Prediction of the developmental 
potential of hamster embryos in vitro by precise timing of the third cell cycle. J Reprod 
Fertil. 105: 1-8 
Goodman SR. (2007) Medical Cell Biology (3rd edition). Academic Press, Technology & 
Engineering. Pp 45.  
Grabowski CT, Schroeder RE. (1968) A time-lapse photographic study of chick 
embryos exposed to teratogenic doses of hypoxia. Exp Hematol. 19(3): 347-62 
Grady D. (1995) Unnatural Selection. Vogue. 
Grinsted J, Blendstrup K, Andreasen MP, Byskov AG. (1980) Temperature 
measurements of rabbit antral follicles. J Reprod Fertil. 60:149-55 
Grinsted J, Kjer JJ, Blendstrup K, Pedersen JF. (1985) Is low temperature of the 
follicular fluid prior to ovulation necessary for normal oocyte development? Fertil Steril. 
43: 34-9  
Guyader-Joly C, Khatchadourian C, Menezo Y. (1997) Glycine and methionine 
transport by bovine embryos. Zygote. 5(3): 273-6 
Halliday J, Oke K, Breheny S, Algar E, J Amor D. (2004) Beckwith-Weidemann 
Syndrome and IVF: A case control study. Am J Hum Gen. 75: 526-8 
Hammer MA, Kolajova M, Leveille M, Claman P, Baltx JM. (2000) Glycine transport by 
single human and mouse embryos. Hum Reprod. 15:419 – 26 
Hampl R, Stěpán M. (2013) Variability in timing of human embryos cleavage monitored 





Hardarson T, Hanson C, Sjogren A, Lundin K. (2001) Human embryos with unevenly 
sized blastomeres have lower pregnancy and implantation rates: indications for 
aneuploidy and multinucleation. Hum Reprod. 16: 313-8 
Hardarson T, Lofman C, Coull G, Sjogren A, Hamberger L, Edwards RG. (2002) 
Internalization of cellular fragments in a human embryo: time-lapse recordings. Reprod 
Biomed Online. 5: 36-8 
Hardarson T, Rogberg L, Ahlstrom M, Wijlan M, Rose P, Burns D. (2007) Non- invasive 
assessment of embryo reproductive potential: metabolomic profiling of biomarkers of 
oxidative metabolism (OM) during embryo development. Fertil Steril. 88(1): S307-8 
Harper JC, Delhanty JDA. (1996) Detection of chromosome abnormalities in human 
preimplantation embryos using FISH. J Assist Reprod Genet. 13: 137–9 
Hassold T, Chiu D. (1985) Maternal age-specific rates of numerical chromosome 
abnormalities with special reference to trisomy. Hum Genet. 70(1): 11-7 
Hay-Schmidt A. (1993) The influence of osmolality on mouse two-cell development. J 
Assist Reprod Genet. 10:95-8 
Henderson LJ. (1908) Concerning the relationship between the strength of acids and 
their capacity to preserve neutrality. Am. J. Physiol. 21 (4): 173–9 
Hentemann M, Bertheussen K. (2009) New media for culture to blastocyst. Fertil Steril. 
91:878–83 
Hentemann M, Mousavi K, Bertheussen K. (2011) Differential pH in embryo culture. 
Fertil Steril. 95(4):1291-4 
Herrero J, Tejera A, Ramsing N, Romero JL, Rubio I. (2011) Establishing the optimal 
time ranges of key events during development using time-lapse video cinematography. 
Fertil Steril. 96(Suppl): S102 







HFEA Multiple births and single embryo transfer review. Viewed 6th February 2017. 
http://www.hfea.gov.uk/Multiple-births-after-IVF.html 
Hickman CFL, Campbell A, Duffy S, Fishel S. (2012) Reverse cleavage: its significance 
with regards to human embryo morphokinetics, ploidy and stimulation protocol. Hum 
Reprod. 27 (suppl.2) 
Higdon LH, Blackhurst DW, Boone WR. (2008) Incubator management in an assisted 
reproductive technology laboratory. Fertil Steril. 89: 703-10 
Hlinka D, Kalatova B, Uhrinova I, Dolinska S, Rutarova J, Rezacova J. (2012) Time-
lapse cleavage rating predicts human embryo viability. Physiol Res. 61: 513-25 
Holm P, Walker SK, Seamark RF (1996) Embryo viability, duration of gestation and 
birth weight in sheep after transfer of in vitro matured and in vitro fertilized zygotes 
cultured in vitro or in vivo. J Reprod Fertil. 07:175–81 
Hong KH, Lee H, Forma EJ, Upham KM, Scott RT Jr. (2014) Examining the 
temperature of embryo culture in in vitro fertilization: a randomized controlled trial 
comparing traditional core temperature (37°C) to a more physiologic, cooler 
temperature (36°C). Fertil Steril. 102(3): 767-76 
Hunter RH, Nichol R. (1986) A preovulatory temperature gradient between the isthmus 
and ampulla of pig oviducts during the phase of sperm storage. J Reprod Fertil. 77(2): 
599-606 
Isiklar A, Mercan R, Balaban B, Alatas C, Aksoy S, Urman B. (2002) Early cleavage of 
human embryos to the two cell stage. A simple, effective indicator of implantation and 
pregnancy in intracytoplasmic sperm injection. J Reprod Med. 47: 540-4 
Jackson KV, Ginsburg ES, Hornstein MD, Rein MS, Clarke RN. (1998) Multiniucleation 
in normally fertilized embryos is associated with an accelerated ovulation induction 
response and lower implantation and pregnancy rates in in vitro fertilization embryo 





Ji J, Li Y, Tong XH, Luo L, Ma J, Chen Z. (2013) The optimum number of oocytes in 
IVF treatment: an analysis of 2455 cycles in China. Hum Reprod. 28: 2728-34 
Johansson M, Hardarson T, Lundin K. (2003) There is a cutoff limit in diameter 
between a blastomere and a small anucleate fragment. J Assist Reprod Genet. 20: 
309-13 
Kahraman S, Cetinkaya M, Pirkevi C, Yelke H, Kumtepe Y. (2013) Comparison of 
blastocyst development and cycle outcome in patients with eSET using either 
conventional or time-lapse incubators. A prospective study of good prognosis patients. 
J Reprod Stem Cell Biotech. 3:55–61  
Kalatova, B., Jesenska, R., Hlinka, D., Dudas, M. (2015) Tripolar mitosis in human cells 
and embryos: Occurrence, pathophysiology and medical implications. Acta 
Histochemica 117: 111-25 
Kaser DJ, Racowsky C. (2014) Clinical outcomes following selection of human 
preimplantation embryos with time-lapse monitoring: a systematic review. Hum Reprod 
Update. 20:617-31 
Kato O, Teramoto S, Morita H, Botros L, Roos P, Burns D. (2007) Metabolomic 
assessment of Day 2 (D2) embryos based on pregnancy outcome after single embryo 
transfer (SET). Fertil Steril. 88(1): S27 
Khalaf Y, El-Toukhy T, Coomarasamy A, Kamal A, Bolton V, Braude P.  (2008) Elective 
single blastocyst transfer reduces the multiple pregnancy rate and increases pregnancy 
rates: a pre- and postintervention study. BJOG 115(3): 385-90 
Khosla S, Dean W, Brown D, Reik W, Feil R. (2001) Culture of preimplantation mouse 
embryos affects fetal development and the expression of imprinted genes. Biol. 
Reprod. 64:918–26 
Kirkegaard K, Campbell A, Agerholm I, Bentin-Ley U, Gabrielsen A, Kirk J et al. (2014) 
Limitations of a time-lapse blastocyst prediction model: a large multicentre outcome 





Kirkegaard K, Hindkjaer JJ, Grondahl ML, Kesmodel US, Ingerslec HJ. (2012) A 
randomized clinical trial comparing embryo culture in a conventional incubator with a 
time- lapse incubator. J Assist Reprod Genet. 29:565–72  
Kirkegaard K, Hindkjaer JJ, Ingerslev HJ. (2013b) Hatching of in vitro fertilized human 
embryos is influenced by fertilization method. Fertil Steril. 100(5):1277-82.  
Kirkegaard K, Hindkjaer JJ, Ingerslev HJ. (2013c) Effect of oxygen concentration on 
human embryo development evaluated by time-lapse monitoring. Fertil Steril. 99: 738-
44 
Kirkegaard K, Sundvall L, Erlandsen M, Hindkjaer JJ, Knudsen UB, Ingerslev HJ. 
(2016) Timing of human preimplantation embryonic development is confounded by 
embryo origin. Hum Reprod. 31(2): 324-31 
Kirkegaard K. (2013a) Time-lapse parameters as predictors of blastocyst development 
and pregnancy outcome in embryos from good prognosis patients: a prospective cohort 
study. Hum Reprod. 28(10): 2643–51  
Kola I, Trounson A, Dawson G, Rogers P. (1987) Tripronuclear human oocytes: altered 
cleavage patterns and subsequent karyotypic analysis of embryos. Biol Reprod 37: 
395-401 
Kolahi KS, Donjacour A, Liu X, Lin W, Simbulan RK, Boise E et al. (2012) Effect of 
substrate stiffness on early mouse embryo development. PLoS One. 7:e41717  
Kovacic B, Vlaisavljevic V, Reljic M, Cizek-Sajko M. (2004) Developmental capacity of 
different morphological types of day 5 human morulae and blastocysts. Reprod Biomed 
Online. 11: 608-14 
Kovacs P, Matyas S, Forgacs V, Sajgo A, Rarosi F, Pribenszky C. (2013) Time-lapse 
embryo selection for single blastocyst transfer - results of a multicentre, prospective, 





Lammers J, Reignier A, Splingart C, Catteau A, David L, Barriere P et al. (2015) Does 
sperm origin affect embryo morphokinetic parameters. J Assist Reprod Genet. 32(9) 
1325-32  
Lane M, Baltz JM, Bavister BD. (1998) Regulation of intracellular pH in hamster 
preimplantation embryos by the sodium hydrogen (Na+/H+) antiporter. Biol Reprod Dev 
Biol. 59: 1483-90 
Lane M, Baltz JM, Bavister BD. (1999a) Na+/H+ antiporter activity in hamster embryos 
is activated durng fertilization. Dev Biol. 208: 244-52 
Lane M, Baltz JM, Bavister BD. (1999b) Bicarbonate/chloride exchange regulates 
intracellular pH of embryos not oocytes of hamster. Biol Reprod. 61: 452-57 
Lane M, Gardner DK. (1994) Increase in postimplantation development of culture 
mouse embryos by amino acids and induction of fetal retardation and exencephaly by 
ammonium ions. J Reprod Fertil.102: 305-12 
Lane M, Gardner DK. (2000) Lactate regulates pyruvate uptake and metabolism in the 
preimplantation mouse embryo. Biol Reprod. 62:16–22 
Lane M, Gardner DK. (2003) Ammonium induces aberrant blastocyst differentiation, 
metabolism, pH regulation, gene expression and subsequently alters fetal development 
in the mouse. Biol Reprod. 69: 1109-17 
Lane M, Gardner DK. (2007) Embryo culture medium: which is best? Best Prac Res 
Clin Obstet Gynaecol. 21(1): 83-100 
Lane M, Hooper K, Gardner DK. (2001) Effect of essential amino acids on mouse 
embryo viability and ammonium production. J Assist Reprod Genet.18(9): 519-25 
Laverge H, De Sutter P, Verschraegen MR, De Paepe A, Dhont M. (1997) Triple colour 
fluorescent in situ hybridisation for chromosomes X, Y and 1 on spare human embryos. 





Le Cruguel S, Ferre-L Hotellier V, Moriniere C, Lemerle S, Reynier P, Descamps P, 
May-Panloup P. (2013) Early compaction at day 3 may be a useful additional criterion 
for embryo transfer. J Assist Reprod Genet. 30:683-90 
Lechniak D, Pers-Kamczyc E, Pawlak P. (2008) Timing of the first zygotic cleavage as 
a marker of developmental potential of mammalian embryos. Reprod Biol. 8: 23-42 
Leese HJ (2002) Quiet please, do not disturb: a hypothesis of embryo metabolism and 
viability. Bioessays, 24(9): 845-9 
Lemmen JG, Agerholm I, Ziebe S. (2008) Kinetic markers of human embryo quality 
using time-lapse recordings of IVF/ICSI-fertilized oocytes. Reprod Biomed Online. 
17(3): 385-91 
Li M, DeUgarte CM, Surrey M, DeCherney A, Hill DL. (2005b) Fluorescence in situ 
hybridization reanalysis of day 6 human blastocysts diagnosed with aneuploidy on day 
3. Fertil Steril. 84: 1395–400 
Li T, Vu TH, Ulaner GA, Littman E, Ling JQ, Chen HL et al. (2005a) IVF results in de 
novo DNA methylation and histone methylation at an Igf2-H19 imprinting epigenetic 
switch. Mol Hum Reprod. 11:631–40  
Lidegaard O, Pinborg A, Andersen AN. (2005) Imprinting diseases and IVF: Danish 
national IVF cohort study. Hum Reprod. 20 (4): 950-4 
Lim D, Bowdin SC, Tee L, Kirby GA, Blair E, Fryer A et al. (2009) Clinical and 
Molecular genetic features with Beckwith-Weidemann syndrome associated with 
assisted reproductive technologies. Hum Reprod. 24(3): 741-7 
Liu Y, Chapple V, Feenan K, Roberts P, Matson P. (2015) Time-lapse videography of 
human embryos: using pronuclear fading rather than insemination in IVF and ICSI 
cycles removes inconsistencies in time to reach early cleavage milestones. Reprod 
Biol. 15: 122-5 
Liu Y, Chapple V, Roberts P, Matson P. (2014) Prevalence, consequence, and 





Embryoscope time-lapse video system. Fertil Steril.102(5): 1295-1300 
Liu Z, Foote RH. (1996) Sodium chloride, osmolyte and osmolarity effects on blastocyst 
formation in bovine embryos produced by in vitro fertilization (IVF) and cultured in 
simple serum-free media. J Assist Reprod Genet. 13(7): 562-8 
Ludwig H. (2005) Archives of Gynecology and Obstetrics: 135 years. Arch Gynecol 
Obstet. 271:1-5  
Lueck J, Aladjem S. (1980) Time-lapse study of normal human trophoblast in vitro. Am 
J Obstet Gynecol. 138(3): 288-92 
Lundin K, Bergh C, Hardarson T. (2001) Early embryo cleavage is a strong indicator of 
embryo quality in human IVF. Hum Reprod.16: 2652-7 
Lyman CP, Hastings AB. (1951) Total CO2 plasma pH and CO2 of hamster and ground 
squirrels during hibernation. Am J Physiol. 167: 633 
Maas DH, Stein B, Metzger H, Schneider U. (1987) Influence of microsurgical 
reanastomosis of the fallopian tube on lumial pH and PO2 and on the fertilization rate 
and embryo development in the rabbit oviduct. Eur J Obstet Gynecol Reprod Biol. 24: 
73-83 
Maas DH, Storey BT, Mastroianni L Jr. (1976) Oxygen tension in the oviduct of the 
rhesus monkey (Macaca mulatta). Fertil Steril. 27:1312–7  
Maas DH, Storey BT, Mastroianni L Jr. (1977) Hydrogen ion and carbon dioxide 
content in the oviductal fluid of the rhesus monkey. Fertil Steril. 28: 981-5 
Macdonald RR, Lumley IB. (1970) Endocervical pH measured in vivo through the 
normal menstrual cycle. Obstet. Gynecol. 35:202–6  
Maher ER, Afnan M, Barratt CL. (2003) Epigenetic risks related to assisted 






Manipalvitari S, DeCherney A, Segars J. (2009) Imprinting disorders and assisted 
reproductive technology. Fertil Steril. 91:305–15  
Massip A, Mulnard J. (1980) Time-lapse cinematographic analysis of hatching of 
normal and frozen-thawed cow blastocysts. J Reprod Fertil. 58(2): 475-8 
Mastenbroek S, Repping S. (2014) Preimplantation genetic screening: back to the 
future. Hum Reprod. 29:1846-50 
Mastenbroek S, Twisk M, van Echten-Arends J, Sikkema-Raddatz B, Korevaar JC, 
Verhoeve HR et al. (2007) In vitro fertilistion with preimplantation genetic screening. N 
Engl J Med. 537(1): 9-17 
McArthur SJ, Leigh D, Marshall JT, de Boer KA, Jansen RP. (2005) Pregnancies and 
live births after trophectoderm biopsy and preimplantation genetic testing of human 
blastocysts. Fertil Steril 84(6): 1628-1636 
McBride W. (1961) Thalidomide and congenital abnormalities. Lancet. 278: 1358 
McLimans WF. (1972) The gaseous environment of the mammalian cell in culture. In: 
Rothblat GH, Cristofalo VJ (eds.), Growth, Nutrition and Metabolism of Cells in Culture. 
New York: Academic Press, pp. 138-170 
Menezo Y, Lichtblau I, Elder K. (2013) New Insights into human pre-implantation 
metabolism in vivo and in vitro. J Assist Reprod Genet. 30(3): 293-303 
Meseguer M, Rubio I, Cruz M, Basile N, Marcos J, Requena A. (2012) Embryo 
incubation and selection in a time-lapse monitoring system improves pregnancy 
outcome compared with a standard incubator: a retrospective cohort study. Fertil Steril. 
98: 1481-9 
Meseguer M, Herrero J, Tejera A, Hilligsoe KM, Ramsing NB, Remohi J. (2011) The 






Milan M, Cobo AC, Rodrigo L, Mateu E, Mercader A, Buendia P et al. (2010) 
Redefining advanced maternal age as an indication for preimplantation genetic 
screening. Reprod Biomed Online. 21(5): 649-57 
Milewski R, Kuć P, Kuczyńska A, Stankiewicz B, Łukaszuk K, Kuczyński W. (2015) A 
predictive model for blastocyst formation based on morphokinetic parameters in time-
lapse monitoring of embryo development. J Assist Reprod Genet. 32(4): 571-9 
Milligan MP, Harris S, Dennis KJ. (1980) Comparison of sperm velocity in fertile and 
infertile groups as measured by time-lapse photography. Fertil Steril. 34(5): 509-11 
Milligan MP, Harris SJ, Dennis KJ. (1978) The effect of temperature on the velocity of 
human spermatozoa as measured by time-lapse photography. Fertil Steril. 30(5): 592-4 
Mio Y, Maeda K.  (2008) Time-lapse cinematography of dynamic changes occurring 
during in vitro development of human embryos. Am J Obstet Gynecol. 199(6): 660. e1-
5  
Miyoshi K, Funahashi H, Okuda K, Niwa K. (1994) Development of rat one- cell 
embryos in a chemically defined medium: effects of glucose, phosphate and 
osmolarity. J Reprod Fertil. 100: 21-6 
Morbeck D, Baumann NA, Oglesbee D. (2017) Compostition of single-step media used 
for human embryo culture. Fertil Steril. (in press).  
Morbeck DE, Krisher RL, Herric JR, Baumann NA, Matern D, Moyer T. (2014) 
Composition of commercial media used for human embryo culture. Fertil Steril.102(3): 
759-66.  
Morgan HD, Santos F, Green K, Dean W, Reik W. (2005) Epigenetic reprogramming in 
mammals. Hum Mol Genet. 14: R47–R58 
Mortimer D, Mortimer ST. (2004) Quality and Risk Management in the IVF Laboratory. 





Munne S, Velilla E, Colls P, Garcia Bermidez M, Vemuri MC, Steuerwald N et al. 
(2005) Self correction of chromosomally abnormal embryos in culture and implications 
of stem cell production. Fertil Steril 84: 1328-34 
Munne S. (2006) Chromosome abnormalities and their relationship to morphology and 
development of human embryos. Reprod Biomed Online. 12(2): 234-53 
Munoz M, Cruz M, Humaidan P, Garrido N, Perez-Cano I, Meseguer M. (2012) Dose of 
recombinant FSH and oestradiol concentration on day of HCG affect embryo 
development kinetics. Reprod Biomed Online. 25:382 – 9 
Munoz M, Cruz M, Humaidan P, Garrido N, Perez-Cano I, Meseguer M. (2013) The 
type of GnRH analogue used during controlled ovarian stimulation influences early 
embryo developmental kinetics: a time-lapse study. Eur J Obstet Gynecol Reprod Biol. 
168:167–72  
Murber A, Fancsovits P, Ledo N, Gilan ZT, Rigo J, Urbancsek J. (2009) Impact of 
GnRH analogues on oocyte/embryo quality and embryo development in in vitro 
fertilization/intracytoplasmic sperm injection cycles: a case control study. Reprod Biol 
Endocrinol.  25: 103 
Nagy P, Posillico JT. (2007) NMR, Raman and Near Infrared Spectroscopy 
determination of embryo culture predicts implantation and pregnancy outcomes in 
human IVF. Unpublished.  
Nakahara T, Iwase A, Goto M, Harata T, Suzuki M, Ienaga M et al. (2010) Evaluation of 
the safety of time-lapse observations for human embryos. J Assist Reprod Genet. 27(2-
3): 93-6 
Niimura S. (2003) Time-lapse videomicrographic analyses of contractions in mouse 
blastocysts. J Reprod Dev. 49(6): 413-23  
Northrop LE, Treff NR, Levy B, Scott RT Jr. (2010) SNP microarray based 24 
chromosome aneuploidy screening demonstrates that cleavage stage FISH poorly 
predicts aneuploidy in embryos that develop to morphologically normal blastocysts. Mol 





Orstavik KH, Eiklid K, van der Hagen CB, Spetalen S, Kierulf K, Skjeldal O, Buiting K. 
(2003) Another case of imprinting defect in a girl with Angelman syndrome who was 
conceived by intracytoplasmic semen injection. Am J Hum Genet. 72: 218-9 
Ozawa M, Nagai T, Kaneko H, Noguchi J, Ohnuma K, Kikuchi K. (2006) Successful pig 
embryonic development in vitro outside a CO2 gas-regulated incubator: effects of pH 
and osmolality. Theriogenology: 860-9 
Palmstierna M, Murkes D, Csemiczky G, Andersson O, Wramsby H. (1998) Zona 
pellucida thickness variation and occurrence of visible mononucleated blastomeres in 
pre embryos are associated with a high pregnancy rate in IVF treatment. J Assist 
Reprod Genet. 15: 70-5 
Park H, Bergh C, Selleskog U, Thurin-Kjellberg A, Lundin K. (2015) No benefit of 
culturing embryos in a closed system compared with a conventional incubator in terms 
of number of good quality embryos: results from an RCT. Hum Reprod. 30(2): 268-75 
Payne D, Falherty SP, Barry MF, Matthews CD. (1997) Preliminary observations on 
polar body extrusion and pronuclear formation in human oocytes using time-lapse 
video cinematography. Hum Reprod.12: 532-41 
Perin PM, Maluf M, Nicolosi Foltran Januário DA, Nascimento Saldiva PH. (2008) 
Comparison of the efficacy of two commercially available media for culturing one-cell 
embryos in the in vitro fertilization mouse model. Fertil Steril. 90( Suppl 2):1503–10 
Phillips KP, Baltz JM. (1999) Intracellular pH regulation by HCO3-/Cl- exchange is 
activated during early mouse zygote development. Dev Biol. 208: 392-405 
Phillips KP, Leveille MC, Claman P, Baltz JM. (2000) Intracellular pH regulation in 
human preimplantation embryos. Hum Reprod. 15(4): 896-904 
Pickering SJ, Braude PR, Johnson MH, Cant A, Currie J. (1990) Transient colling to 
room temperature can cause ireeversible disruption of the meiotic spindle in the human 





Pickering SJ, Taylor A, Johnson MH, Braude PR. (1995) An analysis of multinucleated 
blastomere formation in human embryos. Hum Reprod. 10: 1912-22 
Pommerenke WT, Breckenridge MA. (1952) Biochemical studies of the female genital 
tract. Ann NY Acad Sci. 54:786–95 
Quinn, P. (2014) Culture media, solutions and systems in Human ART (1st edition). 
Cambridge University Press. Pp134 
Ramsing NB, Berntsen J, Callesen H. (2007) Automated detection of cell division and 
movement in time-lapse images of developing bovine embryos can improve selection 
of viable embryos. Fertil Steril. 88 (Suppl 1): S38 
Ramsing, NB, Cellesen H. (2006) Detecting timing and duration of cell divisions by 
automatic image analysis may improve selection of viable embryos. Fertil Steril. 86 
(Suppl): S189 
Richards T, Wang F, Liu L, Baltz JM. (2010) Rescue of postcompaction-stage mouse 
embryo development from hypertonicity by amino acid transporter substrates that may 
function as organic osmolytes. Biol Reprod. 82:769–77  
Rienzi L, Ubaldi F, Iacobelli M, Minasi MG, Romano S, Ferrero S et al. (2005) 
Developmental potential of fully intact and partially damaged cryopreserved embryos 
after laser assisted removal of necrotic blastomeres and post thaw culture selection. 
Fertil Steril. 84: 888-94 
Rinaudo P, and Schultz RM. (2004) Effects of embryo culture on global pattern of gene 
expression in preimplantation mouse embryos. Reproduction. 128:301–11 
Rinaudo PF, Giritharan G, Talbi S, Dobson AT, Schultz RM. (2006) Effects of oxygen 
tension on gene expression in preimplantation mouse embryos. Fertil Steril. 86(4 
Suppl):1252–65 
Rubio I, Galán A, Larreategui Z, Ayerdi F, Bellver J, Herrero J et al. (2014) Clinical 
validation of embryo culture and selection by morphokinetic analysis: a randomized, 





Rubio I, Kuhlmann R, Agerholm I, Kirk J, Herrero J, Escriba MJ et al. (2012) Limited 
implantation success of direct cleaved human zygotes: a time-lapse study. Fertil Steril. 
98: 1458-63 
Sathananthan AH, Trounson A, Freemann L, Brady T. (1988) The effects of colling 
human oocytes. Hum Reprod. 3(8): 968-77 
Schatten H, Schatten G. (1980) Surface activity at the egg plasma membrane during 
sperm incorporation and its cytochalasin B sensitivity. Scanning electron microscopy 
and time-lapse video microscopy during fertilization of the sea urchin Lytechinus 
variegatus. Dev Biol. 78(2): 435-49  
Schini, Bavister BD. (1988) Two-cell block to development of cultured hamster embryos 
is caused by phosphate and glucose. Biol Reprod. 39:1183–92 
Schoolcraft WB, Gardner DK, Lane M, Schienker T, Hamilton F, Meldrum DR. (1999) 
Blastocyst culture and transfer: analysis of results and parameters affecting outcome in 
two in vitro fertilization programs. Fertil Steril. 72(4): 604-9 
Scott L. (2003) Pronuclear scoring as a predictor of embryo development. Reprod 
Biomed Online. 6: 201-14 
Scott L. (2010) The origin and consequences of day 2 multinucleation of human 
embryos. Abstracts of the 26th annual meeting of ESHRE 2010, Rome, Italy. Hum 
Reprod. 25(20100600):i195–i196: P-204 
Scott R, Seli E, Miller K, Sakkas D, Scott K, Burns DH. (2007) Noninvasive 
metabolomic profiling of human embryo culture media using Raman spectroscopy 
predicts reproductive potential: a prospective blinded pilot study. Fertil Steril. 90 (1): 77-
84 
Scott R, Seli E, Miller K, Sakkas D, Scott K, Burns DH. (2008) Non invasive 
metabolomic profiling of human embryo culture media using Raman spectroscopy 
predicts embryonic reproductive potential: a prospective blinded pilot study. Fertil Steril. 





Seli E, Botros L, Sakkas D, Burns DH. (2008c) Glutamate levels in embryo culture 
media determined by proton nuclear magnetic resonance (1H-NMR) metabolomics 
correlates with reproductive potential embryos in women undergoing in-vitro 
fertilisation. Fertil Steril. 90: S42-3 
Seli E, et al. (2006) Non invasive metabolomic profiling of human embryo culture media 
correlates with pregnancy outcome. Initial results of the Metabolomic Study Group for 
ART. Unpublished. 
Seli E, Sakkas D, Scott R, Kwok SC, Rosendahl SM, Burns DH. (2007) Noninvasive 
metabolomic profiling of embryo culture media using Raman and near-infrared 
spectroscopy correlates with reproductive potential of embryos in women undergoing 
in-vitro fertilisation. Fertil Steril. 88 (5): 1350-8 
Seli E, Sakkas D, Scott R, Kwok SC, Rosendahl SM, Burns DH. (2008a) Non-invasive 
metabolomic profiling of embryo culture media using proton nuclear magnetic 
resonance correlates with reproductive potential of embryos in women undergoing in-
vitro fertilisation. Fertil Steril. 90 (6): 2183-94 
Seli E, Vergouw CG, Morita H, Botros L, Roos P, Lambalk CB et al. (2008b) Non-
invasive metabolomic profiling as an adjunct to morphology for non-invasive embryo 
assessment in women undergoing single embryo transfer. Fertil Steril. 94(2): 535-42 
Sepulveda S, Garcia J, Arriaga E, Diaz J, Noriega-Portella L, Noriega-Hoces L. (2009) 
In vitro development and pregnancy outcomes for human embryos cultured in either a 
single medium or in a sequential media system. Fertil Steril. 91:1765–70 
Sermon K, De Rycke M. (2007) Single cell polymerase chain reaction for 
preimplantation genetic diagnosis: methods, strategies, and limitations. Methods Mol 
Med. 132: 31-42 
Sermon KD, Michiels A, Harton G, Moutou C, Repping S, Scriven PN et al. (2007) 
ESHRE PGD Consortium data collection VI: cycles from January to December 2003 





Shapiro BS, Harris DC, Richter KS. (2000) Predictive value of 72 hour blastomere cell 
number on blastocyst development and success of subsequent transfer based on the 
degree of blastocyst development. Fertil Steril. 73: 582-6  
Shapiro BS, Richter KS, Harris DC, Daneshmand ST. (2002) Implantation and 
pregnancy rates are higher for oocyte donor cycles after blastocyst- stage embryo 
transfer. Fertil Steril. 77(6): 1296-7 
Shoukir Y, Campana A, Farley T, Sakkas D. (1997) Early cleavage of in-vitro fertilised 
human embryos to the 2-cell stage: a novel indicator of embryo quality and viability. 
Hum Reprod 12(7): 1531-6 
Shoukir Y, Chardonnens D, Campana A, Bischof P, Sakkas D. (1998) The rate of 
development and time of transfer play different rols in influencing the viability of human 
blastocysts. Hum Reprod. 13(3): 676-81 
Siristatidis C, Komitopoulou MA, Makris A, Sialakouma A, Botzaki M, Mastorakos G et 
al. (2015) Morphokinetic parameters of early embryo development via time-lapse 
monitoring and their effect on embryo selection and ICSI outcomes: a prospective 
cohort study. J Assist Reprod Genet. 32(4): 563-70  
Squirrell JM, Lane M, Bavister BD. (2001) Altering intracellular pH disrupts 
development and cellular organization in preimplantation hamster embryos. Biol 
Reprod. 64, 1845–54 
Staessen C, Platteau P, Van Assche E, Michiels A, Tournaye H, Camus M et al. (2004) 
Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for 
aneuploidy screening in couples with advanced maternal age: a prospective 
randomized controlled trial. Hum Reprod. 19(12): 2849-58 
Summers MC, Biggers JD. (2003) Chemically defined media and the culture of 
mammalian preimplantation embryos: historical perspective and current issues. Hum 
Reprod Update. 9(6):557-82  
Sundvall L, Kirkegaard K, Ingerslev HJ, Knudsen UB. (2015) Unaltered timing of 





study. J Assist Reprod Genet. 32(7): 1031-42. 
Sutcliffe AG, Peters CJ, Bowdin S, Temple K, Reardon W, Wilson L et al. (2006) 
Assisted reproductive therapies and imprinting disorders--a preliminary British survey. 
Hum Reprod. 21:1009-11 
Swain JE (2010) Optimizing the culture environment in the IVF laboratory: impact of pH 
and buffer capacity on gamete and embryo quality. Reprod Biomed Online. 21: 6-16 
Swain JE, Cabera L, Xu X, Smith GD et al. (2012) Microdrop preparation factors 
influence culture-media osmolality, which can impair mouse embryo preimplantation 
development. Reprod Biomed Online. 24: 142-7 
Tang R, Catt J, Howlett D. (2006) Towards defining parameters for a successful single 
embryo transfer in frozen cycles. Hum Reprod. 21: 1179-83  
Tesarik J, Greco E. (1999) The probability of abnormal preimplantation development 
can be predicted by a single static observation on pronuclear stage morphology. Hum 
Reprod. 14: 1318-23 
Tierling S, Souren NY, Gries J, Loporto C, Groth M, Lutsik P et al. (2010) Assisted 
reproductive technologies do not enhance the variability of DNA methylation imprints in 
human. J Med Genet. 47: 371-6 
Trounson, A. (1984) In vitro fertilisation and embryo preservation. In Trouson A and 
Wood C (eds) In vitro fertilisation and embryo transfer. Churchill Livingstone, Edinburgh 
111-30  
Turnpenny P, Ellard S. (2007) Emery’s Elements of Medical Genetics. 13th Edition, 
Churchill Livingstone. Ch. 6 pp98, Ch. 7 pp115 
Valcarce DG, Carton-Garcia F, Riesco MF, Herraez MP, Robles V. (2013) Analysis of 
DNA damage after human sperm cryopreservation in genes crucial for fertilisation and 





Van Royen E, Mangelschots K, Vercruyssen M, De Neubourg D, Valkenburg M, 
Ryckaert G et al. (2003) Multinucleation in cleavage stage embryos. Hum Reprod. 
18(5): 1062-9 
Van Winkle LJ, Haghighat N, Campione AL. (1990) Glycine protects pre- implantation 
mouse conceptuses from a detrimental effect on development of the inorganic ions in 
oviductal fluid. J Exp Zool. 253(2): 215-9 
Vengetesh PM, Ramachandran A, Kumar P. (2015) Choosing GnRH Antagonist 
protocol shows improved oocyte and embryo quality, coherent with perifollicular 
vascularity (PFV) in assisted reproductive techniques. J Clin Diag Res. 9: QC24-8 
Vergouw CG et al. (2007a) Near Infrared Spectroscopy as a toll to predict embryo 
viability: a novel, non invasive method for embryo selection. Unpublished  
Vergouw CG, Lambalk CB, Lens J, Botros L, Roos P, Burns D. (2007b) Non-invasive 
method for embryo selection in single embryo transfer (SET) using metabolomics 
profiling (MetPro) of oxidative metabolism (OM). Fertil Steril. 88(1): S326 
Verlinsky Y, Kuliev A. (2004) Preimplantation diagnosis for aneuploidies in assisted 
reproduction. Minerva Ginecol. 56(3): 197-203 
VerMilyea MD, Tan L, Anthony JT, Conaghan J, Ivani K, Gvakharia M et al. (2014) 
Computer-automated time-lapse analysis results correlate with embryo implantation 
and clinical pregnancy: a blinded, multi-centre study. Reprod Biomed Online. 29(6): 
729-36  
Vishwakarma, P. (1962) The pH and bicarbonate-ion content of the oviduct and uterine 
fluids. Fertil Steril. 13:481-5 
Voullaire L, Slater H, Williamson R, Wilton L. (2000) Chromosome analysis of 
blastomeres from human embryos by using comparative genomic hybridisation. Hum 
Genet. 106: 210-7 
Wale PL, Gardner DK. (2010) Time-lapse analysis of mouse embryo development in 





Whitten WK. (1956) Culture of tubal mouse ova. Nature. 177:96 
Williams N, Kraft N, Shortman K. (1972) The separation of different cell classes from 
lymphoid organs. VI. The effect of osmolarity of gradient media on the density 
distribution of cells. Immunology. 22: 885–99 
Wissing ML, Bjerge MR, Olesen AI, Hoest T, Mikkelsen AL. (2014) Impact of PCOS on 
early embryo cleavage kinetics. Reprod Biomed Online. 28: 508-14 
Wong CC, Loewke KE, Bossert NL, Behr B, De Jonge CJ, Baer TM et al. (2010) Non-
invasive imaging of human embryos before embryonic genome activation predicts 
development to the blastocyst stage. Nat Biotechnol. 28(10):1115-21 
Yakin K, Balaban B, Urman B. (2005) Impact of the presence of one or more 
multinucleated blastomeres on the developmental potential of the embryo to the 
blastocyst stage. Fertil Steril. 83: 243-5 
Yalçınkaya E, Ergin EG, Calışkan E, Oztel Z, Ozay A, Ozörnek H. (2014) 
Reproducibility of a time-lapse embryo selection model based on morphokinetic data in 
a sequential culture media setting. J Turk Ger Gynecol Assoc.15 (3):156-60 
Yang Z, Zhang J, Salem S, Liu X, Kuang Y, Salem R, Liu J. (2014) Selection of 
competent blastocysts for transfer by combining time-lapse monitoring and array CGH 
testing for patients undergoing preimplantation genetic screening: a prospective study 
with sibling oocytes. BMC Med Genomics. 7: 38 
Yeung WS, Li RH, Cheung TM, Ng H, Lau EY, Ho PC. (2009) Frozen thawed embryo 
transfer cycles. Hong Kong Medical Journal. 15: 420-6  
Yoon SH, Son WY, Kim JG, Im KS, Lim JH. (2001) Alternative embryo transfer on day 
3 or day 5 for reducing the risk of multiple gestations. J Assist Reprod Genetic. 18(5): 
262-7 
Zaitseva I, Zaitsev S, Alenina N, Bader M, Krivoharchenko A. (2007) Dynamics of DNA-
demethylation in early mouse and rat embryos developed in vivo and in vitro. Mol 





Zander DL, Thompson JG, Lane M. (2006) Perturbations in mouse embryo 
development and viability caused by ammonium are more severe after exposure at the 
cleavage stages. Biol Reprod. 74: 288-94 
Zander-Fox DL, Henshaw R, Hamilton H, Lane M. (2012) Does obesity really matter? 
The impact of BMI on embryo quality and pregnancy outcomes after IVF in women 
aged <38 years. Aust N Z J Obstet Gynaecol. 52(3): 270-6 
Zander-Fox DL, Mitchell M, Thompson JG, Lane M. (2008) Repercussions of a 
transient decrease in pH on embryo viability and subsequent fetal development. 
Reprod Fertil Dev. 20 (Suppl.), 84 
Zander-Fox DL, Tremellen K, Lane M. (2011) Single blastocyst embryo transfer 
maintains comparable pregnancy rates to double cleavage-stage embryo transfer but 
results in healthier pregnancy outcomes. Aust N Z J Obstet Gynaecol. 51(5): 406-41 
Zenzes MT, Bielecki R, Casper RF, Leibo SP. (2001) Effects of chilling to 0 degrees C 
on the morphology of meiotic spindles in human metaphase II oocytes. Fertil Steril. 
75(4): 769-77 
Zhang H, Zheng Y, Wu Y, Ye D, Huang X. (2016) A prospective randomized 
comparison of early embryo cleavage kinetics between two media culture systems. Pak 
J Med Sci. 32(6): 1375-9  
Zhang JQ, Li XL, Peng Y, Guo X, Heng BC, Tong GQ. (2010) Reduction in exposure of 
human embryos outside the incubator enhances embryo quality and blastulation rate. 
Reprod Biomed Online. 20(4): 510-5 
Zhao Y, Chauvet PJ, Alper SL, Baltz JM. (1995) Expression and function of 
bicarbonate.chloride exchangers in the preimplantation mouse embryo. J Biol Chem. 
270: 24428-34 
Zhao Y, Baltz JM. (1996) Characterisation of bicarbonate/chloride exchange during 












9.1 Appendix 1 - The EmbryoScope® and its use at the Hewitt Fertility Centre	...........	200	
9.2 Appendix 2 – Research ethics process documentation	...................................................	209 
9.3 Appendix 3 – Standard operating procedures	.....................................................................	214	
9.3.1 Setting up for treatment	..........................................................................................................................	215	
9.3.2 Oocyte collection	........................................................................................................................................	221	




9.3.7 EmbryoScope® general use	................................................................................................................	240	
9.3.8 EmbryoScope® annotation and selection	.....................................................................................	250	
9.3.9 Performing an embryo transfer	...........................................................................................................	255	
9.4 Appendix 4 – Triple Media Trial (TMT) documentation	.....................................................	263	
9.4.1 TMT standard operating procedure	..................................................................................................	263 
9.4.2 Sample size calculations	........................................................................................................................	264	
9.4.3 Patient information sheet	.......................................................................................................................	269	
9.4.4 Patient consent form	.................................................................................................................................	272	
9.5 Appendix 5 – Statistical analysis excerpt	..............................................................................	273	


























List of figures 
	
Figure n Title 
Figure 1 The EmbryoScope® Incubator 
Figure 2 Cleavage stage embryo grading scheme  
Figure 3 Blastocyst stage embryo grading scheme 
Figure 4 The published embryo selection algorithm employed at the HFC 
Figure 5 Results of the preliminary validation of the published ESA 
Figure 6 The HFC v1.0 ESA 
Figure 7 Results of the HFC v1.0 development on 173 known implantation 
embryos 
Figure 8 Results of the validation of HFCv1.0 and published ESA 
Figure 9 A schematic to represent an EmbryoSlide® to be used in TMT 
	
	
List of tables 
	
Table n  Title  
Table 1 The proposed guidelines on the nomenclature and annotation of 
human embryos using time-lapse imaging 
Table 2 Results of logistic regression analysis 
Table 3 Head-to-head (A vs. B) Sample Size Calculation; power = 95%, alpha 
=0.05, two-tailed 
Table 4 Multivariate (A vs. B vs. C) Sample Size Calculation; power = 95%, 
alpha =0.05, two-tailed 















9.1 Appendix 1 - The EmbryoScope® and its use at the Hewitt Fertility 
Centre 
	
Figure 1. The EmbryoScope® Incubator 
 


















































































Figure 4. The published embryo selection algorithm employed at the HFC 
 
The first tier of this algorithm is t5 which must fall between 48.8hpi – 56.6hpi. The 
second tier is s2 (time between t3 and t4) which must fall between 0h – 0.76h. The final 






















Figure 5. Results of the preliminary validation of the published ESA 
 
Validation performed at the HFC on 173 known implantation embryos. The x-axis 
represents the score assigned by the algorithm (A+-D-). The y-axis represents the 





Figure 6. The HFC v1.0 ESA 
 
The primary tier of the HFC v1.0 algorithm is s2 (the time between t3 and t4), which 
must be between 0-1.7h. The second tier is cc3 (time between t4 and t5) which must 























Figure 7. Results of the HFC v1.0 development on 173 known implantation 
embryos 
 
The x-axis represents the embryo score given by the ESA described in Figure 6. The y-
axis represents implantation rate as a percentage. Difference in implantation rates 
between A+ and D- was statistically significant (p=0.001, chi-square test).  
 
Figure 8. Results of the validation of HFCv1.0 and published ESA 
 
The x-axis represents the score assigned by each ESA and the y-axis represents 













































Table 1. The proposed guidelines on the nomenclature and annotation of human 


































tPNa Time of first visualization of both pronuclei 
tPNf/tPNB Time immediately following last visualization of both pronuclei 
t2PB Time of second polar body extrusion 
t1 tPNf to the time immediately before cleavage furrow is 
visualized for first cell cycle 
tPNB - (t2-DurFirCyt) 
DurFirCyt Appearance of cleavage furrow to two distinct cells 
t2 Time that the first cleavage has occurred (two distinct cells) 
cc1 Total time of first cell cycle (tPNf – t2) 
t3 Time at which the 3-cell stage is reached 
t4 Time at which the 4-cell stage is reached 
cc2 Total time of second cell cycle 
t5 Time at which the 5-cell stage is reached 
t6 Time at which the 6-cell stage is reached 
t7 Time at which the 7-cell stage is reached 
t8 Time at which the 8-cell stage is reached 
cc3 Total time of third cell cycle 
t9 Time at which the 9-cell stage is reached 
tMx Time that full compaction has occurred 
tMy Time that embryo is partially compacted 
tSB Time to start of blastulation – first sign of blastocele cavity 
forming  
tByz Time before zona pellucida thinning 
tEyz Time of initiation of zona pellucida thinning 
tB Time of formation of full blastocyst –blastocele cavity fills 
embryo, ICM/TE distinguishable, no more than 10% increase in 
outer diameter of zona pellucida 
tHyz Time of initiation of herniation 
tBCi (n) Blastocyst expansion 
tBCend (n) Blastocyst collapse 
tSER(i) Time of first visualization of translucent vacuole (smooth 
endoplasmic reticulum) 
tSER(e) Time of last visualization of translucent vacuole (smooth 
endoplasmic reticulum) 
tRoll(i) Time of initiation of blastomere movement 
tRoll(e) Time to end of blastomere movement 
tCW(i) Time of initiation of cytoplasmic waves 
tCW(e) Time to end of cytoplasmic waves 
tCS Time of first visualization of cytoplasmic strings 
MNB Multinucleation of blastomeres 






Table 2. Results of logistic regression analysis 
 
Logistic regression analysis performed in order to determine statistical significance of 
different embryological parameters in order to develop the HFC v1.0 embryo-scoring 
algorithm. 
 
Parameter Unit Specific Range Unit Specific P Value 
t2 23.36-28.88 Low 0.803 
t3 34.16-39.6 Medium 0.7923 
t4 35.67-38.86 Medium 0.6689 
t5 43.46-51.04 Medium 0.2387 
t2-t3 9-13.5 Medium 0.7308 
t3-t4 0-1.7 High 0.0197* 
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9.3 Appendix 3 – Standard operating procedures 
 
9.3.1 Setting up for treatment 
 
9.3.1.1 Required equipment 
	
Safety cabinet with heated surface 
Electronic BibbyJet 
Electronic pipette 
Printed label/permanent marker pen 
 
9.3.1.2 Reagents and consumables 
	
10ml graduated pipettes (Falcon) 
1ml graduated pipettes (Falcon) 
Extra long pipette tips (Scientific Lab Supplies) 




20% protein supplement (Irvine Scientific) 
OVOIL™ 
60mm round petri dishes (Nunc™) 
14ml round bottom tubes (ReproMed) 
5ml round bottom tube (ReprodMed) 
50ml flasks (Falcon) 
4-well dishes  
EmbryoSlides® 
Coloured incubator tape 
 
9.3.1.3 General information 
	
• All culture dishes should be set up using aseptic techniques and allowed to 





• Prior to the setup of any dishes or tubes staff MUST have the media 
checked to ensure it is suitable for use and the relevant section of the To Do 
list signed. 
• Culture dishes are numbered as 1-4 working in a clockwise manner starting 
from the top left well. 
 
9.3.1.4 Temperature, pH and osmolality 
	
Crucial considerations for embryo culture are temperature, pH and osmolality. 
Temperature and pH changes occur rapidly and are related to the amount of time 
the dish stays out of the incubator.  It is important to ensure culture dishes are out 
of the incubator for the shortest time possible. 
 
• The heated stage in a safety cabinet can be switched off when setting up 
dishes. Alternatively, the unheated surface within the workstation can be 
used.  
• No more than two dishes are to be prepared at one time.  
• The OVOIL™ must be added immediately to avoid evaporation and pH 
changes.   
• Dishes must equilibrate in the incubator for a minimum of six hours. 
• Wherever possible media should be warmed/equilibrated for no longer than 
72h (including duration of embryo culture). This may be exceeded for 
patients being cultured in G-TL™. 
 
NB. Six hours is the minimum recommended time by the manufacturer for the 
medium to reach the correct pH under OVOIL™ (18h is the maximum).  
 
9.3.1.5 Spare media 
	
• Spare tubes of G-TL™ and G-IVF™ Plus should be put in an incubator to 
equilibrate at 5% O2 and 6% CO2 for use the following day. These can be 
used for any new or converted treatments or surplus 





• Spare OVOIL™ should also be placed in a warmer tight-capped (pre-
warmed) and incubator loose-capped (gas-equilibrated) overnight for use 
the next day. 
• The volume of spare media to be pre-equilibrated should be decided on a 
day-to-day basis. The following factors should be taken into consideration 
when calculating volumes of spare media: 
• Number of day 3 patients the following day (G-TL™). 
• Number of patients for oocyte collection with >12 follicles (spare G-IVF™ 
Plus). 
• Spare 0.5ml tube of G-TL™ per embryo transfer list.  
 
NB. Media can only be kept warm in an incubator/warmer for a maximum of three 
days (G-IVF™, G-MOPS™ and EmbryoGlue®) with the exception of G-TL™ which 
can be kept for up to seven days.  
 
If insufficient spare media has been pre-equilibrated, it can be incubated immediately 
and allowed to equilibrate for a minimum of six hours before use. 
 
9.3.1.5 Incubator labels 
	
• Prior to setting up, incubator labels for each patient must be created. 
• Two pieces of coloured tape; each piece of tape should have an RI label (which 
contains the patients details) attached. One of the labels should detail the 
treatment type, and one label should detail the date of the oocyte collection or 
warm/thaw. The labels are loosely stuck to the laminated sheet on the outer 
door of the set-up incubator. 
 
9.3.1.6 Setting up prior to oocyte collection 
	
The following must be made up for each oocyte collection and left to equilibrate 
overnight in the incubator: 
• 1 x G-MOPS™ Plus dish (to hold oocytes during collection). 
• 1 x O/C wash dish (to wash oocytes through after oocyte collection for 





• IVF Insemination dish/es (for IVF only) (number to be made decided 
based on follicle number). 
• ICSI holding dish/es (for ICSI only) (number to be made decided based 
on follicle number). 
• EmbryoSlide® (for ICSI only) (number to be made decided based on 
follicle number). 
• 1-2 x 50ml G-MOPS™ (Follicle Flush) for patients with 5 or less follicles. 
Number is decided based on follicle number.  
• 1 x 8ml G-IVF™ Plus into sperm prep incubator (2 x 8ml needed for viral 
positive sperm samples). 
 
G-MOPS™ Plus dish 
 
This dish is for holding the oocytes during the oocyte collection procedure. 
 
1. Add a patient label (in absence of label use a permanent marker pen and write 
the female patient’s full name and date of birth) to a 4-well dish. 
2. Write the dish type at the top in permanent marker (i.e. ‘G-MOPS™ Plus’). 
3. Add an RFID tag to the underside of the dish. 
4. Add 0.65ml of G-MOPS™ Plus to each well and then carefully add 0.35ml of 
OVOIL™ (see schematic below) and replace lid.  
5. Place the dishes in the warmer overnight.  
 
O/C wash dish (for all oocyte collections) 
 
The O/C wash dish is used to wash the oocyte cumulus complexes (OOCs) through 
after the oocyte collection to ensure that there is no introduction of G-MOPS Plus and 
therefore possible pH changes to the IVF insemination dish or ICSI holding dish. 
 
1. Add a patient label (in absence of label use a permanent marker pen and write 
the female patient’s full name and date of birth) to a 4-well dish, discard lid. 
2. Write the dish type on the top of the dish in permanent marker 
3. Add an RFID tag to the underside of the dish. 
4. Add 0.65ml of G-IVF™ Plus to each well and then carefully overlay with 0.35ml 





5. Place the dishes in the incubator to equilibrate overnight.  
 
ICSI holding dish (for ICSI and IVF/ICSI back-up only) 
 
1. Add a patient label (in absence of label use a permanent marker pen and 
write the female patient’s full name and date of birth) to a 4-well dish, discard 
lid. 
2. Write the dish type on the top of the dish in permanent marker 
3. Add an RFID tag to the underside of the dish. 
4. Add 0.65ml of G-IVF™ Plus to wells 1 & 2 and then carefully overlay with 
0.35ml of OVOIL™ (see schematic below). These wells are for holding the 
oocytes in prior to stripping (max. 10 oocytes per well).  
5. Add 0.7ml of G-TL™ to well 3. This well is to wash the denuded oocytes 
through. 
6. Add 3 x 10µl drops of G-TL™ to well 4 (taken from well 3) and immediately 
cover with 0.7ml OVOIL™ (to avoid evaporation). 
7. Increase the drop sizes in well 4 to 20µl by adding another 10µl G-TL™ 
(taken from well 3). These drops are for holding the denuded oocytes post 
stripping. 
8. Immediately cover well 3 with 0.35ml OVOIL™  
9. Place the dish in the incubator to equilibrate overnight. 
 
IVF insemination dishes (for IVF only) 
 
1. Add a patient label (in absence of label use a permanent marker pen and 
write the female patient’s full name and date of birth) to a 4-well dish, discard 
lid. 
2. Write the dish type on the top of the dish in permanent marker 
3. Add RFID tag to the underside of the dish. 
4. Add 0.65ml G-IVF™ Plus to each well and then cover with 0.35ml OVOIL™.  









Embryo transfer dish  
 
1. Add a patient label (in absence of label use a permanent marker pen and write 
the female patient’s full name and date of birth) to a 4-well dish, retain lid. 
2. Write the dish type on the top of the dish in permanent marker 
3. Add 0.5ml G-TL™ to well 4  
4. Add 0.5ml EmbryoGlue® to well 3 
5. Replace lid. 




For a guide to making EmbryoSlides® refer to section 9.3.9.4. 
 
Embryo transfer tubes 
 
• A loose capped 0.5ml aliquot of G-TL™ should be placed in the set up incubator 
for each patient having an embryo transfer, along with 1 x spare aliquot for each 
list of transfers. 
 
Follicle flush media 
 
• For all patients with <5 follicles place 1-2 x 50ml flasks of G-MOPS™ in the 




Non-gassed OVOIL™ is required for patients undergoing embryo thaws, ICSI treatment 
and oocyte vitrification. Bottles of OVOIL™ should be placed in the warmer (tight-
capped) the day before the treatment is scheduled. The following amount of OVOIL™ 
is required for each procedure: 
• 10ml of OVOIL™ (tight-capped) is required for every embryo thaw  
• 15ml of OVOIL™ (tight-capped) is required for every ICSI procedure. 







Gassed OVOIL™ is required for additional dishes required on the same day. A 
minimum of 25ml should be available in the set up incubator. 
 
	
Dishes required for a patient having IVF using EmbryoScope® 
 
Day prior to oocyte collection:  
• G-MOPS™ Plus dish 
• O/C wash dish 
• IVF insemination dish/es 
Day of oocyte collection: 
• EmbryoSlides® depending on number of oocytes collected  
 
Dishes required for a patient having ICSI using EmbryoScope® 
 
Day prior to oocyte collection: 
• G-MOPS™ Plus dish 
• O/C wash dish 
• ICSI holding dish 
• EmbryoSlides® dependent on follicle number  
 
9.3.2 Oocyte collection 
 
9.3.2.1 Required equipment 
 
Safety Cabinet with heated surface 
Permanent marker pen/printed label 
 Bright field stereo-microscope 
 Hot block  
 Pipette rest 
 
9.3.2.2 Reagents and consumables 
 









60mm round petri dishes  
4-well dishes  
14ml round bottom tube  
50ml flasks  
Sterile Pasteur pipettes (Origio) 
Rubber bung (Fisher Scientific) 
Disposable gloves (non-powdered) 
Disposal container with gel sachet inside 
 Paper towel (to sit under above container in case of spillages) 
Oosafe® (Parallabs) 
 
9.3.2.3 General considerations 
	
One Pasteur pipette should be used for the oocyte collection procedure from picking up 
the oocyte cumulus complexes (OCC’s) from the follicular fluid and placing them in the 
G-MOPS™ Plus holding dish. Once all oocytes are in the G-MOPS™ Plus dish use a 
clean Pasteur pipette to transfer the OCC’s from the G-MOPS™ Plus dish through the 
O/C wash dish and into the IVF insemination dish/ICSI holding dish. This will reduce 
the risk of carrying over any suboptimal components from the follicular fluid into the 
culture system.  This is the same for both IVF and ICSI oocytes but ICSI oocytes could 
potentially be at a higher risk due to the fact that they lack the protection from the 
cumulus cells. 
 
9.3.2.4 Prior to oocyte recovery 
 
1. The embryologist must use alcohol gel on her/his hands upon entering the lab. 
2. An RI Witness™ ID card should be assigned prior to the oocyte collection 
procedure. The patient’s full name, date of birth and unit number, along with the 
partners name (if ID card is already assigned) or partners name and date of birth (if 
a new card has been made) should be witnessed with a second embryologist using 





made to ensure the presence or absence of ‘F’ following the hospital number is the 
same on the ID card, embryology pack and RI Witness™. 
3. All information on the embryology pack should be checked and all discrepancies 
amended before the treatment begins. 
4. Set out pre-warmed petri dishes (bases and lids) on heated surface. 
5. Place a disposal container with a gel sachet inside inside in the safety cabinet, with 
a piece of paper towel underneath to soak up any spillages. 
6. A sterile Pasteur pipettes should be removed from the packaging, a rubber bung 
attached and placed on the pipette rest.  
7. Using the case notes, the embryology pack and the RI Witness™ ID card, the 
embryologist, the oocyte collecting doctor/fertility nurse specialist (FNS) and the 
nurse should ask the patients to state their names and dates of births and the photo 
ID checked. The appropriate section of the witness form must then be signed and 
ticked, respectively, and the RI Witness™ ID card is placed in the card holder. 
8. The embryologist should take receipt of a completed pre oocyte collection lab check 
list form from the nurse and ensure that it is completed fully to include verbal 
confirmation of the patients treatment type, consent to cryopreservation of suitable 
embryos and any telephone numbers. Any consent issues which have been 
documented at the bottom of the form should be indicated as resolved by the nurse 
initialing next to each. The form should be signed as complete by the nurse. 
 
9.3.2.5 The oocyte retrieval procedure  
 
1. The embryologist must wear a pair of powder free gloves. 
2. As the aspirate is collected it is placed in the hot block by the nurse prior to 
examination by the embryologist.  The first follicle is placed in the first position in the 
front row of the hot block with any flushes from this follicle going directly behind.  
The second follicle will then go in the second position again with any flush going 
behind.  This is to assist the clinical and nursing team in identifying which tube the 
oocyte came from and also prioritise looking through follicle aspirate over flush once 
an oocyte has been identified. 
3. Approximately 5mls of follicular fluid should be carefully tipped out into a petri dish 
(use both the base and the lid) for examination and identification of the oocyte 





This procedure should be carried out as quickly as is safely possible, and 
without delay to minimise any drop in temperature. 
 
4. When the first oocyte is located the G-MOPS™ Plus dish should be removed from 
the warmer.  Assign the dish to the patient using RI Witness™. 
5. As the oocytes are located they should be immediately transferred to the G-
MOPS™ Plus dish. Oocytes are washed in well 4 then transferred to separate wells 
to minimise changes in temperature. (The first oocyte is added to well 1, the 2nd to 
well 2, the 3rd to well 3, the 4th to well 1, the 5th to well 2, the 6th to well 3 etc). The 
oocytes remain in this dish for the duration of the collection. 
6. After being checked, the follicular fluid is poured carefully into a disposal container 
and the petri dish discarded in the sharps bin 
7. The oocyte number is circled on the embryology record form to help keep a track of 
the number of oocytes collected so far. 
8. The oocyte collection is officially finished when the nurse informs the embryologist 
that the last tube has been placed into the hot block.  
9. Once all the tubes have been checked through, the lid of the waste tub is secured 
and the tub is discarded in the sharps bin, gloves removed and discarded and the 
used Pasteur pipette replaced with a clean one.   
10. The procedure room door must then be left open until a 2nd member of the nursing 
team comes in to the procedure room. This is in case there is an emergency and 
the nurse needs someone to call for help. 
11. The oocytes are distributed into new dishes depending on their planned treatment 
type as per below. 
12. At the end of the procedure the embryologist must wipe down the surface with 
Oosafe® and wash his/her hands. 
13. When the workstation is clear of all tubes and dishes the embryologist must get a 
second person to check their workstation ensuring there are no tubes in the hot 
blocks or dishes in the workstation area. Both members of staff must then sign the 
witness form.  
 
Distribution of oocytes for ICSI patients  
 





2. Assign the O/C wash dish using RI Witness™.  
3. Using a clean Pasteur pipette, the OCC’s are transferred from the G-MOPS™ 
Plus dish and washed through drops 1-4 (clockwise) of the O/C wash dish  
4. The ICSI holding dish is removed from the incubator and the OCC’s are 
transferred and left in wells 1 & 2 of the ICSI holding dish until the time of 
cumulus removal.  
5. If possible the embryologist should try to avoid placing more than 10 oocytes in 
a drop; drop 2 should be used as a backup if a high number of oocytes are 
collected.  
6. The oocytes are graded at this stage and then placed back into the incubator for 
four hours prior to injection. Oocytes can be rolled using a Pasteur pipette to aid 
visualisation of the OCC, however the duration of time the dish is outside the 
incubator should be considered. 
7. All remaining dishes must be checked before placing them in the sharps bin..  
8. The number of oocytes collected should be written on the white board with the 
insemination time next to the patient name and the oocyte collection time 
removed. 
9.  The oocyte collection details must then be added onto the Infertility Database 
for Embryology and Andrology System (IDEAS V.5.3™).  
10. The embryology record form is then placed in day 0 tray in the embryology 
laboratory in order of insemination time. 
 
Distribution of oocytes for IVF patients 
 
1. The O/C wash dish is removed from the incubator.  
2. Assign the O/C wash dish using RI Witness™. 
3. The oocytes are transferred from the G-MOPS™ Plus dish and washed through 
drops 1 - 4 of the O/C wash dish.  
4. The IVF insemination dish is then removed from the incubator and assigned  
5. The oocytes are then transferred to the IVF insemination dish (es). 
6. The oocytes should be split evenly between the IVF insemination dishes with a 
maximum of 4 oocytes per well, 1-3 (clockwise) with the fourth well of each dish 





7. The oocytes are graded at this stage and then placed back into the incubator for 
four hours prior to insemination. Oocytes can be rolled using a Pasteur pipette to 
aid visualisation of the OCC, however the duration of time the dish is outside the 
incubator should be considered. 
8. All remaining dishes must be checked before placing them in the sharps bin.  
9. The number of oocytes collected should be written on the white board with the 
insemination time next to the patient name and the oocyte collection time 
removed. 
10. The oocyte collection details must then be entered onto the IDEAS™ V.6 
system. 
11. The embryology record form is then placed in day 0 tray in the embryology 
laboratory in order of insemination time. 
12. Any spare IVF insemination dishes for the patient should be checked, patient 
label removed, and the dish transferred to the ‘spare dishes’ shelf of an 
incubator (recording the date ‘made’) on the side.  
 
IVF cases with large numbers of oocytes (>12) collected 
 
1. A second insemination dish must be used, ensuring that the oocytes are 
distributed as described above.  
2. If a second dish has to be made following an oocyte collection (i.e. not set up on 
previous day) then half of the oocytes are transferred into the first IVF 
insemination dish and the remaining oocytes must remain in the O/C wash dish. 
The number of oocytes remaining in the O/C wash dish must be recorded on 
the white board directly next to the number of oocytes in total and the 
insemination time.  
3. Both the IVF insemination dish and the O/C wash dish containing the ‘extra’ 
oocytes are transferred to the patient’s allocated position in the incubator. The 
embryologist must then record on the lab white board that a dish is required 
(including patient name and dish type).  
4. The extra dish must be made using pre-equilibrated G-IVF™ Plus and OVOIL™ 
as soon as a member of staff is free to do so. Once made up, the dish request 





5. The first well of the second dish is labelled ‘5’ etc.   
 
Distribution of oocytes for IVF/ ICSI back up cases 
	
1. When the OCC’s have been collected they must be left in the O/C wash dish 
until a decision has been made with regards to treatment type 
2. This must be recorded on the white board by writing ‘n oocytes in O/C wash 
dish’ directly next to the insemination time 
 
9.3.2.6 OCC grading 
 
Grade 1- (immature) OCC:    -tightly packed, unexpanded cumulus cells,  
-occasionally compact clumps of parietal granulosa 
cells, and dense layer of coronal cells 
-the ooplasm is barely visible through the cumulus. 
 
Grade 1 (mature) OCC: -fully radiating corona surrounded by a loose mass of 
cumulus cells. 
-the oocyte can be clearly seen. 
Grade 1+ (post-mature) OCC:  -cumulus with clusters of darkened cells 
-coronal cells are dark and tight. 
-the oocyte is clearly visible.  
 
9.3.3 Intracytoplasmic sperm injection (ICSI) 
 
9.3.3.1 Required equipment  
	
         Integra Ti Micromanipulator, Research Instruments. 
Safety cabinet with heated stage 
Pipette handle and rest 
 
9.3.3.2 Reagents and consumables: 
	
 5ml round bottom tube 





 60mm round petri dishes  
 10ml graduated pipette 
 Sterile ICSI holding pipette (Smiths Medical) 
 Sterile ICSI injection pipette (Smiths Medical) 
 G-IVF™ Plus 
 G-MOPS™ Plus  
 HYASE-10X™ 
 OVOIL™ 
 ICSI -100™ (PVP) (Vitrolife) 
 
9.3.3.3 Reagent preparation  
 
The day before ICSI: 
 
Put OVOIL™ tight capped in the 37o C warmer overnight. 
 
The day of ICSI (am): 
 
Place one vial of HYASE-10X™ for every four ICSI cases in the warmer.  
Place one 1.0ml G-MOPS™ Plus aliquot (tight-capped) per two ICSI cases & per vial of 
HYASE-10X™ in the warmer.  
Remove PVP from fridge and place in safety cabinet (do not place on heated stage). 
 
Setting up a stripping dish 
 
Enzymatic digestion (hyaluronidase) of cumulus and corona (stripping) is performed 
up to a max. of one hour prior to injection.  
 
1. Remove one 1.0ml G-MOPS™ Plus aliquot from the warmer. Remove a second 
aliquot of G-MOPS™ Plus if a new vial of HYASE-10X™ is required. 
2. Add a patient label and an RFID tag to a 60mm round petri dish. 
3. Place the dish on a cold surface when making up the stripping dish and ensure 
that the process is performed quickly 
4. Add 0.9mls of G-MOPS™ Plus directly into a vial of HYASE-10X™ using a 





5. Prepare a dish for stripping by adding 5-6 x ~50ml drops of G-MOPS™ Plus from 
the tube to the stripping dish 
6. Then transfer ~250ml of the diluted HYASE-10X™ to the dish making two large 
droplets (only one droplet is necessary if the oocyte number is less than five). If 
using a Pasteur to make drops ensure that the G-MOPS™ Plus drops are made 
first, this is to prevent any HYASE-10X™ being transferred into the G-MPOS™ 
Plus. 
7. Cover with 10 ml warmed OVOIL™.  
8. Place the stripping dish in the warmer to equilibrate. 
 
9.3.3.4 Stripping of cumulus cells 
 
1. Set up a flamed Pasteur pipette and the following denudation pipettes: 1x 200µm, 
1 x 155µm, 1x 135µm. Alternatively finely drawn pipettes of appropriate diameter 
may be used. 
2. Remove the stripping dish from the warmer followed by the ICSI holding dish from 
the incubator. 
3. Assign the stripping dish accordingly using RI Witness™ 
4. In the absence of RI Witness™ a second embryologist must cross check the 
patient details on the ICSI holding dish, the stripping dish and the embryology 
forms, and sign the appropriate section of the witnessing form. 
5. Using a Pasteur pipette transfer no more than half of the OOCs to the droplet 
containing pre-equilibrated HYASE-10X™ solution. 
6. Aspirate a maximum of five OOCs in and out of the pipette. The cumulus cells will 
begin to disperse.  
NB. Maximum exposure time to HYASE-10X™ is 30 seconds. 
7. Transfer the partly denuded oocytes into the first of the wash droplets containing 
G-MOPS™ Plus, taking care to carry over a minimum amount of HYASE-10X™ 
solution. 
8. Aspirate each oocyte up and down, using the denudation pipettes to remove any 
corona.  Transfer to next clean wash drop and replace the ICSI holding dish in the 
incubator.  





10. Although all cells do not need to be removed, it is important to clean oocytes 
sufficiently enough to avoid problems with polar body visualisation, or holding and 
rotating the oocyte on the holding pipette during the ICSI procedure 
11. Assess oocyte maturity as follows: 
• Metaphase II oocyte (MII) - one complete or fragmented polar body 
• Metaphase I oocyte (MI) - no polar body 
• Germinal vesicle stage oocyte (GV) - one nucleus with single nucleolus 
12. Wash all mature (MII) oocytes thoroughly in the wash well (well number 3) in the 
ICSI holding dish before being placed in a fresh culture micro-drop.  
13. Immature oocytes (MI) should be placed into a separate micro-drop. Incubate until 
needed for injection.  
14. GV oocytes are discarded following the stripping procedure. MII and MI are kept 
until the ICSI has been performed. 
 
9.3.3.5 Preparation of ICSI dish 
 
• ICSI dishes must be prepared approximately one hour prior to the ICSI on a 
unheated surface, the lid replaced and then the dish placed in the warming 
oven until required.  
• For ICSI’s with >12 oocytes make up a second injection dish and leave in the 
warmer until required. 
 
1. Add a patient sticker and RFID tag to the ICSI dish. 
2. Add 10µl of warmed G-MOPS™ Plus to the centre of the dish and then 
surrounded by eight 10µl droplets (one per oocyte) of G-MOPS™ Plus medium  
3. Remove the 10µl of warmed G-MOPS™ Plus and replace with 5µl PVP. This 
creates a wide flat drop of PVP which helps with observing sperm. 
4. Cover immediately with 4ml OVOIL™ 
 
ICSI dishes should be made up quickly and not more than one at a time to avoid 










• Injection is carried out at approximately 40h post hCG. 
• An ICSI dish should remain on the rig for a maximum of 10 minutes. Please use 
professional judgement regarding how many oocytes are placed in the dish such 
that you can comfortably inject that number within the 10 minute time period. 
• When extremely poor sperm samples (e.g. TESE) are encountered 
consideration should be given to 'harvesting' sperm before oocytes are placed in 
the dish such that the above time restriction can be adhered to. 
 
The injection procedure 
 
1. The holding and injection pipettes are attached to the manipulators: holding to the 
left and injection to the right. 
2. Needles are aligned with the `high' objective. Correct alignment in this position 
means that when the needle is lowered with the coarse movement lever to its 
lowest point it should be positioned correctly in focus with the periphery of the 
drop, requiring the minimum of fine alteration with the joystick. 
3. Immediately before the ICSI procedure collect the final sperm preparation tube 
from the sperm preparation lab. 
4. Remove the ICSI dish from the warmer and add an appropriate volume of sperm 
suspension to the central PVP drop.  
5. Ensure a witness is available and then remove the ICSI holding dish from the 
incubator. 
6. Add one MII oocyte to each surrounding droplet.  
NB. Do not pick all the oocytes up at the same time, split them into two or more 
‘batches’ (i.e. 5 oocytes moved as 3 and then 2, 6 as 3 & 3 etc) 
7. For samples with low sperm count, motility or progression (e.g. TESE) the 
sample may be concentrated (100ml) prior to use and separate droplets may be 
used. 
8. Replace the ICSI holding dish in the incubator 
9. Align the holding pipette first and equilibrate this in a drop of G-MOPS™ Plus 





10. Using the high objective, align the injection pipette with the holding pipette. Using 
the low objective, lower the injection pipette into the PVP drop and allow PVP to 
enter the pipette by capillary action.   
11. At high magnification a motile sperm is selected.  
12. Immobilise the selected sperm by drawing the injection pipette in a downward 
swipe across its tail. Do not damage the midpiece as this contains the centriole, 
but do ensure that the membrane is broken, this is indicated by ‘kinks’ in the tail. 
Permanent immobilisation is important. 
13. Aspirate the sperm tail first into the injection pipette. Ensure that the sperm moves 
freely up and down in the needle. If it does not, select another sperm. Raise the 
pipette and move to a drop containing an oocyte. 
14. Using the holding pipette apply gentle suction to the oocyte so that it is immobilised 
on the pipette with the polar body at six o'clock. This is important to avoid injecting 
the site of the metaphase spindle.  
15. Position the sperm close to the tip of the injection pipette and push the injection 
pipette through the zona pellucida and oolemma at three o'clock. Do not push 
more than half way. Do not push to the opposing membrane, as this will damage 
the oocyte. Move straight in and out, not up and down. 
16. The inner membrane may invaginate and, in order to break the oolemma, gentle 
suction is applied through the injection pipette until a rush of cytoplasm is 
observed, signalling that the membrane has been broken.   
17. Gently release the suction and replace all the cytoplasm back into the oocyte 
together with the sperm. Insert the sperm slowly with the smallest volume of PVP 
possible.   
18. Slowly withdraw the injection needle, which can then be used to help dislodge the 
oocyte from the holding pipette.  
19. Return to the sperm drop to select further sperm.  
20. The above process is repeated for each oocyte.  
21. At the end of the ICSI procedure the needles are lifted out of the way of the dish. 
The lid of the dish is replaced and then the dish is transferred to the designated 
safety cabinet and placed on the heated stage. 
22. The pre-equilibrated culture dish for that patient is removed from the incubator. 
23. The injected oocytes are transferred to the embryo culture dish. 





25. The ICSI dish and pipettes are then disposed of in the appropriate manner. 
26. In cases of poor sperm samples (i.e. TESE, concentrate before use) the ICSI 
practitioner must make a note on the sperm preparation form of the quality of the 
sperm used for the ICSI procedure. This is then added to the IDEAS V.5.3™ 
sperm preparation data entry to ensure the information is available for future 
treatments. 
9.3.4 IVF insemination 
 
9.3.4.1 Required equipment 
 
Safety cabinet with heated stage 
Pipette handle and rest 
Automatic pipette 
 
9.3.4.2 Reagents and consumables 
 
 Extra long tips 
 
9.3.4.3 Sperm concentration 
 
The final concentration of sperm for the insemination should be 100,000 normal motile 
sperm /ml.  In order to calculate the insemination volume: 
 
Normal Motile Sperm (NMS) = Concentration x % motility (A+B) x % normal forms 
 
Insemination Volume = 65 / NMS (for a 650µ l drop) 
 
9.3.4.4 Signing out the sperm for insemination 
 
1. In the absence of RI Witness™ a second embryologist must be present for 
witnessing this procedure. 
2. The rack containing all the preparation tubes is removed from the incubator in 





3. All the labels on all the tubes in the allocated rack are checked (female name) 
against the details on the sperm preparation form and the RI Witness™ screen 
by the embryologist. On the ‘final prep’ tube both partners’ names and dates of 
birth are checked against the sperm preparation form (as this is the tube used 
for insemination). The number and type of tubes in the rack are checked against 
the RI Witness™ screen to ensure all tubes are assigned correctly.  
4. The ‘final prep’ tube is removed from the rack, and the ‘Discard’ option on RI 
Witness™ is used to discard all of the tubes. The label on the front of the rack is 
removed and placed on top of one of the tubes and rack is then placed on the 
bench until the insemination has been performed. 





1. Set up the automatic pipette according to the insemination volume required and 
number of wells containing oocytes to be inseminated, attach a pipette tip and 
place the pipette on the pipette rest ready for use. 
NB. It is the responsibility of the embryologist performing the insemination to 
check the number of oocytes to be inseminated in each well and to ensure that 
the pipettor is set up correctly prior to the insemination.  
2. Remove the insemination dish from the incubator.  
3. Cross check the patient details on the embryology forms, the insemination dish 
and the final sperm tube with the 2nd witness who must then enter their unique 
PIN into RI Witness™ to authorise the insemination and sign the appropriate 
section on the witness form. 
NB. Each well should be briefly checked to ensure the number of oocytes in each 
well corresponds with the embryology paperwork. This must be a brief check 
and must not put the oocytes at an unnecessary risk of cooling.  
4. Gently shake the final sperm tube to mix the sample evenly. 
5. Pick up the pipette from the rest and place the tip in the sperm preparation tube 
and draw up the calculated volume of sperm suspension. 
6. If using the automatic pipette, pre-pipette some of the sample out onto the side of 





7. Position the first well to be inseminated under the microscope so that the well 
can be visualised, place the tip into the well and press the yellow button on the 
pipette. 
8. Move the dish so that each well can be inseminated as described above. 
9. Once all the oocytes have been inseminated check all inseminated wells to 
visualise motile sperm 
10. Place the dish back in the incubator 
11. Discard the sperm ‘final prep’ tube on RI Witness™ and place in a sharps bin 
12. Wipe surface with Oosafe®. 
13. The embryologist must then sterilize their hands using alcohol gel. 
14. The insemination procedure should be entered onto IDEAS V.5.3™. 
15. The patients name should be wiped off the laboratory whiteboard. 
9.3.5 Fertilisation check 
 
9.3.5.1 Required equipment 
 
Safety cabinet with heated stage 
Pipette handle and rest 
 
9.3.5.2 Reagents and consumables  
 
135µm denudation pipette (Research Instruments) 
155µm denudation pipette (Research Instruments) 
 
9.3.5.3 Timescale for checking fertilisation 
 
Oocytes should be checked in the morning following oocyte collection: 
IVF - 16-22hpi  
ICSI - 12-18h after injection as PN may appear earlier. Oocytes cultured in the 
EmbryoScope® can be checked at any point in the morning but the patient call 







9.3.5.4 General information for checking fertilisation  
 
• ‘Cleaning’ of oocytes is carried out using a 135µm denudation pipette (or a 
Pasteur pipette - drawn so its internal diameter is just greater than the diameter 
of a human oocyte. The tip of the drawn pipette should be free of jagged edges 
and at right-angles to the length). 
• Denuded oocytes should be handled using a pipette no smaller than a 146-
155µm pipette 
• Ensure only the minimum volumes of medium are transferred.  
• Care must be taken not to catch the end of the denuding pipette when 
transferring oocytes from well to well. 
• Any oocyte in which normal fertilisation cannot be confirmed should not be 
considered suitable for replacement or cryopreservation without confirmation 
from a Consultant Embryologist. 
• Care must be taken not to use a drawn pipette with an internal diameter that is 
too small. 
• A new pipette must be used for every patient. 
• Pipettes should be discarded immediately at the end of the procedure. 
• If RI Witness™ is not operational, the patient details on the embryology notes 
and on the bottom of the dishes must be witnessed by a second member of staff 
prior to transferring embryos from one dish to another. 
 
9.3.5.5 IVF fertilisation checks 
 
1. To remove the cumulus and corona cells the oocytes should be gently aspirated 
in and out of a 135µm pipette until the majority of the coronal cells have become 
detached to the extent that PN and polar bodies can be clearly observed. 
2. If the cumulus cells are not dispersed, needles should be used to dissect the 
oocyte from the OCC.   
3. The oocytes must then be washed in the 4th ‘clean’ well of the insemination dish. 
4. The denuded oocytes are then inspected under high power on the dissecting 
microscope for the presence of PNs, polar bodies and other inclusions.  The 





to observe the general appearance of the oocyte. Factors to note are micro-PNs, 
cytoplasmic texture and shape, zona integrity and shape, clarity etc.  
NB. Micro-PN’s are classified as nuclear envelopes which are less than 20% in 
size of the two larger PNs and contain no more than one nucleoli. If normally 
fertilised embryos contain micro-PN then this should be clearly documented 
on the embryology pack.  
5. Once all the oocytes have been denuded, check for signs of fertilisation and 
record the results on the embryology form, and then remove the EmbryoSlide® 
from the incubator. 
6. All normally fertilised oocytes (2PNs) are washed through the 4 wash wells of 
the EmbryoSlide® (labelled A-D) before placing them in their designated drops. 
7. Remaining vacant wells in the EmbryoSlide® are filled with unfertilised oocytes 
after they have been washed through the wash wells. These will be rechecked 
for signs of fertilisation at the early cleavage check. 
8. In the event the EmbrosSlide® is full, additional 2PN’s are kept temporarily in 
wash well D, 1PN’s in wash well C and 0PN’s in wash well B. A 2nd 
EmbryoSlide® should be prepared and the embryos/unfertilised oocytes should 
be moved as soon as possible.   
9. Load the EmbryoSlide® containing the embryo(s) into an EmbryScope® 
incubator. 
10. Any immature GV and MI oocytes, along with any abnormally fertilised embryos 
are discarded. 
11. The location of all oocytes must be clearly noted.  
12. In cases of OHSS all embryos are cryopreserved at the blastocyst stage, 
following discussion with a Senior Embryologist.   
13. In cases of low or failed fertilisation a record should be made regarding sperm 
motility and binding.  
14. In cases of complete fertilisation failure, all 1PN and 0PN oocytes should be 
placed in the EmbryoScope® to be rechecked for signs of late fertilisation. 
Where late fertilisation is not observed but the unfertilised oocytes show signs of 







9.3.5.6 ICSI fertilisation checks 
 
1. Oocytes are inspected on the viewer for the relevant EmbryoScope®. 
2. Degenerate oocytes must be discarded by colouring the panel red, annotating 
the panel on the right hand side of the viewer to indicate “0PN” as the 
fertilisation status and selecting ‘Dead’ from the dropdown box on the right hand-
side of the viewer. 
3. 3PN and >3PN oocytes must be discarded by colouring the panel red and also 
annotating the panel on the right hand-side of the viewer to indicate a “3PN” or 
“4PN” (where 4PN indicates anything over 3PN). 
4. All oocytes should be assigned a PN status on the viewer i.e. 0PN, 1PN, 2PN, 
3PN, >4PN 
5. The presence of micro-PN should be noted in the ‘If applicable’ dropdown box 
on the right hand-side of the viewer.   
6. The fertilisation status of each oocyte must be clearly noted on the embryology 
paperwork along with the location and fate if any are discarded.  
 
9.3.5.7 Data entry 
 
All clinical information should be entered electronically into the IDEAS V.5.3™ system 
immediately after the procedure has taken place. 
 
9.3.5.8 Embryo transfer scheduling  
 
Patients who require an embryo transfer are then scheduled accordingly dependent on 
age, number of embryos, number of embryos for transfer and treatment history. The 
patient is booked in to the IDEAS V.5.3™ diary and the scheduled time is noted on the 
front of the embryology pack. 
 
9.3.5.9 Post fertilisation calls 
 
1. Following fertilisation checks, the patients are phoned by an embryologist. 





3. The patients are informed about their fertilisation results, a discussion is had 
regarding the number of embryos to be transferred and the patient is asked 
whether they have any question or concerns. 
4. The day and time of embryo transfer is given to the patient and they are asked 
to remain contactable via telephone in case the embryo transfer date and time 
changes. This decision is dictated by the quality of the embryos.  
5. In cases of complete fertilisation failure, the patient is informed and any 
questions answered. The patient is also informed that the unfertilised oocytes 
will be rechecked for signs of fertilisation until day two and to expect another 
phone call the following day. 
9.3.6 Embryo grading 
 
9.3.6.1 Cleavage Stages (day 2 and day 3 embryos) 
 
Embryo quality is assessed by light microscopy and is based on observing cleavage rate 
and morphology.  Embryo morphology is primarily assessed based on the number of 
blastomeres, evenness of cell division, and degree of fragmentation (Figure 2, appendices 
section 9.1). 
 
Embryos are given a grade comprised of three numbers, in the following order: 
 
• Blastomere number  
• Blastomere evenness 
• Fragmentation 
 
Example:  The grade is recorded as [blastomere number] (size/fragmentation); therefore a 
four-cell embryo with slightly uneven cell division (~10% difference in cell size) and around 
30% fragmentation by volume will be scored as 4(3/2).  
 
9.3.6.2 Blastocyst Stage (day 5 and day 6 embryos) 
 
Blastocyst quality is assessed by light microscopy and is based on the degree of 
blastocoel expansion and the presence and morphology of both the inner cell mass (ICM) 






Embryos are given a grade comprised of a number and two letters, in the following order: 




Example: The grade is recorded as [expansion status] (ICM/trophectoderm); therefore, a 
full blastocyst, where the blastocoel completely fills the embryo, with no ICM cells and a 
trophectoderm made up of sparse cells which may be very large, flat or degenerate will be 
scored as 3 (E/c) 
 
Embryos are not routinely graded on day 4 of their development, however, when an 
embryo is somewhere between the cleavage stage and the blastocyst stage, they are 
graded as follows: 
 
M = Morula. This term describes an embryo in which the cells are starting to or have 
compacted, i.e. the individual cell membranes are becoming or have already become 
indistinguishable. 
 
CM = Cavitating Morula. This term describes an embryo at the morula stage which is also 
showing sign of a developing blastocoel (fluid filled cavity). 
9.3.7 EmbryoScope® general use 
 
9.3.7.1 Required equipment 
 
Safety cabinet with heated stage 
Pipette handle and rest 
Electronic BibbyJet 
Electronic pipette 







9.3.7.2 Reagents and consumables 
 
155µm denudation pipette 
1ml graduated pipettes  
Extra long tips  
G-TL™ 
OVOIL™ 
60mm round petri dishes  
5ml round bottom tube 
 




• Please refer to pages seven, 10-12 in the manufacturer’s user manual 
• The EmbryoScope® provides an environment with controlled temperature, 
CO2 (and other gases) for the development of embryos. 
• It has an integrated inverted microscope and imaging system for embryo 
viewing. 
• The dev ice  inc ludes  time-lapse microscopy at multiple focal planes and 
logging of incubation conditions 
• Air is purified by HEPA and active carbon filters 
• The EmbryoScope® provides  incubation  of  up  to  72  individual  embryos  
in  six  sterile disposable polymer slides each with 12 embryos (e.g. up to 
six patients with 12 embryos each). 
• Built-in tri-gas incubator, which controls temperature, CO2 and O2 levels. 
The device uses N2 and CO2 to maintain desired oxygen partial pressure 
and pH in a bicarbonate buffer system. 
• The device is suitable for continuous operation 
• The EmbryoScope® MUST be operated by trained personnel according to 
instructions contained in this SOP. 
• In the event of system failure or fault the EmbryoSlides® must be immediately 
removed from the EmbryoScope® using the emergency procedures 






Manufacturers safety & maintenance instructions 
 
• Please refer to page five of the manufacturers user manual 
• The device includes moving parts with safety stops. 
• Do not try to block safety sensors to insert a finger or a hand into the 
device while it is turned on. This is dangerous and may cause injury. 
• Do not touch any moving parts when power is ON or during operation. 
• Mishandling or misuse of the EmbryoScope® may result in serious 
injury to the user 
• The EmbryoScope® must remain at the location where it was installed 
• Maintenance/service visits of the device should be arranged every six 
months 
•  
Activation of the incubator alarm 
 
An audible alarm will activate if: 
 
- CO2/O2 deviates by more than 0.5% of the set value or if CO2/N2 pressure is too low 
- Temperature deviates by more than 0.5ºC of the set value 
 
Re-setting the incubator alarm 
 
Press the re-set button (triangle icon) on the control panel. The red LED light will 





Activation of the computer alarm 
 
The following malfunctions of the built-in PC and failure to close the load 
door correctly will activate another audible alarm. The computer alarm 
cannot be reset, the alarm condition must be resolved i.e. closing the door 
properly or re-booting the computer system (see Emergency procedures 
in EmbryoScope® User Manual). 
 
The computer alarm will sound in case of: 
• EmbryoScope® software failure or failure of the operating 
system of the built-in PC  
• Load door open for extended period of time (> 30 seconds) 
• EmbryoScope® software is not running properly (e.g. in case of 
problems with the PC operating system or if the software has 
accidentally been turned off) 
• Errors in data communication  between  EmbryoScope®  software  
and  the  separate  unit controlling the incubation environment 
(Temperature and Gas). 
 
Should the instrument ‘freeze’, it can be prompted to restart by pressing 
‘cmd’ + ‘L’ and entering the appropriate username and password. This is the 





Following a generator test the EmbryoScopes® will lose contact with the 
databases and need approximately 15 minutes to reconnect. The computers 
must not be restarted more than once in this time frame whilst the viewers 
are trying to connect with the database.  
 
In the event that ‘Fertilitech support’ is activated on the viewer (all slide 
entries will appear with red writing indicating that remote access is 





Ensure that the support has been completed before closing the program.  
 
NB.  A computer failure may result in a loss of time-lapse images, 
but will not pose an immediate threat to the embryos incubated in the 
EmbryoScope®, as the temperature and gas concentration is 
controlled separately. 
 
9.3.7.4 The EmbryoSlide® 
 
Please refer to pages 26-29 of the manufacturer’s user manual. 
 
• Only the EmbryoSlide® must be used with the EmbryoScope® 
device. The lid must be replaced before placing the EmbryoScope® 
into the device. 
• An EmbryoSlide® contains a large reservoir for an OVOIL™ overlay 
with 12 wells for single incubation of 12 individual embryos and 4 
wash wells (A-D) 
• Each well holds a volume of 25 µl. 
• Inside each culture well there is a central micro-well where the 
embryo resides, i.e. the micro-well has a diameter of approximately 
250 µm. 
• Individual well numbers (1-12) and wash wells (A-D) are indicated 
beside the bottom of each well, which are legible using a 
stereomicroscope during embryo handling.  
• EmbryoSlides® and lids are individually wrapped in a sterile pouch. 
The pouches must only be opened in a safety cabinet. 
 
 Setting up an EmbryoSlide® 
 
It is essential that the preparation of the EmbryoSlide® is performed 
exactly as described below to minimise evaporation. 
 






EmbryoSlides® must be set up according to the treatment type that is being 
performed which involves the incubation of media prior to EmbryoSlide® 
set-up in some cases.  
 
For IVF patients: 
• 0.5ml of G-TL™ media must be placed in the set-up incubator on the 
afternoon of day of oocyte collection for every EmbryoSlide® that has 
to be made for the following day’s IVF fertilisation checks 
• After at least two hours of equilibration, the EmbryoSlides® can be 
set up for the appropriate cases 
• Once the EmbryoSlides® have been set up they must be placed in 
the set-up incubator for re-equilibration overnight until use the 
following day 
• The embryos are then placed in the prepared EmbryoSlides® after 
the fertilisation check has been performed on day one 
 
For ICSI patients: 
• 0.5ml of G-TL™ media must be placed in the set-up incubator on the 
afternoon of the day before the oocyte collection for every ICSI case 
scheduled 
• On the day of oocyte collection an Embryoslide® must be set up as 
soon as possible after oocytes have been collected 
• Depending on the number of oocytes collected a maximum of two 
Embryoslides® can be set up for each patient 
• If a low number of oocytes are collected then an Embryoslide® can 
be made following the stripping procedure 
 
If Embryoslides® are prepared with pre-warmed medium that is un-
gassed then it must be allowed to equilibrate for 16h before being used. 
 






1. Place an EmbryoSlide® on an ambi-plate on a heated stage in an 
appropriate cabinet. 
2. Place a patient sticker along the front of the dish, with the ‘fin’ at the 
left, and a RFID tag under the ‘fin’. 
3. Fill a 155µm pipette with pre-warmed G-TL™ and place the tip of the 
plastic pitpette at the bottom of the well and fadd directly to the micro-
well until it domes 
4. Repeat this for all micro-wells 
5. Using the electronic pipette immediately add 25µl of G-TL™ media to 
each well including the wash wells. 
6. Carefully layer up to 1.4ml of warm pre-equilibrated OVOIL™ into the 
EmbryoSlide® while observing down a microscope to ensure ample 
coverage of the wash wells. 
7. Ensure all air bubbles are removed using a 155µm pipette by pushing 
the pipette tip down to the bottom of the micro-well and then moving 
the tip in a ‘stirring’ motion while sucking the air bubble/s up into the 
pipette ensuring that minimal media is removed. 
8. All bubbles floating within the well must then be removed as they 
could distort images if they move over where the camera is taking an 
image. 
9. Replace the EmbryoSlide® lid and place the dish in the designated 
incubator for a minimum of 16h if the dish has been set up using 
uneqilibrated media and OVOIL™ or a minimum of one hour if set up 
with pre-equilibrated media and OVOIL™. 
 
NB. Bubbles must be removed relatively fast to avoid evaporation of 
medium from the well, and take care not to remove medium during 
removal of bubbles. Bubbles should be removed before adding the 
OVOIL™ so OVOIL™ droplets are not dragged down to the well. 
 
9.3.7.5 Loading the EmbryoSlide® with embryos 
 
1. Please refer to pages 28-29 of the manufacturer’s user manual 





the incubator and place on a heated surface within an appropriate 
s a f e t y  cabinet. Care must be taken when handling the 
EmbryoSlide® as grease from hands can distort the image. Avoid 
contact with the bottom of the dish at all times. 
3. Select the first embryo to be transferred to the EmbryoSlide® 
using an appropr ia te  handling pipette. 
4. Draw up the embryo into the pipette from the culture dish. Ensure 
there is enough medium in the pipette to be able to ‘waft’ the 
embryo into position. The embryo must sit in the middle of the micro-
well (see diagram below). 
5. Wash the embryo in the designated wash wells (A-D) 
6. Deposit the embryo at the top of the micro-well and allow it to 
float down into the micro-well. 
7. Once all the embryos have been transferred into the 
EmbryoSlide®, and have had sufficient time to settle into the 
micro-well, use the handling pipette to ‘waft’ them into the 
centre of the micro-well. 
 
9.3.7.6 Adding a patient to the EmbryoScope® 
 
Please refer to pages 35-36 in the manufacturer’s user manual 
 
1. Press start on the Welcome screen to start using the EmbryoScope® 
2. On the “Home” screen press the “Add slide” button 
3. The warning light at the EmbryoSlide® load door lock will change from 
red to green indicating that the door is unlocked and may be opened 
4. Open the EmbryoSlide® load door and place the EmbryoSlide® 
containing the embryos in the empty and only accessible position of the 
EmbryoSlide® holder 
NB. The first EmbryoSlide® is placed in position 1; subsequent 
EmbryoSlides® swill be placed in the next available slots. The 
EmbryoScope® software keeps track of unoccupied positions and 





available position. The EmbryoSlide® should be inserted with the 
handling tail fin towards the front of the EmbryoScope®.  
5. Press “OK” 
6. Enter the patient ID, patient name and the date and time of 
insemination of the treatment along with the treatment ID i.e. TX12345 
NB. for patients who have had more than 12 oocytes injected and 
therefore have two EmbryoSlides® the insemination time for the 
second dish must reflect the witness/start of injection time of that 
batch of oocytes, not the time the ICSI was first started 
7. Select on the right hand side which wells in the EmbryoSlide® contain 
embryos by clicking the numbers appropriately 
8. Select “Done” 
9. A dialogue box will appear asking if you would like to “Add more slides” 
10. If more slides need to be added that are ready to do so then click “Yes” 
and follow steps 3-7 
11. If there are no more EmbryoSlides® to add then click “No” 
12. The EmbryoScope® software will automatically find the wells and will 
acquire the optimal focal planes for all wells 
13. If auto-focus did not find the best focused image then it can be 
manually corrected by selecting “Live View” then following section 7.5 
of the manufacturers user manual 
14. If an instrument is constantly not finding the best focus then the re-
calibration of the camera should be undertaken (please refer to the 
user manual for further instruction) 
 
9.3.7.7 Changing medium in EmbryoSlide® wells 
 
• Please refer to pages 29, 46-48 of the manufacturers user manual 
• The culture medium is only changed in unusual circumstances and not 
part of a normal culture period from day 0 to day 6 (where a single-step 
medium is used) 
• New medium must be pre-equilibrated at the appropriate 
temperature and gas concentrations  





petri dish in an appropriate safety cabinet 
2 .  Select the patient requiring a media change on the home screen of the 
EmbryoScope®. 
3. Press “Pause”. The slide holder will move to bring the selected 
EmbryoSlide® to the door which can take up to 20 seconds. During this 
time a tube of pre-equilibrated media that the wells are to be 
replenished with must be removed from the set-up incubator, tight 
capped and placed in the safety cabinet. 
4. When the correct EmbryoSlide® is in the removal position the 
EmbryoScope® door will unlock and a green light will appear below the 
door latch 
5. A box will appear with ‘Ready to proceed’ – select OK. 
6. Remove dish.  
7. Place the dish on the heated stage 
8. Using the manual pipette set at 25µl, attach a tip and place it in first 
well of the EmbryoSlide®. DO NOT PLACE THE TIP NEAR THE 
EMBRYO IN THE MICROWELL AS THE EMBRYO COULD BE 
ACCIDENTALLY ASPIRATED INTO THE PIPETTE. 
9. Remove 25µl of media out of every well in the EmbryoSlide®, 
dispelling the used media between each well into the petri dish 
10. Change the pipette tip and remove the cap of the media tube 
11. Depress the pipette to the furthest point and aspirate media from the 
tube 
12. Place the pipette tip in the first well of the EmbryoSlide® and depress 
the pipette to the first stop allowing some media to remain in the pipette 
acting as a buffer preventing the formation of bubbles 
13. Repeat this for each well in the EmbryoSlide® 
14. Check the dish for bubbles and remove these as described above 
using the 155µm pipette 
15. Ensure that the time the dish is out of the EmbryoScope® is as short 
as possible 
16. Select ‘Reinsert’ on the touchscreen of the EmbryoScope® and, 
when prompted, replace the EmbryoSlide® in the EmbryoScope® 





completed to ensure that all the wells are correctly aligned and the 
embryos are in focus 
 
NB. While an EmbryoSlide® is paused, no images are acquired from the 
remaining EmbryoSlides®. If an EmbryoSlide® has been paused for 
more then one hour the EmbryoScope® will alarm. This alarm can be 
reset by pressing ‘Reset’ on the incubator control panel on the upper 
left side of the EmbryoScope® 
	
9.3.7.8 Additional information 
 
Please refer to the manufacturer’s user manual for additional information 
regarding the following: 
 
• Incubator temperature 
• CO2 and O2 setting of the incubator 
• Camera reset and calibration 
• Live inspection and refocusing of embryos 
• Home screen information 
• Data storage on the EmbryoScope® 
• Routine validation of EmbryoScope® 
• Emergency procedures 
• Technical specifications 
• Symbols 
• Disposal of waste 
 
9.3.8 EmbryoScope® annotation and selection 
 
9.3.8.1 Annotation pathway 
 
Full annotation is only required for those embryos that are utilised. It is 
recommended that annotations take place on the day of use to minimise 






DAY 1 (16-20hpi) – Fertilisation Check 
1. At fertilisation check for ICSI patients annotate PN(n) for ALL oocytes 
 
DAY 1 (26-28hpi) – Late Fertilisation/Early Cleavage Check 
1. Annotate PN(n) (for IVF only), t2PB, tPNa and tPNf using the annotation 
panel on the EmbryoScope® shown below 
2. Perform a ‘late fertilisation check’ on any unfertilised oocytes by annotating 
their PN(n) again and if they remain unfertilised “discard” them by 
colouring the embryo red using the discard tool 
3. A witness is not required for this as a physical discard is not taking. If 
however, the oocyte being “discarded” was once a normally fertilised 
embryo and has converted to a 3PN then “discard” must NOT be written 
next to the oocyte, instead a line must be drawn to indicate that no further 
grading or annotations are required. This oocyte will then be counted in 
the final discard witness check at the end of the treatment as it was once 
an embryo. 
 
NB. Where the PNs fade unequally (i.e. more than one frame apart) 
select ‘tPNf unequal’ from the If Applicable menu when the first PN 
fades then ‘PN faded’ when the second disappears  
 
DAY 2 (40-44hpi) 
1. Annotate t2, t3, t4, using the cell number drop down menu on the 
annotation panel 
2. Annotate ONLY the % fragmentation and blastomere evenness at the 
two and four-cell stages using the relevant boxes on the annotation 
panel (shown below). The percentage fragmentation relates to the 
current grading scheme used i.e. 0-10% = 4, 10-20% = 3, 20-50% = 2 
and over 50% = 1. Blastomere evenness options are simply “even” and 
“uneven”; if the embryo has been graded a 4 or 3 for evenness using 
the grading system then it is to be classed as even, if it is a 1 or a 2 





3. Assess the embryo for MNB at two and four-cell stage. If both cells of 
the two-cell embryo show MNB then click ‘2’ – this will then indicate 
that 100% of cells have MNB.  
4. Assess for irregular division. Where an irregular division occurs the 
irregular division tick box must be selected, the irregular division 
selected from the drop-down menu and the embryo coloured yellow 
using the ‘?’ tool 
5. Where DC occurs select ‘DC1-3 TBC’ from the If applicable drop-down 
menu. At the end of the culture period, the day 5/6 annotater will 
confirm if it is a ‘True DC1-3’ (i.e. all cells divide in next cell cycle, have 
a nucleus or are incorporated into blastocyst) or a ‘False DC1-3’ (i.e. 
cells do not divide in next cell cycle, they don’t have nuclei or they are 
not incorporated into resulting blastocyst) 
 
NB 
• Do not annotate MNB if the fragmentation is 20-50%, if the 
fragmentation obscures the view or if the embryo undergoes DC. 
In this case annotate as ‘N/A’. 
• Do not annotate further if the embryo has undergone DC (this will 
need to be confirmed by the day 5/6 annotater when the nature of 
DC has been established) 
• If the embryo is uneven at the two-cell stage the annotations 
should continue 
 
DAY 3 (64-68hpi) 
1. Annotate t5, t6, t7 and t8 using the same tool as used for annotating t2 
as shown above 
2. Annotate the % fragmentation and blastomere evenness as performed 
for the day 2 check shown above for eight-cell stage only 
3. Assess for irregular divisions as above 
4. Perform the % fragmentation and evenness for any two and four-cell 
stages that were unable to be performed on day 2 following the 






DAY 4 (88-92hpi) 
1. Annotate t9+ and tM using the same tool as used for annotating all 
other cell stages (shown above) 
2. If compaction begins before t9+ select ‘tM (early)’ from the if applicable 
menu 
3. If blastulation begins before tM select ‘tSB (early)’ from the if applicable 
menu 
4. Perform the % fragmentation and evenness for any eight-cell stages 
that were unable to be performed on day 3 following the instructions 
provided above 
5. Assess for irregular division as in point 4 above.  
 
DAY 5 (112-116hpi) – AM Check 
1. Annotate tSB and tB using the same tool as used for annotating all 
other cell stages 
2. Perform any other annotations that have been unable to be performed 
on previous days and confirm any DC (if it cannot be confirmed select 
‘DC1-3 unconfirmed’ from the irregular division menu) and annotate 
evenness and fragmentation at two-cell where applicable 
 
Additional information 
• The final morphology grade should be assigned at the last frame of 
imaging for each embryo 
• If the embryo cannot be annotated due to irregular division or 
quality then the irregular division tick box must be checked and the 
reason for the irregularity selected from the irregular division drop 
down menu 
• Every irregularity MUST have ‘irregular division’ ticked and the 
reason for the irregular division selected from the irregular division 





• If any embryo cannot be annotated due to quality, click irregular 
division and select ‘Fragmented Embryo’ from the irregular division 
drop down menu 
• Where a slide has to be removed from one instrument to another, 
they must be linked by writing the following statement in the slide 
description box; ‘Split run – slide Dxxx.xx.xx_Sxxxx_Ixxx is same 
slide’ 
• Do not write any free text in any of the comments boxes 
• If a treatment cycle is an FET, enter ‘FET’ in the fertilisation 
comment box 
• If annotations are unable to be made due to instrument errors, 
select the appropriate error from the ‘Instrumental Failures’ drop 




The following process should be followed in order to select embryos for 
transfer, cryopreservation and discard.  
1. Grade all embryos on the last image using the ‘View Slide’ option 
2. Identify, based on morphology, those embryos that will be utilised 
3. Every embryo that is selected for utilisation should have its time-lapse 
images reviewed in detail to ensure there are no abnormalities in 
development. For example, a late occurring 3PN. 
4. Highlight three of these and click ‘Annotate’ 
5. Watch the videos from start to finish for all three embryos alongside one 
another on normal speed 
6. Use this to identify any irregular divisions  
7. Rank the embryos based on the footage and leave the top ranked 
embryo selected 
8. Return to the ‘View Slide’ pane and select further embryos to be utilised 
9. Watch the videos for these embryos from start to finish and continue in 
this way until a top ranked embryo is identified 






11. Select “HFC v1.1” from the drop-down menu at the top of the screen 
12. The timings for the appropriate division events will be displayed along 
with the dynamic grade 
13. Where an embryo has not been annotated for one of the reasons 
above a “?” or “(Late)” will be displayed.  
14. The HFC v1.1 grade should then be written in the designated column 
on the embryology pack 
15. Ensure the embryo selected for use (transfer or cryopreservation) does 
not have an unusually low score from the HFCv1.1 ESA  
16. If there are two embryos that are morphologically the same, the ESA 
should be used to choose between them 
 
9.3.9 Performing an embryo transfer 
 
9.3.9.1 Required equipment 
 
Safety cabinet with heated stage 
Pipette handle and rest 
 
9.3.9.2 Reagents and consumables 
 
60mm round petri dishes 
4-well dish 
Equilibrated aliquot of G-TL™ 
1ml syringe (Hunter Scientific) 
Transfer catheter and stylet (Smiths Medical) 




9.3.9.3 Embryo transfer 
	
Embryo transfers are performed on day 3 of day 5, depending on embryo 
development and what the embryologists deem as the best day for transfer 
based on patient age, number of embryos, number of GQE on day 3 and the 






Setting up for embryo transfer 
 
1. The day before embryo transfer ensure there are enough catheters and 
stylets and syringes in the warming oven for all transfers the following 
day. 
2. The day before embryo transfer an embryo transfer dish is prepared 
and placed in the appropriate incubator overnight for equilibration  
Prior to ET: 
3. Remove one petri dish from the warmer and place on the heated stage 
to warm. 
4. Place a pack of disposable scissors in the safety cabinet with the 
plastic removed. 
5. Have a needle for ‘popping’ bubbles in the safety cabinet. 
Selection of embryos for transfer 
 
1. All day 3 embryos are checked on the morning of embryo transfer and 
their grades and cleavage stage are recorded on the embryology 
record form and the IDEAS V.5.3™ system 
2. Day 5 embryos are ‘eye-balled’ on the morning of embryo transfer and 
EmbryoScope® annotations are performed on all blastocysts  
3. Wherever possible the embryologist responsible for performing a list of 
embryo transfers should check all embryos for all patients scheduled 
for embryo transfer before the list starts. The grade and developmental 
stage is recorded on the embryology record form and on the IDEAS 
V.5.3™ system for each patient.  
4. The embryo(s) for transfer are then selected with respect to their stage 
and grade.  
NB. Normally fertilised embryos which displayed micro-PN’s may be 
transferred in cases where no other normally fertilised embryos are 
available. 
5. In cases where an IVF/ICSI spilt has been performed and an embryo 





justifying such a transfer should be clearly documented in the patient’s 
notes. 
6. A transfer of both an ICSI and IVF embryo during the same treatment 
cycle should only be carried out in exceptional circumstances, with an 
upper limit of 2% of all ICSI embryo transfers.    
 
Embryo transfer procedure 
	
Pre-embryo transfer chat with embryologist 
 
1. The nurse should let the embryologist know when the first patient is in 
the procedure room by telephoning the laboratory.  
2. The embryologist should enter the procedure room from the 
embryology lab. 
3. The embryologist must confirm the patient identity by asking both 
partners to confirm their full names and dates of birth. 
4. The embryologist must then summarise the treatment cycle, confirming 
the following: 
• Treatment type 
• Number of oocytes collected 
• Number of oocytes injected (if applicable) 
• Number fertilised 
• Number of embryos to be replaced 
• Number to be frozen (if applicable) 
• Embryo stage and quality 
• Inform the patients that they will receive a letter confirming the outcome 
of any supernumerary embryos within 10 days. 
• Ask the patients if they have any questions 
• Ask the patients if they would like to see their embryos on the monitor 









eSET strategy non-compliance 
 
The Hewitt Fertility Centre Multiple Birth Minimisation Strategy (MBMS) – 
Patient Management Algorithm should be used as guidance to the number 
of embryos to be transferred.   
 
If more embryos are transferred than set out in the MBMS, the MBMS - 
non-compliance log must be completed and the reasons for more embryos 
being replaced should be included. A pre-printed sticker should be placed 
in the clinical case notes at the time of transfer. The patient must sign the 
sticker to acknowledge that they are going against clinical advice and are 
happy with the risks of potential multiple pregnancy.  
 
Three embryos are only transferred in exceptional circumstances – this 
should be following review of the patients with a Consultant or the 
Scientific Director and the appropriate form completed (Consent to transfer 
three embryos form) and details of decision written in the casenotes. 
 
Information to be discussed with patient 
	
Risks to mother 
• Early and late miscarriage 
• Induced hypertension 
• Pre-eclampsia 
• Gestational diabetes 
• Caesarian section 
• Haemorrhage 
• Stress and depression 
 
Risks to child 
• Prematurity 
• Early death (twice as high as a singleton pregnancy) 





• Reduced IQ and ADHD 
• Language problems 
 
EmbryoGlue® 
1. Once embryos have been selected and the patient informed of the 
selection, the embryo(s) should be transferred to a pre-labelled, pre-
equilibrated embryo transfer dish.  
2. The embryo(s) for transfer are washed through G-TL™ (well 4) and 
moved to EmbryoGlue® (well 3) ready for embryo transfer.  
3. The move to EmbryoGlue® MUST be recorded on IDEAS V.5.3™ for 
each patient – indicating the time of the move and which embryos were 
moved. 
4. Embryos can be left in EmbryoGlue® for 10-15 minutes and NO 
MORE THAN 30 minutes for day 3 and NO MORE THAN 45 minutes 
for day 5 embryos. 
5. The embryologist should then ring the nurse recovery station to inform 




1. Patient identity and date of birth must be verbally confirmed for both 
patients, prior to transfer, in the presence of the embryologist, the 
doctor/FNS and the assisting nurse. All parties must check the names 
and dates of birth on the patient identification sheet in the patient notes 
and on RI Witness™ ID card along with the photo ID then sign the 
appropriate section on the embryology pack to record that this has 
taken place. 
2. The embryologist should then insert the ID card into the card reader.  
3. The doctor/FNS informs the embryologist of the size of catheter 
required 






5. The syringe is loosened by moving the plunger up and down several 
times. The syringe is then loaded with the 0.5ml G-TL™ from the 
embryo transfer tube. The media should be drawn up and down the 
syringe to remove any air bubbles. 
6. Only after the doctor/FNS, informs the lab that he/she is ready is the 
embryo transfer dish to be removed from the incubator.  
7. Switch the camera on and ask the patients to observe the monitor and 
confirm that their names and dates of birth on the dish are correct. 
 
NB. If the patient is having transfer under sedation then the partner must 
confirm that they are satisfied with the identifying details.   
 
8. If the patients wish to view their embryos prior to replacement the 
embryologist should place the embryos that have been selected for 
transfer under the camera and ‘zoom’ in. The embryologist should very 
briefly describe the salient features of the embryos to the patients 
bearing in mind that the embryos should be out of the incubator for the 
shortest possible time. 
9. In the absence of a camera the embryologist performing the transfer 
requires a second witness prior to loading the catheter. 
 
Loading the catheter 
1. The packaging for the catheter should be cut so that its packet is used 
for handling by the embryologist at all times.   
2. After attaching the G-TL™-loaded 1ml syringe, the catheter should be 
charged with the G-TL™ and the remainder emptied into the petri dish.  
3. The embryo(s) are loaded into the centre of approximately 0.5cm of 
medium with approximately 0.5cm of air on either side. 
4. The embryo(s) location within the catheter must then be checked to 
ensure they have been loaded correctly. This can be done by 
visualising the embryos within the column just as it is loaded, or can be 
done by placing the lower part of the catheter in the petri dish 
containing the expelled G-TL™ media and visualising the location of 





column, they should be carefully expelled into the well containing 
EmbryoGlue® and reloaded. The loading procedure is then repeated 
and the embryo location rechecked. 
5. The catheter should be carefully handed (the appropriate way round 
i.e. tip of the catheter should be facing towards the patient) to the 
doctor/FNS, clearly stating the patient's name and the number of 
embryos to be replaced. As the doctor/FNS takes hold of the syringe 
and catheter, the packaging is removed. 
 
Use of a stylet 
1. If the embryologist is asked for a stylet once the catheter has been 
handed over to the doctor/FNS, the embryologist must remove the 
appropriate stylet from the warmer and with one hand take the catheter 
from the doctor/FNS and hand over the stylet with the other.  
2. The embryologist must return the catheter containing the embryos back 
into the embryology laboratory and immediately place on the heated 
stage until the doctor/FNS is ready.  
3. The outer packaging can be used to carefully place the tip of the 
catheter containing the embryos onto the heated stage.  
4. When the doctor/FNS is ready to proceed, the embryologist slowly 
removes the outer sheath from the inner catheter, stopping short of the 
end so that the doctor/FNS can ‘feed’ the inner catheter into the outer 
sheath positioned within the cervix of the patient. 
5. If at any stage the embryologist feels the embryos have been out too 
long i.e. during a difficult transfer, they must return the embryos to the 
embryo transfer dish and re-incubate. 
 
ET catheter check 
1. Following the embryo transfer the catheter is passed back to the 
embryologist in order for the catheter to be carefully checked to ensure 
that the embryo(s) have been transferred 
2. The catheter is emptied into the empty dish lid on the heated stage.  
3. The dish of expelled G-TL™ is carefully checked for the presence of 





4. Any bubbles should be removed using a sterile needle. 
5. The embryologist informs the doctor/FNS if the catheter is clear. 
6. If the embryo(s) are present then the process for re-loading should be 
undertaken 
 
Completing the transfer 
1. The empty embryo transfer dish is checked and discarded.  
2. All used petri dishes, scissors, syringes and catheters are discarded in 
the nearest sharps bin.  
3. The embryologist must remove the ID card from the reader. The ID 
card is filed in the embryology pack if there are supernumerary 
embryos to freeze.   
4. Supernumerary embryos from fresh cycles are either cryopreserved or 
incubated for further assessment for possible cryopreservation, or 
discarded.  
5. All records relating to the transfer are completed including the IDEAS 
V.5.3™ systems. 
6. If the cycle is complete (i.e. no embryos remaining post-transfer or any 
remaining embryos are discarded): 
• an electronic HFEA treatment form must be completed, 
validated and sent to the HFEA using the IDEAS V.5.3™ 
system.  
• If there are no supernumerary embryos (i.e. all embryos 
transferred), the embryology pack must be filed in the ‘Cycles to 
close’ tray ready for the cycle to be closed and the pack to be 
filed. If the embryos were cultured using the EmbryoScope®, the 
embryology pack should be placed in the ‘ES Update’ tray. 
• If supernumerary embryos were discarded and not 
cryopreserved, a cryopreservation letter must be generated from 
IDEAS V.5.3™ and printed. The embryology pack must then be 
filed in the ‘Cycles to close’ tray ready for the printed letter to be 
filed in the pack, the cycle closed and the pack to be filed. If the 
embryos were cultured using the EmbryoScope®, the 





9.4 Appendix 4 – Triple media trial documentation 
 
9.4.1 Standard operating procedure 
 
1. The day before the oocyte collection set-up the appropriate dishes 
according to section 9.3.3.  
2. Prepare one EmbryoSlide® per 18 follicles on the day prior to oocyte 
collection as per Figure 9 referring to section 9.3.9.3 on instructions on 
how to prepare an EmbryoSlide®.  
3. On the day of oocyte collection and just prior to the procedure starts, 
the member of staff performing the pre oocyte collection checks should 
reconfirm the patient’s participation in the trial 
4. Perform the oocyte collection, oocyte culture and oocyte stripping (if 
applicable) according to section 9.3.4 and 9.3.5.  
5. If more than 12 oocytes are available for injection, ensure there are two 
EmbryoSlides® available. If additional EmbryoSlides® are required, 
prepare using spare culture media placed in the set-up incubator the 
previous day 
6. Perform the ICSI procedure according section 9.3.5 (if applicable) 
7. Divide the injected oocytes into three equal groups. Wash the injected 
oocytes in the relevant wash wells based on which media the oocytes 
are destined for as per Figure 9 
8. If an odd number of oocytes have been injected, assign the additional 
oocyte to the control group. If two surplus oocytes are injected then 
one should be assigned to the control group (G-TL™) and the other to 
SAGE 1-Step™.  
9. Perform the IVF insemination according to 9.3.6 (if applicable) 
10. Carry out fertilisation check at 16hpi according to 9.3.7 
11. Divide the embryos into three equal groups. Wash the embryos in the 
relevant wash wells based on which media the embryos are destined 
for as per Figure 9. Any unfertilised oocytes should be equally divided 
between the three culture media and washed in the relevant wash 
wells as per Figure 9. If an odd number of oocytes/embryos are 





12. Annotate all embryo characteristics according to section 9.3.10  
13. Complete embryo selection and embryo transfer according to sections 
9.3.10 and 9.3.11.  
14. Take a final grade for all embryos immediately before their 




Figure 9. A schematic to represent an EmbryoSlide® to be used in TMT. 
Red fill indicates control media, yellow fill indicates culture media B and blue 
fill represents culture media C. Wash well D should be filled with control 
media in case of surplus oocytes and no second EmbryoSlide®.  
 
9.4.2 Sample size calculations 
	
Using data from the HFC, a sample mean and standard deviation were 
calculated. From this, the change in minutes was calculated for a 2.5 and 5% 
change for each morphokinetic parameter. Sample sizes were calculated for 
both a head-to-head investigation (A vs. B) and a mutli-variant investigation (A 
vs. B vs. C). The sample size calculation was two-tailed, used a 95% power 
value and alpha as 0.05 (Table 4).  
 
The principle of such calculations is to determine a predicted difference that 
the investigation should yield as significant if this change is present. For 
example, where a 5% change from the mean is chosen, this indicates that if 
there is statistical significance in the investigation equal to, or greater than, a 
5% change either way, it will be detected based on the sample sizes provided. 
Thus, for t2 in the head to head investigation, in order to detect at least a 5% 
change in the actual mean as statistically significant the sample size would 














detect a smaller change as statistically significant then the sample size will 
also need to be higher. Again, consider t2, for a 2.5% change to be detected, 
the sample size would need to be 792.  This is related to the wide variation 
seen in the measurements. If a measurement has a large standard deviation 
compared to the mean, there is already a level of sampling error and so it is 
more difficult to determine if a difference is as a result of a true difference or 
simply sampling error. This is likely to be a common problem in the 
parameters being measured in this investigation due to the human 













































t2PB 232.20 145.20 295 5.81 8117 11.61 2033 
tPNa 493.80 189.00 312 12.35 3044 24.69 762 
tPNf 1479.00 246.00 769 36.97 576 73.95 144 
t2 1635.60 319.20 681 40.89 792 81.78 198 
t3 2300.40 148.20 586 57.51 87 115.02 22 
t4 2412.60 378.60 620 60.32 512 120.63 129 
t5 3129.00 466.80 568 78.22 463 156.45 116 
t6 3265.80 521.40 549 81.65 530 163.29 133 
t7 3417.60 591.00 544 85.44 622 170.88 156 
t8 3621.00 666.00 548 90.53 704 181.05 176 
t9+ 4360.80 585.60 500 109.02 375 218.04 94 
tM 5121.00 602.40 478 128.03 288 256.05 72 
tSB 5913.00 575.40 454 147.83 197 295.65 50 
tB 6663.00 636.60 383 166.58 190 333.15 48 
 
 















t2PB 232.20 145.20 295 5.81 20307 11.61 5266 
tPNa 493.80 189.00 312 12.35 7615 24.69 1906 
tPNf 1479.00 246.00 769 36.97 1440 73.95 360 
t2 1635.60 319.20 681 40.89 1982 81.78 496 
t3 2300.40 148.20 586 57.51 216 115.02 54 
t4 2412.60 378.60 620 60.32 1281 120.63 321 
t5 3129.00 466.80 568 78.22 1158 156.45 290 
t6 3265.80 521.40 549 81.65 1326 163.29 332 
t7 3417.60 591.00 544 85.44 1556 170.88 389 
t8 3621.00 666.00 548 90.53 1760 181.05 440 
t9+ 4360.80 585.60 500 109.02 939 218.04 233 
tM 5121.00 602.40 478 128.03 720 256.05 180 
tSB 5913.00 575.40 454 147.83 493 295.65 124 
















Table 5. A summary for the required sample sizes 
 A vs. B 
2.5% 
A vs. B 
5% 
A vs. B vs. C 
2.5% 
A vs. B vs. C 
5% 
t2PB 8117 2033 20307 5266 
tPNa 3044 762 7615 1906 
tPNf 576 144 1440 360 
t2 792 198 1982 496 
t3 87 22 216 54 
t4 512 129 1281 321 
t5 463 116 1158 290 
t6 530 133 1326 332 
t7 622 156 1556 389 
t8 704 176 1760 440 
t9+ 375 94 939 233 
tM 288 72 720 180 
tSB 197 50 493 124 
tB 190 48 475 119 
 
As can be seen from Table 5, the sample sizes required to perform the multi-
variant analyses are higher. In addition, in order to detect the smaller percent 
change the sample size is greater. Based on the scientific background and 
the clinical relevance of performing a multi-variant analysis, this is the study 
methodology that will be chosen with sensitivity for 5% change detection. The 
rationale for selecting a 5% change detection rate is two-fold. Firstly, if a 2.5% 
change is required to be detected the sample sizes for some parameters are 
too great. For example, to detect a 2.5% change in t2PB using a multi-variant 
analysis the sample size would need to be more than 20,000 observations; an 
unattainable amount due to resource limitations. Secondly, a 2.5% change in 
some parameters equates to less than fifteen minutes and the clinical 
relevance of this change is likely to be small. In the literature, most embryo 
selection algorithms have optimum time ranges of a couple of hours therefore 
detecting a change that is small could lead to over-fitting of the models. If the 
difference equates to over 60 minutes then it is likely that this will be enough 
to effect a change in an algorithm score; the eventual aim of the research.  
 
It has been concluded that a maximum of 500 observations (embryos) will be 
made for each morphokinetic parameter in each arm of the investigation 
totaling 1500 embryos. This means that approximately 150-200 patients will 
need to be recruited to the study based on the average number of oocytes 
collected from each patient at the HFC (ten) and the average fertilization rate.  





tPNa are not attained thus any the investigation will not be powered enough to 
detect true significant differences in these parameters. This therefore means, 
that as these parameters are only relevant for patients undergoing ICSI, 



















































9.4.3 Patient information sheet 
 
 
TIME-LAPSE IMAGING: INCUBATION AND ANNOTATION 
 
PATIENT INFORMATION SHEET 
 
We would like to invite you to take part in a research study. Before you decide 
you need to understand why the research is being done and what it would 
involve for you. Please take time to read the following information carefully. 
Talk to others about the study if you wish. Ask us if there is anything that is 
not clear or if you would like more information. Take time to decide whether or 
not you wish to take part. 
 
The Hewitt Fertility Centre is the only centre in the UK that offers time-lapse 
imaging incubation as a standard for all patients at no extra cost. Time-lapse 
imaging is a new technology that allows an image of each of your embryos to 
be taken every ten minutes while it is inside the incubator. Using these 
machines, that have time-lapse capabilities, we are able to see a lot more 
about an embryos development than we ever could before. Because of this, 
we are developing different ways to select embryos based on very specific 
embryo development timings (called morphokinetics). It is well known that an 
embryos development and quality is linked to the success of a treatment cycle 
therefore we are carrying out a series of studies that will help us develop the 
service offered to all patients at the Hewitt Fertility Centre and get the most 
out of time-lapse imaging.  
 
Why have I been invited? 
You have been invited to take part in this study because you are attending the 
Hewitt Fertility Centre for fertility treatment.  
 
Do I have to take part? 
No. It is up to you to decide. We will describe the study and go through this 
information sheet, which we will then give to you. We will then ask you to sign 
a consent form to show you have agreed to take part. You are free to 
withdraw at any time, without giving a reason. This would not affect the 
standard of care you receive. You can obtain independent information about 
being involved in a research study from the local NHS Patients Advisory 
Liaison Service (PALS) on telephone number 01517024160.  
 
What will happen to me if I take part? 
You will be asked to sign a consent form for taking part in the study. The 
consent form covers three different studies, which will be outlined for you. You 




The purpose of this study is to validate embryo selection algorithms (ESA’s) 
developed on over 1000 embryos using time-lapse imaging facilitated by the 





questions that are asked, the answers to which help to identify the best 
embryo for transfer. During this study you will be chosen (at random) to either 
have your embryos selected using an ESA or to have them selected using 
standard procedures (the way the embryos look); the way embryos have been 
chosen for the last 30 years.  
 
Study 2 
The purpose of this study is to determine if the environment in which embryos 
are cultured has an effect on their morphokinetics. This study will involve 
culturing your embryos in three different types of culture media. You will have 
two-thirds of your embryos cultured in two ‘experimental’ media and one-third 
in the ‘control’ media (the one used routinely at the Hewitt Fertility Centre). 
The ‘experimental’ culture medias used in this study are all commercially 
available and are used routinely around the world for the culture of embryos in 
fertility units. The information from this study will be used to improve 
developed ESA’s.  
 
Study 3 
The purpose of this study is to see if different patient, treatment and embryo 
characteristics have an effect on their environment. This study involves the 
sampling of the culture media used in your treatment cycle once it has been 
completed i.e. after embryo transfer and embryo freezing. We will take a 
sample of the ‘used’ culture media once the embryos have been removed 
from it and run tests to see if there are variations between patient groups and 
embryo qualities.  
 
What will I have to do? 
You will only have to complete the consent form provided. You will not be 
required to attend the unit any more often or take part in any questionnaires or 
surveys.  
 
What are the possible disadvantages and risks of taking part? 
There are no known risks or disadvantages from taking part in any of the 
studies. The ESA’s developed in study 1 have been done so robustly and 
many centres around the world do not prospectively apply them before using 
them clinically, the retrospective validation is seen as sufficient. We are 
conducting this part of the research to fulfil a requirement of a postgraduate 
research qualification. The culture media used in study 2 is commercially 
available and although it is not routinely used at the Hewitt Fertility Centre, 
they are used in many centres around the world. They have all been CE 
marked. A product that is CE marked indicates that it has complied with all EU 
laws for sale within the EU. We require your consent for this study because it 
involves something that isn’t ‘routine’ in a treatment cycle. In study 3, we are 
simply sampling the ‘used’ culture media at the end of your treatment 
therefore there will be no effect on the care/service you receive.  
 
What are the possible benefits of taking part? 
As the ESA’s used in study 1 have been developed to be particularly robust, it 
is hoped that this method of embryo selection will supersede that of standard 





seen when using ESA’s to select embryos for transfer as compared to 
standard embryo selection methods, however this cannot be guaranteed. If 
you are randomly assigned to the control group (no use of ESA’s) you will not 
have any benefit. A possible benefit to participating in study 2 is that the 
‘experimental’ culture media performs better than the ‘standard’ culture media 
resulting in higher quality embryos and an increased chance of success but 
we simply do not know if this is the case which is why we are conducting the 
research. There are no benefits to participating in study 3.  
 
What if there is a problem? 
Any complaint about the way you have been dealt with during the study or any 
possible harm you might suffer will be addressed. If you have a concern about 
any aspect of this study, you should ask to speak to the researchers who will 
do their best to answer your questions. If you remain unhappy and wish to 
complain formally, you can do this through the NHS Complaints Procedure. 
Details can be obtained from the hospital. 
 
Will my taking part in the study be kept confidential? 
Yes. We will follow ethical and legal practice and all information about you will 
be kept strictly confidential. Information gathered will only be used for the 
purpose of the research and the results presented such that the information 
from a single individual cannot be identified.  
 
Who is organising and funding the research? 
The study is being organised and conducted by the Hewitt Fertility Centre 
team at Liverpool Women’s Hospital. Liverpool Women’s Hospital are also 
funding the research. This research is being conducted as part of a 
postgraduate research degree registered at Edge Hill University.    
 
Who has reviewed the study? 
All research within the NHS is looked at by an independent group of people, 
called a Research Ethics Committee to protect your safety, rights, wellbeing 
and dignity. This study has been reviewed and given favourable opinion by 
the Ethics Committee. 
 
What do I do now? 
Please sign the consent form and hand it to us or return them in the envelope 
provided.  
 
If you want to know the results of the study, a summary can be sent to you by 
post. Please contact Ms Amy Barrie (details below). 
 
Thank you very much for considering taking part in our research. 
 
Ms Amy Barrie 
Clinical Embryologist 
The Hewitt Fertility Centre 
Crown Street  
Liverpool Women’s Hospital 









Title of Study: Time-lapse imaging: incubation and annotation.  
 
Name of Researcher: Ms Amy Barrie/ Dr Stephen Troup 
                                                                                                                        Please initial box    
 
 
1. I confirm that I have read and understand the information sheet dated 
September 2015 Version 2.0 for the above study. I have had the opportunity to 
consider the information, ask questions and have had these answered 
satisfactorily.    
 
2. I understand that my participation is voluntary and that I am free to withdraw 
at any time without giving any reason, without my medical care or legal rights 
being affected.  
 
3. I understand that relevant sections of my medical notes and data collected 
during the study may be looked at by individuals from the research and care 
team, from regulatory authorities or from the NHS Trust, where it is relevant to 
my taking part in this research. I give permission for these individuals to have 
access to my records.  
 
 
4. I agree to take part in: 
 
 i) all studies described 
 
 ii) study 1  
 
 iii) study 2 
 




__________________________     ________________         
_______________________  




__________________________     ________________         
_______________________  




_________________________     ________________         
_______________________  
















9.5 Appendix 5 – Statistical analysis excerpt 
 
A multiple regression was run to predict the time of certain morphokinetic 
parameters using pronuclear fading (tPNf) as time-zero (t0) from female 
patient age (patage), female BMI (patbmi), infertility diagnosis (primidiag) and 
suppression protocol (suppressionprotocol). The assumptions of 
independence of errors, linearity, homoscedasticity, unusual points and 
normality of residuals were met. Detailed below is that of t2 as an example of 
the statistical output generated for this analysis.  
 
There are 8 assumptions that must not be violated in order to obtain valid 
results from a multiple regression: 
 
1. The dependent variable must be measured on a continuous scale (i.e. the 
morphokinetic parameter) 
2. There are two or more independent variables that are either categorical or 
continuous (i.e. patient age, patient BMI, infertility diagnosis and 
suppression protocol) 
3. There should be independence of observations 
4. A linear relationship should exist between the dependent variable and 
each of the independent variables  
5. Homoscedasticity must be present; variances along the line of best fit 
remain similar as you move along the line 
6. Multicollinearity must not be present; when two or more independent 
variables are highly correlated with each other 
7. No significant outliers, high leverage points or highly influential points 
8. Errors should be approximately normally distributed 
 
Independence of observations 
 
As patient parameters are often related in an IVF setting, for example, the 
short suppression protocol (cetrotide) is often suited to those patients prone to 
hyperstimulation thus having an infertility diagnosis of polycystic ovary 





of which could lead to invalid regression results. To test the independence of 
observations the Durbin-Watson test was used. To indicate that there is no 
correlation between the independent variables a value of approximately 2 is 








Std. Error of 
the 
Estimate Durbin-Watson 
1 .089a .008 .007 .06860 1.955 
a. Predictors: (Constant), patbmi, suppressantprotocol, patage, primidiag 





The overall linear relationship was determined using the stundentised 
residuals and the unstandardised predicted values of the dataset.  The 
relationship is shown to be linear if a horizontal band is formed in the 
scatterplot. Individual linear relationships were then determined for each of 
the continuous independent variables (patbmi and patage) against the 
dependent variable and linearity was confirmed for all continuous independent 

















































This assumption tests whether the residuals are equally spread over the 
predicted values of the dependent variable. In the first instance, without 
transformation of the data, heterscedasticity was seen (see graph below). It 
was clear that the spread of values increased as the predicted values of the 
dependent variable increased. Therefore a root transformation as performed 
based on the premise that the data was moderately skewed (see graph 
below). However, this transformation was not appropriate as heterscedasticity 
remained. Therefore, a log transformation was performed (for severely 























































Multicollinearity results when two or more independent variables are highly 
correlated with each other. In these data there could be a correlation between 
patient BMI and infertility diagnosis as there is evidence to suggest that 
adipose tissue can lead to hormone deficiencies. 
 
Collineratity was determined using two methods; inspection of correlation 
coefficients and Tolerance/ VIF values. The first method requires that none of 
the independent variables are larger than 0.7. Those of interest are 
highlighted and none are higher than 0.7. The second method requires the 
tolerance value to be greater than 0.1 or its recirpical (VIF) to be less than 10. 
As can be seen from the table below, the tolerance value is greater than 0.1 in 
all cases.  
 
Correlations 
 logt2tPNf patage 
suppressant




logt2tPNf 1.000 -.084 .013 .027 .014 
patage -.084 1.000 .011 -.031 .014 
suppressantpro
tocol .013 .011 1.000 -.015 -.007 
primidiag .027 -.031 -.015 1.000 .033 
patbmi .014 .014 -.007 .033 1.000 
Sig. (1-
tailed) 
logt2tPNf . .000 .248 .075 .229 
patage .000 . .282 .052 .233 
suppressantpro
tocol .248 .282 . .211 .358 
primidiag .075 .052 .211 . .040 
patbmi .229 .233 .358 .040 . 
N logt2tPNf 2763 2763 2763 2763 2763 
patage 2763 2763 2763 2763 2763 
suppressantpro
tocol 2763 2763 2763 2763 2763 
primidiag 2763 2763 2763 2763 2763 







 Coliniarity Statistics 
Tolerance VIF 
Patage .999 1.001 
Suppressantprotocol 1.000 1.000 
primidiag .998 1.002 





An outlier is defined as an observation that does not follow the usual pattern 
of points.  Using the Casewise Diagnostics tool in SPSS, 29 outliers were 
identified based on the standardized residuals being greater than ±3 standard 
deviations. Having assessed the data, these outliers were not removed from 
the dataset until their leverage and influential points had been assessed. The 
basis for this being that a prediction model for embryo selection needs to be 
clinically applicable and to be so must be able to rank those that have 
unusually short or delayed division patterns. However, if they have a high 




Using the leverage values for each observation those with leverage values 
less than 0.2 are considered safe, 0.2-0.5 as risky and over 0.5 as dangerous 
therefore any with a leverage point above 0.2 should be removed from the 
analysis. On this dataset there were no observations with leverage points 




Using the Cook’s distance measure the influence of each data point was 
analysed. Any values above 1 should be investigated and potentially removed 
from the dataset. In this dataset the highest Cooks value obtained was 







In order to perform a regression analysis effectively the data needs to be 
normally distributed when considering the errors in prediction i.e. the 
residuals. A histogram and a P-P plot were analysed for normality. Both 
methods were used as histograms can often be deceptive based on the 
dependence of their appearance of the correct column width. From both plots, 








































In summary, the predictive capacity of the independent variables on the 
dependent variable are weak with an R value of 0.089 and only 8.9% of the 
variance in the dependent variable being explained by the independent 
variables (R2) (Adj. R2 = 0.07).  
 
Patient age, BMI, infertility diagnosis and suppression protocol statistically 
significantly predict t2, F(2, 2758) = 5.565, p<0.0005 however patient age was 




Model R R Square Adjusted R Square 
1 .089a .008 .007 
a. Predictors: (Constant), patbmi, suppressantprotocol, patage, primidiag 







Square F Sig. 
1 Regression .105 4 .026 5.565 .000b 
Residual 12.979 2758 .005   
Total 13.083 2762    
a. Dependent Variable: logt2tPNf 









































































































































































































9.6 Appendix 6 – Published articles 
	
	
 
	
	
284	
	
 
	
	
285	
	
 
	
	
286	
	
 
	
	
287	
	
 
	
	
288	
	
 
	
	
289	
	
 
	
	
290	
	
 
	
	
291	
	
 
	
	
292	
	
 
	
	
293	
	
 
	
	
294	
	
 
	
	
295	
	
 
	
	
296	
	
 
	
	
297	
	
 
	
	
298	
	
 
	
	
299	
	
 
	
	
300	
	
 
	
	
301	
	
 
	
	
302	
	
 
	
	
303	
	
 
	
	
304	
	
 
	
	
305	
	
 
	
	
306	
	
 
	
	
307	
	
 
